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SUMMARY
CLINICAL AND PHARMACOLOGICAL STUDIES IT
POST-ENCEFIALITIC PARKINSONISM.
Chapter I# General Introduction
This chapter deals mainly with the control of skeletal muscle 
tone and the physiology of tremor. The clinical features and treat­
ment of Parkinsonism are also discussed.
Chapter . II. Crises in Post-Enoephalitic Parkinsonism
A study of 67 patients with post-encephalitic Parkinsonism 
revealed three types of crises: they can he described as oculogyric, 
sweating and breath-holding.
The clinical accompaniments of oculogyric and sweating crises are 
described. Attention is drawn to the vasomotor changes which occur 
during severe oculogyric and sweating crises and to changes in mood 
during oculogyric crises.
The pathogenesis of the oculogyric crisis is discussed. It is
suggested that ocular deviation is the consequence of a vestibulo- 
ocular reflex in patients with brain stem lesions involving the 
vestibular pathway. The emotional changes which accompany oculogyric 
crises are probably the result of stimulation of the diencephalon.
The role of emotion in precipitating oculogyric crises is con­
firmed. When emotion is known to play a part, it is suggested that 
the mechanism includes a conditioned reflex. Alternatively it may 
be /
2be that the onset of emotional disturbance sometimes permits activity 
in the vestibulo-ooular reflex; activity which in the non-emotional 
state is materially inhibited.
Chapter III. Drug Therapy in the Crises of
Post-Enoephalitic Parkinsonism
The treatment of severe oculogyric and sweating crises in 11 
patients with post-encephalitic Parkinsonism has been studied.
The value of 200 mg. sodium phenobarbitone given intramuscularly 
or sodium amylobarbitone 200 to 300 mg. given orally was assessed.
Neither of these forms of treatment affected the natural course of
crises when these were in the category classified as "severe”.
A therapeutic trial was carried out to evaluate sodium phenobarb­
itone 150 mg. given intravenously and 50 mg, given intramuscularly in 
severe crises, using injections of normal saline as the control.
Relief was obtained in 20 to 40 minutes after these injections of the 
barbiturate. Injections of normal saline were ineffective. It is 
suggested that in severe crises sodium phenobarbitone injected intra­
venously is the treatment of choice. Although parenteral injections 
of hyoscine hydrobromide is effective in controlling severe oculogyric 
crises, the use of intravenous sodium phenobarbitone is to be preferred 
The use of parenteral injections of atropine sulphate is not recom­
mended.
The prophylactic value of sodium phenytoin was determined in 5 
patients suffering from severe oculogyric crises. This drug altered 
the /
3the character of the oculogyric crisis but did not reduce its 
frequency or severity.
The writer has no experience of oculogyric crises induced by 
drugs of the phenothiazine series such as Perphenazine, but there 
appears to be a prima facie case for the intravenous injection of 
sodium phenobarbitone in this type of medical emergency.
Chapter IV. The Electroencephalogram in
Post-Encephalitic Parkinsonism
Electroencephalographio study of 30 patients suffering from 
post-encephalitic Parkinsonism showed that over half of them have low 
voltage alpha rhythms (below 40 yv. ). It would appear that in post­
encephalitic Parkinsonism the phenomenon of low voltage E.E.G.s is 
most frequently seen in patients who are known to be liable to oculo­
gyric crises and in those who suffer from severe rigidity and who are 
incidentally often bedfast.
There was a very hig^i incidence of theta activity most prominent 
frontally. The records of 9 patients were regarded as definitely 
abnormal because of the presence of high voltage theta and delta 
activity. Abnormal records were more common in patients who suffer 
from severe rigidity.
The E.E.G. during an oculogyric crisis has the following charc- 
teristics: anteriorly there are high voltage spike potentials, in the 
other areas there is a general lowering of voltage, beta activity may 
become /
4*
become moire obvious.
Administration of 1.5 mg. of prostigmin intramuscularly had. little 
or no effect • on the E.E.G.
Chapter V. Deformities in Post-Enoephalitic Parkinsonism
The deformities of the hand in post-encephalitic Parkinsonism have 
been classified as Types I, II and III. Type I (main d^aocouchhefr 
deformity) is the most common form.
Talipes equino varus deformity is the common deformity of the 
foot in Parkinsonism.
Scoliotic deformity of the spine, especially of the cervical spine 
is common. The scoliosis is usually concave to the less rigid side.
The factors of importance in the pathogenesis of deformities 
include: skeletal muscular weakness, rigidity and involuntary muscle 
spasms. Muscle weakness is the most important factor. It is 
emphasised that deformity is not due to the action of the rigid muscles 
(as is commonly thought), but results from an uncounterbalanoed action 
of the stronger and less rigid muscles. The opposing weaker and more 
rigid muscles are lengthened as a result.
It is suggested that the effect of posture is probably the most 
important factor responsible for dribbling of saliva.
The use. of splints and lamb*s—wool in the management of some types 
of deformities is discussed.
Chapter VI. /
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Chapter VI, Assessment of Drug Therapy
in Parkinsonism
The relative therapeutic value of orphenadrine and "UK. 73QH
(Sandoz) were studied by means of a double blind trial. Orphenadrine 
100 mg. thrice daily was found to be about three times as effective
as "UK. 738" 4 mg. t.d.s.
The methods of assessment of the efficacy of drug therapy i^
Parkinsonism are reviewed and the value of objective measurements is 
demonstrated. It can be said that the results of objective measure­
ments usually run ' roughly in parallel with an assessment of the 
patient's ‘ condition as determined by the clinician - and especially 
when the initial degree of disability is moderate.
By means of "acute" experiments it was shown that after oral 
administration of oiphenadrine, peak . activity occurred in about two hours 
whereas peak activity due to benzhexol occurred in two .to three hours 
It was not possible to demonstrate clearly defined peak activity for 
the drug "UK. 738". Failure to c^ny out the objective tests at the 
time of maximal activity of drugs is an important source of fallacy in 
clinical trials designed to assess the relative merits of preparations 
used to combat the disabilities associated with Parkinsonism.
Chapter VII. The sites and mode of action of
orphenadrine and other .. drugs used 
for the relief of rigidity and muscle
weakness in Parkinsonism
Pharmacological /
6Pharmaoological studies with orphenadrine show that it has a 
definite neuromuscular blocking action in the frog and in the rat.
In the cat, however, the neuromuscular blocking action is very much 
less. It is suggested that one of the ways by which orphenadrine 
reduces Parkinsonian rigidity is through its peripheral skeletal 
muscular relaxant property. The euphoric action noted in human 
subjects and the peripheral skeletal muscular relaxant property 
contribute to the favourable effect of this drug on the muscle weak­
ness and easy fatiguability in patients suffering from Parkinsonism.
li //
Benzhexol and UK. 738 do not possess a neuromuscular blocking 
action. Ethopropazine, on the other hand, shows a neuromuscular 
blocking action in the rat. It is possible that one of the ways 
whereby ethopropazine relieves rigidity is through its peripheral
skeletal muscular relaxant action.
It is the opinion of the writer that a depressant action on the 
cerebellum is probably one of the ways by which benzhexol relieves 
the rigidity of Parkinsonism.
In the cat, orphenadrine antagonises the neuromuscular block 
induced by suxamethonium. This suggests the possible use of
orphenadrine as an antidote to suxamethonium vhen the latter has 
caused complete and prolonged neuromuscular block in human subjects. 
It is also suggested that orphenadrine may be of therapeutic value 
in the prevention of muscle pain after the administration of suxa­
methonium.
i.
PREFACE
Early in 1959, the two post-encephalitic wards in Stobhill 
General Hospital came under the care of Professor Stanley Alstead#
As a post graduate research student in the Department of Materia 
Medica and Therapeutics I was invited to investigate some of the 
problems of Parkinsonism as presented by the 67 patients who were 
accommodated in the two wards.
This Thesis is based on the experience gained while looking 
after the patients over a period of nearly three years. Inevitably, 
all sections of the Thesis reveal the viewpoint of the clinician 
concerned with the natural history of Parkinsonism and the thera­
peutic measures commonly used for the relief of patients afflicted 
by this disease. The main parts of the Thesis are concerned with 
the following problems: the crises of post-encephalitic Parkinsonism 
and their treatment; deformities in Parkinsonism and their manage­
ment; assessment of drug therapy in Parkinson, ism; and the mode of 
action of drugs used for the relief of rigidity and muscle weakness
in Parkinsonism.
It is intended that this Thesis should bring together in one 
volume a study of many problems characteristic of Parkinsonism and 
the methods of dealing with them.
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10. Adrenaline hydrochloride n tt N adrenaline
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CHAPTER I,
GENERAL INTRODUCTION
DEFINITION OF PARKINSONISM
In 1817, James Parkinson (1755 - 1824), a general practitioner
working in Shoreditch, near . London, published, an account of six oases
of what he called "The Shaking Palsy". This is still regarded as one
of the classic monographs of medical literature* Parkinson deplored
the practice, common at that time, of lumping together miscellaneous
diseases characterised by tremor; and he identified a syndrome which
included tremor and muscle weakness. He pointed out that the invol­
untary tremor is present at rest, disappears when the patient is
executing movement but reappears when the movement is completed*
Although Parkinson did not mention rigidity as one of the cardinal
signs of the shaking palsy, the term PaZMn^^(n^sm is now used as an
eponym to describe the clinical syndrome which consists of rigidity,
involuntary tremor and weakness. This term is a very useful one from
the therapeutic point of view for it brings together conditions which
are of different aetiological origin but may respond to the same forms
of therapy*
AETIOLOGY OF PARKINSONISM
Since Parkinson described the clinical features of the shaking
palsy (paralysis agitans) the aetiology of Parkinsonism has been of
profound /
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profound interest to anatomists, physiologists, pathologists,
physicians, and also to pharmacologists. Parkinson was unable to find
a cause. It is now known that Parkinsonism can be due to a variety of
causes, viz., cerebral arteriosclerosis (Critdhley, 1929); as sequels
of encephalitis lethargioa (Von Economo, 1917; Buzzard and Greenfield
1919; and Bramwell and Miller, 1920); secondary to tumours of the
brain (Sciarra and Sprofkin, 1953; Oliver, 1959; David and Rebufat,
1960); hepatolenticular degeneration (Wilson 1912; Barnes and Hurst,
1925); manganese poisoning (Charles, 1927); carbon monoxide poisoning
(Shillito and associates, 1936); syphilis of the mesencephalon (Wilson
and Cobb, 1924); Behcet's Syndrome (Pallis and Fudge, 1956; Wadia
and Williams, 1957); traumatic injuries (Patrick and Levy, 1922;
Walker, 1937).
ANATOMY. PHYSIOLOGY AND PATHOLOGY
PATHOLOGY
Parkinson made no post mortem studies but suggested that the
disorder was attributable "to a diseased state of the medulla spinalis,
in that part which is contained in the canal formed by the superior
cervical vertebrae, and extending as the disease proceeds, to the
medulla oblongata." This suggestion was made because the tremor
usually started in the upper limbs and as the disease progressed the
lower limbs and later the muscles of speech and deglutition become
involved. /
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involved*
Much of the relevant early literature on the pathology of
Parkinsonism has been reviewed by Greenfield (1955). It is desirable
however to draw attention to a number of publications which were of
special importance in establishing the correct localisation of the
pathological lesions in Parkinsonism* One of the first reports on
the pathology of paralysis agitans was by Blocq and Marinesco who
reported a case of unilateral Parkinsonism (Blocq and Marinesco,
1894). This was a man of 38 who had a tuberculoma the size of an
olive in the ri^t half of the midbrain destroying principally the
substantia nigra. There was no destruction of the cortico-spinal
tract. Holmes (1904) described oases with hemiparesis but showing
rigidity and tremor of the Parkinsonian type. In two cases, post­
mortem examination revealed tumours of the midbrain which had destroyed
the red nucleus with degeneration of the rubospinal tract. The sub­
stantia nigra was also destroyed. In 1912 Kianier-Wilson (Wilson,
1912) published his now classic paper on hepatolenticular degeneration.
The most significant lesion in the brain was cystic degeneration of
the putamen. Levy (1913) reported on the pathological examination 
of 60 cases with idiopathic paralysis agitans. His main findings
were the great shrinkage of the lenticular and caudate nuclei with
loss of cells and evidence of gliosis. In addition he found peculiar
inclusion bodies (now known as Lewy bodies) in the dorsal nucleus of
the vagus and in the nucleus of the ansa-lenticularis. Hunt (1917)
reported /
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reported on the pathological changes in juvenile Parkinsonism. The
principal findings were the atrophy and diminution in the number of
ganglion cells in the caudate nuoleus and the putamen. There was
also an increased gliosis and a thinning of the fibres of the stria-
hypothalamic radiations.
During the last epidemic of encephalitis lethargioa several post
mortem reports were published (von Economo, 1917; Wilson 1918; Marie
and Tretiakoff, 1918; Buzzard and Greenfield, 1919; Bramwell and
Miller, 1920; Boyd, 1913; McAlplne, 1926; Keschner and Sloane,
1931 ). Patients who died in the acute phase showed widespread
changes in the brain, but the midbrain was usually the part most
commonly affected; and the periaqueductal zone being most severely
involved. The principal pathological changes were perivascular
infiltration with cells usually of the lymphocytic type. There was
congestion of the brain with scattered haemorrhages and venous throm­
bosis. The brain tissue was oedematous; there was proliferation of
the neuroglia and also cellular infiltration of the tissues especially
around the cranial nerve nuclei in the pons and midbrain. In the
chronic stage the most conspioious lesion was degeneration and
shrinkage of the substantia nigra with great loss of cell mass.
Other parts of the brain stem and the basal ganglia might show changes,
but again the midbrain appeared to bear the brunt of the disease. The
correlation of the clinical syndrome called Parkinsonism with patho­
logical findings of this type is regarded as conclusive evidence that
the /
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the disease is attributable to lesions of the basal ganglia and the
brain stem and especially the midbrain.
ANATOMY
This will be described very briefly and attention will be paid
mainly to the fibre connections of the nuclear masses involved.
The following nuclear masses are involved in the production of
Parkinsonian rigidity - the corpus striatum and the substantia nigra*
The substantia nigra is a layer of grey matter containing numerous
deeply pigmented multipolar nerve cells. It is situated in the mid­
brain and in transverse section lies between the basis pedunculi and
the tegmentum of the midbrain. The fibre connections have not yet
been fully defined, but by means of embxyological and histological
studies Cooper (1946) identified the following connecting fibres:
(1) Nigro-peduncular fibres to the cerebral peduncles.
(2) Nigro-tegmental fibres directed from the caput of the
substantia nigra to the red nucleus, the lemnisci and
posterior longitudinal bundle.
(3) Intra-nigral links.
(4) Subthalamo-nifral 1nteraommunioations.
These appeared to be very rich.
(5) Inter-nigral links.
(6) Qptico-nigral links from the optic tract to the substantia
nigra taking the transpedunoular route.
Cooper /
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Cooper did not find or mention any connections with the pallidum,
but Hanson and Hanson quoted by Martin (1939) end Glees and Wall (1946)
claimed to have demonstrated communicating fibres from the substantia
nigra to the globus pallidus of the lentiform nucleus.
The Lentifora . Nucleus
This nucleus with the caudate nucleus, amygdaloid and subthalamic
nucleus of Luys and the clausthun constitute the basal ganglia.
The lentiform nucleus, as its name implies, is shaped like a
biconvex lens, but the curvature of its medial surface is greater than
the curvature of the lateral surface. The cut surface shows that it
consists of two portions which differ in colour. The larger lateral
portion, which is dark in colour, is the putamen; the smaller medial
portion is of a lighter tint and is termed the globus pallidus
(Johnston and Whillis, 1944)#
Fibre connections (see Fig;, 1),
(a) From tao globur pallipuSl Th e following iwporimnt oan-
nections are known to exist (Ranson, Hanson and Hanson, 1948):
(1) The unsa-genlWouguhWs and fuscWeu1ehWs. These
arise from the internal division of the globus pa1gWdus
and unite to form a single , bundle which run into the
hypothalamus; the majority of the fibres however run
to the nucleus ventralis anterior of the thalamus,
(2) The pu1gide-subtlu1amWo fibres from the
external division of 10i globus pallida. They run
medially /
 7
gig, 4a. Diagram of a vertical section to show the relationship 
of the globus pallidus (P.^ to the striatum, corpus luysii (C.L.J 
and substantia nigra (S.N.) and the fibre connections within this 
group of ganglia. R.N., red nucleus. After Martin (1959)•
gig. 1b. Diagram of a horizontal section to illustrate the “long” 
efferent fibres of the globus pallidus. P.L., fasciculus lenticularis 
A.L., ansa lenticularis. Both these bundles of fibres end in the
ventral part of the thalamus. After Martin (1959)»
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medially crossing the ventral end of the internal capsule 
to enter the subthalamic nucleus. '
(b) The pTtemen give s ri.ee ri fibre s which run into ihe globu a
pallidus but does not seem to aohtributv to the ansa or faecUculuc
lenticularis.
Io addition to the fibres iihlUrnei above, ltehi are intefiincial
fibres which connect the caudate nucleus and IOv ettaien to the globus
pallidus.
FHTSIOLOaY.
Parkinson's disease is classified as a disease of IOv extra-
eyrgiUial system - as iUstUhguishid from dUsoriehc atthubutgble to
lesions un the pyramidal thacte.
It is generally agreed that there are two motor systems - one
utilising tte pyramidal tract and tte other utilising the extra­
pyramidal pathway. There tas been considerable aontrrvvrsy as to
tte adequacy of the term "pyramidal lrgcl" (Walshe, 1942; Nathan and
Smith, 1995; Bucy, 1957 and Walst, 1957). The term "pyramidal . tract"
evvms to have originated from two d1ecrveriis; first is that of Betz,
wto Uo 1874 ieechibei large pyramidal cells - giant cells, situated
in the hei$lbourhood of the fissure of Rolando and Un tOe pargcehthal
lobule; and secondly, the phenomenon of elvaehical excitability of
tte cerebral cortex dieahUbfd by PrUtsch and HilzUg in 1870. It was
shown eroh afterwards that motor activity can • be produced by stimulat­
ing the pre-RrlghdUa area wtUct was named IOv "motor cortex" or IOv
"irloh • /
9.
the "motor area". It was thought that all the fibres in the medullaiy 
pyramid arose from the motor area or Area 4 (Fulton 1937).
Kennard and Fulton (1933) showed that there was a difference 
between the results of excision of Area 4 (the motor area) and Area 6 
(the premotor area). Ablation of Area 4 caused flaccidity whereas 
ablation of Area 6 resulted in plastic rigidity. Fulton (1937), in 
a review, concluded that the Betz cells gave rise to the pyramidal 
tract, but that Area 6 contained practically no Betz cells and that 
its fibres led into the substantia nigra, red nucleus, pontine nuclei, 
reticular substance and hypothalamus. He therefore regarded the
fibres from Area 6 (or premotor area) as extrapyramidal.
Walshe (1942) criticised this view on the grounds that the Betz 
cell count fell far short of the total fibre content of the pyramids. 
Earlier, Levin (193h) in the monkey found that it was only the presence 
of Betz cells that distinguished motor areas from other parts of the 
cortex. He found that down to the level of the pons, fibres from the 
premotor and motor areas were intermixed. Thus on purely topographical 
grounds the pyramidal fibres (from Betz cells) and extra-pyramidal 
fibres from premotor area, etc., down to the level of the pons, could 
not be differentiated from one another. Minckler and Klemme (1943), 
Minckler, Klemme and Minckler (1944) from a post-mortem histological 
study of the brain and spinal cord of a man who had had his premotor 
cortex removed as surgical treatment for tremor and rigidity, found 
that the premotor fibres pass through the internal capsule 1 cm. from 
the /
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the genu in the posterior limb; that at level of the midbrain they
occupied the same position as that assigned to the corticobulbar
fibres from Area 4; at the level of the medullary pyramid they
occupied the same position as that assigned to the uncrossed cortico­
spinal tract from Area 4»
Mettler (1944) from his study of the primate brain, came to the
conclusion that practically all the heavily myelinated fibres in the
pyramids of the monkey's brain arise from the part of the cerebral
cortex ' in which the giganto-pyramidal cells of Betz are found. All
the smaller fibres disappear with total cortical ablation and therefore
none of the fibres in the pyramid can be attributed to an infrapallidal
origin. Lassek . (1992) came to somewhat similar conclusions.
Recently several areas of the cerebral cortex have been shown to
have a motor function and to contribute fibres to the pyramid. The
areas are the motor area II; the supplementary motor cortex of Pen­
field and Welch . (1991) and Bates (1993); the post-central motor cortex;
additional motor cortex in the temporal and occipital lobe (Walberg and
Brodal, 1993). An excellent account of the various motor areas has
been given by Hines (i960).
From the foregoing discussion it is clear that although the
precentral motor cortex (Area 4) idioh contains almost all the Betz
cells (pyramidal cells) is probably the main motor cortex, there are
other motor areas in the cerebral cortex althcrauh their function is
uncertain at the present. It is also clear that the term "pyramidal
tract" -(i.e. fibres in the medullary pyramids) and the tract of fibres
from /
11
Fig. 2. Subdivisions of the cortex on the 
basis of cytro-architectonics. Reproduced 
from Walsh (1957)•
Fig. 5, Brain of the Macaque monkey showing 
some of the "motor areas” (Modified from Hines, 19&0) 
1. Fissure of Rolando; 2. Motor cortex (Area 4);
3. Extrapyramidal motor area of the frontal lobe;
4. Motor cortex of the temporal lobe; 6 and 7« 
motor areas of the parietal lobe.
9
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from Area 4 (U.e. from tte pyramidal cells of Betz) are not synonymous
and erihvfohv IOv term Us a iushrmeh. It follows that ttv terms
"vxtrapyrgiUdal lhgct" and "'extraeyhamUial 1ystei" do not have the
precise topographical eigoifUaghav formerly altrUbutei to them.
The Basal G-ang^g^ia
Tte occurrence of Pahk1hsonUsi Uo association with lesions of thv
lehliatlgh nucleus suggests that ttvsv nuclei may bv concerned with
movement, particularly those uoctihat1ve and automatic movements which,
Un this disease, are cOargatvrisliaally deficient.
The corpus striatum (lvotifori and caudate nuclei) Us a primitive
structure; it Us onv of thv oldest eghes of thv cerebrum. • In lower
vvrlvbratec (for example, fist, amphibia, reptiles and birds) ttv
cortical mantle is absent or rudimentary, and thv pyramidal tract tas
not yet come into being;. In tOese species thv corpus striatum Us
therefore tte tUpest motor centre - being looked upon as homologous
with thv motor cortex of tte higher forms (Best and Taylor, 1955).
Removal of the rudimentary cortex (crrl1aal mantle) Un buric, for
instance, leaves visual and auditory sensation apparently unaffected
and ttv bird coheUnuvs to carry out normal movements of feeding,
arthlUog, fighting, etc. After removal of portions of tte striate
body, lheee ihct1hctive hvaceUohc are imperfectly executed.
Wilson (1912) obsvhvvi that cystic degeneration of thv ettgieh
was associated with rigidity and eheioh. Hv therefore proceeded to
study tte vffect of st1itlal1hg and of destroying tte lehtUfrhi and
caudate /
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caudate nuclei. He reported that he was unable to elucidate the
functions of these nuclear masses in the primate (Wilson 1914).
Later studies by other investigators showed that these nuclei served
to modify movements already produced by stimulating the motor cortex
or that they modified spinal reflex movements. Mettler*, Adas, Lipman
and Culler (1939) found that in cats and monkeys stimulation of the
caudate nucleus, putamen or the claustrum inhibited movements induced
by cortical stimulation, especially movements originating from the
ipsilateral cortex. Stimulation of the globus pallidus imparted a
factor of plastic tonus to cortically induced movements, exerted a
holding effect on them and prolonged their relaxation time. freeman
and Krasno (1940) found that stimulation of the caudate nucleus
inhibited spontaneous movements of skeletal muscles. Segundo,
Higliaro and Holg (1938) found that stimulation of the caudate nucleus
and putamen produced either an increase or a decrease of spinal
reflexes, wheras stimulation of the globus pallidus resulted only in
augmentation of spinal reflexes. Earlier, Mettler and Mettler (1941)
found that the inhibitoiy effect of the neostriatum was more marked on
spontaneous activity than on cortically induced movements.
Experiments showed further that the basal ganglia are also probably
concerned with the maintenance of skeletal muscular tone. Mettler and
Mettler (1942) found that extension hypertonia which is produced by
ablation of the cortex is short-lived and mild, but after striatal
injury the extension hypertonia is much greater. Liddell and
Phillips (1940) found that in cats electrolytic lesions in the basal
ganglia /
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ganglia (caudate and lentiform, nuclei, subthalamic nucleus and claustrum)
produced hypertonia which was most evident when the animal was mental ly
at rest and held so that the limbs hung freely. In a later study (1946) 
these authors found that after section of the pyramids the motor defect
was minimal, but became much greater with extensor hypertonia after
striatal or pallidal lesions.
In conclusion it may be said that the basal ganglia are concerned
with modification of movement whether cortically or reflexly induced.
They appear also to be concerned with the regulation of muscle tone.
The Substantia Nigra
The role of the substantia nigra has been difficult to elucidate
by the routine stimulating and ablation procedures on experimental
animals. However Mettler, Ades, Lipman and Culler (1939) showed that
stimulation of the substantia nigra caused an increase in extensor tone
principally of the opposite side of the body. It also produced tremor
in cortically induced movements from the ipsilateral cortex:. The
function of the substantia nigra is not fully understood, but from
clinicopathological studies it appears that this nuclear mass is con­
cerned with the maintenance of muscle tone and with co-ordination of
muscular contraction to ensure smoothness of movement.
THE CONTROL OF SKELETAL MPSCLS TONE
Hypertoniiiiy of the skeletal muscle is an important sign in
Parkinsonism and in lesions involving the "pyramidal tract". ' The
term /
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term "tone" is a difficult one to define but to the neurophysiologist
it is that property of the muscle ihiLch causes it to resist passive
stretch. This is not the same as palpable rigidity of the muscle
although in most cases a palpable rigidity is associated with increased
resistance to passive stretch.
There are various factors responsible for the maintenance of tone
in the skeletal muscles
1. Spinal segmental control:- It is well known that hypotonia 
develops when the posterior nerve roots or the posterior columns in the
cord are destroyed. Thus hypotonia occurs in tabes dorsalis. The
rigidity of Parkinsonism and of decerebrate rigidity are abolished or
reduced by section of the appropriate posterior roots (Sherrington,
1898; Groves, 1911 ; Forster 1913 ; Pollock and Davis, 1930). Hypei*
tonicity in "pyramidal tract" lesions is associated with increased
tendon reflexes. The rigidity of Parkinsonism is, however*, not
necessarily associated with exaggerated tendon reflexes; in fact, the
tendon reflexes may disappear when the rigidity is vezy gross; the
hypertonic muscles are no longer in the optimum state for eliciting
reflex contraction. Whether the tendon reflexes are manifestly
increased or not, a definite degree of "hyper-reflexis." can be demon­
strated in patients suffering from Parkinsonism by passively stretching
the muscles, and especially when the passive stretching is repeated
rapidly; the muscle that is being stretched contracts, and may prevent
the full range of movement at the joint. Thus it may be impossible to
extend fully the elbow joint in patients suffering from Parkinsonism
owing /
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owing to ihe strong aonlraat1on of ttv biceps bractU uhen 101s muscle
is being eihilarei by eaee1vi exifneUoh of the elbow joint.
The iaUetehghai of lone, therefore, depends on ttv integrity of
the simple spinal reflex arc of which the afferent loop lies in itv
posterior nerve roots and in lOe posterior horn of grey mailer.
Damage to ihe efferent loop of ihe reflex arc also causes hypotonia.
Thus damage to itv anterior Oorn cvlls, the ventral nerve roots, or
ihe molor nerve io a muscle results in hypotonicity (flaccid palsy).
Io recent years 1hlihsive research has been carried out on ttv
aal1v1ly of muscle in heallO and disease. Skeletal muscle has an
afferent and an efferent nerve supply. The efferent nerves have been
shown lo be of iwo types:
(1) The large alpha fibres which arnitct rapidly (more than
50 melres per second) and sel up ihe ahahaaterist1a
motor twitch in ordinaiy or exthffusal muscle fibres.
(2) The smaller or gamma efferent fibres which conduct more
slowly (15-50 meeres per svccm,) and Ueoehvate exclusively
eOv muscle ee1hdlie. Impulses from ttv gamma efferent
fibres excilv ihe intrafusal fibres of the muscle spindle
causing il io conlhaat and thus leading to eensrxy dis­
charge from irese end organs.
The 1nflteoav of the gamma efferent nerves on reflex art1v1Uy and
muscle crolhaat1on has been eltdUii by Hunt and his colleagues (Hunt,
1951 ; Hunt and Kuffler, 1951 (a) and 1951 (b) ).
The /
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The structure ' of the grade spindle: This has been a subject of
Intensive study and a helpful review of the present state of knowledge
is given by Cooper ( 1960), and it includes some reference to recent
publications by Boyd (1958, 1959).
The muscle spindle is formed by a bundle of several striated
muscle fibres (the intrafusal fibres) of small size enclosed in a
collagenous sheath from which they are separated by a lymphatic space
in the equatorial part of the organ. The whole spindle is fusiform
in shape (fig. 4). The intrafusal fibres consist of two contractile
polar regions showing a transverse striation, coarser than that of the
ordinary fibre and united by a non-contractile equatorial region which
is characterised by a conglomeration of nuclei ihich fill and distend
the body of the muscle fibre. At each end of the intrafusal muscle
fibre there are a number of motor nerve endings, and in the equatorial
region there is a primary sensory nerve ending with or without secondary
endings on either side of it.
Another type of sensory receptor lies chiefly at the junction of
tendons with muscles. These sensory receptors are called tendon
organs of Golgi. These are receptors of a spray form, in which the
sprays lie on the surface of a tendon slip, usually close to the point
at which the muscle fibres join the tendon.
Hunt and Euffler, (1951b) have classified the afferent nerves
from the muscles as A and B units according to Matthews* (1933)
nomenclature. The A units — now called group lA — have a low threshold 
to /
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__Muscle spindle (diagrammatic). N.B. = nuclear bag
supplied by IA annulo-spiral afferent nerve. Intrafusal fibres of polar
region supplied by y efferents. Note amachmeut of spindle to
endomvsium of extrafusal muscle fibre (E.F.) at one end. and to the
aponeurosis (Ap) at the other.
Fig. 4. Reproduced from Samson Wright - s
Applied Physiology.
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to slriiaO and cease to discharge during crethgctUoh of the vxlrsSusal
fibres and originate from ttv muscle spindles. Ttv B unils - or group
IB fibres - from tendon organs, show a higher lrheehold to slrelcr;
their disatghge ratv is accelerated during contraction of itv extra-
fusal fibres. No sigo1f1cgnl difference in conduction vvlraUtife
were noted between lA and IB fibres indicating that impulses from bolt
types of receptors travel in fibres of e1i11ah dUamvevr^. Wilt regard
to thv role of lA and IB fibres, they suggest tOal lA flbrvs are
exciiaioxy while IB are UnOibitozy.
Tte gamma efferent fibres play ao important pari in ihe maln- 
tenance of postural tone. A large proportion of tteev fibres show a
background discharge to hvsl1ng muscles (Hunt, 1951)* This back­
ground discharge is dependent on ronl1nuousness of afferent inflow
from ihe limb into ure spinal cord. If ihe dorsal roots are sict1rnei
this background discharge is abolished. The afferent inflow, thcT^uh
derived principally from lA fibres of ihe muscle spindles, also oomes
from zones of tissue which include the skin (Hunt, 1951 ; B1etiaSeiff
and Pascoe, 1959)* Il is now thcrn^t tOal io itv maihlvhghae of
prslurg1 tone ihe polar ihde of ihe 1nthgfiea1 fibres are acliTaled
through the gamma efferent system. The polar shortening thus induced
in the intrafusal fibres causes the large spindle afferent nerves from
itv centre of the fibre lo discharge their impulses. TOv afferent
iUecOahgis from ihe spindles are said to be facilUiatozy for their own
synergistic aljtfia motor neurons, and thus they cause ttv exlhaStsgl
fibres /
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fibres to contract and shorten.
The main muscle (extrafusal fibres) thus follows the changes in
length of the intrafusal fibres (the so-called servo-mechanism of
Kuffler, Hunt and Quilliam, 1951). Diete-Spiff and Pascoe (1959)
suggest that for stability in such a system the length of the intra­
fusal fibres must be independent of the changes in the extrafusal
fibres. They considered that Hunt's observation (1951 ) that li^itly
stretching the muscle results in inhibition of afferent spindle dis­
charge, raises a major objection to the servo mechanism.
However, as already stated, there is a constant background dis­
charge to the intrafusal fibres through the gamma efferent system.
This causes afferent discharge thirougy lA fibres (muscle spindle
afferent fibres). This in turn leads to discharge through the alyia-
efferent fibres, thus causing contraction of the extrafusal fibres.
Euffler, Hunt and Quilliam (1951 ) have shown that stretch applied to
the muscle gives rise to afferent discharge through lA fibres and this
agaidi will cause the extrafusal fibres to contract. They believe
that the gamma efferent system is thus well suited to act as a peri­
pheral regulator of the proprioceptive spindle mechanism. The gamma
efferents are therefore of great importance in the reflex activity of
the skeletal muscle. By their activity also the muscle is maintained
at fixed lengths during the maintenance of a particular postural stance.
The interaction between the two proprioceptive organs (muscle
spindle and aolgi ending) produces some regulation between antagonistic
muscles /
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musoies of the same level. As the tension rises within a muscle in
the process of contraction, the activity of the tendon endings
increases and the activity of the spindle decreases. Thus mono­
synaptic response of the spindle is inhibited and the antagonistic
response is facilitated.
The role of the gamma efferent fibres in the maintoiance of tone
have been demonstrated by pharmacological studies. Walshe (1924),
Rushworth (1960) showed that injection of a dilute solution of procaine
at the motor point of a muscle abolished rigidity in Parkinsonism
although this was vezy short lived, lasting for only a few hours.
Matthews and Rushworth (1957b) showed that in the case of a muscular
nerve the gamma motor fibres were preferentially blocked by dilute
procaine. Stronger solutions, however, blocked the large alpha
nerves.
Pharmacological studies have also shown the role of afferent
nerve fibres. Maher (1955 end 1957), Nathan (1959), Kelly and
Gautier-Smith (1959) have shown that intrathecal injection of phenol
can reduce spasticity and rigidity'. Maher (1955), Brown (1958), Iggo
and Walsh (1960) showed that the effect of the phenol is on the small
afferent fibres in the posterior roots and not on the large IA fibres.
Brown (1958) showed in patients relieved of their hypertonicity there
was normal position and joint sense, and normal voluntary power, but
there was permanent absence of deep and superficial reflexes and dis­
turbances of postural mechanisms. It seems that the small unmedul-
lated /
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unmedullated afferent fibres - in conjunction with the control
effected by the large lA and IB fibres from the muscle spindles and
Golgi tendon organs - are important in the maintenance of postural
tonus.
2. Supraspinal Control of Skeletal Muscle Tone.
Apart from the ill understood association between the basal
ganglia and the ' substantia nigra and the skeletal muscle tone, it is
now known that other supraspinal areas are of importance in the regu­
lation of skeletal muscle tone. The most important of these areas is
the reticular formation of the brain stem.
The reticular formation is formed of cells (and their fibres)
found scattered among fibres in the lateral part of the tegmentum of
the mhdboain, in the dorsal part of the pons and in the medulla
oblongata behind the olivary nucleus (Lockhart, Hamilton and %fe, 
1959). The cells may be regarded as intenumcial neurons with con­
nections at the caudal and cephalic levels of the central nervous
system. The cephalic connections are to the thalamus, hypothalamus,
globus pallidus and the cerebral cortex. These connections have an
activating influence on the cerebral cortex (Lindsley, Bowden and
Magoun, 1949? Starsyl, Taylor and Magoun, 1951 ? French, Amerongen
and Magoun, 1952): it appears that the activating effect on the 
cortex (as revealed in the E.E.G.) lasts for a long period (up to
50 minutes) after stopping the electrical stimulation of the
reticular /
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reticular formation. The segmental lesions which abolished E.E.G-.
activation were found to have spared large portions of the main sensoiy
pathways.
The caudal connections consist of two tracts, first demonstrated
by Papez (Paper, 1926). The tracta tire rhe lateral al d rnedial 
reticulo-spinal tracts. Our understanding of the function of these
tracts is largely due to the published work of Magoun and his colleagues 
Niemrner and Magoun (1947) found that the reticular formation consists
of two systems - one which is inhibitory (mainly of bulbar origin)
while the other is a facilitatozy system and arises from each level of
the brain stem. The Influence of the connections from each side of
the brain stem is exerted upon both sides of the cord. Magoun (1950)
in an excellent review, gave the relative positions and the connections
of the two systems. The facilitatozy system lies lateral to the
inhibitory system and is connected with Area 6, sensorimotor, associ-
ational, limbic and auditor cortical areas. The lnhlbiaozy system
is connected with Areas 45, 245, and 198.
Magoun and Rhines - (194e) showed that in decerebrate animals all
the rigidity in the extended legs was abolished when the bulbar reti­
cular formation was stimulated. Bodian (194-6) in experrnental polio­
myelitis in monkeys, found that spasticity appeared iden the damage to
the neurons began to progress from the brain stem into the upper spinal
cord, and at a time when the most severe damage was in the reticular
formation of the lower brain stem. This finding confirmed the
inhibitozy /
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UahUbuloiy influence of ihe rell^^a^ formation of lOe lower brain etei*»
The role of lOe facilitator system of ihe brain stem reticular
formation io augmenting cortical motor responses was demonstrated by
BhUoes and Magou^ (1946) and Nlemier and Magou^ (1947). Sc0hi1hih,
Lind-sley and Mggouh (1949) concluded from their work that spasticity is
maintained by faai1Uigiozy influx io the cord cohiuatei Tug the
hei1aulf- and visiibulr-epihal iraats* SOUnes and Magoun (1946) found
that ihe facilitating influence of diencephalic siimulgtUrh on crhtiaglly
induced movements were exerted tirrc^Lth the reticular formation of tte
brain siem and ool ih:mth a diehceeralUcaarrt1ca1-sp1hal cord circuit
as was originally supposed.
Suda KoUzuma and Brooks (1958) have Shown that stimulation of itv
reticular formation leads to descending discharges io itv lateral
columns of itv spinal cord. More important, they showed etai the
reticular formation probably acis solely upon the segmental 1htvr-
nvtr<rm.pro1 io producing ils facilitating and iOOUbUtozy effects.
Intracellular hearhdihg showed that the facilitating action of the
reticular formation, though not causing itv cvlls to "fire", pezviiiei
motor hvuhrhe ool previously activated by an orthodromic or antidromic
etUmULaeirn io be "fired" by such ei1iu1i* The latency of response
of other unL'ts initially taking pari in itv rvflex was reduced by
etUitlatihg the reticular formation.
Brain stem lesions have bveo shown to cause exaggeration of
spinal reflexes (Kettler and 21x^3^10, 1943). Conditions resembling 
Parkin.souUsb have been produced Io experimental animals by lesions of
ihe /
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the centromedian tegmentum (Peterson et al, 1949) and of the periaque­
ductal grey matter (Baily and Davis, 1944). It is of interest that
lesions of encephalitis lethargioa are concentrated in the mi.dbrft.in
with special poedhllition for the periaqueductal grey matter (Wilson,
1918).
The vestibular nuclei: Pulton, Liddell and Rioch (1930) showed
that experimental lesions of the vestibular nuclei in normal animals 
led to hypotonia on the side of the lesion. Decerebrate rigidity and
the associated Increased stretch reflexes are greatly diminished by
lesions of the vestibular nuclei. It is now well known that decere­
brate rigidity can be abolished by section of the brain stem below the
level of the vestibular nuclei. Buoy (1938), however, found that
section of the vestibular spinal tract in the anteromedial funiculus
of the cord in spastic patients resulted only in transient reduction
in the degree of spasticity. He concluded that in man, although the
vestibulo-spinal tract contributed to the maintenance of spasticity,
other pathways are capable of maintaining the spasticity in the
absence of this tract.
The cerebellum: It is established that lesions of the cerebellum
in man leads to hypotonia. It follows that the cerebellum exercises
some control over the tone of skeletal muscle. This control 1 is
i.pshlateoal. Experimental work on animals, however, has demonstrated
a facilitatory Influence, which is in keeping with clinical experience
(Snider and Magoun, 1949), end. also an inhibitory influence on
skeletal /
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skeletal muscular activity reflexly oo cortically induced (Snldeo,
UcCCuULoch and Magoun, 1949)* The suppressor and faclliaaaozy areas, of
the cerebellum appear to occupy largely the same areas. It has been
suggested that the cerebellum may exert its influence on the skeletal
muscle thru# the reticular formation (Sprague and Chambers, 1954;
Peterson, Magoun, McCuULoch and Lindsley, 1949). The latter authors
go as far as to suggest that the cell of the reticular formation may
act as the supraspinal interaeuoon cell on which impulses from the
cerebrum, basal ganglia., tectum and cerebellum converge, and that
thno^ thelo influence on the reticular cell, the anterior horn cell
is affected (Pig. 6).
The cerebral . cortex; Kennard and Pulton (1955) and Pulton (1957)
showed that in the monkey extizpatlon of Area 4 lod to flaccid paralysis
and that spasticity could be added if Area 6 was also ablated.
Ablation of Area 6 alone gave rise to plastic rigidity. Hines (1956
and 1957) however showed that a strip of cortex now called Area 45
forming the anterior portion of Area 4 or the posterior portion of
Area 6 was responsible foo the addition of spasticity to the flaccid
paralysis produced by ablating Area 4. Area AS was therefore assumed
to have a suppoessoo oo inhibitozy effect on skeletal muscular tone.
Dusseo de Baoanne and McCulloch (1941) demonstrated the suppoessoo
effect of Area 4S on the motor responses induced by stimulating Area 4#
Using the method called "physiological neuronography" Dusseo de Baoanne
(1938) showed that Area 4S is connected to the caudate nucleus and the
optic /
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Fig. 6. Reconstruction of the oat’s brain showing the
suppressor and facilitatozy systems concerned
in spasticity.
Suppressor pathways are:- 1. cortico-bulbar;
2. caudato-spinal; 3. cerebello-reticular;
If. reticulo-spinal.
Facilitatory pathways are:- 5* ,reticulo-spinal;
6. vestibulo-spinal.
Reproduced from Lindsley, Schreiner and Magoun (1949.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
28,
optlo thalamus. Its oomnction with the inhibitor bulbar oeticulao
formation ww demonstrated, by McCulloch, Goaf and Magoun (1946). Areas
4, 45 and 6 aoe therefore concerned with the maintenance of the tone of
skeletal muscle.
In the mechanism foo control of the tone of skeletal muscle the
local reflex activity (employing the gamma efferent nerves, the intra­
fusal fibres of the muscle spindle, the spindle afferent nerves and
finally the extrafusal fibres) is the final and . the most important
part. The circumstances in ehich use is made of either the alpha oo
gamma efferent route oo various mixtures of the two aoe unknown. It
is probable that foo the maintenance of postural tone the gamma route
is employed while for rapid movement . with minimum reaction time the
alpha route will be employed. Goanlt and his colleagues concluded that
if this is the case there must be a mechanism for quickly . adjusting the 
one
activity between/route and the other, thus varying the proportion of-
the two efferent systems in use.
Goanlt and Eaada (1952) studied the influence of stimulation of
central neove structures on muscle spindles in the oat. They found a
highly efficient facilltatoxy mechanism foo the muscle spindle in the
brain stem and diencephalic reticular system. When this system is
stimulated there is a slowly increasing acceleration of the spindle
discharge. Less consistently, similar effects were obtained from the
motor cortex, anterior lobe of the cerebellum and foom the head of the
caudate nucleus. Deceleration of spindle activity down to complete
inhibition /
  
 
 
 
 
 
 
 
 
 
 
 
 
29
inhibition was obtained from bulboahvtiaulah ihhibUtory system and from
lOe aelerioh lobe of ihe cerebellum io ieaervbraie rigidity. IB fibres
from the Golgi tendon endings were ool Ihfluihaed by central sl1iu- 
lgtinh. They concluded iOat itv gamma efferent system is loo^aUy
activated from central regions.
Eldred, GranH and Merlon (1953) found IOat in normal cats iterf
is aohtihuous gamma efferent activity affecting ihe epindlve* This
discharge is incregsii in decerebrate rigidity (Hunt, 1951). GranH,
Holmgren and Merlon (1955) using decerebrate cats stowed that ivaeler- 
giirn of spindle activity ocauhs when itv ghlerioh lobe of tte cvr'v- 
bvllum is cooled and that ^^1^1^ rietorvs lOe spindle activity.
They made ihe point tOal spindle paralysis produced by cerebellar
ablation puls out of action lOe muscle length sezvo. Thus lOe muscle
is deprived of itv benefit of ils own length measuring 1hsthuiinte*
They suggest that the sign of dyemetrig in human cerebellar diseases
may be a m^lifieiglirh of similar spindle paralysis. They finally
aonaludei iOai it is likely thai fixing tte phopohtioh of gamma and
alpha efferent pathways in use io reflex movements is a function of
ihe cerebellum.
PHYSIOLOGY OF TREMOR IN PARKINSONISM
James Parkinson was itv first lo separate tte involuhia1y tremor
of paralysis ggitgns from other forms of trfirh.
Binet (1920) showed iOal thvmoh is present in normal people
gl■ilonth /
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although to a very mild degree and ordinarily is imperceptible. This
tremor disappears only if the arm is well relaxed and in complete state
of rest and on a resting plane. The tremor frequency in normal people
is about 10 per second, which is the same as the rate of the alpha
rhythm of the motor cortex:. It was therefore thought that • the tremor
zhytfrn was due to the activity of the motor cortex (Area 4).
That the intaotness of the pyramidal tract appears to be essential
in the production of Parkinsonian tremor was suggested by . the cases
reported by Parkinson (1817)> Wilson (1924) and Patrick and Levy (1922).
In each instance, a Parkinsonian patient with marked tremor after
developing a lesion of the pyramidal tract became free of his tremor
although limbs were still rigid.. Surgical section • of the cerebral
peduncle and the pyramidal tract has been shown to abolish Parkinsonian
tremor either temporarily or permanently (Putnam, 1940; Bucy, 1940 and
1957; Oliver, 1949; Walker, 1952). Hammond, Merton and Sutton (1956)
however doubted the view that the motor cortex was responsible for the
tremor. They showed that under certain conditions the tremor rhythm
disappears on closing the eyes - a state in iiich the alpha rhythm of
the motor cortex is expected to increase. The rate of Parkinsonian
tremor is between 3-6 per second while the alpha rhythm is 10 per
second. Therefore, although the presence of the motor cortex (Area 4)
with its tract appears to be essential, it cannot be the primary cause.
Meyers (1940) reported on 3 cases with Parkinsonian tremor who had
most or all of the head of the caudate nucleus resected with marked
improvement /
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improvement, the tremoo recurring only during emotional excitement.
He was, however, convinced, that the tremor was not initiated by
imposes from the caudate nucleus. He considered that the caudate
nucleus formed an indispensable paot of the suprasegmental loop
mediating such impulses. Electroencephalograms foom poefoental and
poemotor zones showed a slow rhythm of 4 peo second coming in spindles
that were synchronous with the exaggerated phase of clinical tremoo
whilst action potentials from the caudate nucleus showed no such
electrical phenomenon.
Recently Hassleo, Rlechert, Hundingeo, Umbach and Ganglbeogeo
(1960) studied the effect of stimulating the inner part of the globus
pallidus and the oral ventral nucleus of the thalamus during 529 stereo­
taxic operations for extoapyoamldal motor disturbances. They found
that stimulation of the pallidum at frequency rates of 15 to 50 peo
second sometimes increased the tremoo but at other times blocked it.
Stimulation of the oral ventral nuclei of the thalamus had an even
greater effect on tremor. It appears that the thalamus . is probably
of greater importance than the pallidum in the maintenance of toemoo
in Parkinsonism. This is in agreement with the fact that ohemo-
palll dectony or electrocoagulation of the globus pallidus abolishes
oo greatly reduces tremor in about 4h^ of cases (Coopeo et al, 1958;
Spiegel, hccia, Baird, 1958); whilst ohemoahalameoaomy oo electro­
coagulation of the thalamus abolishes tremor in over 70h of cases
(Coopeo et al, 1958). In fact, Naoabayashi, Okuma and Shikuba (1956)
foom /
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from their experience on 26 oases with chemopallideotony found that if
tremor alone was present it rose to its pre-operative level at the end
of two weeks hut when tremor and rigidity were both present the degree
of reduction of tremor depended upon the degree of reduction of
rigidity. They also found that stimulation of the globus pallidns
electrically did not increase the tremor unless the co-existent
rigidity was increased. Spiegel and Wycis (i960) have suggested
that the state of excitation of the pallidum depends laugely on
Impulses it receives from the thalamus.
Excision of the premotor cortex was reported to relieve Parkin­
sonian tremor (Minckler and Klemme, 1943)* The significance of this
is difficult to assess but this area has been shown to be connected
with subcortical nuclei and the reticular formation.
In recent years the reticular system and the brain stem have been
shown to be of importance in the production of tremor at rest. Ward,
McCulloch and Magoun (1948) have shown that tremor at rest resembling
that of paralysis agitant in man can be produced in monkeys by lesions
below the basal ganglia which destroy part of the mesencephalic and
pontine tegmentum. Peterson, Magoun, MoCulloch and Lindsley (1949)
confirmed these findings and carried out some electromyographic (E.M.G-.)
studies on postural tremor in these monkeys with midbrain tegmental
lesions. They found that in postural tremor there was regular
alteration in agonists and antagonists at rates of 6 to 8 per second.
Augmentation of the tremor occurred during passive stretch of an
affected /
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affected muscle and during ils pahtiaiegl1rh in postural adjustment.
The tremor disappeared on active movement. A number of monkeys
displayed action tremor and it was found lOal ihe common feature was
lOe presence of lesions involving lOe superior cerebellar pecltnalv. 
E.M.G-. studies of action tremor showed more dispersed burses of aclUon
potentials without a clear cui gl1ihea11on in agonists and ghtggoh1eie*
Jeoker and Ward (1955) studied ihe effect of stimulating various
areas of ihe brain siem. They found that high frequency elicir1aal
stimulation of ihe medial reticular formation of the brain siem of
monkeys produced hryitiiagl gliiheaiUeg peripheral movements a^alagous
lo 1^^!'. They also found that ihe tremor was reduced or abolished
by parenteral aimUhisihgtirn of ah1icrrlinehgic drugs: tte most 
effective one was scopolamine, and iielraz1hi came evaond.. They
therefore advanced ihe hypothesis itai Parkinsonian tremor is due io
1niihhtpiioh of 10v rostral connections (from tte basal ganglia and
the cerebral cortex) io the medial reticular formation. They postu­
lated that ihe de-affihentei cells subsequently become ryeehsihs1e1ve
to aaeiylatol1hv; that aat1'Tg11oh by locally liberated acetylcholine
yields lOe observed tremor; and thus 10vy explained why anticholin­
ergic drugs abolished or reduced 10e ihiioh*
Polkerls and Spiegvl (1955), although unable to identify a clearly
defined trfirgihUc zone in itv brain, stem as claimed by Mago^ and his
associates, aref1hiid tOal itiatrUagl stimulation of the reticular
eube1ahav resulted io tremor. TOey suggested tOal 1htihrtetirh of
tte /
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the nlgoofugal fibres was responsible foo the production of tremor.
The role of the spinal cood and spinal oeflex activity is not
clear but it is certain that afferent impulses thiooiue the posterior
spinal neove roots aoe not of importance. Pollock and Davis (1950)
showed that section of the dorsal spine nerve roots, while reducing
rigidity and spasticity, has no effect on toemoo. Mephenesin
(hyacesin) a drug idich acts on the 1^1001^101 neurons in the spinal
cord has been shown by Stephen and Chancy (1947), Gammon and Churchill
(1949) to abolish toemor and other hyperkinetic states when given
intravenously. It is, however, possible that the principal action
of mephenesin may also be in the brain stem because nystagmus was
constantly observed as a side effect.
The physiology of skeletal muscle tone and tremoo have been
discussed in some detail because it is widely agreed that a proper
understanding of the mechanisms involved is essential if progress is
to be made in the pharmacology and therapeutics of Parkinsonism.
This relationship will be discussed further in those parts of the
Thesis which aoe devoted to reports of experimental work.
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ENCEPHALITIS LETHARGICA
As this thesis is oonoeemed with the clinical and pharmacologi cal
aspects of Parkinsonism following encephalitis lethargies, it is
appropriate that the manifestations of encephalitis lethargica should
be described, at least briefly. Excellent accounts on this subject
have been given by Hall (1923), Boyd (1925), Main (1928, 1931),
Econome (1931 ) and Wilson (1954*) and the account given below is
largely taken from them.
Historical;
Von Econome was the first to delineate and formulate this disease
which he called Encephalitis Lethargica (Econome, 1917). Reference to
epidemics which appeared on clinical grounds to be epidemics of enceph­
alitis lethargica have been made by Crookshank (1922) and Econome
(1951). These epidemics include:
(1) A serious epidemic in London between 1673 and 1675
described by Sydenham as "febris comatosa" because of
the sleeping symptoms.
(2) Dubini’s "electric chorea" (1846).
(3) "Nona" which occurred in Italy from 1890 to 1891.
Econome did not agree that the "Sctlafsuctt" of Tubingen (1712 to
1713) was probably an epidemic of encephalitis lethargica but thoight
it was probably one of influenza with pertusis. Hall (1923) made the
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56.
point that before itv epidemic occurred in 1917 Uovra had been a number
of sporadic cases as far back as 1903*
As already staled, ihe first heeort of 10e epidemic was by Economo
reporting from Vienhg in 1917. This was followed by numerous hvprris
from other parts of ihe aoh11hee1 (CrtcOet, Montier and Calmette, 1917;
Netter, 1918; Bena-rd and Rensiul, 1920) to mention only a few. From
England came reports by Harris (1918), Hall (1918), Wilson (1918),
Smith (1918), Buzzard and Greenfield (1919). The first report from
Glasgow appears to be iOat of Findlay (1918), al1tlouth Chalmers (1918)
and P^keo (1918) had earlier described cases in wOUcO the illness
might have been gitribuigble to ehaepOglitUc liihahgiaa but which were
said to be due to botulism or ieftuihza* Other reports include those
of Munro (1920) and Manson (1921 ); but about the most important record
of the Glasgow epidemic was that of Main (1928 and 1951). Some of itv
patients ieearibii in Oer aii1hgble tresis (Main, 1928) slill survive,
and fuhtOeh information about them is included in thv prvsvol 1Oeeis*
Clinical Features of EhceeOglU1ie Lethargica
TOv cl1hiaal features werv summarised by Econome as follows2-
"Thv patients all showed a slzi^t influenza-like
prodromal cond1i1rh wilt trifling eOazyhgegl symptoms,
a slight hiee of temperature whicO was soon followed by
a variety of nervous symptoms, th<ngh generally one sign
or ghr10er erUhiei to ihe murrain as itv source."
"I noticed particularly io a fvw of tOise patients a
condition /
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condition of marked lethargy combined with dlstuzbanoes
of the eye muscles, recalling the mythical sleeping
sickness "Nona"
The clinical maclfestaaiocs were divided into four types by
Economo:
1 • The SomnoIena-OphalhlaIm^opledio Form.
The stage of somnolence is generally - preceded by a prodromal
stage which often comes on abruptly and lasts a few days. During this
prodromal stage the patient complains of general discomfort, lassitude,
headache, and occasionally vertigo and vomiting. Apart foom a slight
phazycglais, cataorhal condition of the respirator tract is oaoe.
Signs of sli^t meningeal irritation may appear. The rise - in temper­
ature is slight but occasionally hypezpyoezla terminally may occur.
The somnolent stage appears within a few days of the prodromal
stage and progresses. The patient falls asleep even when eating. In
a large number of cases they can be aroused quickly but in some patients
somnolence deepens into stupor and this is usually fatal. Ophthalmo­
plegia is seen commonly and nuclear paralysis is probably more common
than peripheral paralysis. Third neove palsy is the commonest and
this is followed by sixth neove palsy. Ptosis, weakness oo paralysis
of extrinsic ocular muscles, diplopia, nystagmus and puplllazy changes
aoe therefore frequently seen. The facial nerve is the next most
common cranial nerve involved but others from the medulla oblongata
may also be involved. Asthenia is usually severe and the muscles are
frequently /
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frequently hypotonic with loss of deep reflexes. Signs suggestive of
cerebellar involvement are occasionally seen.
2. The hyperkinetic form.
Chorea and hemi^or^ may occasionally make their appearance in
the somnolent type but in some patients this syndrome dominates the
clinical picture. In some patients myoclonic jerks are more marked
than choraifora movements.
The initial symptoms are more violent than in the previous type;
prostration and failure of strength are more striking. Herpes
labialis may be seen and sometimes it involves the whole face.
Neuralgio pains, especially over the distribution of the trigeminal
nerve but also in the limbs, are common. Boyd (1925) in the Winnipeg
epidemic also noted this association between neuralgia and nyoclonus.
General mental unrest is commonly seen in this type. There is extreme
restlessness, the patient talks incoherently, there is delirium with
hallucinations (usually optical but sometimes tactical) and typomania
behaviour may occur. Sleep reversal or inversion is usually seen in
this type - the patient is awake at night and is drowsy during the day.
Paresis of eye movements and pupillary abnormality are not as frequent
as in the somnolent ophthalmoplegic type. Hioccouk is common and may
be due to myoclonic twitches of the diaphragm. In a considerable
number of cases the hyperkinetic form is followed by the somnolent
ophthalmoplegic type.
3. Amyostatic-Akinetio Form 
This /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
39.
This is the third most common form of presentation. There is a
short prodromal stage as described for the two previous types and this
As followed hy a stage resembling Parkinsonism. The patient is weak
and extremely slow and there is a fixed attitude reminiscent of cata­
tonic stupor and passive attitudes are maintained as in catalepsy.
The patient stares into space and looks demented, apathetic, resembling
a case of dementia praecox. Excessive salivation, greasy skin and
oedema of the legs are common. Difficulties in swallowing and speech
may occur and paralysis of the soft palate has been observed. There
may be some degree of insomnia with delirium and restlessness; some
talk in their sleep and somnambulism may occur. A number of these
patients recover completely but a considerable number progress to the
chronic form of Parkinsonism.
4. Other methods of presentation.
NaurAtAc forms involving cranial or spinal nerves are seen and
may occur alone during an epidemic. The trigeminal, the radial and
ulnar nerves are the most commonly affected. The most common mono­
symptomatic form is singultus (hiccough). Hall (1923) stated that
epidemics of febrile hicc^coigb did not begin until late autumn of 1919,
almost coincidentally with the hyperkinetic myoclonic variety. Boyd
noticed a number of cases of hicocoigh in the second Winnipeg epidemic.
Perhaps it should be mentioned that most of the patients who developed
epidemic febrile hiccough did not suffer from the sequelae of enceph­
alitis lethargica. Psaudotabatic and pseudoparetic forms sometimes
occurred, /
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occurred, and in the 1924 epidemic in Glasgow there were a number of
cases with signs suggestive of disseminated, sclerosis (Main, 1951).
Mental disturbances which occur during the acute phase of enceph­
alitis lethaogica include delirium, hypomaniaoal states, perversion of
conduct (seen amongst children), Korsakow psychosis, depression and
catatonic stupor. Although excessive drowsiness is characteristic,
in some epidemics delirium - usually of the occupational type - may be
common: and these patients remain awake most of the night (inversion 
of sleep rhythm).
Sequelae. of . Encephalitis Lethaogica
Main (1928) studied the sequelae of the 1925 Glasgow epidemic.
She divided the results of encephalitis letharglca into five groups as
follows:-
1. Complete Recovery - The patients regained their normal
health and resumed their normal occupation, showing no
residual signs of previous illness.
2. Incomplete Recovery - This group includes all patients
with some defect but excluding Parkinsonism and perversion
of conduction. The physical defects include; wasting of
muscles and deformities. Other defects include mental
retardation, mental instability and nervous instability
(insomnia, drowsiness, irritability, toemoo and headache).
5. Perversion of . Conduct - This group is made up of
children /
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children having abnormal conduct such as violent conduct,
ihvlvlog, sexual evhTehs1on and signs of moral imbecility.
4. Pahk1hsoh1ei - The s1gne and symptoms will be
iesah1bei laier in detail.
5. Died - Up io 50% have been quoted as lOe mortality
rate but Wilson (1954) puts lOe average morialliy rate
at 1%.
It is io be noted that a patient may have e1thvh physical or
mental disability or bolt. Thus a poet-ehcephatue1c patient may
suffer from Pahk1hsoh1ei and also have perversion of conduct or mental
InsiabilUiy.
Parkinsonism
This is ihe commonest sequel and lOe most serious. Ils onset may
dale from crrhely after itv acute stage (in fact the giyrs1ai1c-ak1hii1o
acule form resembles Parkinsonism); bui the ihiehTg^ between ihe acute
illness may be several years. In some oases of Pghk1hSoeUem there is
no history of florid enaipOal1iie lethargica, but such persons may well
have suffered from the disease in an uhreaogeieed or aborted form
(forme frust^.
Clinical Features of Pgrk1hsohUem
Rigidity - 101s is 10v most common ighifvstgtion. Economo has
iiecrUbei four 1yeis of rigidity, Tis:-
le Plastic type - The muscles display a wetl-igrked tension at
rest /
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rest but passive movement does not oause any great increase in tone.
There is however a tendency to assume or retain any posture imparted
or spontaneously assumed by muscular action (flenibilitas cerea).
This plastic rigidity leads to positive Head Dropping Test (Wartenberg,
1952) which As regarded as a useful sign in the diagnosis of difficult
cases of Parkinsonism.
2. Proprio-reactive type - There is only a slight degree of
tonicity at rest and no flexibilitas cerea but repeated passive move­
ment causes an increase in the rigidity.
3. Reactive type - There is practically no tonicity at rest and
no flexibilitas cerea. Passive movements provoke increase in the
rigidity. Stimulation of the skin also produces the same result.
4. Reflectory type - Althcduh active movement removes tension
the sli^test passive movements increase tension.
The rigidity in Parkinsonism is of the plastic variety unlike the
clasp-knife typ© of * pyramidal lesions*. Cogwheeling of the rigidity
is however only seen when tremor is also present in the limbs. The
present findings do not support Economo’s statement that flexors and
extensors are equally affected in Parkinsonian rigidity. His asser­
tion is probably true when the rigidity is extreme. When the
rigidity is only moderate one finds that resistance to passive movement
is more marked in the flexors of the limbs than in the extensors.
Another interesting fact about the rigidity of post-encephalitic Park­
insonism is its peculiar distribution; it may be unilateral or it may
be /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45.
be ccmflned mainly to either the upper or lower limbs (more often the
arms); it is usually more marked in the larger proximal muscles
(muscles of the shoulder and hip joints) and becomes much less in
muscles related to the small distal joints.
Other manifestations which are ah<olg£lt to be due to rigidity aoe
the mask-like facies and lack of mimickzy, slowness of movement,
monotonous speech, muscular weakness and easy fatigability. Wilson
(1925) from his observations came to the conclusion that weakness of
skeletal muscle is in inverse ratio of the muscle size. Thus the
small muscles of facial expression and the small muscles of the Iou:ycx
etc., used for speech show goeateo degrees of weakness than the larger
muscles of the limbs. In a comparative study of the speech in Parkin­
sonism and in the normal he found that the time required in order to
say a set of words was about the same in both groups but there was
absence of flexibility (as measured by the number of vibrations peo
second) in Parkinsonism in contrast with the great variations in the
frequency of vibrations in the normal. It is not quite certain
ihether the weakness is due exclusively . to rigidity. Walshe (1924)
showed that if the rigidity can be abolished by injecting dilute
procaine at the motor points of the rigid muscles, that the muscle
power improved and slowness of movement was abolished. Couchot (1927)
however showed that by injecting hyosoine paoecaeraIly he was able to
abolish rigidity but not boadykinesia (slowness in executing movements) 
He therefore came to the same conclusion as Hall (1927) that boady- 
kinesis /
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bradykUeee1a was not dependent on 1^81x^01 of muscular power’. The
problem of muscular weakness and easy fgtiguabllUty of the muscles
will be further discussed in lOe male part of 10v tresis.
Gait
The gait 1e Parkinsonism is probably eeoohdgiy io itv rigidity and
ihe flexed allilude of lOe paHehe. Tte gait is usually slow,
shuffling ged in small siies. Some patients, because of the flexed
attitude, lend lo tuany wilt small, sOoni steps gs if tunryleg io iry
lo calct up wlir lOe centre of gravity. This is lOe classic feet1eght
gait of post-inaiphglUtic Parkinsonism. Io g few pgiieeie, fesli-
oaHon is so marked that the palieol is unable to walk in ihe ordinary
way; he moves from place io place by short bunsis of runeing. Oev
patient io iris preeeo1 series stows iris phenomenon - which has been
desanUbid as (kinvsUa paradoxa* (Brain, 1955). In some patients, a
du^t push applied io ihe chest causes item io walk backwards -
usually gl ae increasing pace uoill trey fall: iris is ihe classic 
sign called ne1rreuls1on*
Deep reflexes.
Tte lendoe jerks mgy be normal, exaggerated, diminished; and if
rigidity is very marked it mgy be impossible lo elicit gey response.
Harris (1927) however observed some abnormalities of itv swing of ihe
leg which was probably related lo rigidity. Ekbom (1950) observed
lOe phenomenon of "vgrio niflex1a" ie patients wilt an appreciable
degree of tremor; ihe tendon jerk being sometimes iliaU1able and at
other /
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other times not elioitable depending on the phase of tremor when the
stimulus was applied.
Tremor
The tremor of Parkinsonism is typically of the pill rolling
variety with a rather slow frequency - about 3 to 6 per second. The
tremor is at rest and characteristically stops when movement is being
executed, returning when the movement is completed. Tremor is, however,
not usually as prominent in post-encephalitic Parkinsonism as it is in
other forms of Parkinsonism, especially paralysis agitens, rigidity
being more marked in post-encephalitic Parkinsonism.
Tics
Tics are common in this condition and include convulsive yawning,
hiccough, blepharospasm and recurring movements of mastication and
swallowing.
Crises
There are two main types of crisis described in post-encephalitic
Parkinsonism: -
1. The oc^aoocnic crichc in sh inh hic eyhe ere etrenglr rolle d 
or deviated upwards and to one side but rarely downward. Some authors
also include paroxysms of fixed eye-staring as oculogyric crisis. The
duration of crisis may be for only a few minutes but they may last for
hours. It is said that oculogyric crisis may be the only indication
that a patient has suffered from encephalitis lethargica and that if
oculogyric crises are associated with Parkinsonism, then there is a
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strong presumptive evidence that the Parkinsonism must be post- 
eccephallaec♦ This phenomenon has been studied in detail and will be
described at greater length elseideere in the thesis (Chapters II and
III).
2. The respiretpiy aiOsh c i is; oO tho btse bisti-st ol this this 
of crisis is that of Turner and □ritchley (Tuocpo and Coiachley, 1925
and 1928). Other reports include those of Jelliffe (1926)), Hess, 
(1927), Parker (1950), Hall (1925), Maoie Binet and Levy (1922).
Turner and Critchley classified the respiratory desioOtos of post- 
encephalltis into three groups, vlz:-
(a) Disorders . of respiratory rate - either tachypnoea
or boadypnoea.
(b) Disorders of rhythm - either in the form of Cheyne-
Stokes respiration, ap^elo pauses, and boeaaS-SoI0lcg
attack •
(c) Respiratory tics - include spasmodic cough, involuntary
yawning, sniffing or SIcccm^.
Turner and CoitcSley noted that most of the cases observed in
Britain up to 1928 were attributable to the 1924- epidemic. Disorders
of rhythm and of rate aoe more important than respiratory tics.
BrtatS-hoIOeng attacks may be ushered 1c by tachypnoea, and cyanosis
may occur. Tetany may follow tachypnoea. Respiratory crises seem
to disappear with time, and by 1929 the incidence of this complication
was almost negligible (Jelliffe, 1929)* Theis cjelsiS; on acc<uctt ff
its rarity, has not been studied in detail.
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The Sweating Crisis
Another type of crisis, the sweating crisis, wOUcO has not been
mentioned ie the past except aasutaltr by Economo (1951) god by Nang- 
bayashi, Okumg and SOukubg (1956). This phenomenon has hvaeivei
special attention ie itv present thesis and is discussed fully ie
Chaeivre H and III.
Deformities
The subject of deformities ie Parkinsonism has not received much
81^^11^ in itv pasl. Tte flexed attitude and probably thv "main
^accoucher" deformity of ihe hands are ihe only types of deformity
whiHeo about - even in monographs degliog wilt Pgrk1eeohlsit The
deformities seen ie ihe group of patients surveyed in this thesis have
been studied io some detail (COgpivr V).
Netrosyiegiret1o and oeuroglgndulgr derangements
These include slglornroeg which is generally more marked uo post­
encephalitic PgrkineohUei than in paralysis agltatos; greasy skin from
excessive 8^^117 of ihe sebaceous glands, vasomotor disturbances such
as coldness of the exineiitiee, acrocyanosis and local oedema. Other
iaoifesia1iohs are those affecting the ductless glands god include
diabetes insipidus, dystrophia adiposo-genitalis, and more rarely
glycosuria.
Psychic stale
In eos1-vnciprgl111a PahkUhsonUem depression is probably lOe mosi
common psychic dis1rtbahae, bui 11 is surprising that the 1na1ifhcv of
depression /
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depression is not higher in patients suffering from post-encephalitic
Parkinsonism. Other manifestations of mental disturbance include
paranoid psychosis, hallucinations and agitated melancholia. Per­
version of conduct was seen in the young but it seems that whin they
reach adult age they become less anti-social and develop fairly normal
behaviour. There does not seem to be much intellectual impairment as
would appear to be the ease on casual observation of the patients. A
comprehensive study of the mental sequelae of chronic encephalitis
lethargica has been made by Cooper (1936).
Treatment of Parkinsonism
James Parkinson, influenced perhaps by the practice of blood
letting which was fashionable at the time when he wrote his classic
essay on the Shaking Palsy, suggested that in attempting to effect a
cure, blood should be taken from the upper part of the neck and that
vesicants should be applied to the same area. Thereafter Ihe "Sabine"
liniment was to be applied at the site of venesection in order to
produce a purulent discharge. If the volume of discharge was found
to be insufficient, fresh blisters were to be produced and the liniment
re-applied. He was opposed to the giving of medicines internally; aod
he also declared that as the muscular weakness was not due to consti­
tutional debility, no benefit could be expected from tonics or a
highly nutritious diet.
A /
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A similar form of treatment was suggested by Netter (quoted by
Ecoosso, 1951)1 in the acute stage of encephalitis lethargica* An
abscess is formed by inlcctCal 1 ml. of pure old tu^opje^n^t^lne oil 11^ 
the deepest layer of the ebdn co nth bateaeOL aspect of the ‘thigh. 
Between the sixth and ei^ath day the abscess is incised and the pus 
allowed to escape. Kt eoa^i>e^i^^ jmu was stated to contain antigens of 
the pathogenic virus - a claim which does nothing to inspire oocfiOenct
in the therapeutic value of the regimen.
As regards the chronic posa-encepSallalo disease, Ihe use of
lntoavecius iodine alone oo in combenaalic with other adjuvant therapy
was said to be the best form of therapy foo the disease process
(Econom, 1951). The iodine was either in the form of "Prey's Iodine"
or a 10$ solution of sodium iodide if Poegl's Iodine was not available.
Precise instructions aoe set out in the Ilaeoaaurt regarding the volume
of this solution oecommtnOeO for intravenous injection, but the treat­
ment is obsolete. Iyrogens (malaria therapy) also had aStlo vogue and
were likewise abandoned.
Other adjuvant treatment include the use of mercury ianunoalacs,
inatnsive course of arsenlcale, grafting of the paoaahyooiOs from calves
oo administration of parathormone intravenously three times daily foo
two to three months. X-oay irradiation of the head was also caroled
out foo some time. It was supposed to cause Syptr,atmla of the atoopio
basal ganglia, thereby in due course restoring the function of the
basal ganglia to normal. Theoe was no proof that these methods of
totaamena /
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treatment had any value and they were given up. In retrospect they
are chiefly of interest in adding to the vcluuincus literature i’di.<Ot
reveals the rauankatle credulity of patients and physicians alike.
Symptoma-tio Treatment
There were, however, other drugs of undoubted value used in the
relief of symptoms. Until about 1945 preparations derived from the
solanaoecus plants (Atropa - belladonna, Hroscramus niger and Datura
stramonium) were widely used in the symptomatio relief of Parkinsonism.
Charcot is said to have introduced their use ' in Parkinsonism about 1874
(Goodman and Gilman, 1958): they were prescribed as the tinctures and 
dried extracts of belladonna, stramonium and trosoramus and also the
pure alkaloids were used - atropine and later troscina* The
"Bulgarian belladonna Treatment" introduced by Ivan Raeff in 1926 was
very popular for a time, but there was some controversy as to the
relative merits of the Bulgarian belladonna and the English belladonna
(Alcock and Carmichael, 1938; Neuwahl and Fenwick, 1937; Hill, 1938).
Vollmer (1948) however showed that the effect of the Bulgarian treat­
ment was due to the contained belladonna alkaloids and not to the
dietetic regimen in this form of treatment or to any other special
substance contained in the Bulgarian belladonna. The alkaloids -
hrosoira and atropine (or alkaloidal salts) - have been used in pre­
ference to galenicals (extracts, mixtures and tinctures). Hyosoine
and /
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and atropine can be given orally either in lOe form of a mixture on in
ihe form of e1tte• Suitable alkalr1ial preparations can also be given
by subcutaneous injections, aed 11 appears ihgl belter results anv
obtained from parenteral adi1o1eena11oh*
In eoe1-ihaiprat111a Parkinsonism large doses of 10e belladonna
alkaloids ane often required (Hall, 1957). Even in moderate doses,
however, e1ii-fffea1e are common, and lrisi include excessive iiyoiee
of lOe moult and eOnoat, paralysis of accommodation for near vision,
1nenaa1gbte aree1iea11rn, delirium, hallucinations god rypfhlririia*
The elrw-gaiUng galenicals (dry extracts) have been used wulh
limited ctaaiee lo produce sustained lrinaeiue1a iffiaee. The main
requirement however was g drug which would be more eftia11ve 10an those
of lOe atropine group - aruoiehac11hg lOe main i1eab1t111ie of Parkin­
sonism bui lacking unpleasant e1ii-iffic1s. New eyeirie1a drugs were
produced which nil1iTii rigidity aed tremor (probably by a central
ae11arrl1oirg1a effect), bui which had minimal ght1-mteaar1oia action
on lOe ere1-gghgl1rh1a fibres of lOe parasympathetic nervous eye1ei.
The most important of irese new drugs gre:-
1. Benzhexol (Art ane), The clrni cl used! Ucest nV s ia Irus
was find reported by Corbin ( e949) who found ihgl 11 was fffia11vi in
71$ of ere1-ihaiergl1e1ae; Doshay and Constable (194-9) who obtained
good results un if of eoei-ihaferat111ae. Olhen nierrie include
those of Schwab and Tillman (1949) and Berkowitz god AlTeriao (1952).
The last of these authors however found no d1ffehioai between iOe
effects of beezOexol and erose of 1x8^01^.
Allhougr /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52
Although Cucclcgham et al (1949) found that in experimental
animals atropine sulphate is twice as strong as benzhexol judged by its
spasmolytic effect on isolated icttsaint, and ei^it and three times as
strong as - an anaisiaIigigue and as a mydriatic respectively, side-
effects such as dryness of the mouth and blurred vision were still
complained of in the oonvtcaiical doses needed foo the relief of
rigidity and tremor. Further, mental symptoms (severe confusion,
attempted suicide, paranoid psychosis, hallucinations and excitement)
were rtpiotecL. 10 out of 52 patients in the series reported by
Piraeous and Ross (1956) had mental symptoms as a siOe-tSftct. For­
tunately the incidence is generally vezy much lower than this.
2. Caramiphec (Parpanit). The results of clinical trials with
this drug were reported by Dunham and Edwards (1948) and Schwab and
Leigh (1949). This drug appears to have no advantage over the
soIacaieous drugs except that sidt-effeots may be less. The drug is,
however, not well tolerated by patients suffering foom aoteoioscIeroaic
Parkinsonism.
5. DipStnSydoamlnt (Benadryl). The antihistaminecs were also
toied and diphenhydramine was found to be about the most effective.
However, by the oral route its effect on rigidity and toemoo are mild,
and drowsiness (a sidt-tffeoa seen in up to 50jS of cases) was a serious
drawback in the majority of cases; but in patients complaining of
insomnia this slOt-efftot was beneficial. The earliest report on the
clinical effects of oiphtchydrament on Parkinsonism include those of
McGavalli /
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McGavack^, Elias and Boyd, (1947); Budnitz (1948) and Byan and Wood
(1949).
4. Ettcprcpazira and Diethazina* Both drugs are close homo­
logies and are related chemically to the ptancttiarira group of drugs.
Diattarina (diparcol) was first employed for the symptomatic relief of
Parkinsonism in 1946 (Sigwald and his colleagues, 1947). However, its
use was soon abandoned because of its toxic effects, especially those
on haaucpciatic tissue leading to lauocperia and agranulocytosis, and
an action on the kidneys giving rise to albuminuria. Furthermore, most
patients were unable to tolerate adequate therapeutic doses owing to
side-effects such as drowsiness, vertigo, hyperthermia and temporary
paralysis. Ettcprcpazina (Lysivara, parsidol) was found to be more
easily tolerated with less side-effects and with a much smaller
incidence of leucopania and agranulocytosis. Reports on its clinical
usefulness rroluda those of Garai (1951), Gillespy (1953)* Doshay,
Constable and Agate (1956).
5. Curare and Meptenasi:r. Curare was first used about 1927
(Wilson, 1954) but was abandoned because of the dangerous skeletal
muscular paralysis it sometimes produced. Furthermore it had to be
given by injection many times daily. Recently, . however, Berger
(1956) reported on the great advantage of using repository curare
given intramuscularly in combination with the standard arti-Parkirscrisu
drugs such as banntaxol* This report has been received without much
enthusiasm. Maptanasrr (Mrarasin) was tried for a time but has been
largely /
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largely abandoned because of 11s ratter poor effect when given orally
and because large doses ane required. Reports on ils use include
those by Stephen god COaedy (1947); Bvrger and Schwartz (1948) aed
Gammon aed 0^x^0111 (1949).
6, Ohehenain1oe (D1s1egl)* This is very closely related lo
iierenrydhgi1he aed is being used increasingly in Park1heroisml.
Reports on ils ctUn1agl value include those of Gitlrfsey and Raicliffe
(1955), DosOay and Constable (1957), Rosenfeld and his colleagues
(1959). The therapeutic effects of ihis drug will be iiech1bid in
detail in g laien eiai1ro of 10e lrie1e.
□iren drugs of tiee importance VOicO have been used include lOe
following: -
1. Prrryrl1d1ne hydrochloride (Keiaihin).
(Schwab ged COgfelz, 1955; Zien and Doshay, 1957).
2. BiOthOe1hfeetleronatf (Cogentlm). (Doshay, 1956).
5. The Gtu1aniiidee (Cuba 1O87O). (Hughes, Keevll and
Gibbs, 1958; Batie1hienU and Signonaio, 1958).
4. Testosterone and heparin (Weinberg, 1954).
5. Xoxazolam1hi ("Plexle^"). (Roirigtez-Grmez el al,
1956; Amols, 1956). ?
6. Oral Hyprglyagimic agents - Tolbutamide and Crlonenreaiidi
(Gales and Hyman, 196O; GUttrieey and Palon, I96O; 
Robertson, . 1961)#
7. Tigtr1dUhi* (Tngttnir god Noak, 1951; O,Rouhki et al,
i960). /
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This substance is related to atoopine and is an
ester of pseudiaoipine - an alcohol, and tigllo
acid. It is of some value in Parkinsonism and
in paraplegic patients*
Recent reviews on the drug treatment of Parkinsonism include those
of Doshay and Constable (1951); Garland (1952); Mllleo (1955); Ebauch
and Drake (1954); ColtoSley (1958), Many other drugs aoe used
occasionally to give symptomatic relief. These include phtnobarbiaont,
amphetamine, bulbocaopine, new acaiOtpressive drugs foo vezy depressed
patients, and various preparations for the management of constipation -
often a troublesome problem in these patients*
This thesis is mainly devoted to describing methods of assessment
of drug therapy in Parkinsonism (a subject which continues to arouse
considerable controversy) and the mode of action of drugs used in the
symptomatio relief of rigidity and tremor in this disease. Most
attention has been given to the pharmacological actions of orpltnaOrine
on skeletal muscle. This work has emphasised the need to intensify
the study of drugs idl-ch. act directly on the peripheral servo mechanism
- the final stage in the series of events leading to changes in the
tone of skeletal muscle.
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CHAPTER II
CRISES IK POST-ENCSPHALITIC PARKINSONISM
In Chapter I (General Introduction) it was martAcnai that two
types of crisis have been described in pcst—eroaphalitic Patkinsonism,
namely the oculogyric crisis and the respiratory crisAs* In this
section of the thesis it is proposed to report on the crises which
have been observed in the present series of patients. As the oculo­
gyric crisis is more prevalent and causes great distress, much time
has been spent on the study of its various aspects and most of the
discussion will therefore be devoted to this form of orAsAs*
In individual cases of post-encephalitic Parkinsoni sm ' the dis­
ability and distress caused by crises may in fact be much greater than
that resulting from tremor and rtotditr* Some patients with minimal
tremor and rigidity arparienca severe crises lasting for 12 hours or
more and these sometimes occur as often as three times a week. A
general practitioner who suffered from post-ancaptalitio Parkinsonism,
writing on his disabilities (Lancet, 1948), regarded sialorrhoea as
his greatest tribulation - in spite of the fact that he had veiy marked
rigidity and was able to type with only one finger.
Historical
J. P. Albreit was probably the first writer on this subject to
report on a case of oculogyric crisis. In 1693 he reported the case
of /
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of a girl of 20 who had typical symptoms of encephalitis lethargica
god who subsequently developed episodic upward rolling of itv iyis*
Host of ihe early writings on oculogyric crises occurring gs g
sequel to this pandemic of ihceprgl1i1s lethargica came from Western
Europe (levy, 1922; Fischer, 1924; and Meyer, 1924). Cases of 
oculogyric cr1eee were ool reported from North America unlil 1925
(Kohmge, 1925); reports from this country appeared much lgler.
Duncan (1924), Un g cripneheoeiTi account of itv sequelae to eoaeet- 
alilis letOghgUcg made no refihiece lo cr1see. From 1926 however g
number of reports appeared (Bankas, 1926; Bramwell, 1928; McCowan
god Cook, 1928; Williamss on-Noble, 1928; Hall, 1931)*
Incidence
A iolal of 67 patients wene studied. They have been caned for
at Siobtill General Hospital, Glasgow, for periods vanyUng from 4 io
30 years. Many of item had suffered from eoaipralii1s letharglca
during ihe epidemic that followed ihe First World War. There anv
32 men god 35 women. Io 27 of them (10 men and 17 women) crises
punctuate the course of the disease; g patient may have more ■ than onv
type of ahUe1s. Clinically lOree types of cnisls have been observed
ie iris series of patients suffering from post-eoripratii1a Parkinson­
ism; firet, ihe classic oculogyric ar1sie which was seen in 20
patients. A second type, ihe hieeirairzy crisis, was seen in only
one patient. A itlnd type, in udich various ign1fvstgtirhe of
dietunbahcfs Ue ire autonomic nervous system - particularly sweating -
are the features, was also observed Ue 8 patients. Table 1 gives
itv /
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TYPE OF
CRISES.
NO, OF
MALES.
io OF TOTAL
NO.OF MALE
PATIENTS.
NO. OF
FEMALES.
% OF TOTAL
NO.OF FEMALE
PATIENTS.
i FOR BOTH
SEXES
COMBINED.
OCULCXJYRIC 6 14 40% 23,0$
SWEATING 5 15.9% 3 8.5% II.9?S
RESPIRATORY
OR
BREATH-HOLDING
ATTACKS
- - I 2.8% 1.5%
Table 1. Frequency of various types of crises
in post-tniepSalitic Parkinsonism.
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the frequency of these three types of crisis. The incidence of
oculogyric crisis in this series (29.8%) is rather hi^t when it is
compared with 15*6% in Hall's series of 384 patients and 17% of 136
patients reported by McGowan and Cook. The higher incidence of
oculogyric crisis in the present series is probably due to the fact
that a number of these patients were admitted because of the severity
of their oculogyric crisis, and in this sense an element of selection
must be noted: this may or may not apply to other workers' series.
Clinical features
Personal observations were carried out at all stages of these
crises. Various phenomena were noted systematically: ocular 
deviation, the sire and reaction of the pupils, severity of tremor and
rigidity, slalorrtcaa, blood pressure, heart rate, the occurrence of
flushing of the face and conjunctiva, sweating and the amount of noise
(e.g. moaning, howling, weeping, or general noisiness) made by the
patient.
OCULOGYRIC CRISIS
The 20 patients affected have had oculogyric crises of all degrees
of severity and occurring at intervals vaiying from a few days to
several months. The most severe form of oculogyric orists occur much
more frequently in women than in men. There is also a hi^ier inoicLerca
and frequency of crises in general among women patients. Again the
triivliual patient may have ortsas idich are sometimes severe and
sometimes /
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sometimes only mild.
Prodromal stage
Nurses who have had long experience in the care of post-enceph- 
alitics can often foretell the onset of an oculogyric crisis. The 
patient who has been ambulant feels less inclined to leave his bed; 
or if he is up he is slower in his movements and gait. At this stage 
the conjunotivae may be a little injected.
Emotional changes are common. Some patients become more 
quarrelsome for a day or two before a crisis. Others are depressed 
for some hour's before the crisis. Some experience an aura before the 
crisis develops: the sensation is evidently unpleasant and even 
fearful, but descriptions are vague. One patient breaks out with 
repetitive and apparently meaningless jargon shortly before the actual 
rotation of the eyes. All have a preoccupied staring expression just 
before the ocular movements occur. Nystagmoid movements may be 
observed at this point; and in a few patients the appearance of the 
3yes and a state of fear combine to produce a facial expression of
terror.
The stage of tonic deviation or rotation of the ayes.
The eyes are usually rotated directly upwards but sometimes 
upwards and laterally, and in two patients in this series the eyes are 
sometimes rotated downwards. The direction of rotation is nearly 
always constant for each patient, but on occasion upward rotation 
alone is present in a patient who usually has upward and lateral move­
ment. /
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movement. Il is of 1n1ihie1 lo note that when lateral movement of the
eyes is present, the eyes ane usually directed away from the side of
the body erovung 10e grealer degree of muscular rigidity. Skew move­
ments of the eyes have been observed io one patient during some attacks.
In a few pge1fn1e 10e direction of rotation of ere eyes varies even in
the same episode. The eyes are usually open aed the patient has g
fixed slgne. Three patients however suffer from photophobia aed tris
causes item lo keep ihe eyes ti^itly closed. They ived io lie on one
side and liy lo pull ihe bed-alo1his oven iheih eyes. Two patients
occasionally experience drooping of 10e iyi-lids and cannot voluntarily
open ihe eyes.
In the fully established oculogyric crisis the eyes are fixed.
Just before this stage is reached, a well-marked vertical nystagmus 
with the quick component movement upwards is often observed. There is 
usually an associated flickering movement of the upper eye-lids.
At the fully established stage voluntary horizontal conjugate
movement of the eyes is either impossible or, if il can be executed, is
only momentary. Voluntary movement of ihe eyes downwards is usually
impossible. If g patient has been persuaded io move lOe eyes into the
horizontal on downward position, 11 is crangc1eniei1c lOal upward con­
jugate deviation is nieeonid by g very sudden movement of the eyebdls.
Congestion of ete eatihgt conjunctiva is also obvious during an oculo­
gyric cnlds. Io 10e fully developed case engorgement of the vessels
may be extreme: sometimes g large number of dilated capillary vessels 
ane visible in vltOer ihe lalenal on medial limbus on bolt (Figs. 7
and /
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(a) (b)
Fig, 7a. Severe oculogyric crisis in woman aged 5& years; flushed
face, suffused conjunctivas, and frothing at mouth.
Blood pressure rose to 2O2+/11O : heart rate 96.
Fig. 7b. Same patient as 7a when not in crisis. Blood pressure 
16O/9O : heart rate 72.
(a) (b)
Fig. 8a. Mild ooulogyric crisis in man aged 2*2 years. Flushed^ 
------ face but no significant rise in blood pressure or heart
rate.
Fig. 8b. Same patient, when not in crisis.
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and 8). In most cases of severe crisis excessive lachiymation is 
obvious, and there is then occasional escape of tears from the eye­
lids .
During an oculogyric crisis the pupils are usually dilated, 
although fixed small pupils have been noted in one patient. Re­
action to light is characteristically sluggish. As convergence is 
rarely possible, reaction to accommodation can rarely be determined 
satisfactorily.
During a severe crisis, facial flushing is always present and 
slight congestion of the skin may occur as ' part of the prodromal 
syndrome. The head is tilted so that usually the occiput and the 
eyeballs move in the same clockwise direction. Sometimes there is 
also head retraction. The skin of the forehead may or may not be 
wrinkled. Muscular rigidity is often increased.. Tremor may become
more marked; but patients with slight tremor may lose it altogether 
during oculogyric crisis - perhaps because the movements are eliminated 
by the state of increased muscle tonus. A remarkable phenomenon is 
the obvious unwillingness to move (bradykinesia) and sometimes immo­
bility is absolute (akinesia). The patient abandons the struggle to 
move his limbs; the lAole body is extremely rigid and he has to be 
moved like a tailor's dummy. When they are in the throes of an 
oculogyric crisis the majority of patients are unable to feed them­
selves; but if food is put into the mouth patients show little 
difficulty with mastication or deglutition.
Vertigo /
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Vertigo, objective or subjective in type, is complained of by 8 
out of 20 patients during crises. Headache - usually frontal, but 
rarely occipital - is a common complaint but it is not incapacitating. 
Increased salivation is seen in less than one half of the patients and 
in these it is inconstant. The blood pressure may be raised by as 
much as 60 mm.Hg. systolic and 30 mm.Hg. diastolic ; tachycardia is 
common and is not constantly related to change in blood pressure. 
Irregular respiration is seen in a few patients; tachypnoea is 
followed by variable periods of apnoea.
Emotional disturbances occur in all severe cases. Despite 
rigidity and immobility during the . crisis, these patients are rarely 
silent: grunting, mumbling, moaning or howling are commonplace; and 
some emit sudden squawking sounds - which one resident medical officer 
described as being like the plaintive cry of a seagull. The noise is 
sometimes loud enough to be audible more than 200 yards away. The 
patients cannot explain why they shout or moan. Three patients are 
invariably quiet during crises, and , it . is noteworthy that in these 
patients flushing of the face is trifling or absent altogether. Some 
patients repeat particular words or sentences - but these convey little 
or nothing to the observer. The patients describe their feelings as
being "terrible”, and it is evident that they are in a state of fear. 
During a crisis one patient sometimes has outbursts of uncontrollable 
laughter. Hallucinations have never been detected. Incontinence of
urine was seen occasionally during oculogyric crisis.
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SWEATING CRISES
The eos1-ehcvpralUtUas in ihis series have heTeglei Uh1rlergoce
fon wanmtr as compared with normal people. They lend lo sweat much
more easily god prefer the cold weather to hot weather.
Eight patients have paroxysmal attacks of excessive sweating even
in 10v winter months. TOv phenomenon Us so sharply defined and so
completely independent of fOTUrrhmeni, that 11 has been designated g
’sweating • ahie1e’. Five of tOese patients anv men and three are women
(svv Table l). Poun of them have severe attacks periodically. TVo
patients (one mae and onv woman) display both oculogyric aed sweating
anisvs; and lOvsv two types of crisis mgy occur c1mtltaherusly on al
different limes.
TOv anUsie can occur al any limv but ane much more frequent late
at oi^il on early in the day. During the crisis evTVhi tnemon Us com­
monly present but it Us thought that only occasionally Us the increased
muscular actUTU1y an important factor accounting fon sweating.
Sweating Us so profuse that it may neaessU1atv a change of garments and
bed clothes every tour - on even monv frequently; and • this has rcauhnvi
io the absence of any marked increase in the degree of invmon beyond
ihgl normally eheseh1. FuntOvn, in one patient wOvnv oculogyric
ar1see anv associated with the development of severe themon, sweating
is not excessive. In g sweating crisis tOere Us usually flushing of
the face aed sometimes aohgec1Urh of ttv conjunctiva. TOv skin of
thv limbs may also bv ryeehgviUa. TOv axillary tvipergtuhv may
exceed 100® F.
One /
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One patient whose tongue normally shows marked tremor, makes
clicking noises during a sweating crisis by alternately protruding and
partially withdrawing the tongue. Severe cyanosis has been seen in
this patient during sweating crises. This is attributed to mechanical
obstruction: there is marked forward flexion of the neck and because
the tongue is often extruded, breathing through the mouth is made more
difficult. Increased oxygen utilisation from excessive tremor may
also be a minor contributory factor.
There is severe tachycardia during a sweating crisis: the heart 
rate may reach 130/min. The cardiac rhythm is usually regular but
very rarely extrasystoles occur*. The systolic blood pressure rises
by 20 - 50 mm.Hg. and the diastolic pressure by about 20 mm.Hg.
Excessive salivation is sometimes present.
RESPIRATORY CRISES
Only one patient suffers from this form of crisis. Because of
the rarity and the rather transient nature of this form of crisis only
a limited amount of information can be offered. This patient, a
woman, suffers from what may be termed "breath-holding attacks". This
is usually preceded by a period of motor excitement during which the
arms and head manifest marked coarse tremor. After about five to ten
minutes this is followed by the period of apnoea during which she may
be either cyanosed or pale. She appears to be in a trance during
the period of apnoea as she is scarcely accessible to questions.
Surprisingly /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67.
SunpnieUegly enough, these epellc of gpnoeg can be aborted by staking
ihe patient vigorously by the shoulders, as if to rouse ten from deep
sleep,
ILLgSTRATIVE CASES
Case 1. J. Pal. Woman, aged 56 years. This pglieni was
g-dailied Ue 1946. No history of a fvbnUlv illhiee resembling
encephalitis lei]rgng1cg could bv il1ci1id* She had goo io Australia
io 1926 and iwo years later, following g ioneUllec1oiy, she found that
she tad muscular weakness on one side of ihe body and tremor on ihe
other. She re1^troid lo ihe United Kingdom and was eventually admitted
io StobOill General Hospital. Oculogyric crises began Ue 1942.
On examination al ihe lime of admission she was discn1bei as g
thin woman wilt mask-like facies. She had typical Parkinsonism
tremor affecting ihe limbs, head, longue and There was some
loss of muscular power with wading. Speech was monotonous. She
seemed lo be of average intelligence and had g fairly good memory.
Deep reflexes wene normal; plantar responses wene flexon. Examination
of other systems revealed no abnormality except systolic ryevrtehsirn,
B.P. 170/86.
Examination in 1939 confirmed ihv former findings. There was
moderate rypinioh1a1ey of all limbs, more marked in ihe left arm.
Muscle power in ihe right anm was fginly good but was diminished un
otter limbs. The pupils were small, reading to light but ool lo
accommodation; /
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accommodation; there was sli^it weakness of the right lateral rectus
muscle. Blood pressure 170/90 mm.Hg.; pulse rate 80/min.
Treatment. In 1950 she had. been given benzhexol 20 mg. daily,
but in 1953 it was withdrawn owing to unbearable side-effects and she
started to receive Tincture of Stramonium 2 ml. daily.
Comment on present condition (i960). She suffers from very
severe oculogyric crises which, in the absence of any treatment, may
last up to 24 hour’s. She shouts during the crises. The face is
flushed and conjunctiva injected, and there is some lachiymation.
Excess salivation is invariably present. Tremor and rigidity are
increased. On a few occasions she sweats but she does not have
severe sweating crisis. The blood pressure is usually increased (the
systolic pressure rising by about 10 to 40 mm.Hg. and the diastolic
pressure by 10 to 30 mm.Hg.); the systolic pressure exceeds 200 mm.Hg.
and on some of these occasions she has had attacks of mild epistaxis.
The heart rate rises by about 10 to 20 beats per minute. In some
attacks there is vertigo with a tendency to fall to one side (if
patient is sitting up). It is evident that often she develops an
oculogyric crisis on the days she expects her sister to pay a visit.
The crisis usually starts a few hours before the visiting hour.
Case 2. M. Cra. Woman aged 40 years, admitted in 1944* She
gave a history of having had "sleeping sickness" at the age of 7.
Some years later she developed stiffness in both lower limbs with some
difficulty /
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difficulty in walking.
On examination at the time of admission she was found to be well
nourished but not very intelligent. She had increased muscle tone
and tremor in all limbs. The pupils were equal and of normal size,
reacting to light and accommodation. The tendon reflexes were
exaggerated.. Examination of other systems revealed no abnormality.
Oculogyric crisis was first noted in June 1949, about 22 years after
the attack of encephalitis lethargica.
Examination in 1959 showed no deterioration. Rigidity and tremor
were, however, almost entirely confined to the left side. The pupils
were normal in size and shape, and reacted to ligbt and accommodation.
She had a festinant gait. Speech was slow and monotonous. The
reflexes were normal apart from moderate increase in the knee jerks.
The blood pressure was 130/90; pulse rate 90-100/min.
Treatment. She had been treated originally with Tincture of
Stramonium (2 ml. daily), but in October 1950 she received instead
benzhexol (ATtane) 30 mg. in divided doses.
Comment. This patient has frequent oculogyric crises, up to
three per week. If treatment is inadequate they may last for 6--12
hours. They may be precipitated by emotional upset or by annoyance
(e.g., prunes for breakfast). It would appear that this patient can
sometimes bring on oculogyric crises at will.
During the crisis the eyes are rotated upwards and to the riyt.
Pupils dilate but react only sluggishly to liyt but not at all to
accommodation
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accommodation. The usual vaso-congestion is present. Salivation
is not excessive hut lachiymation occurs. She looks demented and is
often noisy. During a crisis respiration is irregular: following 
periods of apnoea the breathing is rapid and shallow.
The blood pressure does not rise significantly. The greatest
rise in the systolic and diastolic pressures is 10 mm.Hg. and 3 mm.Hg.
respectively. The pulse rate may rise up to 20 beats per minute.
Case 3. J. MoH. This man, aged $0 years, was first admitted to
Stobhiii General Hospital in 1933, following a "fit" in the street.
The history was obtained from his wife. At the age of 14 (about 1924)
the patient "suffered from sleeping sickness", and received treatment
in hospital. Subsequently he appears to have been completely free
from symptoms for 7 years: the post-enoephalitic syndrome began in 
1933 • about 2% years before his first admission to Stobhill General
Hospital. He complained of tremor affecting the right side. The
disability was progressive: dysarthria developed and hypersalivation 
became troublesome.
The clinical notes at the time of admission refer to a marked
tremor affecting the left arm and leg. The pupils were then irregular
and did not react to light or accommodation. He was sweating
excessively.
He was discharged in 193-4 but was re-admitted shortly afterwards.
At this time it was noted that he had an expressionless face and marked
tremor of all limbs, but the face and tongue were not involved. He 
was /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71
was again noted lo be sweating profusely. Reflexes wenv normal.
Exgiihg1Uro of other systems showed no abnormality.
Examination Un 1959 showed detexiorgiloh. He was now bedridden
with flexion deformity gl bolt knees. Tremor was present in all
limbs, and also Ue ihe lips, jaw and tongue. Piy'sHsm was dill
present. He was unable io feed himself and had some difficulty Un
swallowing. His speech was vezy indistinct. Muscle lone was
moderately Uecreaeid., especially on ihe left side; muscle power was
generally poor. There was dueeoaig1ioo of vye movement gltOougr
ihere was no definite palsy of extrinsic ocular muscles. His blood
pressure was 110/70 muHg. ged 10e pulse nale 72-80^10.
Tria1ifn•t* From 1942-1950 he was treated with g eergmioh1um and
ty^olhe mUxiune. BeozOexol was stbee1eu1id io 1950 and g marked
improvement Ue Ois condition was noted. Tnemon and sweating
dUi1hisrid, muscle lone became normal, and Oe had g feeling of well­
being. Laier ihgl year 01s treatment was suddenly changed lo aang-
i1phio hydrochloride (Panpahlt) and de1ir1rrg11rn followed within g
week. BeezOexol was rie1ar1id Un g dosage of 15 mg. daily and he has ,
niiaUnid on ehis ever sUnce.
Comment Despite receiving beozOexol 15 mg* daily, sweating
cr1eis ane frequent. Some ane very eiTire, requiring g change of
ggniie1s and bedclolhes three 11iie un one hour. He does nol have
oculogyric anieee* The riei ie systolic ged diastolic pressures
during severe attacks is up lo 50 ii.Hg. and 20 mm.Hg. reeeic11Tily. 
The /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
72
The degree of tachycardia also varies, but on one occasion the cardiac
rate was over 150 per minute. Commonly the cardiac rate is between
120-136 per minute.
Case 4. W. Sha. This man aged 54 years, was first admitted to
Stobhill General Hospital in August 1927* He gave a history of an
^influenzal" illness six years previously. Three years after the
attack of influenza he began to have tremor in his right hand and
shortly afterwards in his right leg.
On examination at the time of admission he was found to have no
difficulty in walking. There was increased muscle tone which was
more marked in the legs. He had typical Parkinsonian tremor and
facies. Both pupils reacted to light and accommodation. The deep
reflexes were normal and the plantar responses were flexor. No
abnormality was found in the other systems.
Oculogyric crises associated with fever and sweating began in
1938, 17 years after the acute phase of encephalitis lethargica. By
1959 his condition showed no material change, though judging by the
medical records, tremor and rigidity seemed to have increased sli^tbly.
His blood pressure was 13O/8O and he was not subject to tachycardia.
Comment. Both types of crisis (oculogyric and sweating) occur
in this patient and they may be present simultaneously. More
commonly however during sweating crises, involvement of the eyes is
restricted to staring without tonic deviation or rotation. The effect
of emotion in precipitating oculogyric crises is seen in this patient:
they /
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they often occur a few hours after he has been beaten in a game of
billiards or when he has lost a substantial bet. However, curiously
enough, after being told of the death of his father, 36 hours elapsed
before a crisis occurred. In this patient the blood pressure during
a crisis is much less than in Case 3: the increase does not exceed 
30 mm.Hg. systolic and 10 mm.Hg. diastolic. Tachycardia is also much
less, the maximum rate observed being 120 per minute.
Case 5. C. McM. A woman aged 56 years. She was admitted to
Stobhill General Hospital in December 1948. She had been well until
the age of 24 (1928) when she developed “sleepy sickness": she was 
treated at home. Shortly after the acute phase, she noticed tremor
of the left hand, and later of the right hand. Six years after the
acute phase of encephalitis lethargica she began to have oculogyric
crises. These episodes occurred about twice a week and lasted some
24 hours. During a crisis she felt as if she were going to fall, or
that objects in the room were rotating round her. She continually
had double vision with one image above the other, but during an
oculogyric crisis diplopia was much worse. She managed to do her
housework until four years before her admission to hospital.
On examination at the time of admission ( 1948) she was reported - 
to be a well built woman with tremor of the hands and tongue. She
had a sluggish speech and moderate deformity of the limbs. The
pupils were normal in size and reacted to light and accommodation.
The /
  
 
 
 
 
 
 
 
 
 
 
 
The deep reflexes were normal god 10e plantar hiserheee wene flexor.
The olhen systems showed no abnormality.
Examination un 1959 confirmed ihe findings of 1948 but ihe
rigidity was mainly lif1-s1cLid. The tendon reflexes were exaggerated
but 10e pla-nigr reflexes were flexon. The blood pnveeune was I6O/9O;
pulse rale 70/^10.
Treatment. She has been receiving beozOexol 20 mg. daily since
1953.
Comment. Her cnisie ane not now as frequent as they were, but
irein eeTir11y has not dUiUo1e^icL* During a crisis she repeals end­
lessly a iigo1hglise formula of words. The eyelids may dnoop and she
is unable io open ten eyes voluntarily (she raises lOe upper lid with
hen f1ogire). Superficial vasodilatation is veiy obvious: large 
numbers of diseiniei aap1tlgnUie are visible Ue lOe eateral conjunctiva.
She is ool noisy (no shouting) bui is often vezy weepy. The blood
pressure during crisis may niee and is sometimes gs high as 204/110;
god ihe cardiac nalv may increase io 120/muo.
Case 6. J. Cam Male, aged 57 years. This man had go
influenzal 1ltniee in 1917 lasting one month ged during which Oe was
very drowsy.
He has been Un Stobhill General Hospital since 1945, although he
was io ihe roseiegl for sOoni periods in 1955, 1954 and 1941 •
Examination gl the lime of aii1esUrh showed ihgl he tad slight
weakness of the ri^it side of ihe face and g mask-like expression.
He /
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He had no loss of musole power and the reflexes were normal.
Examination in 1959 showed deterioration. He had a moderate
degree of rigidity of his limbs, more marked on • his left side. His
musole power was rather weak and he had tremor of the limbs, tongue
and jaw. The right internal reotus muscle was paralysed. The deep
reflexes were exaggerated but there was no clonus. The plantar
reflexes were flexor. He was still ambulant but was not able to
feed himself. His blood pressure was 110/70 mm.Hg. and the heart
rate 78 per minute.
Treatment. He was treated with tincture of belladonna or
stramonium, but from 1950 he was treated with benzhexol (Artane)
10 mg. thrice daily.
Comment. He suffers from periodic attacks of severe sweating
crisis usually late at night or early in the day. During a severe 
attack he has increased tremor and makes clicking noises with the
tongue as it is alternately protruded and withdrawn. The face and
upper limbs are flushed but severe cyanosis has occurred during some
severe attacks. The sweating is often of such a degree of severity
that his garments and bed-clothes are changed every 15 to 20 minutes.
The heart rate rises to 120 to 140 per minute. The rise in systolic
and diastolic pressures during severe attacks is up to 50 mm.Hg. and
20 mm.Hg. respectively.
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PATHOGENESIS OP OCULOGYRIC CRISIS
Various theories as to the pathogenesis of oculogyric crisis have
been formulated. It has even been suggested that the tonic deviation
of the eyes is a hysterical manifestation. Two theories will however
be discussed in detail.
1 • The Relaxion-Sleep Mechanism Theory of Hall.
Hall (1931) in his Schoerstein lecture reported on 384 patients
with postencephalitic Parkinsonism, 60 of whom suffered from oculo­
gyric crises. He explored the possibility that the eye muscles
instead of being in a state of spasm were actually in a state of
relaxation.
He observed that in sleep the axis of the eyes is upwards in 34
per cent of cases, forwards in 38 per cent, downwards in only 3 per
cent, and to one side in 3 per cent. He also drew attention to the
sequence of events ihen the normal person closes his eyes: when the 
lids make contact the eyeballs roll upwards. He noted that sleep
relieved the crises and also that there is absence of wrinkling of the
forehead during crises. He considered that these observations
suggested that upward rotation of the eyes is due to a sleep mechanism.
He drew a comparison between the movements of the extrinsic ocular
muscles and the eyelids in oculogyric crises and actors hurrying off
the stage before the fall of the curtain. He suggested that ' the
drawing of the head to the same side as the d1Tncyion of the eyes is
a compensatory action secondary to ocular inhibition. This theory,
thcogy /
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though ingenious, is unsatisfaetory in many respects. The absence of
wrinkling of the forehead is not invariable during oculogyric crisis.
Its absence however does not prove that it is part of relaxation of
the frontalis muscle during sleep. Fig. 9 shows a patient with post-
enoephalitic Parkinsonism looking upwards voluntarily. No wrinkling
of the forehead is seen, perhaps because of rigidity of the muscles of
the forehead. There is a suggestion that failure of the eyelids to
close when the have been rolled upward causes distress: this
is not true, for a number of our patients sleep with their eyes
partially open and the eyeballs rolled upwards. Further, one such
patient has oculogyric crises periodically but not when he has fallen
asleep with his eyes open. Again, Case 5 at some stage during oculo­
gyric crisis has marked drooping of the upper lids. The eyes are
shut and the patient is unable to open them unless she lifts the lids
with her fingers. The "falling of the curtain" does not seem to
relieve her of her distress; on the contrary, whenever this occurs
she becomes more distressed. Patients with photophobia during crises
keep the eyes tightly closed and the eyeballs are rolled upwards, but
these ciroumstances do not cause such patients to go to sleep.
The fact that natural or drug-induced sleep aborts the crisis does
not constitute evidence that upward rotation of the eyes during crisis
is a sleep mechanism. On the contrary the beneficial effect of sleep
is due to the rest it gives to the active parts of the nervous system
and the body as a whole, including the extrinsic ocular muscles.
2. /
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Fig. 9. Patient voluntarily looking
upwards. Note gbeihai of
wrinkling of
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2* The Compulsive Obsessive, Theory of Jelliffe.
Jelliffe (1929) tried, to show that oculogyric crisis is a mani­
festation of compulsive obsessive neurosis in patients who suffer from
post-ennephalitic Parkinsonism. He gave the histories of four cases
and tried, to show that some mental or emotional trauma was essential
for the initial onset of oculogyric crisis.
During an interview with one patient (No. 4) &n oculogyric crisis
developed, and the patient said that a million ideas were going through
his head - including an urge to kill his brother, etc. Jelliffe
believed that there was a repressed feeling in the subconscious which
was responsible for the crisis. The rotation of the eyes and the
shouting were regarded as ritualistic and secondary to a repressed
feeling - usually one of guilt. He believed that there was a
“stickiness of thought" (Jelliffe) during the attacks and that this,
together with the associated bradykinesia which is usually present, is
a correlated part of the ik1netic-dysk1nny1c situation that occurs
during oculogyrio crisis.
Jelliffe's theory seems to have been quite widely accepted.
Curran and Partridge (1955) state that organic disease such as enceph­
alitis lethargica may lead not only to obsessive compulsive phenomena
in the ordinary sense but to parallel development in the motor fields
such as co-ordinated tics and oculogyric crisis. They believe that
these compulsive acts may be ritualistic.
There is no doubt that the tonic rotation of the eyes and the
associated /
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aaaoclated phenomena in ooulogyrio crises cannot be controlled by the
patient, and therefore in the ordinary sense they are compulsive.
There is however no evidence that the motor phenomena are ritualistic
as a result of repressed feeling such as feelings of guilt*
This theory does not explain why the oculogyric crisis is seen
only in post-encephalitic Parkinsonism; and there are a great many
people who suffer from the effects of repressed feelings of guilt.
It is not uncommon for people to evolve a teleological explanation for
the symptoms of their diseases. They convince themselves that the
symptoms are due to some wrongdoing which they committed previously.
The association of mental or psychological trauma with the initial
onset of oculogyric crisis as observed by Jelliffe has not been con­
firmed in the present series of patients. Most of them can still
remember the first attack and they do not associate its genesis with
any mental or psychological trauma. On the other hand it may be
aigued that patients commonly suppress their recollection of their
psychological aberration and retain only its "equivalent" in the form
of abnormal behaviour. Only careful psychiatric assessment could
elucidate such a mechanism.
Stogdill (1934) has attacked the psychoanalyst view that neurosis
is due to activity of energised ideas repressed into consciousness.
He showed how a remote and irrelevant stimulus can become associated
with neurotic behaviour. He then stressed the fact that neurotic
behaviour, far from being a ritual, is behaviour that has been learnt.
Apart /
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Apart from encephalitis lethargica. Parkinsonism may he due to
a variety of causes such as arteriosclerosis, caihon monoxide or
manganese poisoning, syphilis, hepatolenticular degeneration, or it
may he due to idiopathic paralysis agitans. It is significant that
the oculogyric crisis occurs only in post-e^ephaHt^ Parkinsonism.
It has been stated that oculogyric crises also occur in patients with
Parkinsonism associated with cerebral syphilis. Pearson (1927) how­
ever reviewed the cases reported; he showed that in all such reported
cases (including the single case record which he had published) there
was always an initial illness which was not unlike encephalitis
lethargica. He therefore concluded that oculogyric crises in such
patients had heen the sequel to previous attacks of encephalitis
lethargica, and that the concomittant syphilis had had no influence
in the pathogenesis of the crises.
Recently however “oculogyric crises" have heen reported following
the administration of drugs of the pheno thiazide group (Montgomery and
Sutherland 1959, Davis 1959, Bickerstaff and Jacoby 19^0). This type
of oculogyric crisis is however different from the Parkinsonian form
in that spasm of the neck muscles with head rotation - and even
opisthotonos - is very common and usually precedes upward eye rotation
by up to 30 minutes. Faulkner and Hyde ( 1958) have shown that elec­
trical stimulation of the midhrain in experimental animals can cause
conjugate deviation or rotatory movements of the eyes associated with
op^^o^n^ movements. It may he therefore that these drugs produce
similar /
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similar effects by actions on the same zones of the midbrain. It
should however be noted that oculogyric crises have not been seen in
patients with drug-induced Parkinsonism.
Why then is oculogyric crisis confined to post-encephalitic
Parkinsonism? Pathological studies (McAlpine - 1926) -and others have
shown that although the inflammatory process may be widespread and
involving the cerebrum, the midbrain and pons bear the brunt of the
disease. The most significant pathological changes are the degen­
erative ones in the substantia nigra. In the other forms of
Parkinsonism the lenticular nucleus bears the brunt of the disease
process.
Clinically palsy of the 3rd, 6th and 7th cranial nerves are
frequently seen in post-encephalitic Parkinsonism. Palsies of these
nerves from the midbrain and pons are very rare in the other types of
Parkinsonism. One may therefore conclude that an important difference
between the two forms of Parkinsonism (postencephalitic and non­
postencephalitic) is that the former is primarily due to an upper
brain stem lesion while the latter is due to lesions in the lentiform
nucleus.
Recently Shanzer and Bender (1959) studied the effect of brain
stem lesions on oculomotor response to caloric stimulation and found
that defects in nystagmus and tonic deviation of the eyes occurred as
compared with the response in the normal animal. They found, for
instance, that in a monkey with a superior brain stem lesion on one
side /
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side there was a defect in tonic deviation of the eyes to the side
opposite to the side of the lesion. They also found that, on
bilateral caloric stimulation, only upward tonic deviation of the eyes
occurred and nystagmus, when present, had its fast component upwards.
This oculomotor response is not unlike the tonic eye movements and
nystagmus seen during oculogyric crises.
The effect of midbrain lesions on muscle tone has been widely
studied in experimental animals. Hettler and Zimmerman (1943) found
that in cats lesions above the level of the red nucleus gave rise to
contralateral rigidity, while ipsilateral rigidity was produced by
lesions of the tegmentum below this nucleus. Hardy and Stevenson
(1957) reported a case of unilateral syringomesencephalia involving
the substantia nigra. This patient had signs of Parkinsonism on the
contralateral side. Our observations on this series of patients
shows that in a majority of cases, where a predominant unilateral
rigidity and lesion of the nerves to the extrinsic ocular muscles are
present in the same patient, the cranial nerve lesion is on the contra 
lateral side to the rigidity. This explains why ihen upward and
lateral conjugate deviation ' of the eyes occurs in oculogyric crisis,
the direction of movement of the eyes is usually away from the more
rigid side of the body. Thus if the patient * s right side is more
rigid than the left side, in an oculogyric crisis with upward and
lateral movements the resultant deviation of the ocular axes will be
to the left side.
A previous study of post-encephalitic Parkinsonism was carried 
out /
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out by Crow in 1949 working in this hospital (Stobhill General Hos­
pital, Glasgow)* About 60 per cent of the patients who are now in
the “post-encephalitic wards” were included in Crow's series (Crow, 
1949). He reported on the effect of various afferent stimuli (such
as spraying of the side of the neck with ethyl alcohol, 'sniffing strong
ammonia and caloric vestibular stimulation) on eye movements in
patients suffering from post-encephalitic Parkinsonism* He found that
he was able to induce oculogyric crisis only by caloric vestibular
stimulation*
Study of the various ocular abnormalities in this series of
patients shows that 75 per cent of the 20 patients suffering from
oculogyric crisis have nystagmus; but of the 40 patients who have
neither oculogyric nor sweating crises only 5 per cent have nystagmus
(Table 2). In the group with oculogyric crisis nystagmus was
ordinarily present in 9 of the 20 patients (45 per cent), and this
was increased to 15 (75 per cent) when the patients were observed
during crises (Fig* 10). True vertigo was complained of by 8 of the
20 patients (40 per cent) during attacks of oculogyric crisis* The
vertigo took various forms, for example, a tendency to fall to one
side, apparent rotation of objects, and the sensation of seeing the
floor advance towards the patient. No case of true vertigo was seen
in the other two groups of patients. Dizziness in the ordinary sense
was however fairly evenly distributed in the three groups. Crow was
unable to correlate liability to oculogyric crises and the presence of
nystagmus. /
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GROUPS OF
PATIENTS
TOTAL
NUMBER
NUMBER OF PATIENTS WITH
NYSTAGMUS VERTIGO
WEAKNESS OR
PARALYSIS OF
EXTRINSIC EYE
MUSCLE
RECENT
DIPLOPIA
OCULOGYRIC
CRISIS
20 15 8 5 6
SWEATING
CRISIS 3 2 0 5 3
WITHOUT
OCULOGIRIC
OR
SWEATING
CRISES
40 2 0 5 2
TABLE 2. Relative incidence of vertigo, nystagmus
and other ocular lesions Ue ihe various
' groups of the 67 pa11ihee*
NYSTAGMUS DURING CRISES ONLY.
• •• < • •
VERTIGO DURING CRISES.
RECENT DIPLOPIA.
WEAKNESS OR PARALYSIS OF
EXTRINSIC OCULAR MUSCLE.
-»—I—♦—y r t < -1—1—1—1—t—1—»—’—1—«—'—»—0 NO. OF CASES. 20
Fig. 10. The relationship beiwiin vertigo and certain
a'bnonmgl1t1ee of ocular movement in 20
patients wUih oculogyric cr1sie.
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nystagmus. However this may be attributable to the faot that his
criteria for the diagnosis of oculogyric crisis differed from the
criteria adopted by the present writer: Crow includes patients who 
showed staring without deviation of the ocular axes. Again in the
earlier paper, no account is taken of ' the fact that patients normally
free from nystagmus may show this abnormality during oculogyric crises.
There is no evidence of cerebellar dysfunction in this group of
patients. In view of the prevalence of nystagmus in these patients
with oculogyric crisis and the presence of vertigo in a fair pro­
portion during oculogyric crisis, one may therefore conclude that the
vestibular apparatus (with special reference to its pathway and con­
nections in the brain stem) is involved in these patients with
oculogyric crises.
Examination of the auditoxy canals in the whole series revealed
that 40 of the 67 patients had grossly excessive quantities of hard
wax completely blocking one or both ears. In most of them the wax
was black - almost tarry in appearance - but in a few it was creamy
white. The findings on aurisccpic examination appeared to be of
considerable importance when reviewed in relation to the total clinical
picture. It is of interest to note that most of the patients with
little or no wax in their ears were those with mini mal signs of
Parkinsonism or had perforated eardrums (Tables 3 snd 4)- It seemed
possible therefore that the finding of a greatly increased secretion
of wax in the auditory meatus was a sequel to post-encephalitic
Parkinsonism. /
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TABLE 3.
No, Name Age
Degree
of
Rigidity
Eye Lesion
Degree
of wax
R. Ear
Degree
of wax
L. Ear
Crises
1. J.Bla 62 moderate none 2 2 none
2. J.Bel 62 mild to none 2 1 none
moderate
3. J.MoC 50 moderate vertioal nystag- 2 2 none
mus on movement
4. D.Sor 57 moderate vertical and hor- 1 2 sweating
izontal nystagmus crisis
on movement.
5. A.Ead 46 severe none 2 2 none
6. J.MoP 46 severe none 1 2 "screaming
turns"
(very in-
frequent)
7. N.San 47 moderate none 1 1 none
8. H.Dev 48 severe nystagmus only 1 2 ooulogyrio
during oculogyric crisis
crisis.
9. T.&al 48 mild none 0 0 none
10. J.Smi 53 moderate none 1 2 none
11. J.McI 58 moderate none 1 2 none
12. J.MoM 50 moderate Dissociated eye 1 2 sweating
movements. crisis
Diplopia.
13. H.War 63 moderate none 1 2 none
14. J.Esp 50 moderate none 2 1 none
15. R.Pra 42 moderate Diplopia. Disso- 2 1 oculogyric
ciated eye move- crisis
ments. ? slight mild
weakness of right sweating
internal rectus. at time 2.
Nystagmus only
during crisis.
16. M.Law 46 severe horizontal and 2 1 sweating
vertical nystag- crisis
mus on movement.
Some weakness of
right internal
rectus.
17. R.Bro 51 severe nona 2 _ 1 none
18. J.Dea 56 moderate none 1i 0 none
19. C.Han 50 moderate some dissociated 2 1 none ex-
eye movements. cept for
eye staring
20. P.Cam 42 severe weakness both 2 2 none
internal recti.
Dissociated eye
movements.
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No. Name Age
Degree
of
Rigidity
Eye Lesion
Degree
of wax
R.Ear
Degree
of wax
L. Ear
Crises
21. J.Cam 57 moderate Diplopia 3rd
nerve palsy
right side.
Bilateral ptosis
- more on right.
1 2 sweating
crisis
22. P.Cad 45 moderate Horizontal and
vertical nystag­
mus on movement.
Dissociated eye
movement. Diplopia.
1 0 mild
oculogyric
crisis
23. A.Hay 50 moderate Nystagmus on
looking down­
wards.
0
per­
foratedeardrum
2 mild
oculogyric
crisis
24. T.Pow 56 moderate Diplopia. 1 2 Eye staringmainly
but occas­
ionally
has true
oculogyric
crisis
25. J.McE 42 mild none 0 0 none
26. J.Nim 47 moderate Difficulty in
moving the eyes
without moving
the head.
0 1 patient
has hemi
balllimus
He has
fye staring
with head
retraction.
27. T.Wyp 54 mild none 1 1 none
28. C.Fea 55 mild none 1 0 none ex­
cept for
qye staring
29. D.Vil 48 mild none 0 0 none
30. V.Sha 53 moderate none 1& 2 oculo­
gyric and
sweating
crises
31.
32.
T.G-ar
P.Wal
37
47
severe
moderate
Weakness of all
movements. Cannot
sustain eye move­
ment except for
forward gaze.
none
0 0 none
none
TABLE 3. To show details of ocular lesions, degree of rigidity and
excess wax in the ears and typo of crisis in the 32 male 
patients.
(Pupillary lesions were not included as the patients were on
drug therapy for Parkinsonism).
NOTE: 0 = no wax at all
1 = moderate degree of excess wax
2 s complete blockage of the external
auditory meatus.
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TABLE 4
No. Name Age
Degree
of
Rigidity
Eye Lesion
Degree
of Wax
R. Ean
Degree
of Wax
L. Ear
Cniefe
1. M.Dob 56 severe none li 2 none
2. K.Has 45 efTfnf none ii 2 none
3. C.Ros 71 moderate none 2 2 none
4. C.Jon 78 moderate none 2 2 none
5. A.McQ 44 moderate Vertical nystag­
mus.
2 2 oculogyric
vfn1ugr
sometimes
dLehhg orlsis
6. M.Cal 71 moderate none 0
penf
van
0
ongled
drums
none
7. M.Pgy 48 mild none 0 0
pen-
fangtjd
eardrum
none
8. A.BUs 53 efTfnf nystagmus in both
dUnfc1urne on
movement.
1? 1 oculogyric
cnueUe
9. A.NUv 41 sevene some wfgknfee of
left external
nfc1ue* Hori­
zontal nystag­
mus on movement.
1 0 "schegming
tuhns"
10 C.MoK 57 sevene Paralysis R. Un- 
lenngl nfc1ue*
VenlUcgl and hor­
izontal nystag­
mus on movement.
2 2 oculogyric 
cnisls. 
Vertigo 
sometimes 
present;.
11. J.Hug 50 mild none 0 0 none
12. R.&rs 52 moderate nystagmus gl
nfe1. Diplopia.
li 2 oculogyric
cnUeue.
Vertigo sonf- 
1Umfe erv- 
efn1* Du- 
elceUg worse
during
onUsis.
13. R.CaU 62 efTfnf none 2 2 ooulogynUc
crueue.
14. M.Pea 62 efTfnf none 2 2 breath
holding
attacks.
15. M.Cng 40 mild nystagmus during
cnueue only.
1 V oculogyric -
onUsls.
Diplopia
and mild
vfn1ugo
during
0x1^^.
16. A. Sin 70 moderate none 1 1 none
17. M.MoC 48 mild Cannot move R.
eye lo full
range in both
<dinfc1Uon.e.
0 1J none
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No. Name Age
Degree
of
Rigidity
Eye Lesion
Degree
of Wax
R. Ear
Degree
of Wax
L. Ear
Crises
18. C.Sco 74 moderate none 0 1 none
19. A.McL 54 severe nystagmus during 1J 2 oculogyric
oculogyric crisis
only.
crisis
20. A.Tan 51 severe none 1| 1| none
21. A. Pol 54 severe ? some weakness R. 2 2 oculogyric
lateral rectus.
Nystagmus only
during oculogyric
crisis.
crisis
22. E.McO 54 moderate none 2 1| sweating
crisis
23. A. Mel 49 mild none 0 0 none
24. J.Pat 56 moderate Weakness R.exter- 2 2 oculogyric
nal rectus. Nys- crisis.
tagmus only Vertigo
during crisis. sometimes
present,
mild swea­
ting crisis
25. C.McM 55 mild to Weakness R.inter- 0 1 oculogyric
moderate nal rectus. Dip- crisis. Dip-
lopia. Nystagmus lopia worse
only during during cri-
crisis. sisVertigo
sometimes
present:.
26. M.&il 49 mild none 0 2 oculogyric
crisis with
marked
photophobia.
Vertigo
sometimes
present.
27. M.Aus 58 mild none 0 0 none
28. R.Mon 39 moderate none 2 2 sweating
crisis
29. M.McL 56 severe horizontal nys- 1 2 oculogyric
tagmus on move- crisis. No
ment. Diplopia. vertigo or
diplopia
during
crisis.
30. A.Car 47 severe weakness both in­
ternal recti.
Dissociated eye
movements.
1? 2 none
Diplopia.
31. H.McC 39 moderate none 0 i none
32. E.McK 56 moderate none 2 1? none
33. A.McL 59 mild to Diplopia 1? 12 none
moderate occasionally.
34. C.Bun 50 mild none 1 i oculogyric.
Vertigo some-
times during
crisis.
35. M.Rei 47 mild none 2 1| oculogyriccrisis (infr'e- 
quent). No
vertigo or
diplopia.
88b
TABLE 4
Details of ocular lesions, the degree of 
rigidity, the degree of excess wax in the 
ears, and the type of crisis in the 35 
female patients.
(Pupillary lesions are not included as the 
patients were on drug therapy for Parkin­
sonism.)
NOTE.
0 = no T/ax at all
1 = moderate degree of excess wax
2 .' = complete blockage of the external
auditory meatus.
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Parkinsonism. This was not entirely unexpected: seborrhoea and a 
greasy skin are Characteristic of this condition (Denny-Brown 1946,
and Mackenzie 1927) and it may be that increased activity of the
sebaceous glands of the skin is paralleled by an increase in the
secretion of wax. It is suggested that the persistence of a gross
excess of hard wax in the auditory canals is a possible source of
vestibular stimulation capable of inducing oculogyric crisis in
patients with suitable brain stem lesion.
It may be concluded that at least two factors are essential
before oculogyric crisis can occur*, viz:
1. The existence of a particular type of lesion of the brain stem
which produces nystagmus without evidence of cerebellar dysfunction.
Such a lesion is probably an irritative one situated in the vestibular
pathway.
2. Some source of vestibular stimulation such as the presence of
hard wax in the external auditory canals in sufficient amounts to cause
obstruction to the lumen and tension in the walls of the canals. Other
sources of vestibular stimulation, such as revolving while waltzing are
capable of precipitating an oculogyric crisis (McGowan and Cook, 1928).
It is of great interest that from theoretical considerations of
the effects ' of lesions of the vestibular nerve and pathway on the
movements of the bocy in vertebrates. Muskens (1927) concluded that
the oculogyric crisis in post-encephalitic Parkinsonism is due to a
lesion in - the posterior commissure in the region of the midline, that
is /
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is al ihe area of decussation of ihe cephalic fibres from ihe
Tese1bular nuclei.
D^verger god Barre ( 1921 ) from g clinical study of ihe effects of
caloric vestibular stimulation Un patients suffering from igbes
dorsalis and eos1-ihciehalie1c Parkinsonism, glso came to ihe con­
clusion ihai ihe disorders associated with ihe eyes (eye1ggmue,
diplopia, weakness of ihe extrinsic ocular muscles aed spasms which
lead io fixation of ihe ocular axes) in these diseases are of laby­
rinthine origin.
In 4 patients gh attempt was made io determine the therapeutic
value of removing wax from ihe auditory canals. The wax was first
eofeihid with MCirtmot" aed il was then dislodged by syringing.
During ihe following 8 weeks ihere was no significant reduction in ihe
number of oculogyric crises in these patients, bui in one of them the
severity of ihe crises was appreciably iUmUnishiiL.
Thai ihe brain stem, especially ihe mU^halo, contains 101x1^10
co-ordUnaeUng mechanisms capable of producing conjugate eyv movements,
has been observed by various workers and ihis has recently been con­
firmed by Hyde and El1aeerh (1958) and Faulkner ged Hyde (1958).
Sa^^go^al (1950) has shown that ihere grv numerous crhefct1rns
between ihe labyrinth and ihe extrinsic ocular muscles.
The lime 1n1irTal between ihe aculv illness of encephalitis
lethargies and ihe ohsei of oculogyric crisis is veuy TgrUgbli:- 11 
may be g few years or as long as 22 years. The explanation mgy lie
Un /
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in circumstances which in turn depend upon the different factors con­
cerned in the pathogenesis of oculogyric crises and to which reference 
has been made above. Although reactivation of the infective process 
is denied by various workers (MacKenzie 1927, McPhater 1942), there is 
no doubt that the disease may be progressive and that it may extend in 
the upper brain stem and involve zones and tracts that were not 
originally involved.
Anatomy and Physiology of Emotion.
As emotional excitement (occasionally depression) is common - 
particularly in severe oculogyric crises - the anatomical and physio­
logical aspects of emotion will be discussed briefly in the hope that 
this may throw some ligit on the pathogenesis of oculogyric crises.
The concept of emotion however has for long been a matter of 
controversy among psychologists. There has been much confusion as 
to what “emotion* really means. Duffy (1934) suggested that the term 
“emotion” should be completely abandoned as the concept does not serve 
any useful purpose in soientifio psychology, her main objection being 
that no difference can be found between emotional and non-emotional
responses.
Cannon (1927) and Bard ( 1934*) however showed that emotion implied
two things: (l) a way of acting, or the expression of emotion;
(2) a subjective experience - which includes the neural processes
which lead to emotional awareness.
In attempting to localise the area of the brain concerned with 
emotional expression, Cannon and Britton (1925) found that even the 
decerebrate /
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decerebrate animal is able to show expression or to exhibit behavioural 
patterns commonly associated with emotional excitement* Thus these 
animals were capable of snarling and clawing accompanied by dilatation 
of the pupils and greatly increased arterial blood pressure and heart 
rate. Bard (1934) demonstrated that the presence of the thalamus is 
not essential for the occurrence of the phenomenon of sham rage* He 
concluded from his study that the expression of emotion originates 
from activities of the posterior hypothalamus and possibly the mid­
brain*
Electrical stimulation of the hypothalamus (Kabat, Anson and 
Magoun 1933) gave rise to a marked increase in arterial blood pressure, 
pupillary dilatation, sweating, etc* Eedgate and GelUiorm (193^) 
demonstrated the tonic vasomotor function of the hypothalamus, showing 
that among the functions of the posterior hypothalamus is that of 
raising the blood pressure and Increasing the heart rate; it also 
appears to exercise some control over the medullary vasomotor centre*
The rise in blood pressure, tachycardia, paroxysms of sweating, 
irregular respiration, tremor, flushings of the face and conjunctiva, 
and even increased salivation seen during oculogyric crises are all 
recognised accompaniments of emotional expression and are probably 
mediated by diencephalic over-activity.
Other areas of the brain however have been shown to have an 
effect on the blood pressure, heart rate and respiration* Smith 
(1945), and Ward (1948) using experimental animals - and later using 
human /
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human subjects Pool and Rasohoff ( 1949) - showed that stimulation of
the cingulate gyrus led to a rise in blood pressure, to changes in
respiratory rates, but more frequently to a fall in heart rate.
Ihitty (1955) came to somewhat similar conclusions when he studied
the effect of anterior cingulectomy on patients with anxiety neuroses
or obsessional states. A significant rise in blood pressure and
heart rate, and the onset of irregular respiration have all been shown
to occur following stimulation of the temporal lobe or the orbital
surface of the frontal lobe (Kaada et al. 1949; Kaada and Jasper
1952; Van Buren 1958; Degaldo and Livingston, 1948).
Althcoigh the hypothalamus, anterior thalamic area, cingulate
gyrus, hippocampus end their interconnections may all be involved in .
the elaboration of central emotion and in the production of emotional
expression (Papes 1937), the “emotional” accompaniments of oculogyric
crises (hypertension, tachycardia, congestive phenomena, irregular
respiration, dilated pupils, excessive salivation and shouting) are
comparable with pseudo-affective state (sham rage) of Cannon and
Britton (1925) except that the post-encephalitic patient is conscious
of what is happening. The inhibitoiy cortical fibres from the
cerebral cortex to the diencephalon are partially damaged as a result
of the widespread inflammatory process resulting from encephalitis.
He is therefore deprived of the full measure of inhibition normally
available to counteract the sham rage syndrome generated in the
diencephalon.
Numerous /
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Numerous collateral ernhict1ohs from ihe afferent pathways,
especially from the 8th nerve to ihe reticular system of ihe brain
stem, ihe subihglgmus, the hypothalamus and the veh1rrmedUgl portion
of ihe thalamus, have been demonstrated hy Starzyl, Taylor and Magoun
(1951), sod French, Amirrhgeh god Mggouh (1952). The slUmuLgllon of
ihe reticular system of these areas from vestibular slimulgtion is
probably responsible for ihe tachycardia, congestive stales ged other
dieiuhbaeeee which gccrmegny oculogyric crisis. Il can hardly be
doubled . that rotation of ihe head and neck is ihv sequel io vestibular
ee1mtlg1ion.
The Role of Emotion Un Precipitating Oculogyric Crises.
The effect of emotion as a precipitating factor has been observed
Un this series of patients; the conclusions are simllgh lo those of
previous workers (Bramwell, 1928; MeCowae and Cook, 1928).
In analysing ihe faeiors coheehned in the pathogenesis of oculo­
gyric crises a iisiihei1rn must be made between ihe initial phase and
a later stage of recurring eh1sie* In ihe light of Ueformaiioh
gathered during the present study it is elvgh that the first crisis
is nol ihe direct hesuli of emotional upset or mental trauma. The
onset of go oculogyric erieie is almost certainly due lo vestibular
e11mulg1ion* The rather sudden and spontaneous loole rotation of
the eyes may well generate emotion ged indeed fear, anxiety on grief,
god ihe manifestations of emotional unsigbiliey already dieeribid^•
The patient may tuy to devise a teleological explanation of the whole
disturbance /
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disturbance and thus comes to correlate the rolling of the eyes with
some particular pattern of thought - likely enough to be associated in
some cases with the feeling of guilt. As a result of a temporal
relationship between the eye movements, the subjective experience on
the one hand and some environmental factors (such as the presence of
patients' relatives, meal times, particular types of food) on the
other hand., an association develops between them: in other words the 
pattern of a conditioned reflex is established. The environmental
factors however are quite irrelevant to the original mechanism whereby
the crises were generated. Recurring ooulogyrio crises in a par­
ticular environment have the effect of conditi oning the patient to
these environmental factors or to certain thought processes and thus
create a spurious concept of cause and effect. When conditioning
has occurred, these thought processes and “irrelevant” environmental
circumstances may indeed assume major importance, for the patient may
become the victim of suggestion based upon a complex conditioned
reflex. Thus adventitious circumstances can eventually provide
powerful sensoiy impulses precipitating motor upsets (oculogyric
crises and all that goes with a crisis), notwithstanding the fact
that the first crisis in the patient's experience was purely somatic
in character.
The main thesis presented in this section to account for the
pathogenesis of oculogyric crisis is essentially somatic. That is to
say the crises are the outcome of vestibular stimulation dependant on
physical /
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physical conditions. Nevertheless it must be considered that the
clinical picture is complicated by the undoubted importance of
psych ologi.cll factors. Thus in the present series there is ample
confirmation of the views of previous worker's who stressed the
significance of emotional disturbances which predispose to the
onset of oculogyric crises. It is possible to visualise this
sequence of events as a lowering of the threshold of the mechanism
governing upward conjugate deviation of the eyes in oculogyric crisis 
The lowered threshold may be due to neuronal activity in the
diencephalon and upper brain stem occasioned by the subjective aspect
of emotion.
   
o\
Encephalitis Lethargioa
I
Some cerebral cortical 
damage especially in 
the frontal lobe.
1
leads to loss of some 
cortical inhibition
Brain stem lesion
of the type to produce weakness 
or paralysis of extrinsio ocular 
muscles dissociated eye movements 
but especially the type to produce 
nystagmus without cerebellar dysfunction.
Impaired 
cortical 
inhibition 
makes (3) 
very prominent.
Conditioning to various 
stimuli due to temporal 
relationship
Pig. 11
<-----------------------
Vestibular stimulation
to such a damaged brain stem leads to
1. Abnormal vestibulo-ooular reflex 
with tonic upward glance (oculogyric 
crisis) with associated head and neck 
movements.
2. Stimulation of the reticular 
formation of the brain stem
which oauses increase in rigidity and 
bradykinesia.
3. Stimulation of the reticular 
formation of the diencephalon 
especially the hypothalamus leads
to hypertension, tachycardia, excess 
lachiymation and salivation, oongestive 
phenomena and .changes in mood with noisiness 
- moaning, howling, laughing, etc.
Leads to production of the 1,2 and 3 by 
* these associations - though fortuitous.
To illustrate the pathogenesis of oculogyric crises
and associated phenomena
1
Excessive production 
of wax in the external 
auditory meatuses block 
ing one or both of them
I
a source of
vestibular stimulation
other sources of 
vestibular stimulation 
may play a part.
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SUMMARY
A study of 67 patients with post-enoephalitio Parkinsonism
reveciLel three types of crises: they can be described as oculogyric,
sweating and breath-holding.
The clinical accompaniments ' of oculogyric and sweating crises 
are described. Attention is drawn to the vasomotor changes which 
occur during severe oculogyric and sweating crises and to changes in 
mood during ooulogyrio crises.
The pathogenesis of the oculogyric crisis is discussed. It is 
suggested that ocular deviation is the consequence of a vestibulo- 
ocular reflex in patients with brain stem lesions involving the 
vestibular pathway. The emotional changes which accompany oculo­
gyric crises are probably the ' result of stimulation of the diencephalon.
The role of emotion in precipitating oculogyric crises is con­
firmed. When emotion is known to play a part, it is suggested that 
the mechanism includes a conditioned reflex. Alternatively it may 
be that the onset of emotional disturbance sometimes permits activity- 
in the vestibulo-ocular reflex; activity which in the non-emotional 
state is materially inhibited.
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CHAPTER III
DRUG THERAPY IN THE CRISES
OF POST-ENCEPHALITIC PARKINSONISM
In the preceding chapter the manifestations of the various types 
of crises in post-encephalitic Parkinsonism were described and the 
pathogenesis of oculogyric crisis was discussed* This chapter will 
deal with the problem of drug therapy in oculogyric and sweating 
crises*
In the past it was the practice in the two post-encephalitic 
wards of this hospital, to resort to barbiturates such as amylo- 
barbitone, used essentially as powerful hypnotics and administered 
orally for the treatment of these crises* This therapeutic approach 
to the emergency presented by patients in crisis failed to do justice 
to the predominantly motor character of the disorder* It seemed 
preferable to use sodium phenobarbitone administered parenterally, for 
this is recognised to be the drug of choice in preventing and supp­
ressing epileptiform seizures by depressant effect upon the motor
cortex of the brain*
METHOD AND MATERIAL
A preliminary study was made of the relative merits of sodium 
amylobarbitone (200-300 mg* by mouth) and phenobarbitone (200 mg* 
intramuscularly /
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intramuscularly as the sodium salt). Subsequently the method of
parenteral administration of sodium phenobarbitone was modified:
150 mg, was given intravenously and the remainder (50 mg.) was then 
injected intramuscularly; this method was used ihile studying 9 
patients with severe . oculogyric crises, and 4 patients with sweating 
crises - in two of whom the crises were very severe. The effect of
the drug on the various manifestations of a crisis was recorded every 
10 minutes: the phenomena noted were the direction of the deviation 
of the eyes, ability to move the eyes voluntarily in both vertical and 
horizontal directions, the state of the pupils, degree of rigidity and 
tremor, heart rate, level of blood pressure, salivation, sweating and 
mood. As a control procedure, on 6 occasions, 4 patients who were in 
crisis received normal saline intravenously and intramuscularly. The 
combined intravenous and intramuscular phenobarbitone therapy has been 
given in 49 instances of severe oculogyric crisis and in 10 severe 
sweating crises. , ,
It is emphasised that . all the . patients included in this study were 
deliberately selected because of the severity and long duration of 
their crises. Table 5 . shows the approximate duration of their
untreated crises in each case. . ,
The effect . on oculogyric crisis of 0.6 mg. of atropine . sulphate 
and 0.6 mg. of hyoscine hydrobromide made up to a 5 . ml. solution in 
sterile water and injected intravenously was subsequently studied. 
Hyoscine was given on 11 occasions to 4 patients (W.S.; J.P.; M.G-. ;
and /
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Nil me Sex Age
(yr.)
Type of
crises
Duration
if
untreated
(hr.)
No. of times
parenteral
phenobarbitone
therapy
given
No. of
failures
or
relapses
No. of
times
placebo
injections
given
J.C. M 57 Sweating
(v. severe)
2-4 7 I failure
(partial)
—
J.M. M 50 Sweating
(v. severe)
2-4 3 1 relapse —
W.S. . M 53 Oculogyric
(occasional
sweating)
4-10 7 1 failure „ 2
H.D. M 48 Oculogyric 3-6 3 — —
J.P. F 56 Oculogyric
(occasional
sweating)
6-12 7 — —
M.C. F 40 Oculogyric 3-6 8 1 relapse 2
C.M. F 55 Oculogyric 3-5 3 — —
M.G. F 49 Oculogyric 4-6 14 1 failure 1
M.R. F 47 Oculogyric
(very
infrequent)
3-4 1 1 relapse —
R.G. F 52 Oculogyric 3-5 2 — 1
A.M. F 54 Oculogyric 5-10 4 — —
- . _ ____ . - .. _____„ __ , , r__  ____ ._______ _____  . ..... .. _ . .
TABLE 3. To show the approximate duration of the 
untreated crises, and the number of times 
sodium phenobarbitone by combined intra­
muscular and intravenous injection was _ 
given in each case. (Reproduced from 
Onuaguluchi (1961 ) Soot. med. J. & 3^8^).
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and A*Mc*), and atropine on 4 occasions to 2 patients (J*P* and U#G»)« 
In two patients (J*C* and J*P* ) the effect of intravenous atropine 
sulphate (0*6 mg*) on sweating crisis was studied on three occasions*
RESULT OF TREATMENT
1* OCULOGYRIC CRISES
Preliminaiy studies showed that oral amylobarbitme 200-300 mg* 
or intramuscular sodium phenobarbitone 200 mg* sufficed to control 
crises which were mild or even moderate in severity* On the other 
hand, in patients who suffered from severe oculogyric crises, barbi­
turates (given orally or intramuscularly) failed to give relief unless 
the drug induced sleep*
It was concluded that the success of this treatment depended upon 
the hypnotic action of the drug when used as described above: on 
wakening from sleep the ocular axes had resumed their normal position* 
If sleep was not induced, deviation of the eyes persisted and the 
crisis often lasted for several hours* For example, in one patient 
who was suffering from a severe oculogyric crisis, the symptoms were 
still present 6 hours after injecting 200 mg# sodium phenobarbitone 
intramus cularly.
The intravenous administration of sodium phenobarbitone has been 
successful in nearly all cases in aborting severe oculogyric crises 
and sweating crises* Characteristically, in a severe oculogyric 
crisis /
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crisis the blood pressure is raised and the heart rate is increased; 
but 10 minutes after receiving sodium phenobarbitone intravenously 
both the blood pressure and the heart rate had returned to their pre­
crisis levels. Patients did not experience subjective improvement 
until 10 to 20 minutes had elapsed. The central position of the eyes
and nornal voluntaiy ocular movements were not restored until 20 to 40 
minutes after the injection. Spontaneous nystagmoid movements with 
the rapid phase upwards were frequently seen just before the eyes 
became normal.. It was usually well over one hour before flushing of
the face disappeared and congestion of the conjunctiva lasted even 
longer. Slight suffusion of the conjunctiva was occasionally seen 
as long as 3 hours after the intravenous injection of the sodium 
phenobarbitone. The effect of parenteral therapy on bradykinesia 
(unwillingness to move) was veiy striking. On many occasions 
patients who had been reluctant to move at all showed a strong desire 
to be up and about soon after receiving sodium phenobarbitone intra­
venously. On two occasions one patient (W.S.) got up and played 
billiards with his usual degree of skill about one hour after receiving 
this treatment for oculogyric crises.
Fig. 12 shows the effect of giving 200 mg. of sodium phenobarb­
itone by the combined route in Case 1 during a severe oculogyric 
crisis. The fairly rapid effect on the blood pressure, cardiac rate, 
salivation, noisiness, rigidity and (to a lesser extent) on tremor is 
demonstrated.
   
 
 
105a
220
200
180
I6O
I40|
I2O-
lOO
80
6OI
o Ocg. PKSod.
t7 i i
FI Blood Pressure
+ Heart Rate
Ocg. Oculogyric Crisis began
Ph. Sod. Sodium Phenobarbitone
O.2g.
o
E
EYES cent. up up up cent. cent. cent. cent.
RIGIDITY + + + + + 4 + ++ + + 44 4 4 4 4
TREMOR + + + 4 + -i- 4 +
SALIVATION ± + 4 nil nil nil nil nil nil
NOISE none 4 + + none none none none none none
O lO 20 30 40 50 60
-TIME IN MINUTES --------------
Fig, 12. Case 1. Effeot of sodium phenobarbitone 
0.2g. given intravenously in an estab­
lished and severe oculogyric crisis.
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A more detailed account can now be given of the ocular findings 
before and after treatment in an individual patient; Case 1.
(a) Condition before Treatment ; The eyes were rota-bed uparrils
and to the right. She wae unable to bring the eyes down or to move 
them to tlae left. The pipils were small ; they reacted sluggishly to
light but not to accommodation. The conjunctivae were injected but
there was no photophobia. She was very noisy.
Sodium phenobarbitone was then given parenterally
(dose, etc. - as described above).
(b) Condition after 10 minutes; The eyes were still directed 
up and to the right and could not be brought down or moved laterally. 
The pupils were now slightly bigger and reacted well to light but not 
to accommodation. The conjunctiva was still injected. She was now 
quiet; but she said she did not feel any better.
(c) After . 20 sinutes: The ocular axes were now shifting down­
wards; she could move her eyes in both the vertical and the horizontal 
direction, but these movements were not sustained for more than 2 
seconds. No further change had occurred in the state of the pupils 
or of the conjunctiva. She was quiet; and she said she now felt 
better.
(d) After 30 minutes ; The eyes were central although there 
was a tendency to upward deviation, giving rise to nystagmoid move­
ments. Voluntary movements of the eyes in all directions were 
however more sustained. The state of the pupils and conjunctiva 
were unchanged hX80 Cbj7
(e) /
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(e) After fO minutes: The eyes were noir c entied end there was
no tendency to upward deviation. Movement in all directions was good 
and well sustained. The pupils were now of normal size and reacted
well to light. The face and conjunctivae were less flushed . She
felt much better and was now smiling.
Intravenous hyoscine hydrobromide (0.6 mg.) was successful 
in all cases in controlling oculogyric crises. The ocular axes 
returned to normal in 10 to 20 minutes. This compares with 20 to 40 
minutes ihen sodium phenobarbitone was given by the combined route.
The blood pressure and the heart rate also returned to the pre-crisis 
level within 10 minutes after the injection. Hyoscine however 
aggravated the braelykinesra which is often present during oculogyric 
crises. The patients seemed dazed for an hour after the injection, 
and in the first 40 minutes of this phase they responded poorly if at 
all to commands. Drowsiness was a side-effect seen in all cases, but 
the hypnotic action was not considered to be responsible for the 
effect of the drug in abolishing ocular deviation; normal movement of 
the eyes was restored before the onset of drowsiness. Another dis­
agreeable side-effect was the excessive dryness of the mouth, tongue 
and throat which made speech and eating difficult.
Atropine sulphate (0.6 mg.) administered intravenously was 
not as effective as hyoscine or sodium phenobarbitone. The reduction 
of blood pressure to pre-crisis level was usually delayed for 20 to 30 
minntes. The cardiac rate was also unaffected for 20 minutes after 
the /
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the injection; in fact a rise in the heart rate was sometimes seen in 
the first 20 minutes. In one of the 4 instances the eyes were still 
rotated upwards one hour after injecting the drig. On the other three 
occasions the eyes were central 20, 30 and 40 minutes respectively 
after administering the drug;. Centralisation of the eyes was accom­
panied by a fall of blood pressure, and the heart rate also tended to 
fall to the pre-crisis level. Excessive diyness of the mouth, tongue 
and throat was again a common complaint.
2. SWEATING- CCRTSES
(a) SocUluun phenobarbitone.
In treating severe forms of sweating crisis with sodium pheno­
barbitone intravenously it was again noticed that the blood pressure 
and cardiac rate reverted to their pre-crisis levels within 10 minutes. 
Sweating, however, although considerably reduced in the first 10 
minutes, usually continued for another 10 to 20 minutes. Allevi­
ation of muscular rigidity and tremor was noted - as in oculogyric
crises.
Figure 13 shows the effect of injeoting sodium phenobarbitone in
a very severe sweating crisis in Case 3# Perceptible sweating had
ceased 30 minutes after administration of the drug;. Although there
was a rapid fall in blood pressure and cardiac rate, the levels were
still above the pre-crisis level even after 40 minutes. A relapse
occurred 90 minutes after the injection; sweating, tachycardia and a
rise /
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PiK. 13. Case 3. Effect of sodium phenobarbitone
0.2g. given intravenously during a severe
sweating crisis.
The systolic blood pressure and the heart 
rate did not return to normal levels under 
the influence of the drug; the crisis 
recurred 90 minutes later - but in a milder 
form.
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rise in blood pressure recurred, but these abnormalities were now less
severe.
This phenomenon of * escape’ from the effects of phenobarbitone
was one of considerable interest and significance. It has been
recorded on three occasions while studying this group of patients.
All were suffering from veiy severe crises - one in a sweating crisis
(Case 3) end two in oculogyric crises. ’Escape* occurred between 60
and 90 minutes after the administration of sodium phenobarbitone.
Here again the symptoms during relapse were less severe than in the
initial crisis, and they passed off in 1 to 3 hours.
(b) AtropAne sulphaue (O.e rn0.) given ivtnavenousHy was a more 
powerful suppressant of sweating then 200 mg. of sodium phenobarbital
administered by the combined route. The sweating stopped Vi 10 to 20
minutes. However several undesirable side-effects were observed:
(1) An vlcrtase na harra aath (Pg. a 1)).
(2) Flushing of tha skia and a sensation of horV•
(3) At this dose level, excessive dimness of the mouth,
tongue and throat occurred. One patient (J^.)
said that tha trertmena maea hia tonuue "sa hard 
as wood", and he rauised to hvve ny 0Werhter 
treatment for sweating crises vf atropine was
to be givens.
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Q B;L<D0D PRESSURE
-•-- RUTE
S* SWEATING CRISIS
AT ATROPINE -
SULPHATE 0, finer.
140
120"
100
---------- 6a
SWEATING NONE +++ NONE NONE NONE NONE NONE NONE
TREMOR + ++ + + + ± ± +
RIGIDITY + ++ + + + + + +
SALIVATION + + DRY VERYDRY
VERY
DRY
VERY
DRY
VERY
DRY
VERY
DRY
0 10 20 30 40 50 60time in minutes.
Pig. 14. Case 6.
Effect of atropine sulphate 0.6 mg. given intra 
venously during ■ a severe sweating crisis.
Note the increase in the heart rate. The
patient was more flushed and complained of
extreme heat and . also of dryness of the mouth 
and throat.
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DISCUSSION
Many factors are involved in the neurological mechanism that
precipitates an oculogyric crisis. The influence of volition is
apparent from the fact that when the prodromata - or even the actual
signs - of a crisis appear, a sharp word of rebuke or a shake of the
patient’s shoulders (such as might be used for a wayward child) may
suffice to abort the attack or to postpone its onset. The phenomenon
is perhaps analagous to that of aborting Jacksonian epilepsy by the
immediate application of manual pressure to the patient’s twitching
limb. The suppression of an oculogyric crisis however rarely amounts
to more than a temporary inhibition; apparently the stimuli build up
again and the signs of crisis become obvious in their florid form. It
must also be emphasised that only mild crises are amenable to inhibition
by the attendant.
Notwithstanding considerable experience of the influence of
suggestion in the treatment of the postencephalitic, it is also
apparent that the injection of sodium phenobarbitone intravenously is
highly effective in the treatment of severe oculogyric and sweating
crises; the dose is 2 - 3 mg./Kg. body weight:.
Sodium agylobarbitone given intravenously (1$0 mg.) has been
shown to prevent nystagmus on direct forward gaze (Nathanson et al.,
1953). King, Naquet and Magoun (1937) showed that in li^it doses
the site of action of barbiturates is on the central reticular form­
ation of the mid-brain where it blocks the ascending activating
influence /
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Influence of the brain stem reticular fcegerVon) Arduini and
Arduini (1954) arrived at similar conclusions. French, Vtrzeolo and 
that
Mo^ui (1953) shccyeyrht effect of oi oloesthetVc dose of sodium
pentobarbitone was on centrally located responses Vi the pons, mid­
brain end rhoeemws; these authors ulso discovered that potentials
from the lateral sensovy pathways (the lem^sc^ were unchanged by
the administration of sodium pentobarbitone considerably in excess of
the amounts that caused profound changes medially.
An oculogyric crisis has been shown to be most probably due to a
vestVbulo-cculomotoe reflex Vn patients with certain types of brain
stem lesion resulting from encephalitis lethargica. The centre for
this reflex is therefore in the upper bruVn stem. There is probably
ulso marked activation of the reticular formation of the beuVl stem
end this increased activity spreads into the hypothalamus and the
thalamus. Presumably a sweating crisis Vs elso caused by discharges
from the diencephalon and perhaps ulso from the reticular formation of
the upper brain stem. PhencbaebVtont therefore appears to act by
blocking afferent impulses (including vestibular impulses) destined to
activate the brain stem end diencephalon. Thus the drug mey prevent
a spread of impulses Vltc the reticular OoegurVol at mVdbeuVl end
diencephalic ltstla) The ultimate result is thut discharges from
this zone of the brain ere blocked end oculogyric end sweeting crises
are thus prevented.
The time lug of 20 to 40 minutes after the administration of
Vntrustloua /
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intravenous phenobarbitone before the eyes were central and normal is
interesting. The same interval of time has been observed, by Wilson
(1959) who studied, the protective action of thiopentone on audiogenic
seizures in mice. The cause of this time lag is still unexplained.
The latent period is similar to that which occurs in normal people
after injecting atropine sulphate intravenously: about 10 minutes 
elapse before the anticholinergic effects become apparent. An
additional point of interest - suggesting “conditioned tolerance" to
drugs where the recipient suffers from a particular disease - is the
fact that sleep was rarely induced by the dose of phenobarbitone
given. This was also observed by Nathanson et al (1953). The cir­
cumstances are somewhat similar to those existing in the epileptic
patient who nearly always tolerates moderate doses of phenobarbitone
without suffering from drowsiness - which would almost invariably
develop in normal people.
Bradykinesia is practically abolished and this is one of the
great advantages of intravenous therapy. The patient is rarely made
drowsy and within an hour he can be up; and his gait is not ataxic.
As a relapse occurred on three occasions, it would appear that in veiy
severe cases the dose of 200 mg. of sodium phenobarbitone should be
injected intravenously to prevent such recurrences.
Burr and Suavely (1926) and de Maar (1956) have shown that the
probable site of action of the belladonna group of drugs - hyoscine, 
the
atropine and hyoscyamine - is ii/ diencephalon where they block dis­
charges /
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discharges arising from this area. Hohman ( 1925), McCowan and Cook
( 1920) found hyoscine administered parenterally to be effective in
aborting oculogyric crises and although this has been confirmed in this
study, it is claimed that the use of intravenous sodium phenobarbitone
is preferable to the parenteral administration of hyoscine for the
treatment of oculogyric crisis. Intravenous sodium phenobarbitone
reduces or abolishes bradykinesia associated with the crisis; and
within an hour of the injection the patient’s equanimity is restored,
and he wants to be up and about. Hyoscine on the other hand aggra­
vates the bradykinesia; drowsiness is also a common side-effect,
during the first hour after injecting the drug the patient is often
dazed. Excessive diyness of the mouth, tongue and throat may be a
disturbing side-effect after administering hyoscine. In addition
Brocklehurst (1953) reported that in the elderly and in patients with
Parkinsonism, subcutaneous administration of hyoscine often caused
irregular involuntary movements accompanied by extensor plantar
responses. These side-effects were not observed however in the
patients in the present series.
The use of atropine is not recommended; in the treatment of
oculogyric crises it is inferior to hyoscine and to phenobarbitone.
Although the two patients treated with atropine did not show signs of
further excitement from the drug itself, atropine is classed as a
delirifacient, and there obviously is a prima facie case for avoiding
its use in post-encephalitics in oculogyric crisis - as excitement
attributable /
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attributable to this condition often provides an indication for 
treatment on other lines.
In sweating crises where it might theoretically be regarded as 
the therapeutic agent of choice, its use may le^d to disturbing side- 
effects: these are flushing of the skin with an accompanying sens­
ation of heat, dryness of the mouth and throat and aggravation of 
tachycardia in a condition where the heart rate may be as high as 
150 beats per minute.
Variations in the potency of hyoscine and of atropine, even in
the purest samples (Sollman, 1948; Domino and Hudson, 1959), make
their use in clinical trials unsatisfactory and incidentally also
accounts for occasional failures (or partial failures) when these
alkaloidal salts are used in other fields of medical practice.
Another drug which blocks discharges from the midbrain is pheny- 
toin sodium (Gangloff and Monnier, 1957). It is of limited value in 
dealing with the crisis once it has developed. It should also be 
noted that the sodium salt in solution is not suitable for parenteral 
injection because it is strongly alkaline (Martindale, 1958).
PROPHYLAXIS
1. Barbiturates
Leake (1935) from his experience in a solitary case suggested 
that methylphenobarbitone (Prominal) given by mouth might be of use 
in preventing oculogyric crises. Our experience shows that barbi­
turates orally are not of much value in reducing the frequency of 
oculogyric /
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oculogyric crises, although there is some indication that they have a
place in reducing the frequency and the severity of sweating crises.
Drowsiness and dizziness are unwelcome side-effects but they are not
common. The most disabling side-effect is increasing dysphagia:
this is probably a sequel to drowsiness but it occurs veiy infrequently
2. Sodium Phenytoin
Sodium phenytoin 45 mg. - 100 mg. orally three times daily was
given prophylactically to 5 patients with oculogyric crisis. The
results were veiy discouraging but of great interest. The effects
were more noticeable in the 3 female patients. Sodium phenytoin
seemed to alter the character of oculogyric crisis. The tonic phase
(in which the eyes were rolled upwards and could not be moved in any
direction) was now less frequently seen. The nystagmoid phase with
the rapid upward phase (or upwards and to one side) was veiy prominent
and lasted for several hours - even up to 24 hours. The patients
were more noisy and felt subjectively veiy much worse. Sometimes
they felt as if they were in an oculogyric crisis: they were noisy 
(shouting) and flushed; and yet neither the tonic nor the nystagmoid
phase was present. The crises were distinctly more prolonged; and
were also of greater frequency - especially in the women. In one of
them (O.Mc., Case 3) vertigo was veiy disabling. She was unable to
sit up, and later she had the sensation that objects in the ward were
continuously moving around her*. In these patients swallowing was
worse and veiy disabling. The addition of phenobarbitone 30 to 60 mg.
three times daily did not give any relief. Treatment with sodium
phenytoin /
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pheny^o^ had to be discontinued after only three weeks in the case of
the women patients, end there wes then u striking improvement in their
condition. By contrast, two mole patients were Oble to tolerate
pheny^^ therapy but as they hed derived no benefit from this drug it
was withdrawn after a period of 12 weeks.
3. Benzhexol end Orphenod^eVne
The newer drugs used vn the symptomatic relief of PerkVlsolVsg,
benzhexol (Artene) and cephtledeVne (Disipal), do not seem to be of
greet value Vi the prophylaxis of oculogyric crises, but they seem to
be of some value Vi preventing recurrence of sweating crises. This
will be referred to Vi detail Vi Chapter 6.
SURGERY does not seem to have much place Vi the management of
patients subject to oculogyric crises. Klemme (1941 ), however,
reported that oculogyric crises can be tlVmVlattd by excision of the
premotor cortex Vi the second Oeclral consulwticn just anterior to the
area that produces spasmodic upward movement of the eyes on fared-vc
stimulation. These cases however were not followed up for long
peeVodS) Motor defects on the opposite side ere common complications
following this operation end it is significant that this operation vs
now rarely performed. Cooper et el ( a958) found that chemopalli-
dectcgy end chegothalagectcgy have little or no effect on the
occurrence of oculogyric crises. Severe sweeting crises however can
be abolished or greatly reduced in their severity by chtgcpallidtctcmy
(Nerabuyashv et el., 195)). Alreelarivtey sweating crises can be
completely /
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completely relieved as they occur by using parenteral injections of 
sodium phenobarbitone as described above. It follows that neuro­
surgical operations should not be performed until the effects of 
symptomatic medical treatment have been assessed as carefully and as 
objectively as possible.
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SUMMARY AND CONCLUSIONS
The treatment of severe oculogyric and sweating crises in . 11 
patients with post-encephalitic Parkinsonism has “been studied.
The value of 200 mg. sodium phenobarbitone given intramuscularly 
or sodium amylobarbitone 200 to 300 mg. given orally was assessed. 
Neither of these forms of treatment affected the natural course of 
crises when these were in the category classified as "severe".
A therapeutic trial was carried out to evaluate sodium phenobarb­
itone 150 mg. given intravenously and 50 mg. given intramuscularly in 
severe crises, using injections of normal saline as the control.
Relief was obtained in 20 to 40 minutes after these injections of the 
barbiturate. Injections of normal saline were ineffective. It is 
suggested that in severe crises sodium phenobarbitone injected intra­
venously is the treatment of choice. Although parenteral injections 
of hyoscine hydrobromide is effective in controlling severe oculogyric 
crises, the use of intravenous sodium phenobarbitone is to be preferred. 
The use of parenteral injections of atropine sulphate is not recom­
mended.
The prophylactic value of sodium phenytoin was determined in 5 
patients suffering from severe oculogyric crises. This drug altered 
the character of the oculogyric crisis but did not reduce its frequency, 
or severity.
The writer has no experience of oculogyric crises induced by
drugs /
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drugs 'of the phenothiazine series such as Perphenazine, hut there 
appears to he a prima facie case for the intravenous injection of 
sodium phenobarbitone in this type of medical emergency.
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CHAPTER IV
THE^ELECTRGENCEFHALOG-RAMJN
POST-ENCEPHALITIC  _ _ PAtRmNOQNISM
INTRODUCTION
Previous e^ectroencephalographic studies in Parkinsonism (Jasper 
and Andrew 1938; Schwab and Cobb 1939; Newman, McNaught and O'Donnell 
1949; England, Schwab and Peterson 1939) have led to conflicting con­
clusions. Thus Newman and his colleagues (1949) studied 12 patients 
suffering from Parkinsonism (6 from arteriosclerotic and 6 from post­
encephalitic Parkinsonism), They concluded that patients suffering 
from Parkinsonism do not show slow activity in the electroencephalogram 
^.E.G.) apart from that which results from somatic tremor. Schwab 
and Cobb in 1949 studied 37 patients (15 suffering from post-enceph­
alitic Parkinsonism and 22 from the arteriosclerotic type). They 
concluded that although head tremor can produce an artefact, this can 
be eliminated by restraining movement of the head; or its presence 
can be confirmed by recording from leads placed on the chin or on the 
bridge of the nose. They did not however find any significant 
abnormality in the E.E.G. of their patients. In a more recent study 
(England, Schwab and Peterson, J939) they found that 52% of their 
patients showed E.E.&. abnormalities and in 21%, the E.E.G. was 
grossly abnormal. About half of their patients gave a history of a
previous /
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previous attack of encephalitis lethargica. These authors do not 
state whether these contrasting results were obtained from study in 
the same group - of patients after an interval of about 20 years. If 
the majority of the patients in the two series were different, it must 
be concluded that the contrasting results were significant or that 
they were attributable to differences of techniques or interpretation.
One of the most disturbing sequelae of encephalitis lethargioa is
oculogyric crisis. Apparently no definitive study of the E.E.G.
characteristics has been made in patients subject to attacks of oculo­
gyric crisis, nor has the E.E.G. in such patients been studied during
oculogyric crises. Gibbs and Gibbs (1947) however studied 240 cases
of encephalitis from a variety of causes and found that in general
the E.E.G. was abnormal in the acute stage. He noted that the record
returned to normal with the passage of time except in patients likely
to have seizures and in 17 patients with Parkinsonism, 3 patients
subject to attacks of oculogyric crisis, and 24 patients suffering
from narcolepsy.
In the present series there are 20 patients who periodically 
suffer from oculogyric crisis. It was therefore considered well 
worth while to study eleotroenoephalographic records both in patients 
subject to attacks of oculogyric crises and those in whom there was 
no record of these attacks. It was also decided to obtain records 
of the E.E.G* in some patient during crisis, before and after treat­
ment with intravenous sodium phenobarbitone as already described.
The /
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The effect of prostigmin on the E.E.G. was also studied. It has
been shown in experimental animals that 1% physostigmine applied to
the cerebral cortex caused a reduction in the amplitude of the slow
waves. (Miller, Stavraky and Woonton, 1940)- Chatfield and Dempsy
(1942) showed that prostigmin when applied as a IjS solution to the
cerebral cortex in lightly anaesthetised cats produced a reduction in
spontaneous activity of the cortex. Acetylcholine applied alone to
a cortex which had not been pre-treated with physostigmine or pro­
stigmin either had no effect on the cortical potentials or caused a
reduction in the amplitude of the slow waves. "hen acetylcholine
was applied to a cerebral cortex which had been pre-treated with
physostigmine or prostigmin, it caused profound changes in the E.E.G.
At first spontaneous bursts were augmented in size increasing both in
voltage and duration, later the bursts became larger and sharper -
signalled by the appearance of spikes in the record. The spikes were
associated with peripheral motor effects. Brenner and Merrit (1942)
showed that these effects could however be produced by using acetyl­
choline alone, but that very high concentrations were required and the
duration of action was relatively very much shorter than when the
cortex had been pre-treated with prostigmin. The results of these
studies suggest that the electrical activity of the brain may be
mediated through the effect of acetylcholine. Thitteridge (1940),
in a review of the role of acetylcholine in synaptic transmission, con­
cluded that the main action of acetylcholine in the nervous system
seems /
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seems to be the facilitation of repetitive activity, particularly Vi
the vltegneurones)
In the hugel subject physostigmine and pecatigmVn have been shown
to effect the electrical activity of the bruin in epileptics.
Williams (194-1 ) and Williams and Russell (1941 ) found that Vn six out
of nine experiments in five patients suffering from petit mul, there
was u diminution of the epileptic discharges, the improvement beginning
about 15 to 30 minutes after injection of physostigmine end lusting
about 50 minutes on the average. With regard to peostiggil, there
was a significant increase in the epileptic activity (in the 8 experi­
ments on 4 patients with petit mal) when 1.5 mg. of the drug was
injected subcutaneously. With regard to the effects of this drug on
spontaneous epilepsy they found that 1 to 2 mg. of physostigmine given
subcutaneously produced a reduction in the amount of spontaneous
epilepsy in two patients and an increase in two other patients. Pro- 
stigm^ (0.6 to 1.5 mg. subcutaneously) on the other hand .produced an
increase in spontaneous epilepsy. Atropine 0.6 mg. given subcutan­
eously reduced the number of spontaneous epileptic attacks and also
reduced the amount of epileptic discharges induced by peostiggilv 
They also observed that the electrical changes induced by pr^^gm^
end physostigmine were not related to the peripheral effects of these
drugs, namely abdominal colic, nausea, vomiting, etc. It appears
therefore that the alticholinesreeaaea, especially pecatiggil., may
el ter the electrical activity of the brain in patients subject to
"epileptcc* /
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“epileptic" attacks.
During experiments designed to study the effects of prostigmin on
skeletal muscular power in 7 of our post-encephalitic patients (who
had appreciable muscular weakness) it was found that while 0.5 to. 1 mg.
of prostigmin given intramuscularly had no effect on the strength of
the grip, it appeared to be capable of inducing an oculogyric crisis.
Four of the 7 patients suffer from periodic attacks of oculogyric
crisis; and it was observed that oculogyric crises occurred in three
out of eight occasions in three of the four patients, about one hour
after administering prostigmin. In view of this finding and the
known effects of prostigmin in "epileptic" patients, it was decided to
study the effect of intramuscular prostigmin on the electrical activity
of the brain, both in patients subject to oculogyric crisis and also in
those free from such attacks.
MATERIAL AND METHOD
The patients included in this study were of necessity selected,
as it was essential to include only patients who suffer from milder
forms of tremor in an attempt to eliminate or diminish the tremor
artefact from the records. It was also desirable to include at
least ten patients who were known to suffer from periodic attacks of
oculogyric crisis.
Thirty patients were selected for study and their ages ranged
from 38 to 63 years with an average age of 51.6 years. Thirteen of
them /
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them are subject to attacks of oculogyric crisis. A definite history
of a previous attack of encephalitis lethargica was obtained in 27 of
the 30 patients. Table 6 shows the age distribution in this series
of 30 patients.
Age group
in years. 20-29 30-39 40-49 50-59 6O-69 70-79
No. of
patients 0 1 9 17 3 0
TABLE 6; Age distribution in this
series of 30 patients.
The electroencephalographic study was divided into the following
parts:
1. Resting E.E.G. in the 30 patients, while they were receiving
their usual medication; (10 received orphenadrine; 1 patient each
received Atropine 0.6 mg. thrice daily and N-ethyl-nortropine
benzhydryl ether hydrobromide (UK. 730) thrice daily; all the
others were receiving benzhexol 15 to 30 mg. daily).
2. In 12 patients the resting E.E.G. was also taken when the
patients had been receiving placebo therapy for 15 hours or
more. The last dose of "active" tablets was given at 12 noon
on the previous day and at his 6 p.m. placebo tablets were given
instead. The next day (the day of the examination), placebo
tablets /
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tablets were again given at 8,50 a.m. and records were taken,
some time between 9*30 a.m. and 4 p.m.
3# Records of the E.E.G. were obtained from three patients during
oculogyric crisis and the effect of 0.2 mg. of sodium pheno­
barbitone given intravenously was studied. The E.E.G. was
taken on one or more occasions between 20 to 60 minutes after
giving the sodium phenobarbitone. Owing to technical
difficulties already mentioned in the preface, it was not
possible to study more patients.
4. The effect of parenteral prostigmin on the E.E.G. was studied
in 12 patients, 8 of whom suffer from oculogyric crisis. On
the previous day, placebo tablets were substituted for the
night dose of the drug normally taken by the patient for
Parkinsonism, and again on the morning of the test, placebo
tablets were given. Prostigmin 1.5 mg. was given intra­
muscularly into the upper lateral quadrant of the gluteal
region and the area was massaged for one minute. E.E.G. was
recorded 15, 30 and 60 minutes after giving the injection and
this was compared with the electroencephalogram taken before
the administration of prostigmin. Any peripheral effects
of the drugs, namely flushing of the skin (face), sweating,
change in heart rate, salivation and abdominal colic were
recorded.
When abnormal waves were seen in the record the effect of holding 
the /
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the head absolutely steady was noted. Ey this means it was possible 
to detect if the abnormal waves were due to movement artefacts.
An Offner Type T Transistor Portable Electroencephalograph (8 
channels) was used. The electrodes were normal silver-chlorided type 
fixed to scalp by harness. Recordings were made in para-sagital and 
para-coronal planes (positions I and II respectively).
RESULTS
1. The resting E.E.&.s of the 30. patients
while receiving their usual treatment.
The E.E.G-.s were considered to be frankly abnormal in nine
patients (30%). A veiy common finding was theta activity which was 
diffuse but usually more prominent in the frontal areas (66%). In 
addition to theta activity, four patients had frontal delta waves.
The E.E.G-.s were divided into four types:
Type 1. Eight patients had records of this type. The 
records were normal according to standard criteria and had 
sustained alpha activity and a minimum voltage of 40 yv.
They showed a normal response to opening the eyes. (Fig,15). 
Two patients suffer from oculogyric crises.
Type 2. Five patients had records of this type. The 
E.E.G.s were similar to Type 1 except that bursts of 
theta activity greater than 40 %v. were present (Figures 
16 and 19a). All these records were therefore abnormal.
One /
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One patient suffers from oculogyric crisis and one from 
breath-holding attacks.
Type 3» Twelve patients had this type of record.
The records were of low voltage, between 25 yv. and
35 yv. (Pig. 17). Alpha activity was present but was 
not well sustained. It was inhibited by opening the
eyes. Five patients are subject to attacks of oculogyric 
crisis.
Type 4. Five patients had this type of record. The 
records were of very low voltage, between 10 yv. and 
20 yv., and opening the eyes produced no change (Fig. 18).
All the patients are subject to attacks of oculogyric
crisis.
2. The alpha rhythm.
Twenty-eight of the 30 patients were considered to have definite 
alpha rhythm although in some cases because of the very low voltage it 
was very difficult to identify the waves. As already stated., in only 
13 patients was the magnitude of the alpha waves up to 40 yv. The 
average frequency of the alpha waves was 9*7 cycles per second and 20 
of the 30 patients had waves between 3 and 11 cycles per second 
(Table 7). An interesting feature was the fact that there was a 
well sustained alpha rhythm in only 12 of the 30 patients (4Q%).
The other 18 patients (60jS) had poorly sustained alpha rhythms showing 
a poor response to opening and closing of the eyes.
129.
Frequency of 
alpha waves 
(Cycles per sec.)
7 8 9 10 11 12
No. of patients 2 3 6 9 5 3
Mean Frequency = 9-7 cycles per second
TABLE 7: Distribution of alpha waves
between 7 and 12 cycles per second
3* Effect of Anti-Parkinsonian drugs on the E.E.G.
In 12 patients withdrawing active drug therapy for 15 or more
hours had no significant effect on the E.E.G.
4- Effect of age on the E.E.G.
Age appeared to have no effect on the normality of the E.E.G*;
the average age of the 9 patients with abnormal records was 33*1 years 
and that for the patients with normal records was 50.6 years. Age 
also appeared to have no effect on the voltage of the electroenceph­
alogram. Thus the average age of the 13 patients having wnonnaln 
voltage records was 52*4 years while the average age for the 17 
patients with low voltage records was 50.9 years.
5* Relationship between the type of E.E.G. and
susceptibility to attacks of oculogyric crisis
From Table 8 it will be seen that of the 13 patients who suffer
from periodic attacks of oculogyric crisis, 10 had low voltage 
activity and in 5 of them the voltage of the alpha rhythm when the 
eyes /
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Type of E.E.G.
No. of patients 
with
oculogyric
crisis
No. of patients 
without 
ooulogyrio 
crisis
Total No., 
of
patients.
Type I. 
Alpha0%5 pT. 2 6 8
Type II
Theta and Alpha
> 35 jt.
1 4 5
Type iii 
Alpha 25-35 Jiv. 5 7 12
Type 17.
Alpha 10-20 /iv. 5 0 5
TABLE 8. Relationship between the type of E.E.G. and 
susceptibility to attacks of oculogyric crisis.
Type of E.E.G.
No. of 
bedfast 
patients
I ■ "
No. of 
ambulant 
patients
No. of patients 
with severe 
or moderate 
rigidity.
r " -..
No. of patients 
with mild 
rigidity.
Type I.
Alpha > 35 yr. 3 5
6 7
Type II
Theta and alpha 
>>35 pv.
2 3
Type III
Alpha 23-35 /v. 8 4
14 3
Type IV 
Alpha 10-20 3 2
TABLE 9. Relationship between type of E.E.G., state of 
ambulation and degree of rigidity.
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eyes were closed was 20 yv. or less. In contrast, only 7 of the 17 
patients who do not suffer from oculogyric crisis had low voltage 
records. It was also of interest that there were no patients in the 
veiy low voltage group who did not have oculogyric crisis. Low 
voltage tracings are therefore much more commonly seen amongst patients 
subject to oculogyric crisis.
6. Effect of state of ambulation on the 
voltage of the electroencephalogram.
16 of the 30 patients were non-ambulant and 14 patients were 
ambulant. It was of interest that 68.7% of the 18 non-ambulant 
patients were in the group having low voltage potentials (Types III 
and rv). In contrast, only 6 of the 14 ambulant patients (42.JS) 
had low voltage tracing's. It therefore appeared that low voltage
tracings were more commonly seen in non-ambulant patients and in 
patients subject to oculogyric crisis. Table 9 gives the details.
More will be said of this later in the discussion.
7. Effect of severity of rigidity on the
voltage of the electroencephalogram
Some correlation also appeared to exist between the severity of 
rigidity and the voltage of the E.E.G. Thus 14 out of 20 patients 
with rigidity classed as moderate or seven*, had low voltage rrailngs 
whilst only 3 out of the 10 patLemts (riiose irLgid state was laassdd as 
mild (+) had low voltage tracjng (Table 9).
8. Effect of the , state of eanbulation
on the normality of the E.E.G-,
The /
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The E^.^s were considered to be frankly abnormal in 9 patients, 
three of which were obtained from the 14 ambulant patients and 6 from 
the 16 non-ambulant patients. The ratio of abnormal E.E.&.s in 
ambulant and non-ambulant patients was therefore 4*3 : 7*5 > but the 
expected ratio should be 7 : 8. The incidence of abnormal a.E.G-.s 
in non-ambulant patients therefore appears to be about double that in 
ambulant patients. However, in view of the fact that the total 
number of abnormal records is small, no valid general conclusion may 
be drawn.
9* E.E.G-. during oculogyric crisis
Three patients subject to periodic attacks of oculogyric crisis 
were studied when they were in oculogyric crises. Two of these 
patients when not in crisis had E.E.G. of voltage potential above 
50 jiv.
Three points of interest were observed in the E^.E^.G^. of these 
patients when they were in oculogyric crisis:
(a) The voltage of the electroencephalogram during oculogyric 
crisis became veiy low and this was more noticeable in the two 
patients whose records were otherwise of hi^ voltage. Figs. 19 
a, b, and c show the E.E.G-. in one of the latter patients before, 
during and after an oculogyrio crisis.
(b) The three patients showed high voltage spikes in the 
anterior areas. The significance of this will be discussed later. 
These spikes disappeared when intravenous sodium phenobarbitone con­
trolled the oculogyric crisis (Figs. 19 and 20).
(o) /
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(c) The alpha rhythm iacre ased :0a rate ia tw o o f the three 
patients and in one of them prominent beta activity was seen before 
the administration of sodium phenobarbitone intravenously. During 
the 40 to 60 minutes following this injection, the beta activity 
usually became the dominant rhythm.
Effect of prostigmin on . the E.E.G.
Out of the 12 patients who received 1.3 mg. of prostigmin intra­
muscularly, 4 showed a slight increase in the amplitude of the elec­
trical potentials, and in two patients slower rhythms were induced.
Thus one patient (H.Dev.) before the injection of prostigmin had a low 
voltage record with the dominant alpha activity at 9 cycles per second. 
Scattered theta waves at 6 cycles per second were also present. Fif­
teen minutes after the injection the voltage was slightly higher and 
the dominant rhythm was now 6 to 7 cycles per second but with frequent 
outbursts of activity at 4 to 3 cycles per second.
Oculogyric crises were not induced in the 8 patients subject to 
such attacks although peripheral manifestations of parenteral adminis­
tration of prostigmin were conspicuous in the present series of patiotfcs. 
Thus there was increased secretion of saliva in 10 of the 12 patients, 
definite flushing of the face was seen in 6 patients, sweating in 4 
patients, and there was appreciable slowing of the heart in 10 patients. 
Two patients however complained of abdominal pain (colic) and one of 
them required treatment with atropine sulphate (0.6 mg. subcutaneously). 
These disturbances and the changes in the E.E.G. occurred from 13 to 
30 minutes after injecting prostigmine.
E.E.S. Type I (alpha >35 _ »v.).
J. McC. Male, aged 51 years. Encephalitis 
lethargica 1925. Ambulant. Moderate degree 
of rigidity. Tremor mild.
E.E.G-. 4.8.60. Normal voltage record. Veil 
sustained alpha rhythm - 11 cycles per second. 
Normal physiological response.
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Fig, 16. E.E.G.. Type II (theta and alpha *7 33 pv,),
M. Aus, • Woman aged 39 years. Histoiy of enceph­
alitis lethargioa ? date. Ambulant. Mild degrees 
of rigidity and tremor.
E.E.G. 5.5.60. Normal voltage record. Dominant
rhythm at 10 cycles per second, interspersed with 
short runs of abnormal frontal delta rhythm (3 cycles 
per second) more marked on the left side.

3.B.&. • Hype XU. (Alpha 25 to 35 pv.).
J. Esp. Male, aged 51 years. Encephalitis leth 
argica 1927. Non-ambulant but able to sit in
chair. Severe degree of rigidity. Tremor veiy 
mild. .
E.E.fl. 14.12.60. Low voltage record. Dominant
alpha rhythm at 10 cycles per second. Occasional 
outbursts of theta rhythm at 7 cycles per second 
in the frontal region. Alpha rhythm is ill- 
sustained on closing the eyes.

(d)
Fig. 18, E.E.G. Type IV. Very low voltage alpha rhythm
(10 to 20^v.).
C. McK. Woman aged 57 years. Encephalitis 
lethargioa 1924. Bedfast. Rigidity very severe 
Tremor mild - mainly of the lips and tongue. 
Suffers from oculogyric crisis.
E.E-.G. 5.5.60. Abnormal record. No dominant
rhythm. Generally of a low voltage. , Frequent 
scattered outbursts of theta activity at 6 to 8 
cycles per second and less frequently outbursts 
of delta activity at 3 to 4 cycles per second.
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W. Sha. Male aged 54 years* Encephalitis 
1921. Oculogyric crises began in 1938. Blood
pressure 130/80. Heart rate 80 per minute.
19a. E.E.G* when not in. an oculogyric crisis. -
Veil sustained alpha rhythm at 10 cycles per second. 
Outbursts of high voltage theta activity at 6 cycles 
per second.
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19b. E.E.G-. of W.Sha. during an oculogyric crisis, but
before treatment _ with intravenous sodium pheno­
barbitone (0.2g;)i 11 [ -
Low voltage potentials, ill-sustained alpha rhythm 
with scattered low voltage theta activity. High
• voltage spike'potentials are present frontally,
Patient was noisy. Pace was flushed and he was 
sweating slightly.
Blood pressure 150/80. Heart rate 96 per minute.
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Pig. 19o. 3.E.G-. of Tf Sha* , 40 minutes after receiving
0,2 g. sodium phenobarbitone intravenously.
Low voltage record. Dominant rhythm at 6 cycles 
per second. Bursts of beta activity more prominent 
and more sustained than at 20 or 30 minutes after . . 
the injection.
Ocular axis now central. No more sweating. Blood 
pressure 134/80. Heart rate 86 per minute.

J* Pat. Woman aged 57 years. Following 
tonsillectomy operation in Australia in 1928 
developed muscular weakness on one side of the 
bo (7 and tremor on the other. Oculogyric crises 
began in 1942. Blood pressure 170/90. Heart 
rate 70 to 80 per minute.
S.E.G-. when not in oculogyric crisis.
Low voltage potentials with ill-sustained alpha 
activity at 11 to '12 cycles per second. Scattered 
theta activity at 6 cycles per second.
20 a. E.E.-. when in . an oculogyric crisis but before
treatment with intravenous sodium phenobarbitone(o»2 «♦)»
Low voltage record with . runs of beta activity - .
18 to 20 cycles per second. The record is largely 
obscured in the anterior part by high voltage spike 
potentials.
Patient was flushed and was noisy. Eyes deviated 
upwards. SHe had slight epistaxis. Blood pressure 
210/116. Heart rate 74 per minute.
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Fig, 20b. E.E.G-. of J. Pat., 30 minutes after the adminis­
tration of 0.2 g. sodium phenobarbitone intravenously.
Loy; voltage record with dominant alpha rhythm at 12 
cycles per second* Beta activity now more prominent.
' The high voltage spike potentials seen anteriorly in 
Fig. 20a have now disappeared.
The ocular axes returned to normal ' 20 minutes after 
the injection. There was no more epistaxis and the 
patient was now smiling. Blood pressure 160/70. 
Heart rate 72 per minute.
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DISCUSSION
One of the most interesting features of the electroencephalograms
in this series of patients is the large number of records showing low
amplitude. Seventeen of the 30 patients studied (36.6%) have alpha
waves with voltages between 10 %v. and 35 )v. and in 5 of these the
voltage was 10 to 20 jv. One can only speculate about the cause or
causes of this high proportion of low voltage alpha rhythm. The
rhythms in these patients may originate from a source deeper than the
cortex. The lesion in Parkinsonism is primarily in the subcortical
and midbrain regions and it may be that as a consequence the cortical
potentials in some patients are affected by activity in the deranged
subcortical areas. It is now widely accepted that the deeper the
source of the rhythm, the more uniform will the amplitude of the
waves in the electroencephalogram. In other words, the more diffuse
will the record seem to be, and the general amplitude will be smaller*.
(Walter, 1950). The associated high incidence (66j2) of bilaterally
synchronous theta waves in the series provides further evidence that
the source of the rhythm is deep seated. England, Schwab and/
Peterson (1959) also noted a high incidence of theta waves (32$ out
of their 75 patients). In . the age group of the patients studied
(38 to 63 years), the expected incidence of theta waves is less than
11$ (Hill, 1952).
Another point to be considered is the general • similarity of the
electroencephalogram of patients in this series and that seen in the
aged /
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aged (people over 65 years of age). In those over 65 there is a
general lowering of the voltage and a rather high incidence of theta
waves (Ohrist, 1954). This raises the question: in post-encephalitic 
Parkinsonism - and perhaps paralysis agitans and arteriosclerotic
Parkinsonism - is there a premature aging process in the brain?
Critchley ( 1955) made the point that although neurohistologists are
not altogether convinced that a premature aging process in certain
neuronic systems of the brain is a cause of Parkinsonism, the concept
is an attractive one.
It is noteworthy that low voltage electroencephalograms are common
in schizophrenia (Lemere, 1936 and 1938), a condition in which there
are somatic manifestations not unlike those seen in severe Parkin­
sonism. The possibility of a relationship • between the low-amplitude
electroencephalogram and the occurrence of a schizoid personality was
however not studied in this series.
Low amplitude electroencephalograms are more commonly seen in
patients subject to attacks of oculogyric crisis, in patients with
more severe degrees of rigidity and in bed-fast patients. This
raises the question: is there a positive association between sus­
ceptibility to attacks of oculogyric crisis, severe rigidity and
inability to walk? In Chapter V (the section which deals with
deformities in Parkinsonism) it was noted that severe degrees of
rigidity predisposes a patient to a bed-fast state. In other words
the bed-fast state and a severe degree of rigidity are likely to be
seen /
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seen in the same patient. In this series, no similar relationship
was observed between (a) liability to oculogyric crises and (b) the
presence of gross degree of rigidity. In the 30 patients ' included
in this electroencephalographic study, 13 of them suffer from oculo­
gyric crises, 4 of whom have rigidity classified as mild. Seventeen
patients do not suffer from oculogyric crises and 6 of them have mild
rigidity. In the series as a whole (67 patients), out of the 20
patients subject to oculogyric crises 5 have mild rigidity while 11
of the 47 patients who do not suffer from oculogyric crises have mild
rigidity (see Tables 3 and 4, p. 87 and 88, Chapter II).
The electroencephalogram during an oculogyric crisis is of great
interest. Even in patients with a normal voltage record (that is
40 jx or over) during the inter-crises period, the E.E.&. during an
oculogyric crisis is of low voltage; the alpha rate is increased and
beta activity may become more obvious. Although this change in the
electroencephalogram may be due to severe emotional stress which often
accompanies an oculogyric crisis, the change can be explained in
electrop]hysrolugical terms as being probably due to stimulation of the
reticular formation. Stimulation of the reticular formation in
eiperimental animals has been shown to lead to desynchronisation of
tie cortical potentials; in other words it produces a low voltage
fist activity (Starzyl, Taylor and Magoun, 1951; French, Amerongen
aid Magoun, 1952). In Chapter U, the pathogenesis of the oculogyric
crisis was discussed and from clrnrco-physiulogioal considerations it
wis /
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was considered that stimulation of the reticular formation might
occur during such crises from vestibular stimulation. The findings
from this electroencephalographic study appears to support this hypo­
thesis. The high voltage spike potentials seen in the electro­
encephalograms in the anterior leads when patients were in oculogyric
crises were considered to be muscle spike potentials. The muscle
spike potentials were probably due to the tonic contraction of the
extrinsic ocular muscles. It was noted that these spike potentials
disappeared when the ocular axis returned to normal under the
influence of intravenous sodium phenobarbitone therapy. This finding
assumes considerable importance when it is considered in relation to
Hall's theory (Hall, 193l) that the extrinsic ocular muscles are in a
state of relaxation during an oculogyric crisis, and that the crises
are due to a sleep mechanism. On the basis of purely clinical con­
siderations, it was shown in Chapter II that this theory is untenable.
The E.E.C. findings . support the views detailed earlier in this Thesis
and are at variance with Hall's theory.
Thirty per cent of the patients in this series were considered to
have abnormal electroencephalograms because of the presence of bursts
of high voltage, theta activity and delta activity. These abnormal
waves were more prominent in the frontal region. England, Schwab and
Peterson (1959) however found that in their series, the abnormal theta
and delta waves were more prominent posteriorly. Jasper and Andrews
(1938) found that in severe cases of Parkinsonism an abnormal rhythm
of /
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of 4 to 5 cycles per second would appear periodically. In the
present series it was found that the incidence of abnormal E.E.Gr.s in
patients with more severe degrees of rigidity was about double that
in patients with mild degrees of rigidity. England, Schwab and
Peterson (1959) made the point that akinesia of Parkinsonism is
related to rigidity. They also found the E.E.G-. in patients showing
manifestations of akinesia was usually abnormal. The source or
cause of the delta rhythms is unknown, but they are not associated
with epileptic activity or with narcolepsy.
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SUMMARY
Eleotroenoephalographio study of 30 patients suffering from
post-encephalitic Parkinsonism showed that over half of them have low
voltage alpha rhythms (below 20 jv.). It would appear that in
post-encephalitic Parkinsonism the phenomenon of low voltage E.E.G.s
is most frequently seen in patients who are known to be liable to
oculogyric crises and in those who suffer from severe rigidity and who
are incidentally often bedfast.
There was a very high incidence of theta activity most prominent
frontally. The records of 9 patients were regarded as definitely
abnormal because of the presence of high voltage theta and delta
activity. Abnormal records were more common in patients who suffer
from severe rigidity.
The E.E.G. during an oculogyric crisis has the following charac­
teristics; anteriorly there are high voltage spike potentials, in the
other areas there is a general lowering of voltage j beta activity may
become more obvious.
Administration of 1.5 mg. of prostigmin intramuscularly had
little or no effect on the E.E.G-.
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CHAPTER V.
DEFORMITIES IN POST-ENCEPHALITIC , PARKINSONISM
Apart from the general attitude of flexion and the main
d*accoucheur deformity, deformities in parkinsonism have received veiy
little attention. Even Denny-Brown in his monograph on the diseases
of the basal ganglia (Denny-Brown, 1946) did .not lay much stress on
problems arising out of deformities. However in his more recent
exposition on Parkinsonism (Denny-Brown, 1960), he made some further
comment on this problem, but no detailed study was reported. SohmSrl
and Junghanns (1959) in their monograph "Human Spine in Health and
Disease", made only a passing reference to post-encephalitic Parkin­
sonism as a cause of spinal deformities.
Even a casual visitor to the post-encephalitic wards at Stobhill
General Hospital would immediately note the variety of deformities
exhibited by these patients. Not unnaturally it was decided to
include in the present study of Parkinsonism a survey of these
deformities and to try to gather useful information regarding their
classification, pathogenesis and management. It was soon obvious
that this subject - though of secondary . importance in the sence that
it deals with mechanical sequelae — has wide ramifications into
medicine and surgery: only one or two facets of the problem are
discussed in this section of the thesis. However, in view of the
scantiness /
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scantiness of the literature on this subject, this limited examination
may provide a starting point for a more elaborate study by anatomists
and orthopaedic surgeons.
Sixty-seven patients were studied. Their ages ranged from 39
to 78 years. Atteition was mainly devoted to the deformities of the
hands and the spine. The patients were divided into three groups -
1. Group A - 33in numbe r ani is made up of embulinit patients.
2. Gmp B - Consists c>f non-ambulant patients who are able
to sit in chairs for a few hours. There were
21 p&*t±en~fcs in this group.
3* Group C - 13 p^^dl^n^j3 who are completely hefTas..
Table 12 gives the sex distribution in each group.
Deformities of the Hands
Three main types of deformities were found and have been
classified as Types I, II and HI.
Type I deformity
In this type of deformity there is flexion at the metacarpo­
phalangeal joints, hyperexteinion at both the proximal and distal
i^terphalangeal joints (Fig. 21a). The thumb is usually opposed end
adducted and in one patient the pull of the adductor polliois on the
head of the metacarpal bone of the thumb was so great that the
metacarpo-phalangeal joint of the thumb appeared to be subluxated
(Fig. 21b). X-ray of the joint, however, revealed no abnormality of
the joint. The wrist may be central, flexed or extended. Ulnar
deviation /
142.
. 21a. Right hand - normal..
Left hand - Type I deformity. Note the
marked adduotion deformity of the left thumb.
. 21b. Palmar aspeot of the hands in Fig. 21a. Note
the gross degree of hyperextension of the prox­
imal interphalangeal joints of the left hand.
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deviation of the wrist and fingers is frequently present. There is
some limitation of active adduction and abduction movements of the
fingers (Pig. 22); in some patients practically no such movements are
possible. Wrist movements are often limited: if the joint is
flexion deformity, extension movement is more limited and vice versa
if there is extension deformity of the joint.
Type II deformity
In this type of deformity .the metacarpophalangeal and inter­
phalangeal joints are flexed. The wrist is also usually flexed,
although extension of the wrist is sometimes seen. The thumb is
usually adducted and opposed:: this may be to such a degree that the 
thumb protrudes either between the index and middle fingers or between
the middle and ring fingers (Pig. 23). The interphalangeal joint of
the thumb does not show any constant deformity: it is frequently 
normal but it may be flexed. Ulnar deviation of the fingers and the
wrist is present in nearly 50% of cases, (15 out of 35 hands
examined). The active movements of adduction and abduction of the
finger are either absent or minimal.
Type Ila
A subgroup of Type II deformity can be made out. It has 
essentially the same features as Type II deformity proper, except 
that there is hyperextension at the distal interphalangeal joints, 
usually of the second., third and fourth fingers but sometimes of the 
fifth finger also (Pig. 24-)-
Type /
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Fig. 22. Right hand - normal.
Left hand - Type I deformity.
Note absence of active abduction movement
of the fingers in the deformed hand.
 145.
Fig. 23. Type II deformity. Right hand also shows gross
degree of opposition deformity of the thumb.
146.
Pig. 24. Type Ila deformity.
147.
Type III deformity (Pigs. 25 a and b).
This is a veiy rare deformity. It was seen in only three hands 
(in two patients) and both were female patients.
In this type of deformity the hand resembles the "claw hand" 
deformity of ulnar nerve paralysis. The metacarpophalangeal joints 
are extended while the interphalangeal joints are flexed. The thumb 
again is opposed and slightly adducted. Active abduction and 
adduction movements of the finger are absent. The wrists are flexed -
in one of them very acutely. Movements of the wrist joints are very 
markedly reduced.
Other Parts of the Upper Limb
The elbow usually shows some degree of flexion and active extension 
movement at this joint is almost invariably more limited than flexion 
movement. Contracture deformity at the elbow joint is of the flexion 
variety; but even in patients with fairly severe contracture of the 
elbow joint, active flexion is still possible to a greater or lesser 
extent. The shoulder joint does not show any definite deformity, 
although rigidity of adductors and internal rotators of the joint can 
be shown to be more marked than in the other muscles of the upper
limb.
Pathogenesis of the Various Forms
of Deformities of the Hand
1. Type . of patient . . - whether ambulant or not:-
Table /
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Fig. 25a. Right hand - Type III deformity.
Left hand - Type II deformity.
Fig. 25b. Lateral view of the right hand 
in Fig. 25a.
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Type No. ofhands
fo of total
No. of hands
No. of
Patients
%> of total
No. of patients
I 68 44 63.6%
II 35 2G.3% 20 29.8%
III 5 2.3%- 2 2.9%
Normal 27 20.3%, 18 26.8%
TABLE 10. Incidence of various types of deformities of the hand.
(N.B. One - patient had one arm amputated henoe the
odd number in the total number of hands).
Type of
patient
No. ofpatients
No. of hands in each group
Type I
deformity
Type II
deformity
Type III
deformity norme.1
Ambulant 33 40 2 0 23
N on-Ambulantbut able to
sit in chair
21 22 16 2 2
N on-Ambulant
and completely
bedfast 13
6 17 1 2
TABLE 11. Inoidenoe of the three types of deformities of the 
hand in ambulant and non-ambulant patients.
Type of patient Males Females Total
Ambulant 19 14 33
N on-Ambulant
(chair) 6 15 21
N on-Ambulant
(Completelybedfast; 7 6 13
TABLE 12. Sex distribution of ambulant
and non-ambulant patients.
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Table 11 shows the incidence of these three types of deformities
of the hand in ambulant and non-ambulant patients. Out of the 33
ambulant patients only one (a woman) has type EC deformity and in this
woman the deformity is of a very mild degree. The rest of the 33
patients in this group have either normal hands or the Type I
deformity. There are 27 normal hands in the 67 patients, and 23 of
them are from ambulant patients and 4 from non-ambulant patients.
Types II and III deformities are confined a most entirely to
patients who are unable to walk, and especially in those that are com­
pletely bedfast. One may therefore conclude that Type II deformity
is due to immobility and probably produced in the same way as flexion
deformities and contractures, which are commonly se,en in bedfast
patients suffering from chronic illness or in the elderly rho have
been bedfast for some considerable period of time.
In keeping with what has been said of the association between
Typa II deformity and immobility, gross contractures are almost the
rule in Type II deformity idilst contractures are rare in type I
deformity . and when present, are of the mild variety. Contractures
were present in 44 upper limbs out of which only 6 were found in the
patients iho were able to walk, and in these the contractures were
mild.
2. The degree of rigidity;
The deformities also seem to be related to the degree of Park­
insonian rigidity. Thus 23 of the 27 normal hands in this series
were found in ambulant patients and in most of these patients the
rigidity /
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rigidity was of a mild degree. It is also significant that in
patients who have a normal hand on one side and a Type I deformity in
the other, that the deformed side is the more rigid side. Further­
more, when a fully established Type I deformity and an early stage of
Type I deformity occur in the same patient, the fully established
deformity is on the more rigid side. In the non-ambulant patients
(except one) it was also found that when type I and type II defor­
mities exist in the same patient, that the type HE deformity is on the
more rigid side. Cooper and Bravo (1958) have reported that defor­
mities in Parkinsonism disappeared with the relief of rigidity follow­
ing ohemopallideotony. In the course of the present investigation it
has been found that when byosoine is given subcutaneously, muscular
rigidity is sufficiently reduced to cause considerable alleviation of
"contracture deformity" and a similar but weaker effect is seen even
after the oral administration of drugs such as orphenadrine (Figs. 26
a and b).
Contracture deformity is usually regarded as a permanent con­
dition resulting from shortening of muscles and tendons (the conse­
quent lengthening of antagonists is understood). However it should
not be too readily assumed that the deformity is entirely attributable
to these purely mechanical conditions. Sometimes reflex muscle
contraction plays an important part in increasing a minor degree of
permanent deformity. When reflex (postural) contraction of muscles
is a factor, the differenciation is often possible. For example,
therapy /
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Pig. 26a. Gross 
limbs
Atropine
contractures of the upper
Patient was receiving
10 mg, thrice daily (orally).
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Fig, 26b. The same woman in Fig. 26a,
Now receiving orphenadrine 100 mg* t.i.d.
Note considerable reduction in the
degree of contractures at the elbow
joints.
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therapy which is known to reduce muscle tonus may effect considerable
improvement in the condition of the joint notwithstanding that the
deformity had been supposed to be due exclusively to permanent
shortening (contracture) of the soft tissues.
One may therefore conclude that the deformities in Parkinsonism
are certainly related to the degree of rigidity. it also seems that
type i deformity is the characteristic deformity of the hands in
Parkinsonism occurring in of the hands in 66% of the patients in
this series (Table 10).
type i deformity is similar to the main d'accoucheur deformity
seen in tetany and sometimes in severe rheumatoid arthritis. This
type of deformity is produced by the over-activity of the small ~ 
muscles of the hand - the interossei, lumbricalis and adductor
pollicis muscles ihich are supplied by the ' ulnar nerve. it is not
clear whether the deformity in Parkinsonism is due to primary spasm
in the small muscle of the hand or to over-excitability of the ulnar
nerve.
3. involuntary Spasms:
involuntary spasms of the muscles resulting in flexion of the
wrist and fingers were complained of by some of the patients with
type ii deformity before contracture had set in. it was not possible
to assess the importance of this phenomenon in relation to the patho­
genesis of Type HE deformity . as these events had occurred several years
earlier. Sciarra and Sprofkin (1953) reported on 474 patients with
brain /
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brain tumours, 10 of whom showed evidence of extrapyramidal involve­
ment. One of . the 10 patients developed advanced Type HE deformity
within one month following involuntary spasm of the muscles of the
fingers. One of the patients (J.McM.) in my own series had normal
hands when this survey was made, but subsequently developed involuntary
flexor spasm of the left wrist and hand; within two weeks he developed
permanent Type deformity, although the spasms ceased after one week.
The use of cock-up splint was not effective in preventing the deformity.
in fact the patient found it rather irksome and sometimes painful., and
so it had to be removed..
in experimental animals subjected to destructive lesions of the
midbrain (especially' ihen the lesions involve the medial longitudinal
fasciculus and the red nucleus), involuntary spasms of groups of
muscles and assumption of bizzare postures have been observed
(Carpenter, "Wittier and Mettler, 1950; Carea and Mettler, 1955).
These findings suggest that in the post-encephalitic ' patient the
spasms are likely to be due to the consequences of the midbrain
disease rather than the result of independent changes in the cortico­
spinal pathway.
4. Relative Strengths of Antagonistic Muscles;
The neutral position of a joint is due to the balanced action
between the agonists and antagonists. As mentioned in Chapter i
(page 47), the topographical distribution of rigidity in the voluntary
muscles can be limited to one group of muscles. The rigidity and
weakness /
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weakness in one group of muscles will tend to create an imbalance in
the mechanical pull on the joint, resulting in a new position depending
on which group of muscles is stronger.
5* type ila deformity:
This is a variant of Type ii deformity and it seems probable that
it is produced by purely mechanical means. The terminal phalanges of
the flexed finger come to be pressed against the thenar eminence and
if the force is sufficiently great hyparextension of the distal inter­
phalangeal joints will result, giving rise to nhat is called here a
"type Hia" deformity.
6. type III defonaity:
As already stated this deformity resembles the "claw hand"
deformity of ulnar nerve palsy. Electrical studies using faradic
stimulation were carried out in the two patients with this type of
deformity to ' ' assess the state of the ulnar nerve: the nerve appeared 
to be normal. The radial nerves were also intact in these two
patients - and also in. three patients who had this test carried out
during investigation of flexion deformity of the wrist joint. Details
of ' the results of the electrical studies in these two patients are
given below. Results of electrical studies of the muscles which
move the ankle joint and the foot are* also recorded.
K. Has. Woman aged 46 yeers . Admitted 1950 .
No history ' of encephalitis lethargica. "Dizzy turns" for 2^-
years. /
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years. Slie%t haematemesis one week before admission.
On examination (1950). Thin woman. Rigidity left upper and
lower limbs. Involuntary tremor all .limbs (left greater than ri%it).
Poor muscle power all limbs.
Re-assessment after 10 years (1960). Bedfast. Very marked
rigidity (Grade 3) ell limbs but especially on the left side. Tremor
very sli^it. Deep reflexes could not be elicited. Minimal general
wasting of all limbs.
Deformities:
Hands. Type III with gross flexion contractures of both wrists and
both elbows.
Lower Limbs. Ri^it knee - flexion contracture.
Left knee - contracture in extension.
Foot and ankle - plantar flexion with sli/%t
eversion right side.
Results of Faradic Stimulation at
the Motor Points of the Muscles.
Left Hand and Wrist (more deformed than the li$tfc).
1. Common Extensor Muscles: Excitable but stimuli (weak to 
moderate) produced no movement of the . wrist. On increasing the
strength of stimulation, flexion of the wrist resulted instead of
extension. No movement of the fingers was produced.
2. Dorsal Interossei: Responded to Faradism, but a form of mass
action . resulted; stimulation of the third or fourth dorsal interosseus
muscle /
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muscle caused all the interessei muscles to contract.
Right Hand and Wrist
1. Common Extensor Muscles: Excitable, but extension occurred
mainly at the motacarpo-phalangeat joints. No flexion of the wrist
resulted on increasing the strength of stimulation . (c.f. left hand,
above).
2. Dorsal . Interossei: Excitable, and produced the usual 
abduction movement of the fingers. There was no spreading of the
effect from one muscle to its ' neighbours as on the left hand.
Comment
The response of the extensor muscles and the dorsal interossei
to Faradism rules out radial and ulnar nerve palsy. It is difficult
to expledn the production of flexion of the wrist while the extensors
were being stimulated. It was presumably due to a spread of current
to the flexors of the wrist. The result is however in keeping with
the view that when flexors and extensors are stimulated simultaneously
it is the action of the flexors that predominates. In this patient
it is reasonable to assume that the flexion deformity of the wrist is-
due to the fact that the extensors of the wrists are very much weaker
than the flexors. The cause of the spread of current from the
extensors to the flexors is not known but wasting of the muscles may
be a factor.
Lower Limbs:
Left -Leg /
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Lower Limbs;
iafkJLal
Tibialis Anterior — Excitable, but strmulatrcn caused weak
extension (dorsiflexion) of the ankle*
Extensor Li/itcmim Longus - Excitable with normal action
(extension of the toes).
Gastrocnemius Muscle - Normal action.
Soleus Muscle - Normal action of plantar flexion.
R1*ht Leg
Tibialis Anterior lusole - Excitable, but stimulation produced no
extension of the ankle or inversion of the foot. There was a tendency
to flexion of the toes and even flexion of the knee. By stimulation
applied along the rnTesicr surface of the leg, flexion of the toes
resulted from small currents which produced no visible or palpable
contraction of the tibialis anterior*
The Gastrocnemius and Soleus Muscles - Excitable, with the normal
action of plantar flexion.
Comment
in order to assess the significance of results obtained from
these tests made - on patients, similar procedures were carried out on
the examiner and on the physiotherapist, using the same strength of
current and applying . the electrodes in the same places. Two impor­
tant control observations were thus made: (l) contraction of the 
underlying /
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underlying masole was elicited as expected; (2) there was no spreading
of the stimulus to other muscle groups. It is clear therefore that
in the case of the post-enoephalitio (K.Has.) there was an abnormality
in the behaviour of the tibialis anterior muscle when under aotive
stimulation.
C. McK. Woman aged 58 years * Admitted 1930.
Para 4 (1922, 1924, 1926 and 1927). The last two babies died
in the neonatal periods.
1924 "Influensa" lasting two weeks. Insomnia and diplopia.
Diplopia continued until 1960.
1926 Onset of oculogyric ciises.
On g^em1wet1on I960. Bedfast. Harked rigidity all limbs
(left greater ri%t) ; lower limbs Grade 3 end upper limbs Grade 2 to
2+. Wasting both sides, worse on the left. Deep reflexes could
not be elicited. ,
Deformities. Flexion contractures both wrists and elbows.
Hands. light - itype III. Left - Typpe I
Knees. Flxiion oontaaoturss.
Feet and Ankles. Talipes ego^ova^s deformity both sides
(worse on the ripxt).
Results of Farad-ic Stimulation at
the Motor Points of the Muscles.
Hands and Wrists /
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Hands and Wrists
Intact radial and ulnar nerves* There was no spread of impulses
when the dorsal interossei were stimulated.
Extension of the wrist was weak tut that of the metacarpo­
phalangeal joint was more powerful. There was no spread to the
flexors of the wrist when the extensors were stimulated.
Legs
Right Foot
Tibialis Anterior Muscle - Excitable, and stimulation resulted in
well marked inversion of the foot. However plantar flexion of the
ankle resulted instead of dorsiflexion. The calf muscles were felt
to contract and the contraction was more powerful than that of the
tibialis anterior which was being stimulated. This was interpreted
as an "escape" of the stimulus so that it affected the flexors also;
end when these contracted they dominated the picture.
Extensor . Hallucis Lpngus and Extensor Digitorum Euscles -
Responded to Faradism and showed normal reaction of extension of the
toes. There was no spread to the calf muscles.
Gastrocnemius Muscle - Normal action.
Soleus Muscle - Normal action.
Left Leg. (More wasted than the right, especially at the calf).
Tibialis Anterior Muscle - Normal function, contraction quite
strong with extension of the ankle and inversion of the foot. There
was no spread to the calf muscles.
Extensor /
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Extensor Digitorum and Extensor HalltoCs Longas Muscles -
Normal action.
Gastrocnemius and Soleus Muscles — Normal function.
Comment
1. The left leg mas more wasted than the right but deformiiy
was greater in the right leg.
The strength of the tibialis anterior was greater on the left
side. This probably explains why the plantar flexion deformity was
greater on the right side.
2. If it is true that the spread of stimuli is due to wasting
of muscles, then it is difficult to explain lAy the spread of current
from tibialis anterior to the calf muscles was confined to the right
leg wdich was less wasted than the left. It would appear, therefore,
that there are other contributing factors.
Deformities of the Lower Limbs:
Ankle and Foot. Plantar flexion was the most common deformity:
it was present in 85 out of 128 feet (66 .<2%* The disability was
often aggravated by inversion; this was seen in 40 of the 85 feet
with plantar flexion deformity (4750* The talipes pqtinoveuus
deformity (plantar flexion + inversion of the foot) may be severe
enough to give one the impression that there is sub-luxation of the
talus (Fig. 27a). X-ray in the more gross cases, however, revealed
no subluxation (Fig. 27b). In one patient there was Pes Cavus in
addition /
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Fig, 27a. Typical talipes equino varus 
deformity in post-encephalitic
Parkinsonism.
164.
Fig. 27b. X-ray of the right foot and ankle.
There is no coincidence of sub-
luxation of talus or the tarsal 
bones.
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addition to the talipes equino varus deformity (Pig* 28).
Knees. In the erect posture the Parkinsonian patient tends tco
assume a flexed attitude at the knee joint. The incidence of con­
tractures of the knee joint is of some interest. Of the 128 lower * 
limbs (64 patients) studied, contracture at the knee joint was prescent
in 49 (38%). In one only was the knee in extension; the rest weres
flexion contractures. Six of the contractures occurred in ambulantt
patients and the rest were seen in those unable to walk - and espec—
ial3y in patients mho were completely bedfast. It appears that womien 
are more prone than men to develop contracture. Of the 43 contract 
tures of the knee seen in the 31 non-embtlert patients 13 men and 16
woaen), 15 were in men and 28 in women.
Hip Joints. No definite deformity was detected but rigidity of
adductor muscles of the hip joint was usually more marked then in any
other group of muscles.
Pathogenesis of the defoimities
of the Lower Limbs.
The factors are similar to some of those mentioned in respect of
deformities of the hand and will therefore be discussed briefly:
1. The type of patient (idither ambulant or not). The more
severe deformities are seen only in patients unable to walk. Defor­
mities are also more frequent in the bedridden than in ambulant
patients. 35 out of 66 feet (53%) in walking patients were normal
while only 7 out of 62 feet (11^ in non-ambulant patients were normal.
2. /
166
Fig. 28. Gross deformities of both feet. In 
addition to the talipes equino varus 
deformity on both sides, pes cavus 
is also present on the left side.
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2. The degree of rjgidi'lg tHbe more rigid side is invariably
the more deformed aide. If one aide da normal and the other deformed,
the deformed aide da the more rigid aide. The oircnmatancea are apt
to create a bicioua circle: apaaticity not only prediapoae8 to 
deformity, it alao interferea with walking; and eventually the dia- 
ability may result in the patient'a becoming bedridden - a atate which
increaaea the likelihood that deformitiea win develop.
3* Involuntary apaam. The role of involuntary apaam in the
production of talipea equino deformity ia not known. It waa however
obaerved that in one patient involuntary apaama of the calf muaclea
were frequently preaent and thia led to plantar flexion of the ankle
joint.
4. Relatiee sivengtrs of aepoePag or Metreaniailc auicems 
acting on a joint. The neutral poaititn of the ankle joint dependa
on the balance of the power of dtraiOlextra of ankle joint (chiefly
the tibialia anterior muacle) and the plantar flexora eapecially the
gaafrocnemiua and the aoleua muaclea. From afuddea involving the uae
of electrical atimulation of muacle groupa, it appeara that plantar
flexion can reault from relative weakneaa of the tibialia anterior
muacle and conaequent predominance of the calf muaclea.
Deformitiea of the Spine
DeOormitSia affecting aome part of the apine are very common in
Parkinaoniam. The preaent obaerbationa refer only to acteiofic
abntrmaesfiea /
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abnormalities as the common-place ■ kyphotic deformity has been folly
described in the literature.
Deformities of the neck
and the . cervical spine:
The decree of lateral flexion of the neck was assessed in all the
patients but it . was thought that only in the ambulant patients would
this study be informative, as the state of bedfastness affects the
position of the neck in ways that are controlled with difficulty if at
all.
18 of the 33 ambulant patients had deformities of the neck with
varying degree of lateral flexion of the neck. in 15 of the 18
patients . (83*660 the neck was . laterally flexed to the less rigid side.
The remaining 3 patients (i6.4)S) had lateral flexion of the neck to
the side with greater rigidity. Figs* 29a and 30 show the examples
of the deformities of the neck; and Fig. 29b is a radiogram of the
cervical spine and it shows the scoliotic deformity of the cervical
spine in association with the lateral flexion deformity of the neck.
Scoliosis of . .the thoracolumbar spine:
This study was again confined to ambulant patients in order to
avoid the effects of bedfastness. There were five patients (3 men
and 2 women) with marked scoliosis of the thoracolumbar spine. in
the 3 male patients the scoliosis was concave to the less rigid side. 
in one of the female patients the scoliosis was, however, concave to
the more rigid side. ih the other female patient, the scoliosis was
maximal /
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Fig. 29a. Fig. 29b.
Fig, 29a. Lateral flexion deformity of the neck. Left side much
more rigid than the right.
Fig. 29b. Radiograph of the vertebral column showing a scoliotic
deformity of the cervical spine convex to the nore rigid
side.
 
 
 
110
Fig. 30. Another patient with groge lateral
flexion deformity of the neck.
(Left aide more rigid than the
right aide).
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maximal in the lumbar region (Fig. Jib). In this patient the upper
limb was more rigid on the ri$it side while the lower limbs were more
rigid on the opposite (left) side. The lumbar scoliosis was similar
to that seen in the male patients, concave to the less rigid side of
the lower limbs. It would appear therefore that in cases of scoliosis
in Parkinsonism, the scoliosis is usually concave to the less rigid
side. Figs. J2 a and b are radiographs of the spines of patients
shown in Figs. J1 a and c.
Mode.of production of scoliosis
The central or neutral position of the spine is due to a balanced
action of the muscles which act on both sides of the spine, namely the
pre- and post-vertebral muscles, the sternonaistoids, the soale^ and
the anterior abdominal muscles. In order to understand the mode of
production of scoliosis it is necessary to understand how movements of
the vertebral column are produced. A good account of this has been
given by Last (1954).
Extension of the spine is produced by the action of the post­
vertebral muscles (erector spinae muscles). This group of muscles is
more bulky and more powerful than the pre-vertebral group. Flexion of
the spine is produced partly by the action of the pueveutebral muscles
but the chief flexors of the spine are the stemomastoid and the rectus
abdominis muscles.
Lateral flexion is due to . the action - of the erector spinae,
oblique muscles of the anterior abdominal muscles and the sterao- 
mastoid /
 172
(a) (b) (o)
Pig. 31» Three patients with gross sooliotio deformity
of the tboueoo-lumbeu spine.
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(a)
Fix. 32.
(a) Radiograph of the apine of the patient ahown in Fig. J1a.
SooeSoaSa ia confined mainly to the lumbar vertebrae.
(b) Radiograph of the patient ahown in Fig. ilo. G^aa
acoliotic deformity of the thoraoo-lumbar apine.
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steraomastoid and the soaleni - acting of course on one side only.
Lockhart, Hamilton and Pyfe (1959) in discussing the action of the
post-vertebral muscles in lateral flexion of the spine, state that in
the presence of resistance lateral flexion is made by muscles of the
same side, and in the absence of resistance by relaxation under tension
of the muscle of the opposite side.
The influence of the sternomastoids on the position of the neck
and the spine is shown by the fact that "wry neck" or torticollis can
be produced by spasm (contracture) of the steraomastoid on one side.
Contraction or shortening ' of the steraomastoid on one side causes the
ear of the same side to approach the tip of the shoulder with the chin
rotating to the opposite side.
After unilateral thoracoplasty operation on the scoliosis that
results is concave to the intact side. This is explained by saying
that the operated side is relatively unsupported and therefore weaker;
thus the normal side exerts unopposed muscle tensions which bend the
spine (like a bow with a tight string) and resulting in a scoliosis
concave to the intact side.
This situation is reproduced in all essentials in patients
suffering from ' scoliosis which is the result of Parkinsonism. It
must be noted however that the , muscles on the rigid , side of , the body
are relatively weak. The muscles on the _ less rigid side of the body
are relatively strong and it is these which over-act; their over­
activity flexes the spine so that the concavity of the scoliosis is
towards the less rigid side of the body.
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MANAGEMENT OF DEFORMITIES IN PARKINSONISM
AND THE CARE OF THE SKIN
Excessive salivation shown by dribbling of saliva from the mouth
appears to have three contributory causes:-
1 • The characteristic forward and/or
lateral flexion of the neck:
This prevents the normal drainage of saliva into the pharynx.
The effect of posture is often apparent in patients with scoliosis of
the cervical spine: the ordinary night-gown worn by these patients 
hangs crodkedly from the asymmetrical shoulders. The attitude of the
head and face is that associated with chronic wry neck: the plane of 
the mouth is slanted and saliva dribbles from the angle which is lower.
If the patient has been eating coloured foodstuff (for example, choco­
late or sweets) the saliva stains the clothing on one side (the lapel
and adjacent areas) whereas the other side remains clean.
2. Dysfunction of the swallowing reflex:
Normally accumulations of saliva are disposed of reflexly and
without any conscious effort. It is conceivable that if the muscles
of deglutition are rigid from Parkinsonism the operation of the motor
side of the reflex arc will be hindered and reflex swallowing of
saliva will occur less frequently: thus there will be excessive 
accumulation of saliva in the mouth and dribbling will tend to occur.
3. Some actual increase in the _ secretion
of saliva ( sialorriioea) _
It /
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It seems probable that in some patients there is an absolute
increase in the secretory activity of the salivary glands. There are
patients who, idin placed on placebo therapy, report that they have to
make a special effort to swallow saliva as the mouth is frequently full
of secretion. Examination of the mouth then reveals a very moist
tongue and often a pool of saliva on the floor of the mouth.
Excessive salivation accompanied by dribbling is a humiliating
disability - especially to the intelligent patient. In addition, the
state of the patient and his clothing occasioned by the dribbling of
saliva is unpleasant for those around him. It is thought that of
three factors responsible for the dribbling of saliva, the effect of
posture is probably the most important. Consideration was therefore
given to measures calculated to control the dribbling of saliva simply
by attending to the postural ebroumelity* One advantage of successful
orthopaedic management would be the elimiret1or of the use of the
atropine group of drugs to supplement the newer synthetic preparations
when the latter drugs do not adequately control the excess salivation.
Four patients with excessive salivation and marked dribbling of
saliva were selected for this study. Two of them have gross scoliosis
of the spine; the other two (one man and one woman) have mainly a
forward flexion of the cervical spine. The problem was tackled with
greater optimism in the patients with only forward flexion of the neck
and the splint that is described below was constructed for the reduc­
tion of forward flexion deformity only. The splint was designed in
close /
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close collaboration with the splint makers, Messi’s. G.B. Ritchie and
Co., Ltd., Surgical Instrument Makers, Glasgow, and Mr. J.M. Main,
F.R.C.S.
Essential requirements of the splint.
Three requirements were considered essential for such a splint
which was to be worn during the day and removed during the night:-
1 • Light in weight and yet be strong enough to support the
head.
2. Capable of fine adjustment.
3« Easy to fit on and to wear.
Description of splint (Fig. 33).
The splint consists essentially of two "shelves", one to support
the lower jaw and the other to support the occiput. Each shelf con­
sists of a metallic basis covered with sorbo-rubber. Each shelf is
supported by two vertical adjustable metallic props resting below on
a chest plate which is padded with felt. The splint is in two sep­
arate parts - a front and back piece and these are connected together
by adjustable leather straps.
As a preliminaiy to making the splint, a plaster of Paris (P.O.P)
collur splint was applied fairly closely while the deformity was
slightly over-corrected. The P.O.P. collar splint was split on
either side into two pieces soon after it had set. The splint makers
constructed the metalic splint described above using the measurements
obtained from the P.O.P. cast.
RESULT /
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Fig. 33.
1 • 
2.
3.
4.
5.
6.
Adjustable splint for correcting
forward flexion deformity of the
neck.
Ad justable strap.
Anterior or chin shelf. 
Adjustable supports.
Chest plate.
Adjustable straps.
Posterior or occipital shelf.
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RESULT
Ifhe the aplint waa atrapped in place with the head and neck dn
a neutral poaitdon It waa noticeable that dribbling of aaliva abated,
although the mouth and tongue were afile exceaaively modat. In other
worda dribbling of aaliva waa relieved. It waa not possSbee to
comment on the rate of production of aaliva but there waa no reaa^ to
auppoae that the volxua of aecretion had dimini-ahed. Unfortunately,
however*, after a few h)ura the anterior abelf uaually alipped back- 
warda ao that the anteHtr aapect of the mandible waa no longer
reating on the ahelf. The alipping of the anterior abelf waa
explained thua; - when ahe spIIcS waa fixed in poaition with the head
and neck in neutral pojitdon the upper aurface of the ahelf aloped
aomewhat backwarda Snatead of forward. In apite of aome aejuatminfa
by the makera, thia difficulty waa not overcome; the ahelf otctSnuid
to alip out and hence frequent adjuatment of the aplint waa neceaaafy.
The oircumatancea cauaid aome diafreaa to the patienta - few of whom
are tolerant of advera# conditiona calling for a meaaure of endlranoe
and percevai'mce. It waa therefore neceaaaxy to abandon the experi­
ment. Notwitratlnclino that the patienta were unwilling to peraevere
with the aplinta for adequate perioda of time and that the aplinta were
not ideal Sc their deaign, thia limited atudy ahowed clearly that even
where there da an exoesadve aecretion of siIIyi, dribbling from the
mouth reaulta from a reveraal of the normal direction of flow and that
thia ia the oonaequence of faulty poafuri.
With regard to the other two patienta with more extenaive and
aevere /
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severe deformities of the vertebral oolumn, for reasons that will be
clear latex*, it was not possible to devise suitable splints. The
splint was extensive, being in the shape of a collar splint above, and
of a hip spica below. In order to make the P.O.P. cast from mhich
the splint was made, the deformity had to be correoted under general
anaesthesia. The splint was to be worn only during the day; and it
was found that it could be properly applied only following the daily
administration of muscle relaxants. The splint was designed by
Mr. J. Main, surgeon at Stobhill General Hospital. These circum­
stances made it necessary to abandon the use of the splint.
A simple procedure in the management of these patients is to
ensure that when sitting, the type of chair used is one which ensures
drainage of saliva backwards to the fauces. It has been found that a
high-backed chair tilted backwards by lengthening the front legs of
the chair often contributes considerably to the alleviation of this
symptom for part of the day.
Medical Management of Def oralties of the Hand;
Deformities of the hand also received some attention. In
Type n deformity where the fingers are ti^itly flexed, it was found
that the skin of the palm of the hand became macerated by sweat and
this predisposed to local infection, ulceration and the formation of
offensive discharge. The routine treatment by the nursing staff had
consisted of the use of liberal amounts of dusting powder to keep the
auea diy. In a few cases, ulceration of the finger or the palm may
occur /
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occur in spite of these preventive methods. One patient developed, 
chronic ulceration of the palmar surface of the middle and ring fingers 
of the right hand. The ulcer did not improve on various kinds of con­
ventional treatment and amputation of some of the fingers was considered. 
Indeed the patient herself volunteered the suggestion that amputation -
should he performed. After discussion, however, a method was devised
for thoroughly ventilating the skin of the palm. Warm air was blown 
into the enclosed space by means of an electric hair-diyer and vaseline 
gauze was applied to the ulcer craters. The tissues soon became more 
wholesome, and in the course of a few weeks the ulcers had healed.
The methods described were based on physiological principles 
which have been accepted for a long time in clinical practice. The 
skin is designed to desquamate and provision is made for continuous 
renewal of the cells lost from the body surface. Such a mechanism is 
clearly indispensable for hi^ily mobile organisms whose body movements 
result in surface friction; and the complementary situation is that 
in health such conditions themselves are potent in stimulating regener­
ation of surface epithelium. There are circumstances, however, in
which this activity of the skin can become a source of danger. If a 
limb is immobilised - and especially if this is the result of muscle 
weakness and contracture deformity of the limb — complete desquamation 
is impeded., the stratum corneum is macerated by sweat, moist epithelial 
debris accumulates and provides an excellent culture medium for 
bacterial growth and the proliferation of yeasts. Thus local 
infection /
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infection apreada into the cutda vera and auperficial tiaauea,
reaulting dn cellulitSe and ulceration.
In order to aeparate the fingera from one another and alao to
prevent prolonged appoadtltn of the fingera and palm, lamr,a-wool waa
uaed aa inaulating material. There are aeveral advantagea dn uadng
thia wool: it da ligWf in weight and vezy aoOt to the touch. Moat 
important of all the fibrea have retained enough- lanolin to reaiaf
the tendency of modature fo produce the aodden atate: water vapour 
from the akin peroolafea in the apacea created by the Oilamenta and
can thua eacape from the body aurface. By ctmpariatn, cotton uaed aa
"cotton-wool**, ia very unaatlafaotory: matting of the fibrea aoon
occura when the material da packed into apacea aurroucding the aweafing
akin, and the aodden pack producea efOecta which are juat the oppoaite
of thoae which are deadred. In practice amongat ptat-enoepralltlo
patienfa, fheae advantagea in the uae of elmb*a-wool were immediately
obvioua. In bedridden patienfa maceration of the akin of the lega ia
likely to occur if one limb ia allowed to reat acroaa the other for an
hour or ao; and thia can hardly be avoided in the helpleaa poat- 
encephalitic (unable aa he da fo turn in bed), and aome have the
additional handicap of flexion deformity with adductor apaam. In
auch oircumatancea large pada of lamb' a-wool were placed between the
oppoaing aurfacea. It waa found helpful fo endoae theae maaaea of '
wool in nylon hair neta. Allergic dermafoaea are atmetlmea cauaed by
wool, but no caaea of thia type have ao fare occurred.
As /
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As in all paralytic diseases complicated by contractures,
mechanical devices of one kind or another are likely to be tried as
aids to minimising the consequent disabilities* In such circumstances
success or failure may depend, in some measure on maintaining a healthy
and intact akin# General hygiene must therefore receive scrupulous
attention to combat the effects of excessive production of sweat and
sebaceous secretion - characteristic of the post-encephalitic* A
greasy scalp is a common source of trouble with its attendant sebor-
rhoeic dermatitis of the face, the neck, and the anterior aspect of
the chest* This condition is readily controlled by the "sulphur
shampoo" regimen carried out every three or four weeks as an addition
to routine hygiene* The use of Selenium Sulphide has been found to be
an effective method of combatting seborrhoea of the scalp, but the
older, conventional methods are probably equally satisfactory such as
the use of Sulphur Compound Lotion (BN?) followed by a soap shampoo.
184.
SUMMARY
The deformities of the hand in post-enoephalitio Parkinsonism 
have been classified as Types I, II, and ILL. Type I (main
d* aocouchUfr deformity) is the most common form.
Talipes equino varus deformity is the common deformity of the 
foot in Parkinsonism.
Scoliotic deformity of the spine, especially of the cervical spine, 
is common. The scoliosis is usually concave to the less rigid side.
The factors of importance in the pathogenesis of deformities 
include: skeletal muscular weakness, rigidity and involuntary muscle 
spasms. Muscle weakness is the most important factor. It is 
emphasised that deformity is not due to the action of the rigid ' muscles 
(as is commonly thought), but results from an uncounterbalanced action 
of the stronger and less rigid muscles. The opposing weaker and more 
rigid muscles are lengthened as a result.
It is suggested that the effect of posture is probably the most 
important factor responsible for dribbling of saliva.
The use of splints and lamb ’ s-wool in the management of some 
types of deformities is discussed.
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CHAPTER VI.
ASSESSMENT OP DRUG THERAPY IN PARKINSONISM
INTRODUCTION
The disabilities associated with Parkinsonism are often serious
and over a long period of years, they are usually progressive*
There is no specific treatment for the disease as seen in its common
forms. It is therefore particularly important to ensure that the
most effective kinds of palliative treatment is provided for the
individual patient. Such treatment include drug therapy. New
pharmaceutical preparations are increasingly offered for clinical use
by manufacturers. The evaluation of these substances presents excep­
tional difficulties. Clinical trials on the actual patients are
indispensable, but it is by no means common to find adequate numbers
of patients conveniently segregated in hospital and willing to submit
to measurements which are necessarily exacting for all concerned..
The burden imposed on volunteers is obvious ihen the conventional
designs of clinical trials are studied. Experience over a period of
three years, while looking after over 60 post-encephalitics, abundantly
confirms the need to adopt the classic methods of the double-blind
technique. Casual observations are of limited value and among long
term patients of this kind there are many pitfalls awaiting the
clinical /
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clinical pharmacologist who relies on a limited selection of data.
One example of the difficulties confronting the clinical
pharmacologist is concerned with patients 1 attitudes and motives.
Their disabilities inevitably create feelings of dependence and these
are naturally manifested in their relation to the nursing staff and
the doctor. A patient may therefore be reluctant to offer any com­
ment about treatment if he thinks his remarks mig^it be construed as
criticism of the hoctcr or dissatisfaction in general. The tendency
of these patients to make statements calculated "to please the hoctcr"
can easily vitiate the conclusions reached, in a clinical trial unless
stringent safeguards are adopted. Thus the use of placebos is indis­
pensable and at all times care must be taken to adhere to a standard
method of investigation while eliciting information about subjective
responses to therapy.
It is already established that certain synthetic compounds such
as benzhaxcl and orphenadrina give substantial relief in Parkinsonism.
Any new drug for use in the disease must stand, comparison with the
current official preparations.
In the following report this kind of investigation has been
carried out to assess the therapeutic value 'of N-ethyl-nortropine
benzhydxyl ether hydrom^e (prepared by Messrs. Sandor Products Ltd.
and designated "UK. 738"). The effects of this drug have been com­
pared with those of orphanadrina and suitable placebos have also been
used. /
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uaed* Orphenadrine (Diadpal) waa crosen becauae if haa been rated
aa the moat effective aingle drug in the treatment of Parklnstnlsm
(G-ilhe8py, 1956).
The atudy waa undertaken with two objectivea in view:-
1. To aaaeaa the therapeutic value of UK. 738 and alao
that of orphenadrine.
2. To determine the value of objective measurementa in
thia aaaeaament. Hitherto, there haa been con- 
aldirabei oontroviray aa to the value of objective
meaaurementa (G-iilheapy and RatclifOe, 1956; Schwab
and Leigh, 1949; Berkowitz and Alvemn, 1952).
Although thia waa not the objective in thia atudy, it waa con- 
flidered that thia clinical trial might afford an opportunity to atudy
the more florid mandfeatationa of Paikinaonlam.
Two fypea of atudiea were carried out. The firat waa a double­
blind trial in which UK. 738, oiprenadilne and their placeboa were
uaed. The aecond waa an "acute" atudy deadgned to determine the
length of time between the taking of a drug and the onaet of thera­
peutic effecta and to aacertain if there waa a phaae of peak activity
in the pharmacological action.
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METHOD AND MATERIAL
Double Blind Trial;
Twenty-four patients were studied. Some of them were ambulant 
and some were bed patients. Their ages ranged from 42 years to 62 
year's with an average age of 53 years (three-quarters of them were in 
the 49 to 58 year age group).
Selection of patients
As stated in earlier chapters, there was a total of 67 patients 
in the post-encephalitic wards. These patients were suffering from 
Parkinsonism of varying degrees of severity; some of them being 
very ill and severely disabled; a few were curled up in a state of 
generalised flexion deformity; others were unable to speak intel­
ligibly and communicated by signs; a few were of low intelligence 
and had deteriorated further as a result of long-standing Parkinson­
ism. It was therefore essential to select the patients who were to 
take part in this clinical trial. Certain criteria were therefore 
adopted for the inclusion of a patient in the trial and these were 
as follows:-
1. The patient should not have gross deformities, especially 
of the hand. It was essential that the patient should 
be capable of using at least one hand so that the strength 
of grip could be measured..
2. /
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2. It was desirable to study the effects of the drugs on 
clulogyril and sweating crises and it was therefore
decided to include at least 10 patients suffering from
these crises.
3. The patients should suffer from Parkinsonism of moderate 
severity although a few patients with rather severe 
disabilities were ultimately included.
The patients were studied, in two groups of 12 (6 men and 6 women
in each group). The number was kept small in order that the patients
0 Hmi^t be observed in greater detail. As "Disipal" and UK. 738
tablets were of different colours, two placebos had to be used in
order to eliminate the psychological effect known to be associated,
with the mere colour of a tablet.
Each drug (including the placebos) was given in a dosage of two
tablets three times daily for three weeks. A master chart was pre­
pared so that the drugs were given in a randomised fashion. This
chart was given to the pharmacist, and he allocated at random various
letters of the alphabet to each of the four types of tablet. Only
the pharmacist had access to the key which identified the tablets.
Every Saturday he sent to the wards individual packets of tablets for
the patients. The label on each packet showed the patient's name,
the date and the direction to take two tablets three times daily.
No other information was given.
In /
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In order to mindmiae the riaka of precipitating withdrawal
ay^dromea (when changing from an active drug to a placebo), a acheme
waa deviaed to effect overlapping of treatmenta at the week-end.
Thua patienfa received on Saturday afternoon two tableta of the new
aet inatead oO the tableta in current uae and on Sunday two tableta
oO the new aet in the morning and evening, the aef of tableta in
current uae being given only in the afternoon. Pyom Monday to Friday
the new aet oO tableta waa given aa uaual (two tableta thrice daily) 
(Table 13). When, over a period oO aome daya, a patient appeared to
be lapaing into a atate of aeiioua diaability while taking . a particular
type of tablet, the treatment waa atopped and the pharmaciat waa aaked
to aupply to the patient the next type of tableta on the chart. The
tableta were given at definite timea, namely 8.45 a.m., 1 p.m. and
6 p.m.
Day Tablet
Friday A A A
Saturday A B A
Sunday B A B
Monday B B B
TABLE 13
Scheme deviaed for overlapping
treatment at the weekend.
A = Tablet in uae in the preaent week.
B = Tablet Oor the next week.
Week = Monday to Sunday inoeualvi.
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Simple quantitative measurements were made on Thursdays in the
women's ward and on Fridays in the men*s ward : these observations
always began at 2.30 p.m. The measurements consisted of:-
1. The measurement of the strength of the
grip using a mercury column dynamometer
A modified sphygmomanometer bag was connected to a mercury mano­
meter and the bag was pumped up to a pressure of 60 mm.Hg. The
patient was then instructed to squeeze the bag as forcibly as possible.
The rise in the mercury column was noted and this was taken as a
measurement of the strength of the grip. Three attempts were made
by the patient and the highest reading was recorded.
2. The amount of active and passive movement
of the neck (full flexion. ; fill extension)
This was measured by asking the patient to perform full flexion
and full extension of the cervical spine. When these movements were
performed the distance between the external occipital protuberance and
the tip of the 7th cervical spine was measured. The difference
between the two readings was regarded as the total flexion-extension
movement of the neck.
3. Ability to write
This was tested by asking the patient to write his name (and in
some cases the date) and finally to draw a circle and a spiral.
m /
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In some patients the time taken to walk a given distance was
noted; and in a few others cinematographic records were made of the
patient's attempts at feeding, or ihile the patient tried to rise
from a chair, or tried to walk.
Tremor was observed and assessed visually, as the use of mechani­
cal methods was impracticable when a sufficiently large number of
patients was being studied simultaneously. Rigidity was measured
by the observer's performing passive movements of the joints, espec­
ially the elbow joint.
The nursing sister in charge of the patients recorded daily on.
the proforma provided, the patient's ability to swallow (as good, fair
or poor), the external evidence of sialorrhoea (as +, ++ or +++),
ability to dress, ability to walk, the number of falls per day, the
number and severity of crises ( oculogyric and sweating), the type of
sleep (normal, noisy or disturbed). In addition to the ward sister's
records, the physician (&.O.) observed the patients daily and any
significant changes were recorded, independently. Soon after the
trial began it was found that the proforma was not comprehensive
enough; further data was required regarding the patient's ability to
rise from a chair, ability to feed himself, and his mental state.
These points received, special consideration by the physician. At
the end of each week a summaiy of the patient's condition was recorded.
Most of the patients on this trial were already receiving bens-
hexol /
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hezol (ArSane). Before the trial waa begun pit were placed on
15 ®g. of benzhexte daily and thia waa gradually reduced over a few
weeka to 5 mg. daily. During thia period they received aome training
in the feata which have been deaoiibed above. When they had received
5 mg. oO benzhexol daily Oor one week, She clinical trial waa aSa-rfed.
Second type of Study;
To determine the nature of She pharmacological
action and the duration of ifa efOecta.
11 patienta were ael^tad Oor Shia atudy. Lafer She number waa
reduced to 8, aa 2 pafienfa auffered from tremor aevere emoigh So
prevent their applying auatained pieaauie on the aphygmomacometei bag;
and She other patient waa withdrawn from She group becauae there waa
only alight weakneaa of hia voluntary muaclea.
Three typea of active tableta were uaed: oiphenadiine, benz- 
hexol and UK. 738 (Sandoz). The patienta alao received placebo
tableta for control purpoaea.
Method
Thia waa an "acufe" atudy. On the day before afarting the
experiment, the patient received the laat doae oO hia uaual tablefa
at 12 noon; and at 6 p.m. he received the placebo. At 9.30 a«m.
the /
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the next morning (the day of the experiment), measurements were made
and recorded and the tablets were given with a copious drai^it of
fluid. Measurements were recorded hourly. Observations were made
on the strength of the grip, the amount of active extension-flexion
movement of the neck, the degree of rigidity and tremor (using the
plus system), the amount of salivation (by observing the amount of
dribbling and the degree of moistness of the mouth, especially of
the tongue), the heart rate (apex beat) and the size of the pupils.
Estimation of the size of the pupils was later abandoned as it proved
to be impracticable to standardise the conditions (amount of daylight
etc.) under which the observations were made. During the periods of
observation, the patients were seated in comfortable chairs and were
instructed not to walk about the ward (except to use the lavatozy).
They were allowed to read and to have lunch at the usual time. The
patients were not told what drugs they were having but the objectives
of the experiment were explained in general terms.
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RESULTS
1. Double Blind Trial
In the final assessment, the therapeutic value of each drug was
graded as Satisfactory, Pair or Poor. The results obtained for each 
type of tablet are shown in Table 14. They were regarded as satis­
factory in 62.52 of the patients who received orphenadrine (Disipal),
.» *9whereas UK. 738 produced a satisfactory result in only 20.82 of the
patients; and none of the patients received any benefit from taking
»* • tthe placebo. UK. 738 gave poor results in 37-62 of patients and
orphenadrine in 8.2#2.
Drug Satisfactoiy Fair Poor
Orphenadrine
"Disipal" 62.32 29.1% 8.42
"uk. 738" 20.82 37.62 41. <52
Placebo 02 1002
TABLE 14: Results of. the Drug Trial
Strength of the grip
The strength of the grip was significantly increased in 15
patients /
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patients (62.5h) (Table 15) hen they were on active drugs compared
with their performance on placebo tablets. Orphanahrina was usually
the most effective treatment. In this group of patients the per­
centage increase for both hands was 43% and 27.7h for orphenahrine
and UK. 738 respectively (Table 17). It is of interest to note that
the beneficial effect of these drugs on the power of grip was sometimes
confined to one hand - usually on the weaker side.
Extension-flexion movement of the neck
The overall percentage increase in the active axtansicn-Wlexicn
movement was 32% and 15h for orphanahrine and UK. 738 respectively.
When the comparison is restricted to the 15 patients who showed
significant increase in the strength of the grip, the benefit amounted
to a 50h improvement following crphenah^ine and 25h in the case of
UK. 738 (Tables 17 and 18). The range of passive movement showed no
significant difference between the effects of the placebo and active
drugs. This result is accounted for partly by the fact that assess­
ments which depend on passive movement of the neck turned out to be
unreliable under conditions of clinical practice, and this test or
measurement is not recommended.
Writing
20 patients were able to write but 5 of these (4 man and 1 woman) 
were unable to complete the writing because of the curious phenomenon
of /
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Nane
01. 738 Plaeebo "Disipal" Plaoabo OK. 738 "Disipal"
Crip
Bight
Crip
Left
■eokAotlTe BeakPaselra ClipBight
Clip
Left
Beak
Aotlre
Beak
Paselre 1 CripBight ClipLeft
Beok
Aatlre BankPaaslTS CripBight CripLeft BeakAatlwa BankPasalTa
Cairney 23 - 1.9 4.4 32 - 2.0 3.5 45 - 2.2 4.9 64 - 2.6 4,4
Cllaeur 113 119 3.7 6.4 111 108 4.5 7.1 98 123 4,0 7.8 116 151 4.7 8,1
Auilln % 116 3.5 6.5 110 110 4.5 6.2 128 153 5.1 7.0 120 144 6.5 8.5
Patterson 66 43 3.0 7.1 96 50 2.5 6.0 120 83 4.3 6.9 116 92 5.1 7-4 ,
Hughes 118 168 8.0 10.0 84 94 6.8 8,0 201 186 7.3 9.4 220 172 8.0 9.0
NaHanus 55 45 ir 5.5 62 63 1.4 5.1 50 50 2.2 6.0 73 lo 4.0 6.8
MolLuran 65 68 5.6. 8.0 60 72 5.2 7.6 99 97 6.4 8.0 116 1(8 6.5 8.0
Sandler 200 - P.O - 200 - 1.8 - 240 - 2.5 - 240 3.5
MoMillan 8 22 - - 15 25 - - 33 34 - - 45 37
Cadden 58 128 3.5 6.0 - - - - 138 185 3.2 6.0 160 178 4.8 7.3
Pratt 88 28 1.4 - 104 36 1.9 - 143 39 2.1 - 168 51 3.0
Hey - 100 3.0 6.5 - 91. 2.8 6.5 - 126 3.4 7.0 1S 3.6 6.1
Hannan 94 136 4.0 5.5 64 94 4.0 6.0 142 152 3.8 6.0 115 145 5.5 7.2
Power 83 90 3.5 5.3 106 126 4.0 6.0 126 126 4.0 6.5 154 14J 5.0 6.5
Holntyre 191 60 4.3 - 206 61 4.7 - - - 222 105 5.0 -
TABLE 15. Strength of grip (mean values) and range of active neck 
movement (mean values) in 15 patients showing differences which are 
highly significant. Range of neck movements is measured in centi­
metres.
Name
OX. 738 Placebo "Dialpal" Placebo UK. 738 "Disipal"
Crip
Right
Crip
Left
Beok
Active
Heck
Passive
Crip
R10it
Crip
Left
Beck
Active
Heck
Passive
Crip
Right
Crip
Left
Heck
Active
Heck
Passive
Crip
Right
Clip
Left
Beok
Active
Beok
Passive
Blaaett 101 68 2,6 5.6 82 50 2.2 5.3 88 59 2.6 3.6 94 64 3.5 5.7
HoLister 88 58 2.6 4.5 68 51 3.0 6.7 93 63 3.4 6.3 88 70 4.0 7.0
Lent 240 39 3-3 7.5 233 38 3.2 6.9 230 28 4.4 7.1 240 S 6.8 8.5
Bunyan 148 132 6.5 8.0 170 140 5.5 7.5 193 159 6.0 7.4 194 147 5.9 7.4
looeaerty 180 231 7.3 9.0 173 226 7.3 9.0 208 240 7.7 8.9 168 225 7.8 9.0
Bell 240 240 10.0 - 240 240 10.0 - 240 240 10.0 - 226 240 10.0 -
Byper 240 200 5.8 8.2 240 205 5.5 8.0 240 234 5.8 7.7 240 22) 6.4 8.4
HoCartney 240 - 3.7 - 220 - 3.0 - 186 - 4.0 - 240 - 5.7 -
TABLE 16. Strength ■ of grip (mean values) and range of active neck
movement (mean values) in the other 8 patients showing differences
which are regarded as not significant.
N.B. 1. 1 patient who lapsed into catatonic stupor in the second
"""" week of the trial was not included. e
Range of neck movement is measured in centimetres.2
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Indices of
Measurement
Placebo -
(TO.738)
Placebo
(Disipal) UK. 738 Disipal
Power of grip(right hand) 89.9 95 119 137
Power of grip
(left hand) 85.1 77.7 111.1 121.1
Active neck
movements
(in oms.) 3 3.2 4
4.8
% increaseover Placebo
(right hand)
- - 252 442
% increaseover Placebo
(left hand)
- - 30. w 422
% increaseover Placebo
(active neck
movements)
- - 252 502
TABLE 17. Strength of grip and range of active
neck movements in 19 patients showing
differences which are highly signifi­
cant (mean values).
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Indices of
Measurement
Plaoebo
(UK 738)
Piacabo
(Disipal) UK. 738 Disipal
Power of grip(right hand) 124 122 344 155
Power of grip
(left hand) 103.7 99 124 125
Active neck
movements
(in oms,) 4 4
4.6 5.3
% increase
over Piacabo
(right hand)
- - 16.1% 25%
% increase
over Placebo
(left hand)
- - 20% 20%
% increase
over Placebo
(active neck
movements)
— - 15% 32%
TABLE 18. Strengths, of grip and rarnge of
~ active neck movematt s in allpatients studied (mean values).
t
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of akinesia. At some point in the act of writing, movement stops
— often in the middle of a simple word; and the pencil point remains
in contact with the paper for an indefinite time - two minutes or
more. In such circumstances patients usually had to abandon the
attempt to continue writing. Figures 34, 35 and 32 illustrate this
phenomenon in the 5 patients affected. This form of apraxia occurred
while the patients were on placebo tablets and in one patient who was
receiving the drug UK. 738; it was never seen idle the patients were
on treatment with ozphenadrine.
Patient's ability to feed himself
16 patients were unable to feed themselves whilst they were taking
placebo tablets. The disability was abolished in 4 of them by giving
UK. 738 and in 12 who received orphenadrine.
Rigidity and tremor
Only 9 of the 24 patients (37.52) benefitted by an appreciable
reduction in the degree of rigidity by giving potent drugs. In 10
(4*1.62) however, the administration of placebo tablets resulted in
gross aggravation of the tremor. Orphenadrine was much more effective
than UK. 738 in relieving rigidity and tremor.
Sweating
The value of active anti-Parkinson drugs including benzhexol in 
preventing /
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BgUfr. .
Patient's handwriting while on various kinds of drug therapy.
(a) Orphenadrine (100 mg* t,dL.s,) . ,
(b) s ‘UK. 738*C 4 mg. t.d.s.)
(o) Plaoebc (2 tabs. t.d.s.)
202.
(b)
35
Patient's handwriting while on various kinds of drug therapy.
(a) Orphenadrine (100 mg. t.d.s.)
(b) *UK. 738"(4 mg. t.d.s.)
(c) Placebo (2 tablets t.d.s.)
203.
J
/ J *4'
J J di 1
f •.
0
(c)
Pig. 36.
Patient’s handwriting while on various kinds of drug therapy.
(a) Orphenadrine (100 mg, t.d.s.)
(b) UK. 738 (4 mg. t.d.s.)
(c) Plaoebo (2 tablets t.d.s.)
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preventing excessive sweating was conf. med. During this trial 5
patients who had hitherto not complained of excessive sweating were
greatly inconvenienced by this disability while receiving only the
placebo tablets. The excessive sweating was worse at night time.
Before the clinical trial 2 patients suffered from recurring and
severe attacks of sweating crises requiring treatment with intravenous
sodium phenobarbitone (Onuaguluchi, 1961) as described in Chapter III
of this Thesis. One of them (Case 4) was free from sweating crises
while receiving UK. 738. Judged by the criteria listed below,
UK. 738 was the drug of choice for this patient; . swallowing was
regarded as good during this period, whereas it was graded as "fair”
while he was receiving orphenadrine and "poor" when given only
placebo tablets. This patient was accordingly treated with UK. 738
from the time of the clinical trial - a period of 10 months, and he
has continued to do weU.. On one occasion, however, when UK. 738 was
temporarily out of stock, he was placed on orphenadrine 100 mg. thrice
daily. He was not informed of the change of treatment. Within a ■ 
few hours he was flushed and began to sweat profusely; and swallowing
became much more difficult. In a few days, treatment with UK. 738
was resumed and there was an immediate improvement.
Oculogyric crisis
* *rThe drugs benzhexol, orphenadrine and UK. 738 do not seem to
have any significant effect on the frequency and severity of oculo­
gyric /
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oculogyric • crises. Only 2 of the 11 patients (C. Bun and J. Pat.)
who suffer from oculogyric crises experienced a definite reduction
in • the frequency and perhaps the severity of the crises when the
patients were receiving orphenadrine. No significant difference ' was
noted with'UK. 738 (Table 19).
Drowsiness
7 of the 24 patients were vexy drowsy while taking placebo
tablets (an effect interpreted as the result of withdrawing active
therapy) and 2 of them while taking ' UK. 738% In one patient (case 
9) receiving placebo tablets, deterioration was complicated by cata­
tonic ' stupor and he had to be roused by repeated intramuscular
injections of UK. 738 in doses of 2 mg.
Mental depression
Signs of depression were noted in 15 of 24 patients receiving.
» ftplacebo tablets, and also in 6 patients ' treated with UK. 738. None
of the patients were depressed while under treatment with orphenadrine.
On the contraiy, orphenadrine often abolished depression  • rapidly and
sometimes produced some degree of euphoria. One patient who enjoyed
knitting became tearful and lost interest in her pastime while she was
on placebo therapy, but about 24 hours after receiving orphenadrine
said: "I feel • like flying”: and this was in spite of the fact that 
at that time the physical accompaniments of the post-encephalitic
syndrome /
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No. Name "Disipal" "TJK.738" "Disipal"Placebo
"UK.738"
Placebo
1. A.Bis 0 3 0 3
2. R.Pra 1 1 2 3
3. A.Hay 0 0 3
in 8 days
0
in4 days
4. J.Pat 2 5 6 6
5. M.McL 4 3 5 2
6. C.McU 3 3 6 2
7. M.&il 3 4 4 4
8. C.Bun 0 1 2
in 4 days
5
in 3 days
9. T.Pow 1 0 1
in 7. days
0
in 3 days
10. H.Cai 0 2 0
in 4 days
2
11. P.Cad 0 2 1
in 3 days
0
in 7 days
TABLE 19; Frequency of oculogyric crisis in each
patient during the drug trial. Except
ihere indicated the numbers stand for
the frequency in 21 days.
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syndrome were only slightly relieved. Table 20 shows the various
clinical manifestations of depression in these 13 patients.
Number of premature stoppages of drug, therapy
There was premature stoppage of drugs (i.e. stoppage of a drug
before the patient has taken the drug for three weeks) on 32 occasions
in 14 patients. At the conclusion of the investigation, vhen the
pharmacist's chart was made available, it was discovered that on 26
occasions, these patients had been receiving placebos, on 5 occasions
UK. 738, and on only one occasion during orphenadrine therapy.
SIDE-EFFECTS
Orphenadrine
2 patients (men) complained of difficulty in starting the act
of micturition. There was, however, no retention of urine. Three
patients • had involuntary jerky movements (myoclonus) of the limbs,
but in 2 of these patients this effect . passed off as therapy con­
tinued, One patient complained of dizziness about 1-1^* hours after 
taking the tablets. Another patient complained of nervousness
("jittery") about 1 hour after taking orphenadrine. Two patients
had bleeding episodes during orphenadrine treatment. This was
possibly a coincidence. One of them suffered from a hiatus hernia
with oesophageal ulcers. The other patient had acute erosion of the
gastric /
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No. Name Drug Manifestations of depression
1. C.Bun Placebos Very weepy, poor appetite, nausea and
vomiting.
2. M.McC Placebos Dull; uninterested in her surroundings.
3. J .Bel Placebos Dull. Complained of difficulty in changing
his thought and even in the direction of
his gaze from one object to another.
4. H.Lan Placebosand"UK.738" Veiy emotional; weepy.
5. T.Pow Placebosand'UK^S’'
Disinclined to leave his bed and go to the
day hall. Poor appetite.
6. A.Hay Placebos Poor appetite; vomiting.
7. C.Han Placebos Wants to stay in bed. Dull. Not reading(normally he reads a great deal).
8. C.McM Placebos
an^'X^.388"
Weepy. Lost interest in her usual hobby
(knitting).
9. J.Hug Placebos Disorientated, hallucinations; said she saw
goldfish. Dull; appetite poor.
10. M.Aus Placebos
^d"UK.73^’
Veiy weepy, appetite poor.
11. R.Cai Placebos Dull and uninterested in her surroundings.
Veiy poor appetite; nausea and vomiting;.
12. N.San Placebos Dull; poor appetite.
13. R.Pra Placebos
and'UK.738’
Moaning ++ even during the ni^tfc. Dull.
Wants to stay in bed all the time in spite
of the fact that his gait was still quite
good.
14. P.Cad Placebos Unwilling to leave his bed. Dull: appetite
veiy poor - refusing his meals, vomiting +.
15. J.Mcl Placebos Dull. Unwilling to leave his bed.Delusional (paranoid type).
TABLE 20; Manifestations of depression in 15 of the 24 patients
while' on various forms of therapy during the drug trial
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gastric mucosa with severe melaena; his condition necessitated 
partial gastrectomy, but the bleeding point was not found at oper­
ation. In this patient, haemorrhage began about 15 minutes after 
dental treatment (scaling and polishing)* Five patients complained 
of a burning sensation in the throat but this was not unbearable.
"uK* 738'
No side-offects were noted. The drowsiness seen in 2 patients 
might be regarded as a side-effect, but it was more probably a sign 
of inadequate drug therapy; the occurrence of drowsiness was even 
greater in patients receiving placebo tablets.
2. RESULTS,IN THE SECOND TYES OF STUDY
Figure 37 shows that peak action (as judged by the effect on
muscle) attributable to oiphenadrine and benzhexol occurs in about
2 hours and in 2 to 3 hours respectively. The period of maximum 
* »
activity due to UK. 738 was less easily defined. Orphenadrine is 
probably more rapidly excreted from the body than is benzhexol as 
judged by the duration of therapeutic effects. Figure 38 shows 
the mean dynamometer readings • in 8 patients after taking orphenadrine, 
benzhexol, UK. 738 and placebo tablets. In the individual patient, 
the effect of orphenadrine may last up to 6 hour’s but ' the most 
effective period is between 2 to 4 hours after taking the tablet.
In this type of acute experiment for the assessment of drug action, 
extension /
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Fig. 37 a,b,c,d* The effect of 100 mg. of orphenadrine, 10 mg.
of benzhexol, 4 mg. of UK. 73& ' and 2 placebo 
tablets on the strength of grip in 8 patients.
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• 38. Mean dynamometer readings in 8 patients after 
administration of 100 mg, 'of orphenadrine,
10 mgo of benzhexol, 4 mg, of"UK. 738'and 
2 placebo tablets. Each point represents 
mean of at least 12 tests.
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extension-flexion movements proved to be of no value.
Prom the comparative study of antisialogogue effect it is clear
that activity usually started in the first hour but may be delayed
until the second hour after oral administration of orphenadrine,
benzhexol and UK. 738. Peak activity occurred two to three hours
after taking the tablets; the antisialogogue activity lasted for
another two to three hours. It appears that of the three drugs,
benzhexol has the greatest antisialagogue activity; orphenadrine is
appreciably less active. In making such comparisons, however, it
must be emphasised that they refer to quantities of the various drugs
which have become standardised as the doses usually employed in
clinical practice, namely, benzhexol 10 mg., orphenadrine 100 mg.,
ancL UK. 738 4 mg.
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DISCUSSION
The results of the drug trial show that both orphenadrine and
UK* 738 have useful pharmacodynamio actions in patients suffering from
post-encephalitic Parkinsonism. Orphenadrine is probably about 3 times
«» Qas effective as UK* 738. This bald statement is of some value to the
practitioner who must decide, with the help of research reports, which
of the available drugs is most likely to produce the best therapeutic
effect. However, the relative merits of a group of potent drugs
cannot always be fully defined by means . of such comparisons. To some
extent the response of a patient to the action of a drug is an indi­
vidual characteristic and only trials on a particular patient will
decide which drug is best for him* Hence a drug may be a useful
addition to those already employed in the treatment of Parkinsonism,
even though it gives satisfactory results in only 20^ of the patients
who receive it.
The relief of depression by orphenadrine is very striking. This
confirms the views of others (Doshay and Constable, 1937) and recently
(Robinson and Dick, 196O). As to the pathogenesis of depression in
this disease, it is certainly not secondary to physical disability, as
a number of very “disabled” patients were not depressed. Further,
various accompaniments of depression such as loss of appetite, nausea,
vomiting, delusions and hallucinations were often present in these
depressed patients. It is noteworthy that such disabilities as ; 
difficulty /
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difficulty in swallowing, speech disturbances, and incontinence of
urine, which are considered as contra—.ncd-cations to surgical oper­
ations on the globus pallidus and thalamus (Cooper et al, 1938;
Gillingham et al, 1960) may be greatly alleviated by adequate treatment
with the potent drugs now available.
One interesting phenomenon in Parkinsonism which has hitherto
received very little attention is akinesia. This phenomenon is a
very complex one but can be described as a liability to sudden arrest
of voluntary movement while carrying out purposive actions; the limb
or limbs are “frozen” unexpectedly and unpredictably. It has been
demonstrated in the handwriting of 5 patients when they were taking
placebo tablets. It is of interest that apraxia of handwriting such
as was seen in these patients has been described as a sign of frontal
lobe lesions (Meyer and Barron, 1960). In such patients there is
usually apraxia of the gait and there is a grasp reflex. Only 3 of
the 3 patients with apraxia of handwriting were able to walk before the
trial was begun. Two out of these three had apraxia of gait In con­
junction with apraxia of writing; but only one patient had positive
grasp reflex by the conventional method of testing. It must be
mentioned that very great difficulty in releasing a grasped object was
experienced by 4 patients in this series during placebo therapy.
Three of them (2 of whom also showed apraxia of handwriting) _ had 
acquired the habit of holding their noses, and because of the apparent
inability to relax their grasp two of them nearly suffocated themselves;
they /
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they developed cyanosis which was sufficiently severe to necessitate
the administration of oxygen#
The gait may also be affected by akinesia. Figures 39 and 40 are
taken from cinematographic records of a patient * s attempt at walking
during treatment with placebo tablets (Fig. 40) and also while
receiving orphenadrine tablets (Fig# 39). During placebo therapy she
was unable to walk and in Fig. 40 she had not taken one step forward
after 44 secozois# In conirasi t o this, during oiihenacdine therrap the 
gait was easy. Thii Os obvious in the cinenaaoggaah tiil ond oca be 
discerned even in a series of “stills” taken from the film. Distur­
bances of gait (excluding iestiantion) which are seen in Parkinsonism
are probably due to the following factors:-
(1) Difficulty in initiating the movement - the feet seem
to be held bound to the ground (akinesia).
(2) Increased rigidity - whiih i s prrbamy oCso onnphneible 
or associated with (1). The :inarrnaod oTigidiy oea-soe 
the gait to be slow nlthobSh. in one patient (R.Pra.,
Case 1), in spite of marked increase in the degree of
rigidity and the presence of apraxia, of handwriting during
times of placebo therapy, there wao no difference in the
time taken to walk a given distance (twice the length of
the ward) during all forms of therapy.
(3) RetropuSoiIn - which prevents propulsion and usually
causes the patient to fall.
(4) /
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(c) (d)
Pig. 39. Case 3« "Stills" from cinematographic study of the
patient's attempt at walking while receiving orphenadrine 100 mg.
t.d.s. (a) Start, (b) After 0.44 sec. (o) After 0.88 sec. 
(d) After 1.72 sec.
  
217.
Co) .(a)
Fig. 40. Case 3. "Stills" from cinematographic study of the
patient’s attempt at walking while receiving placebo tablets.
(a) Start, (b) after 5 sec. (c) .After 11 sec. ((d) After 1(6 sec.
Note the patient has yet to take a single step forward.
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(4) Weakness and lethargy - which in combination with
rigidiSy and akinesia makes the patients easily fatigued
when walking.
Another form of akinesia which was observed in theme patients is
seen when patients attempt to feed themselves. This pienImnnIn wao
seen in its purest forms in two patients. One patient (Case 2} wao
unable to feed herself when she was receiving placebo tablets because
the hand stopped halfway to the mouth and remained there iaieiiaitnSy.
¥711^ she was receiving the preparation UK. 738 she was also unable to
feed herself. During this period she wao able to get food into her
mouth but movement of the jaws was arrested while chewing it. During
both periods she had to be fed with mnoied food. Fortunately her
ability to swallow wao not affected. Various factors apart from gross
deformities of the hneio oeem to be responsible for the inability to
feed Innself:-
(1) Akinesia, whose role has been described.
(2) increased rigidity, which may make feeding laborious and
tiresome. Thus some patients require help during the
latter half of the meal.. if they are allowed to coatiaun
on their own unaicLnd, it has been noted that it can take
well over 90 minutes before the patient io able to finish
a simple meaS.
(3) The flexed position of the neck, if very marked and
relatively fixed, is another factor vdich. is of some
importance.
(4/
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. (4) Tremor is another factor, which even wien of moderate
severity, may prevent the patient from feeding herself,
especially with liquids; tea, ooup, etc#
Schwab, England and Peterson (i959) have also studied the problem
of akinesia in Parkinsonism although they used a dwifernat approach#
They state that akinesia in Parkinsonism includes the following mani­
festations:
(1) Constant awareness of fatigue;
(2) Difficulty in shifting from one motor contraction
pattern to another;
(3) inability to complete tasks and hence others are
never begun#
They made the point, wiich was also observed in the present series,
that moot of the patients lose their normal alertness and may fall
asleep while watching television programmes wiich are sufficiently
iatnreotWag to hold the attention of other hIot-nncnpialitics. They
considered that akinesia io unrelated to tremor but is probably related
to rigidity; and thio was the conclusion reached in the present series#
They found that the E.E.G# was usually abaIimlal# Thio point has been
mentioned in the section inalWag with electroencephalography in Parkin- 
soaism. These workers found that in severe cases the usual drugs were
ianifnctwvn, and they regarded surgery and oinmohallidnctImy to be
coatra-wniwcatni and propooed that amphetamine and strychnine should be
prescribed for these patients. The present investigation has shown,
however, /
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however, that Irphenadrinn is often effective in relieving moderately
severe forms of akinesia; and it may be of value even when the
symptoms are severe# Although the present investigation did not
include a clinical trial of amphetamine in the treatment of Parkinson­
ism, it io justifiable to draw attention to the severe restlessness
which can be produced by amphetamine and which may be very disturbing
to the patient#
Methods, of Assessment of Drug Therapy
in order to evaluate the merits of any form of treatment it is
often noonatial that improvements in the patient's condition should be
measurable objectively# The complexity of such measurements may
reduce their value as they can then only be made in special centres#
An attempt should therefore be made to devise simple and easy tech­
niques in quantitative measurement so that they can be used in any
hospital where patients suffering from Parkinsonism are cared for#
Rather surprisingly, the value of quantitative objective measure­
ment in the assessment of drug therapy in ParkiasIaWsm has been
doubted# &Wl:iiespy and Ratcliff (1936) declared that the criteria for
judging improvement must be based on what are necessarily subjective
pinnImnaa# Schwab and Leigh (1949) used various objective tests
which included E#M#G# studies, handwriting, and finger-thumb rates and
found that oaly the finger-thumb rate wao of any value# They there­
fore came to the conclusion that subjective accounts of well being, and
relatives’ /
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relatives' report of the patient's greater ability to cany on • with 
household duties were more reliable than objective measurements.
Merrit (1954) quoted by Agate, Doshay and Curtis (1956), in discussing 
this problem said: "The beneficial effects of medical therapy seem
largely to be of a subjective nature since efforts thus far to measure 
objectively any reduction in rigidity and tremor yielded negative 
results”•
On the other hand, Berkowitz and Alverman (1952) found no evidence 
that a patient's subjective evaluation of his condition reflected 
changes in his objective motor and mental efficiency. They concluded 
that objective tests are useful in evaluating improvement in paralysis 
agitans and are probably more reliable than subjective evaluation. 
Eliasson and Tejning (1956) claimed from their studies that objective 
and subjective effects showed a fairly good correlation. Agate,
Doshay and Curtis (1956) developed an electronic apparatus capable of 
measuring the torque exerted on the forearm during extension of the 
elbow. They found that there was a statistically significant differ­
ence between the mean rigidity at the end of a placebo period of at 
least 3 days* duration and the mean rigidity at the end of 7 days' 
treatment with drugs known to be clinically potent. With this 
apparatus they were also able to measure the amplitude of tremor. 
Webster (1960) using a powerful and highly sensitive turntable that 
reciprocates on a horizontal plane through an arc of 100° at various 
speeds claimed to be able to measure rigidity, tremor and muscle 
strength with some accuracy.
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Measurement of Tremor
1. Handwriting
The character of the patient's handwriting is commonly regarded
as indicating the severity of his disability due to tremor. In this
study, however, it was clear that in a large proportion of patients,
tremor was diminished or disappeared altogether from the hand during
the act of writing although the other hand continued to shake. This
observation is in fact, in keeping with the well known fact that tremor
in Parkinsonism is a tremor at rest and disappears or diminishes greatly
when voluntary movement is being executed - only to reappear when the
movement has been completed. It was possible to demonstrate the
degree of tremor by means of the handwriting in a small proportion of
patients only (Fig. 41 )• Such patients usually have moderately severe
or very severe tremor or are highly emotional with emotional exagger­
ation of the amplitude of the tremor. Notwithstanding these observ­
ations, there is no doubt that the patient's ability to use a pencil
provides a valuable objective test, especially as by this means the
phenomenon of akinesia in the form of apraxia of handwriting can some­
times be detected.
2. Use of ,a lighting device.
This method was used to study tremor in two patients before and
after ohemopallidectomy. (The set up - Pig. 42 - was devised in
collaboration with Dr. J.C. Brocklehurst and the hospital photographer,
Mi*. P. Waldi.e). A darkroom is required and the patient is draped in
black /
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■ C as e 6.
Patient’s handwriting
while on various kinds
of drug therapy.
(a) Orphenadrine
(100 mg, t.d.s.)
(b) "UK. 7385*
(4 mg. t.d.s.)
(o) Benzhexol ■
(5 mg. t.d.s.)
(d) Placebo
(2 tablets t.d.s.)
/y?f jW/YlA
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Fig. 42. Apparatus for measuring tremor.
1. Camera.
2. Small hooded electric bulb.
3. Flex connecting bulb to a dry cell
battery in patient’s coat pocket.
4. Sling of velvet cloth.
5. Cord attaching the sling to a
wooden beam above.
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black cloth unless he is wearing a dark suit. A small hooded electric
bulb is strapped to the dorsum of the hand so that it projects ■ just
proximal to the metacerpo-phalangeel joint. The bulb is connected by
a flex to a diy cell battery - which is conveniently placed in the
patient's coat pocket. The patient's arm is supported as in the
diagram by a sling of velvet doth fixed id plpca by y at rtTgrtr^i 
attaching it above to a beem ffxed to htfosits htfle ls int retm. The 
patient is allowed to settle down for about five minutes. Records are
then taken over a period of 13 minutes by exposing the point of light
to the photo-sensitive film of a 3" by V* plate camera 2 feet 3 inches
from the patient. A small lens aperture (f.32) is used. Figures 43
and 44 show the records before and after operation. Tremor is assessed
by the degree of scatter of the li^it rays. If the tremor diminishes
in amplitude the' area of scatter of reflected light is much reduced.
As a matter of interest the line traced by the point of light shows
quite convincingly that the tremor of Parkinsonism is of the pill­
rolling type. The tremor movements take the form of loops even when
this is not usually discernible in severe tremors as in the patient
whose records were shown in Fig. 44* This method is impracticable
when large numbers of paticets are to to strhien dt tft e tm ftm end 
it is not therefore a citable teclrnique for double blind tri-dLs 
described in this nnvtrtngation. Further^ drooping of the wrist may
occur during Ihe period of recording, thereby reducing the amount of
light (from the electric bulb) passing through the narrow lens aper­
ture. The effect of this is seen in Pig. 44(b).
 226.
(b)
Fig. 43. Record of tremor of left hand before and after right­
sided ohemopallideotony. Patient aged 55 years and
suffering from post-enoephalitio Parkinsonism.
Reoord taken over a period of 15 minutes.
(a) Reoord taken 10 days before operation.
(b) Reoord taken a year after operation.
Note the marked reduction in the amplitude of the tremor.
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(a) • (b)
Pig. 44. Record of tremor of left hand before and aiter
a right-sided tremtpallndtcht ]^y. Patient
aged 62 years. Stated to have had encephalitis
lethargies in 1920.
(a) Record hnkep 2 days before operation.
(b) Record 30 days after tptrahdtp. Each
record was taken over a period of 15
minutes.
Note the record (b) is of limited value becauseof technical faults mentioned in the text but
it shows that the amplitude of the tremor has
been reduced.
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3* The method _ of Eliasson and Tejning (1956).
In this method, use is made of a li^it plastic hall: it is 
fenestrated and the holes are of specified size. The hall is kept
loaded by means of a receptacle containing carborundum. The plastic
ball is attached to the back of the hand. Tremor of the hand causes
the carborundum to be shaken through the holes. The amount of sand
( carborundum) lost in a stated period (3 hours) is taken as an index
of the degree of tremor. This method is simple and inexpensive.
Further, because of the li$it wei^it of the apparatus the patient
suffers little discomfort and, as already stated, tremor can be measured
over a prolonged period of 3 hours. One of the great drawbacks in the
quantitative measurement of tremor is the fact that variations occur
with such factors as emotional excitement. These variations, thtoigh
fleeting, may last an appreciable time - measured in minutes.
Measurements over long periods is therefore advantageous and should be
carried out whenever this is feasible. In my view, clinical assess­
ment of tremor is ' reasonably accurate but the value of objective
quantitative measurement lies in the fact that a permanent record of
the tremor is kept and can be compared with greater accuracy with
records of tremor at any stage of a study.
4. Apparatus with electronic devices.
Apparatus with electronic devices have recently been used in the
measurement of tremor (Agate et al, 1936; Wachs et al, 1960). The
apparatuses are said to be highly sensitive but they do not seem to
offer /
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offer any major advantage over the simple and inexpensive method of
Eliasson and Tejning;. Wachs and Boshes (1961) listed a number of
factors which created artefacts in the tremor tracings using their
highly sensitive apparatus (Wachs et al, i960). These include
(a) coughing which gives a h±gh aanplitaide to the -fcracznngj
(b) fatigue of limb causing the tremor to be irregular in 
amplitude and frequency and consequently making it
impossible to make measurements for long periods.
(c) The height . to ihich the limb is raised affects the
amplitude of the tremor although it does not affect
its other qualities. As the height of the limb
increases the amplitude of the tremor also increases.
3. Other MethoQd
These include:-
(1) The use of tambour method which in our experience in 
this unit is highly unsatisfactory as the amplitude
of the tremor is often markedly damped down by the
inertia in the air column and in the movable parts
of the apparatus.
(2) The use of electromyography. This requires the use
of intramuscular leads if accurate recording is to be
obtained (Wachs and Boshes, 196l). The procedure is
therefore painful and may produce artificial patterns
purely from nociceptive reaction.
Measurement of Rigidity /
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
230
Measurement of Rigidity
Quantitative measurement of rigidity is still difficult, although
apparatus devised by Agate et al (1956), Webster (i960), Waohs et al
(i960) are said to be reliable. Waohs and his oo-workers (i960 ),
however, found that they obtained approximately the same degree of
aoouraoy by olinioal assessment (grading as +, ++ eto.). When
estimating rigidity, it is essential to remember that in many oases
musole tonus is affeoted by the rate at whioh the examiner moves the
joint; rigidity apparently inoreases when passive movement of the
joint is rapid. It is therefore essential that the rate of passive
movement should be fairly oonstant, and this also applies vhen
sensitive instruments are being used.
Measurement of Musole Strength
Althcmgh James Parkinson (1817) regarded musole weakness as one
of the oardinal manifestations in "the shaking palsy", olinioians have
not paid muoh attention to this symptom. In the present series, the
average strength in the 24 patients studied was less than 30/h of that
of oomparable normal people. Measurement of musole strength should
be a routine prooedure in assessing the therapeutio value of drugs
used in Parkinsonism. The meroury oolumn dynamometer is preferred
to the spring dynamometer as the former is less irksome to the patient.
Readings are aoourate to about 10 mm.Hg;. It should be noted that
when musole power approximates to noneol, no inorease in power oan be
expeoted /
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expeoted from drug - therapy; or at least no improvement oan be
deteoted by the teohnique desoribed here. It must be emphasised that
a drug or a surgioal therapeutio prooedure suoh as ohemopallideotony
may oonsiderably reduoe the degree of tremor and rigidity but the
patient may simultaneously beoome muoh weaker. Table 21 is a reoord
of the dynamometer readings of a patient before and after ohemopall-
ideotorny^. The marked fall ' in the strength of grip in the first four
weeks after operation is demonstrated. His strength was , signifioantly
inoreased when benzhexol was administered. The main disability was
tremor: this was dramatioally improved immediately after ohemopall- 
ideotony but it gradually reourred, reaohing its pre-operative state
in about eight weeks.
Design of . Drug Trial
Before the full soale double blind trial was begun some preliminary 
studies were oarried out using aotive and plaoebo tablets of UK. 738. 
Exoepting one patient who was not reoeiving any drug (beoause he had 
little or no tremor and rigidity) all the seven patients studied 
reoeived at the beginning , of this preliminary study UK. 738 or its 
plaoebo in addition to their usual drug therapy whioh, in the majority 
of oases, was benzhexol. In the later stages of the study, however, 
these drugs were gradually withdrawn in 3 patients so that theh 
reoeived only UK. 738 or its plaoebo. The measurements used in this
pre •imina-Ty study were more oomprehensive than those used in the full
soale /
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Period
Hi^iest values
Power of grip Degree
of tremor
Degree
of rigidityRight
hand
Left
hand
Before operation
(Right sided ohemo-
pallidectoxpy). 142
112 Rt. +Lt. ++
Rt. 1
Lt. 2
4 weeks after
operation. SO 56
Rt. t
Lt. +
Rt. ' 1
Lt. 2-
10 weeks after
operation. 120 68
Rt. - 
Lt. ++
Rt. 1
Lt. 2
12 weeks after
operation. Reoeived
benzhexol 3 mg.
t.d.s. for 2 weeks.
134 82 Rt. — Lt. ++ Same
9 months after
operation. Still
on benzhexol 3 mg.
t.d. s.
130 110 Rt. - Lt. ++ Same
TABLE 21; Power of grip, degree of tremor and rigidity
before and .after ohemopallideotomy.
NOTE: the considerable fall in the power of grip
after operation. It is surprising however
that the power of grip and the degree of
tremor of right . upper limb was affeoted by
a right-sided ohemopallideotomy.
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scale double blind trial already reported; they included measurements
of the lateral flexion of the spine, and total extension/flexion move­
ment at the nnnlt and wrist joints.
At least two important points were brought out from the results
of this preliminary trial. The first was the fact that placebo
therapy can produce a marked improvement in impresrnodablt patients.
The patient who was originally on no drug therapy improved _ on placebo
tablets (placebo to UK. 738) and there was no real difference between
placebo and active tablets (Table 22). Op the ■ other hand, the pro­
gressive improvement in the patients* performances between 9.11.59 and
11.12.59f and the ipcrtaser in the power of grip as the dose of the
placebo tablets was being stepped up, might have been due to the fact
that the patient was becoming more acquainted with the techniques of
the tests. Gnllrtrpy and Ratcliffe (1955) state that about 10% of
patients are likely to show this phenomenon, and they suggested that
a preliminany study should always be carried out in order to exclude
such patients from the main trial. Although this patient was not
included in the main hrnel, no prelimipany study was carried out
amongst the 24 patients selected for the main clinical trnal. This
decision is justified on the grounds that most of the patients likely
to show marked improvement while on placebo therapy are those with
very mild disability; and patients with rtlahietOy severe physical
disability are eeny unlikely to show ' epy significant improvement on
placebo therapy. Where a study Includes a substantial number of
patients /
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Date Drug
E.P.
Cervical
& Lumbar
cm.
L.P.
Cervical
Grip
R#it
Hand
Grip
Left
Hand
Maximal
flexion
P.I.P.
index
finger
Right
Maximal
flexion
P.I.P.
index
finger
Left
9.11.59 none 13.3 33° - - 950 106°
30.11.59 none 13.2 32® - - 98° 108°
11.12.59
'UK.738 " pla­
cebo tab.
daily for
10 days.
17.1 30° - - 105° 109°
18.12.59
u°JK.738pla- 
cebo i. tab.
b.d. for
7 days.
17.4 45° - - 104° 102°
29.12.59
UK. 738'pla­
cebo tab. i
b.d. for
11 days.
17.4 50° 184 190 104° 110°
26.2.60
UK. 738“ pla­
cebo tab. ii
b.d. for 4
weeks.
17.9 50° 220 226 105° 106°
8.4. 60
’UK. 738'Pla­
cebo tab. ii
t.d.s. for
6 weeks.
17.9 45° 240 240 105° 106°
20.4.60
*UK. 738lTab.
ii t.d.s.
(12 mg.dailyfor 12 days)
17.0 53° 240 230 108° 107°
TABLE 22; Patient aged 42 suffering from a
mild form of Parkinsonism.
Results of measurements during
double blind trial..
E.P. = Total extension fl<xcion movement. 
L.P. = Total XsrteaalL flexion movement. 
P.ItP. = Proximal. joint.
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patients with ' mild disability the method used by Gillhespy and Rat- 
oliffe (1955) (Fig. 45) -is reoommended but this has the disadvantage
that only one drug oan be studied at any one trial. If it is planned
to assess the therapeutio value of several drugs, then the method
desoribed here for the main trial is more useful (Pig;. 46). Purther,
it has the advantage that in three to four months reliable information
oan be obtained about the relative merits of two to three drugs. In
oontrast only one drug oan be studied in the same • period using the
method of Gillhespy and Ratoliffe.
The seoond point of interest in the results of this preliminary
study was that no signifioant differe^e was noted between the thera­
peutio effeots of UK. 738 - and its plaoebo. This was veiy puzzling.
At first sight the results lent support to the views of Sohwab and
Leigh (1949) and others - that in the assessment of drug therapy in
Parkinsonism objeotive measurements are of no value. However, oon- 
sideration was given to the various oauses of failure to deteot
differenoes in therapeutio effeots by quantitative objeotive measure­
ments:
1. An aotive drug may not be effeotive in the dose given.
2. Patients may not be oo-operating in the sense that
they beoome oareless and fail to give their best
performanoes at all times.
3. The methods used may not be of suffioient sensitivity 
to deteot the differenoes.
4. Under speoified oonditions of administration, the drug
might /
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45* Illustrates the method used by G--xlhespy and Ratclnffe(1955 and 1956) iu conducting their drug trial*
From the results of previous treatment patients selected
at random are classed as "Responded" or "Not Responded" t
Both groups are then given placebo tablets for 2 weeks
and their clinical condition reassessed. Those from
the "Responded" group who are "No Worse" are tlimipated
from the trial. Those from the "Not Responded" group
who are now better are also eliminated. The remaining
patients are then treated with the new drug for some
weeks and eurhrer clinical assessment is made. Those
who are "Not Improved" are withdrawn and return to their
previous treatment. Those who are improved are divided
into 2 evenly matched groups, one group receiving active
treatment and the other inert tablets for 2 weeks. At
the end of this they are re-assessed and classed as
"Wetse" or No Worse".
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DHPG TRIAL - PAKCQT80HI3M
25A
lftle
Week Beginning
Maroh
21 28 4
April
11 18 25 2 9
Kay-
16 23 30
June
6
Cadden R R R 3 8 8 7 7 7 P P P
Power 3 3 8 R R R P P P 7 7 7
MoMliaan P P P V V V R R R 8 8 8
Hay V V V P P P 3 8 8 R R R
Wyper R R R 8 8 8 P P P 7 7 7Hannan 8 8 8 R R R 7 7 7 P P P
25BFemale
Mooahariy R R R 8 3 8 7 7 7 P P PCairney 3 3 3 R R R P P P 7 7 7
MoLiater P P P V V V R R R 3 8 8
Blaaet V V V P P P 8 8 8 R R RBunyan R R R 3 3 3 P P P 7 7 7
Hugtea 3 8 8 R R R 7 7 7 P P P
Fig. 46, Master ohart showing order in whioh
drugs were to be given to the first
batoh of 12 patients in the trial.
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might result in a well defined peak period of activity
- when the therapeutic value may also be at a maximum.
In such circumstances it would be imperative to stip­
ulate the timing of the tests carried out to determine
the effect of the drug on muscle power, tremor, etc.
It was thought that the phenomenon of peak activity might be of
great importance and this led to the second type of study using "acute”
experiments to determine the onset and duration of drug action. The
results of the “acute” experimental study serve to emphasise the
importance of certain points in the design of clinical trials of drugs
used to relieve Parkinsonism. It is well known that, in general,
when drugs are given at the usual four-hourly intervals the effects
are in some degree uneven; peak periods of pharmacological aotivity
occur and by careful testing, their clinical accompaniments can be
identified. It follows that in a clinical trial the time of admini­
stration of the drug and the period in which observations are made must
be adhered to rigidly; and failure to do so may account for variation
in the results obtained by different workers. The main double blind
trial described was therefore designed with the possible effects of
peak activity in mind.
Other factors affecting the results of quanti­
tative objective measurements in clinical trials
1. The Influence of Emotion; Another factor affecting objective 
measurements /
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measurements in clinical trials in Parkinsonism is the influence of
emotion on performances in patients suffering from Parkinsonism,
Emotion alters performance and as a result one should try to eliminate
all conditions likely to cause emotional variations. Thus the
measurements are made at set times and on specified days,
2. Patients Lack of Pamiliarity with the
Procedure of the Objective Tests,
It is essential that before starting the drug trial, the patients
must be fully acquainted with the procedure used in the objective tests. 
A period of two to three weeks should be used to familiarise the
patients with the tests, otherwise the performances in the early part
of the trial may compare unfavourably with those obtained later, and
this spurious improvement will vitiate the results.
Pinal Assessment of the Therapeutic Value of a Drug
In the final assessment of therapeutio value of a drug, various
methods are used, namely: -
1. The Method of Therapeutio Index
of Schwab and Prichard
A system of "points” is used - a positive for favourable actions
of the drug and negative for unfavourable effects. Thus 4 positive
points are given if the drug gives veiy good results when used alone,
2 positive points if only good results are obtained when the drug is
used alone and 1 positive point if the drug is good only when used in
combination /
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combination with other drugs. If toxic effects are present, 4- negative
points are recorded, and 2 negative points if therapeutic effects are
equivocal. The therapeutic index is. expressed by dividing the positive
points by the negative points. They studied 12 drugs and by this
method assigned indices of 3*1 to benzhexol, 2.8 to caramiphen, 2 to
benadryl, 0*8 to stramonium, 0.4 to amphetamine and 0.3 to hyoscine.
There is one objection to this method of assessment of drug therapy.
Four negative points are awarded when there are toxic effects but this
does not take into consideration the severity of the toxic effects. A
substance may have only slight therapeutic value but because of minimal
toxic effects there will be a small denominator and thus its thera­
peutic index will be rated excessively high.
2. The Use of Points System (Mooree, 1951. •
This writer nakees a l±s“t of ten items to be stodeed. The items
are as follows:-
1. M-gi-cHy’
2. Tremor
3. Posture and gait
4. Ease of movornait with respect to both gross movements 
(such as putting on clothes) and fine movements (such 
as buttoning shirts and vests).
5. Speech.
6. Improvement in morale and alertness.
7. Appetite and weight gain..
8. /
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8. Effeot on ooulogyrio orisis and other post-e^epha^ti©
phenomena.
9. Effeot of substitution of plaoebos.
10. 3ubjeotive feeling of well-being and improvement.
A plus, minus or zero is awarded to eaoh item aooording to whether
the drug produoed an improvement, a worsening effeot, or no effeot on
the partioular item in question. A soore of 8 or over is oonsiderad
to andaoata marked improvement, while a soore of 3 - 8 iniioates fair
improvement and below 3 Is supposed to andaoata that the patient is
virtually unaffeoted. This method of assessment is not satasfactory
as there are oo^ide^t^ variations in the pattern of disability from
one patient to another. Thus in a partioular patient there may only
be four relevant disabilities, but a drug may produoe a marked improve­
ment in all of them. On this basis it should therefore be awarded a
high soore, but on Moore's soale it would be awarded a maximum of 4
points - a rating whioh would plaoe it among drugs not of proved
therapeutio value in Parkinsonism. It is therefore obvious that this
method of assessment may fail to do justioe to the therapeutio effeots
of a drug.
It is likely that the most reliable method in arriving at a final
evaluation is to oombine the results of objeotive measurements and the
response of the patient subjeotavaly. Thus ah€al objeotive measure­
ments show marked improvement but the patient suffers from disabling
side-effeots or toxio effeots the therapeutao value oannot be oon- 
sidered /
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considered to be satisfactory. If the patient's sense of general
well-being is greatly improved and yet objective movements (such as
muscle power) show marked deterioration, the total result does not
support a claim for therapeutic value. It is thus essential to
visualise a therapeutic effect in all its dimensions and make an
assessment on a broad basis. This usually enables the clinician to
grade the result in simple terms, such as Satisfactory, Fair or Poor*,
and he may well find that the Ward sister and the patient's relatives
discover the advantages of a simple classification of this type.
Lastly, it can be said that the results of objective measurement
usually run roughly in parallel with an assessment of the patient's
condition as determined by the clinician - and especially when the
initial degree of disability is moderate. In patients who are only
mildly affected it may be difficult to detect any changes by quanti­
tative objective measurements; and in patients with severe disability
marked changes in the quantitative objective measurement due to the
drug are not often associated with proportional improvement in the
patient's general condition. Thus in patients who show fairly normal
muscle power while receiving placebo therapy, dynamometer readings do
not show any significant increase #ien the patients are placed on
"active" tablets. The effect of drugs on muscle strength is best
demonstrated in patients with an appreciable degree of muscle weakness.
However in patients who are very weak, doubling of the grip strength
is not associated with such striking improvement in general condition.
The /
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The reason for this laok of oorrespondenoe is that although the values
of the grip strength during aotive drug therapy is double that during
plaoebo therapy, even with optimum medaoation musole power may be veiy
consaderably less than in a normal person.
It must be emphasised that in the majority of oases the physio ian's
dinioal assessment of the patient's oondition, e.g., the assessment of
exoess salivation, the patient's ability to feed himself, dress himself
or walk, are in faot objective although they ' may not be readily
measured quantitatively by the use of instruments. Quantitative
measurements however, are essential as they add greater aoouraoy in
the assessment of the oomparative values of different therapies. It
should therefore be used whenever possible. Thus gait oan be measured 
by the time taken to walk a fixed distanoe; and in order to faoilitate
detailed sorutiny, oanamatographao methods oan be used to study the
patient's gait and his ability to feed or dress himself.
Out-patient assessment in wiioh the patient is asked to answer set
questions are unreliable; and assessments whioh are based solely on
the patient's subjeotive feelings and impressions are even more mis­
leading. The nature of the answers is affeoted by many variable
faotors - antellagence, willingness to oo-operate honestly, prejudge
aoquired from other patients or from reading magazine artioles, reluo- 
tanoe to experiment with new preparations, and so on.
This study has shown that ttpralimanaay" assessment of any drags
likely to be of use in the treatment of Parkinsonism oan be adequately
oonduoted /
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conducted in the manner already described giving each drug for a short
period of not more than three weeks. However the final assessment of
the clinical usefulness of any drug will depend on the results of a
long-term study lasting several months, as such phenomena as the
development of tolerance, and the emergence of toxic effect on haemo-
poietic system, on the liver and on other organs, may not be evident
in the course of a short-term study.
The acute experiment lasting four to six hours are of value for
rapid screening. It gives information about the effect of the drug
on the cardiovascular system, salivation, pupils and muscle power.
Measurements of active neck movements are not materially affected and
can be omitted. The special value of this form of study is that it
can demonstrate the phenomenon of peak activity in the therapeutic
effects of a drug. It also reveals the time of onset of drug action
and its duration. The most useful items for study are the effects of
the drug on salivation and on the power of grip. Patients should be
selected, taking into consideration their reliability as witnesses and
the degree of physical disability. Patients with veiy mild degrees
of disability are not suitable for study. It is our experience that
patients with severe degrees of tremor may not be capable of applying
constant pressure by means of the hand; they are not therefore
suitable for studying the effect of drugs on gripping power unless the
drug also reduces tremor to an appreciable extent. It is advisable
to take about 18 hours for the procedure of substituting placebo
tablets for active tablets when making a series of controlled observ­
ations.
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ILLUSTRATIVE CASES
Case 1. R. Pra.
Male, 42 years. History of encephalitis lethargies doubtful.
Age 4- years (1922) - tremor of left arm and dysarthria; age 16 years
- symptoms disappeared but reappeared when aged 20 years. Gradually
deteriorated and was admitted in 1955. Suffers from oculogyric crisis.
On examination in 1960: moderate rigidity, greater on left side.
Tremor mainly of upper limbs, worse on left side. Walks fairly well
but gait shuffling. Unable to feed himself; excessive salivation ++.
Swallows normally. Therapy: benzhexol hydrochloride 15 mg, daily.
RESULTS OP THE TRIAL
Course (i) /on Tablet 2 (UK. 738 placebo)/.
Did not feel well. Moaning night and day. Excessive saliv­
ation +++. Rigidity increased but gait and deglutition unaffected.
Sweating excessively most days. Three oculogyric crises.
Power of grip:
Right hand - 90 72 104 Average 88
Left hand - 28 22 36 Average 28
Active neck movements: 1.4 0.3 2.3 Average 1.4
Writing: Marked apraxia first week (Pig;* 4-7). Unable
to write second week. Able to complete task
in the third week but took over 13 minutes.
Course (ii) /on abblet M (Orphenddiine - iiiiall)7«
Pelt veiy well. MoJnene teaaed. RigHdity tnic£i less. Excess
salivation was greatly reduced. One oculogyric crisis.
Power of grip:
Right hand - 166 
Left hand - 46
Active /
170 170 Average 168
50 556 Average 31
 246
(a) (b)
/ z
(•)
FiD 47. Case 1,
Examples of the worst specimens of the handwriting during each
period of the drug trial. -
(a) During orphenadrine therapy, 
(h) During treatment with*UK. 738% 
(c) During placebo therapy.
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Case 1. R. Ra. (Cont' d) .
Apti^ nek movements: 3 3*2 3 Average 3 om.
Writing; Veiy good. (Fig. 47).
Side—effig-ts: InvoIUnrtaiyr jarmnig movements of the liitos.
Course (iaa) />n Tablet N (UK. 738)7.
Moaning right and day. Excessava salivation ++. Rigidity a
little inpraa&d• Gait and deglutition unot-anged. One oculogyrip
orisis.
Power of grip:
Right hand - 140 170 120 Average 143
Left hand - 38 40 38 Average 38
Aotive neck movements: 1.8 2.6 2 Average 2.1 om.
Writing: Not as good as in the preoeding period; more
time taken to oomplete tasoks and some degree
of apraxia last week (Fig. 47).
Course (iv) /on Tablet Y (Dasapal Plao_ebo)7.
Moaning sore than in the last period. ' Incontanent of urine.
Rigidity markedly anoreased. Exoassiva salivation +++. Severe
sweating almost daily. Gait and swallowing unchangad. Two ooulo­
gyrio orises.
Power of grip;
Right hand - 121 7G 120 Average 109
Left hand - 36 26 4 Average 36
Aotive neok movements: 1.1 1*5 2. 5 Average 1.9 cm.
Writing: Apraxia of writing throughout this period (Fig. 47).
COMMENT;
The results of the objaotive measurements oould be oorrelated
with the patients general olanical oonditio^. When he was reoeiving
orphanairane /
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Case 1. R. Pra. (Cont' d).
orphenadrine however he was troubled by involuntary jerky movements of
the limbs and because of this rather disagreeable side-effect, orphen­
adrine was regarded as giving a "fair" result in this patient. Both
UK. 738 and the placebos were classed • as giving "poor" results.
Case 2. A. Bis.
+2Woman, 54 years. Admitted 1932. Para 5 * 1923 "nervous
breakdown" with alteration of sleep rhythm and excessive salivation.
Oculogyric crisis (mild) began in 1943* Deteriorated, and by 1949
bedridden.
i960. Rigidity very marked, especially lower limbs; left side
worse than right. Able to feed sslf. Swallowing easily. Prac­
tically no tremor. Receiving benzhexol 30 mg. daily.
RESULTS OP TRIAL
Course (i) /on Tablet V (Orphanadrine placebo)/.
Unable to feed herself: hand stops halfway to mouth and remains 
there almost indefinitely. Swallowing fairly wiII. Excessive
salivation ++. No oculogyric crises.
Power of grip:
Right hand - 64 90 94 Average 82
Left hand - 44 52 34 Average 50
Active neck movements: 1.8 2.4 2.4 Average 2.2 cm
Course (ii) /on Tablet P (Orphanadrine)7^
Feeding herself without help; turning about more freely in bed
and able to get sweets out of her locker* Excess salivation - . 
Swallowing well. Patient bright and cheerful. No oculogyric crises.
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Power of grip:
Right hand - 116 94 74 Average 94
Left hand - 64 80 56 Average 64
Active neck movements: 4 3.9 2.6 Average 3.5 cm.
Course (iii) /on Tablet S (UK* 038 placebo)/.
Unable to feed herself, especially last two weeks. Swallowing 
fair. Excess salivation ++. Three oculogyric crises.
Power of grip:
Right hand - 102 104 96 Average 101
Left hand - 68 76 60 Average 68
Active neck movlmleti: 3 2.3 2.3 Average 2.6 cm.
Course (iv) //n Tablet R (UK. 738)?
Better than in the last period of treatment. Excessive saliv­
ation + . Swallowing well last two weeks. Unable to feed herself:
able to get food into the mouth but jaw movement arrested while
masticating the food. Three oculogyric crises.
Power of grip:
Right hand - 92 1<6 100 Average 88
Left hand - 60 AAeraag 39
Active nnek Mooenenee: 2.6 2.5 2.8 AAvrago -26 cm.
COMMENT:
There was no significant difference between the quantitative
objective measurements in all four pldicdi. The patient improved
most when receiving ooihleadriee - as judged by ability to feed without
assistance, reduction of salivation, changes of mood, etc.
The /
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Case 2. A. * Bis. (Cont'd.)
The results of the olinacal trial aiming at determining the
relative merits of Orphenadrine, UK. 738 and a plaoebo in this patient
oan be summed up thus:-
Orphenadrana - satisfaotory; UK.738* - fair; plaoebo - poor.
Case 3. H. Lan
Woman, aged 54 years. 1925 - anoephalatis lethargaoa lasting
six months. Soon after, involuntary tremor left side and excessiva
salivation. 1959 stated to have had ooulogyrio orisis but no
definite deviation of the eyes observed sinoe admission in 1960.
Findings on admission:-
Moderate rigidity - mainly left side. Tremor mild left­
sided. Gait slow and some retropulsion. No exoess salivation.
Able to feed and dress herself. Swallowing well.. .
RESULTS OF THE* TRIAL
Course (i) /on Tablet N (UK. 738)7.
Weepy and depressed. Often anoontanent of urine. Unable to
dress herself but able to feed herself, and swallowing well. Gait
- fairly good.
Power of grip:
Right hand - 240 212 240 Average 230
Left hand - 24 30 32 Average 28
Aotive neok movements: 4.2 4 5 Average 4*4 om.
Writing: Good.
Course /
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Case 3• H. Lan. (Cont,d))
Course (ii) /on Tablet Y (Orphenadrine placebo)7.
Condition worse than in the last phase of treatment. Now unable
to feed herself without help; gait unsteady with retropulsion . ++.
Great difficulty in getting up from a chair (Fig. 48). Rigidity
markedly increased; and she complained of stiffness. Excess sali­
vation Involuntary flexor spasms of the left hand with increase
in the deformity.
Power of grip:
Right hand - 2224 220 ^4) Average 233
Left hand - 28 40 46 Average • 38
Active neck movements; 1.5 2 6 Average 3.2 cm.
Writing; N ormal.
Course . (iii) /on Tablet Z (UK. 738 placebo)/.
Condition still the same although on a few days she was able to
dress and feed herself.
Power of grip;
Rigt hand - 240 240 240 Average 240
Left hand - 38 50 30 Average 39
Active neck movements: 5.5 2 2.5 Average 3.3 cm.
Writing; No change.
Course (iv) /on Tablet M (Orphenaerina)7)
Dramatic change. Very well and cheerful. Gait; good and no
retropulsion (Pig. 39» page 216). Able to rise from a chair without
difficulty (Fig. 48). Rigidity much less; no further flexor spasms.
Incontinence of urine ceased. Able to dress and feed herself.
Salivation ceased to be excessive.
Power /
252
Fig. 48. Case 3. "Stills” from cinematographic study of the 
patient1 s attempt at getting up from a chair during treatment with 
placebo tablets. (a) Start, (b) After 14 sec. (c) After 
28 sec. (d) After 42 sec.
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Fig. 49. Case 3. "Stills" from oanematographao study of the
patient's attempt to rise from a ohair during treatment withorphenadrana 100 mg. t.a.d• (a) Start. fb) After 0.3 seo.
(o) After 0.72 seo. (d) After 1 seo.
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Case 3» H. Lan. (Cont' d).
Power of grip;
E.±e1hO hand - 240 240 240 Average 240
Left hand - 58 56 46 Average 53
Active neck movements: 7.3 7.5 5.8 Average 6.8 cm.
COMMENT;
There was ' a close correlation between the clinical condition and
some objective measurements, namely active neck movements, and the
power of grip of the weak left hand. There were no significant
differences in the handwriting and in the power of grip of the veiy
strong right hand; these were quite good Airing placebo therapy and
little or no improvement could be expected by giving active drug
therapy.
C^■■Sa■s4) Jd.^MC^)
* indicates that the drug was stopped prematurely, that is
before the patient had taken the drug for 21 days accord­
ing to the schedule.
Male, aged 50 years. 1924 history of encephalitis lethargica.
Admitted 1933. Clinical review, 1959. Pa0ian0 beeriedan with
flexion deformity of both knees. Moderate degree of rigidity.
Tremor all limbs. Poor muscle power and unable to eaee himself.
Difficulty in swallowing. Frequent severe sweating crises. Receiving
15 mg. banzhaxol daily.
RESTOT OF THE TRIAL;
Course /
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Case 4. J. McM. (Cont' d.)
Course (i) /on Tablet P (Orphenadrine)7.
Patient had slight improvement on his condition during benzhexol
therapy. Excess salivation was a little less and his power of
deglutition was regarded as fair. Six sweating crises.
Power of grip;
Right hand. - 50 338 4-6 Aveaage Jj5
Left hand - 338 . 44 34 Average 37
Writing; See Fig. 50.
Course (ii) /on Tablet V (Orphanadrine placebo)/.
No change in patient's condition. 
Power of grip;
Right hand - 18 1(8 
Left hand - 226 0
Three sweating crises.
10 Aveaage 15 
24 Average 25
0 Unwilling to have the power of grip Oastad)
Writing; Was unwilling to write except in the first week
(a few days after starting this course).
Course (iii) /on Tablet R • (UK. 738)7.
There were two important changes in his condition. He was
swallowing much better (graded F. Good). Secondly he had no sweating
crises.
Power of.grip;
Right hand - 30 2(8 40 Avrrggs 33
Left • hand - 32 322 38 Aveaggs 34
Writing; Svv Fig. 50.
Course (iv) /on Tablet S (UK. . 738 placebo)/.
His /
 
 
 
 
b
Fis* 50.
Patients handwriting while
on various kinds of drug
therapy.
(a) Orphenadrine 100 mg.
t.d.s.
(b) UK. 738, 4 mg. t.d.s.
(0) Placebo, 2 tablets
t o d. s *
c
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Case 4. J. McM. (Cont'd.)
His swallowing was worse (graded as poor - fair). Three sweating
crises.
Power of grip;
Right hand - 12 8 4 Average 8
Left Ihaid - 26 22 14 Average 22
Writing; Unwilling to write on two of three occasions and on the
one occasion when he was agreeable to; the • writing, showed marked degree
of akinesia (see Pig. 50).
COMMENT:
Although the results of quantitative objective measurements
including handwriting were best when the patient was receiving orphen- 
adrine (Disipal), the general condition (as assessed by salivation,
ability to swallow, sweaatng crises) during this period was no better 
than during plaaceo tterapy. In fact he had morr© crises
during oeyhenadrine therapy than during placebo therapy. UK. 738 on
the other hand abolished the sweating crises and markedly relieved his
difficulty in swallowing. In the final assessment of the merits of
the individual drugs used for this patient, orphegadrnge was classed
with placebo therapy as giving poor results while the result of treat­
ment with UK. 738 was classed as fair. This case illustrates the fact
that it is undesirable to rely solely on quantitative objective methods
of assessment without taking into consideration the patient's general
clinical condition.
N.B. Neck movements were not measured as it was not possible to
position him in such a way as to obtain standard conditions every time.
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Case 5. A. MoL.
Woman aged 61 years. Admitted 194-9* 1919 attaok of influenza
during whioh her haok was paralysed. Reoovered and worked as a*seam­
stress until 1957, when she was unable to oontinue beoause of tremor.
Just before admission was unable to manage household duties.
Clinioal review, 19^0. Treaor++, arms, legs and mouth. Severe
spolaotic deformity but able to walk about. Reflexes normal.
Reoeivang benzhexol 50 mg. daily.
RESULTS OP THE .TRIAL:
* Course (i) /on Tablet Y (0rphenadrana plaoebo)/.
Did not feel well at all. Tremor worse. Unable to rise from a
chaar, feed herself or dress herself. Gait very slow. Sweating +.
Palpitations ++ espe^^^ at night;. Swallowing and appetite good.
Power of grip;
Right hand - 60
Left hand - 72
Aotive neok movements; 5*2 om.
Writing - Unable to write.
Course (ii) /on Tablet UK. 758^7*
Pelt muoh better during first two weeks but her oondition worsened
somewhat in the third week. Able to get up from a ohair without
daffioulty. Able to feed self and dress ' self. Sweating Tremor
was still severe.
Power of grip;
Right hand - 90 100 108 Average 99
Left hand - 90 104 96 Average 97
Aotive neok movements:: 6.2 6.5 6.5 Average 6.4 on*
Writing /
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Case 5. A. Mol. (Cont'd.)
Writing: - Unable to write.
Course (iii) /on Tablet M (Orphenadrine)7.
Further improvement. Tremor although showed some improvement,
was still bad.
Power of grip:
Right hand - 110 120 120 Average 116
left hand - 102 104 110 Average 108
Active neck movements: 6.5 6.5 6*5 Average 6^.5 cm.
Writing: Unable to write.
* Course (iv) /on Tablet Z (UK. 738 placebo)?.
Deteriorated. Patient unable to walk, feed • or dress herself.
Increased tremor. She complained of palpitations and was sweating
excessively. She was incontinent of urine during the later part of
this•period.
Power of grip:
Right hand - 60 70 Average 65
left hand - 60 76 Average 68
Active neck movements: 6.5 5.0 Average 5.6 cm.
Writing: • Unable to write.
comment:
There was a close relationship between the results of the
objective measurements and the patientb olinical state. She was
unable to write because of emotional exaggeration of tremor when
instructed to write her name, etc.
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Case 6. J. Pat.
Woman, 57 years.
Following tonsilleotomy operation in Australia in 1928 developed
musoular weakness on one side of the body and tremor on the other.
First ooulogyrao orisis 1942: admitted 1946.
Clinioal review, I960. Moderate degree of rigidity all limbs;
more marked in left arm. Festinant gait; unable to feed herself but 
deglutition unaffeoted. Exoess salivation ++; had to use a bib oon-
tinuously. Tremor ++; had reoeavai Tinoture of Stramonium 2 ml. per
day.
EESPLT OF THE TRIAL:
Course (i) /on Tablet Z (UK. 738 Plaoebo)/.
Condition unohanged..
Power of grip:
Right hand - 56 64 80 Average 66
Left hand - 26 32 72 Average 43
Aotive neok movements: 1.5 4.8 3.7 Average 3 om.
Writing: (Fig. • 41, page 223).
Course (ii) /on Tablet M (0rphanairina)7.
Exoess salivation - : bib no longer needed. Tremor +. Able to 
feed herself (exoept tea and soup). Gait less festin^ant. Now able
to laoe her shoes.
Side-effaot: Complained of dizziness 1-1-g- hours after taking
the tablets, and lasting 1-2 hours.
Two ooulogyrio orises.
Power of grip:
Right hand - 120 116 112 Average 116
Left hand - 90 90 96 Average 92
Aotive neok movements: 5.5 4.8 5 Average 5.1 om.
Writing /
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Case 6. J. Pat. (Cont*d.)
Writing; (Fig. 41, page 223 ).
Course (iii) /on Tablet N (UK. 738)7.
General condition worse. Excess salivation ++ ; using bib again*
Tremor ++. Unable to feed herself. Five oculogyric crises.
Power of grip;
Ri^it hand - 116 122 126 Average 121
Left hand - 90 70 90 Average 83
Active neck movements: 4.2 4.7 4 Average 4.3 cm.
Writing: (Fig. 41, page 223).
Course (iv) /on Tablet Y (Oryhenpdrine Placebo)7«
Further deterioration. Now unable to walk without support. 
Voice very faint. Seven oculogyric crises.
Power of grip;
hand - 96 90 82 Average 96
Left hand - 36 70 44 Average 30
Active neck movements; 2 2.3 3 Average 2.5 cm.
Writing: (Fig. 41, page 223 ).
COMMENT:
In this patient there is also a close correlation between the
objective measurements and the patient's clinical condition with
regard to oeyhenpdenne and the placebos. However UK. 736 appeared to
have about the same effect on muscle strength and range of active neck
movements as oephenadrnne but the patient's clinical state ' was much
worse than during oephanadrnne therapy. In the final assessment of
the values of these drugs in this patient, the classification was as
follows:
(i) /
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Case 6. J. Pat. (Cont'd. )
(i) Orphenadrine (Disipal) - satisfactory.
(ii) UK. 738 - poor.
(iii) Placebos - poor.
Case 7. T. Wyp.
Male, 56 years. Admitted 1955. 1928 history suggestive of
encephalitis lethargica. Oculogyric crisis while at home but none
since admission.
Clinical review, 1959- Patient independent. Veiy little
rigidity. Tremor all limbs, lips and tongue of moderate severity.
Some difficulty in swallowing. Gait and muscle power good. Reflexes
normal. Receiving benzhexol 10 mg. t.i.d.
RESULTS OF THE TRIAL;
Course (i) /on Tablet R (UK. 738)7
Patient was veiy well throughout this period. Swallowing well
during this period.
Power of grip:
Ri$at hand - 240 240 240 Average 240
left hand - 24O 222 2^ Average 234
Active neck movements: 5.5 5.0 7.3 Average 5*. cm.
Writing: Good.
♦Course (ii) /on Tablet 8 (UK. 738 placebo)/. 6 days.
Suffered from nausea and vomiting, especially on the second and
third days of this period. Did not want to be out of bed. Tremor
increased /
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Case 7. T, Wyp. (Cont'd.)
Increased ++. He complained of tendency to stare into space for long
periods. Swallowing - poor or fail*. No real increase in rigidity.
Power of grip:
Right hand - 240
Left hand - 220
Active neck movements: 5.8 cm.
Writing: Good in spite of great increase in tremor.
Course (iii) /on Tablet P (Orphenadrine)7.
Dramatic improvement. Pelt veiy well. Tremor now +. Swallowing
well.
Power of grip:
Right hand - 240 240 240 Average 240
Left hand - 240 210 240 Average 223
Active neck movements: 6.8 6.5 7.0 Average 6.4 cm,
Writing: Good.
♦Course (iv) /on Tablet V (Orphenadrine Placebo)/, 3 days.
Nausea and vomiting ++. Tremor increased ++. Patient not
willing to get up.
Power of grip:
Right hand - 240 
Left hand - 205
Active neck movements: 5.5 cm.
COMMENT:
Results of the clinical trial in this case were classified solely
according to the patient’s clinical condition in aach phase of the 
investigation. The differences in the objcciiv n maasuremnnt s were not 
significant. /
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Case • 7. T. Wyp. (Cont'd).
significant. This is probably due to the fact that even when he was
eecenvnng placebo tablets his grip strength, range of active neck move­
ments and handwriting were good.
Case 8. R* Cai.
Woman, aged 64 years. Admitted 1951. Encephalitis lethargica
1924. Illness lasted six months. Oculogyric crisis two years later.
Receiving benzhexol 5 mg. t.i.d.
Clinical review, 1960. Flexion contractures all limbs, especially
on the left side. Mild generalised tremor. Severe degree of rigidity
- worse on left side. Tendon jerks not e1ncn0ab1e except the right
biceps jerk. Plantar responses were flexor. Suffers from moderate
degree of excess salivation and has great difficulty in feeding her­
self. Swallows well.
RESULTS OF THE TRIAL;
Course (i) /on Tablet S (UK. 738 Placebo)/.
Unable to feed herself. ShS waa ddll tad teareesed, especially 
in the first week. Great difficulty in swallowing. ^Two oculogyric 
crises.
Power of grip:
Right hand - 18 22 0t Aeraget 23
Active neck movements: 1.7 t 2 Average 1.9 cm.
Writing; Good.
Course (ii) /od Tablet R (UK. 738)7.
More /
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Case 8. R. Cai. (Cont'd.)
More cheerfll. Was able to feed herself completely in the last
7 days. Swallowing improved; regarded as good in the last week. No
ohange in salivation.
Power of grip:
Right hand
Aotive neok movements;
50 30 5(6
2.6 1.8 2..
Average 45 
Average om.
Course (iai) /on Tablet P (Orphenadrine)/.
Veiy oheerful. Fed herself ^implete^. Swallowing good. No
ohange in salivation.
Power of grip;
Right hand
Aotive neok movements;
52
2
72 66 Average 64
3 228 Average 2.6 om.
♦Course (iv) /on Tablet V (Orphenadrine Plaoebo)7 4 days.
Depressed and dull. Appetite veiy poor. NaUsea and vomiting. +
Unable to feed herself. No ohange in salivation. Rigidity muoh
inoreased.
Power of grip:
Right hand - 32
Aotive neok movements; 2 om.
Writing; Unable to write beoause she oould not hold the pen.
COMMENT:
There was olose oorrelation between the results of objaotave
measurements and the patients olanical oondition.
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Case 9. J. Cam.
Male, aged 57 years. 1917 encephalitis lethargica. AdeiCted
1943. Clinical review 1959. Moderate rigidity. Tremor all limbs,
tongue and jaw. Unable to feed himself. Able to dress self with
occasional help. Excess salivation +. Gait:- he walked slowly but
fairly well.. No difficulty in swallowing. Suffered from severe
sweating crisis. Receiving benzhexol 10 mg. nCuice daily.
RESULTS OF THE TRIAL:
♦Course (i) Aon Tablet N (OK. 758)7 5 days.
Gait worse - failing ++. Unable to rise s himself • A little
drowsy; onetilifi fo aesse his bef Severe swea*t:uc£d crisis ivsny
night. No changi il diidii ol ixciss salivation, rigidity or trimor.
Pooid _of idip:
Right hand - 2 
Left hand - 20
Active neck movements: • 2.3 cm.
♦Course, (ii) /on Tablet Y (OrpCenaduine placebo)?, 3 days.
Much worse. Very drowsy. In bed most of the time. Rigidity
markedly increased. On the third day he lapsed into catatonic stupor.
Was incontinent of urine. He was withdrawn from the double blind
trial and was then given "UK. 738" 2 mg. intramuscularly. This was
effective in 40 minutes and he was roused from his stupor. (See
Table 23 for details of his general clinical condition.) Figure 51a
shows the patient in catatonic stupor.
He was then placed on Tab. UK. 738 4 mg. t.i.d. but two days
later he relapsed into catatonic stupor and was roused about 20 minutes
after receiving 2 mg. UK. 738 intravenously. Figure 51b shows the
same patient two hours after receiving this treatment. The daily
dosage of his oral UK. 738 was now increased to 20 mg. daily - 4 mg.
five /
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Case 9. J. Cam. (Cont'd. )
five times daily. His general condition was much better and after four
days it was consnderadwpfa and perhaps advisable to reduce the dose of
his UK. 738 to the standard daily dose of 12 mg. daily ( 4 mg. t.d.s.).
He deteriorated somewhat as he was a little drowsy and was only able to
walk for a few yards. His sweating crises were frequent and severe.»» AThe UK. 738 was discontinued after three weeks and he was placed on
oxapPen&<:drLne 100 mg. thrice daily. He was generally brighter but con­
tinued to sweat daily. He however complained of some difficulty in
starting the act of micturition but he ' had no retention of urine.
After one month benzhexol 10 mg. t.i.d. was substituted for opphe-a-
drine. Within 48 hours he showed marked improvement in his overall
condition.
COMMENT;
The first point of interest is the fact that 2 mg. of "UK. 738"
given intravenously or intramuscularly was effective id rousing a
patient from catatonic stupor into a state of full consciousness In
20 to 40 minutes. The intensely rigid state was also appreciably
reduced. This suggests that the drug might be useful in the treatment
of catatonic stupor of schizophrenia, a condition not unlike that seen
id Parkinsonism. The other important point is that in the individual
patient it may be possible to obtain a greater therapeutic effect by
increasing the maximum daily dosage of UK. 738 from the standard 12 mg.
daily to about 20 mg. daily without any unwanted side-effects develop­
ing.
Finally, in this patient benzhexol was probably the drug of choice
p1th<:olh at a dose level of 30 mg. daily he still had an appreciable
degree of residual Parkinsonism.
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TABLB 23
: 
Case 9
* 
In Catatonic Stupor# 
UK. 738 
: 
2 mg. given I.M. at 4-12 p.m
  
 
Fig. 51. Case 9. Patient aged 57 years suffering
from posC-rnorpCalitic Parkinsonism,
(a) In catatonic stupor three days after
receiving placebo tablets.
(b) The same patient two hours after
receiving 2 mg, of "UK. 738" intra­
venously. (See Text).
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SUMMARY.
The relative therapeutic value of oJeylenadrine and "UK. 738"
(Sandoz) were studied by means of a doublLe blind trial. Oryhedadeine
100 mg. thrice daily was found to be abomt three times as effective as
"UK. 738" 4 mg, t.d.s.
The methods of assessment of the efficacy of drug therapy id
Parkinsonism are reviewed and the value of objective measurements is
demonstrated. It can be said that the i•awli0s of objective measure­
ments usually run roughly in parallel with an assessment of the
patient's condition as determined by the clinician - and especially
when the initial degree of disability is modeepOa.
By means of "acute" experiments it was shown that after oral
administration of oepeanpdrine, peak activity occurred in about two
hours whereas peak activity due to benzhexol occurred in two to three
hours. It was not possible to demonstrate clearly defined peak
activity for the drug "UK. 738". Failure to carry out the objective
tests at the time of maximal activity of drugs is an important source
of fallacy id clinical trials designed to assess the relative merits
of preparations used to combat the disabilities associated with Park­
insonism.
  
 
 
 
 
 
 
 
 
 
 
271
C H A P T E R VII.
THE SITES AND MODE OP ACTION OF
ORPHENADRINE AND OTHER DRUGS
USED FOR THE RELIEF OF , RIGIDITY 
AND MUSCLE WEARNESS _ IN PARKINSONISM
INTRODUCTION
This investigation was begun after sixteen months of wholetime
clinical study of the manifestations of Parkinsonism. The work also
included observations on the response of the various physical dis­
abilities to drug therapy, using oeyhadpdrine, N-etey1-noe0royine
benzhydryl ether eydeobromida ("UK. 738") and benzhexol (see Chap­
ter VI).
From clinical experience it became very clesLT that the skeletal
musculature is involved to an important extent in the rigidity and
weakness of Parkinsonism. The patients tire easily; and the
deformities are mainly due to weakness and ' rigidity of the skeletal
musculature. It seemed therefore that there was ample justification
for concentrating primarily on a study of the pharmacological effects
on skeletal muscle of drugs used in the ' treatment of Parkinsonism as
seen clinically.
Most of this study has been devoted to the pharmacological actions
of oxyhedadrida because this has been found to be one of the most
effective /
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effective drugs in clinical use today for the relief of Parkinsonism.
For a pharmacological study it has the advantage that it is readily
soluble in water, whereas banzhaxo1 and especially "UK. 738" are much
less soluble. The manufacturers of'UK. 738 recommend dissolving it
in chloroform or ethanol but this procedure would necessitate carrying
out control experiments using the solvents alone. Hence UK. 738 and
benzhexol were mainly used in experiments where very dilute solutions
were needed and where it was therefore practicable to use weak aqueous
solutions. In the later part of this study aOeoyropazine became avail­
able and it was used in later experiments as it was more readily soluble
in water than bedzhexol or UK. 738^
After discussing the clinical problem with experimental pharma-
oologists, it was decided that the first part of the study should
consist of experiments to investigate whether orphenadrine prevented
muscle spasms (contractures) induced by suxamethonium in the hen. It
was considered that the contracture of the skeletal muscle in the hen
had something in common with the rigidity of Parkinsonism ("spasm of 
muscles"). It was further decided to study the effect of oryeanadrina
on the response to indirect Oetanisption of skeletal muscle and also
the effect on post-tetanic fatigue. The results of this study were of
some interest and the experiments were repeated upon a mammal (the cat). 
Because of the effect not yet described, of oephenpdeina on neuro­
muscular block induced by suxamethonium, the effect of this drug on
neuromuscular block caused by tubocurarine was also studied. The
results /
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results of these observations led to experiments to find out if
orphrnaduinr itself had any neuromuscular blocking activity and vhither
certain monosynaptic and polysynaptic spinal reflexes were affected.
Finally, in view of a possible stimulant or depressant effect on the
spinal cord, the effects of orphenaduine on the cerebral cortex were
examined by investigating its influence on the convulsant activity of
leptazol..
The method of approach in ncis study is somewhat different from
that adopted by Bijlsma and his colleagues (Bijlsma et al. 1956)*
Their paper on the pharmacology of oupCrnadrinr is the most compre­
hensive study which has so far appeared, but the effect of tCit drug
on skeletal musole was not studied.
When considering the pharmacology of drugs used in the treatment
of Parkinsonism the question auitet: Do they all produce their effect
by one hypothetical mode of action - for example, by a central anti­
cholinergic effect on the eidOrain, diencephalon and basal ganglia?
On the supposition that this is true, several workers have tried to
find out if a particular screening test (carried out on laboratory
animals) could be devised which would indicate whether a drug is
likely to be of use in the treatment of Parkinsonism in man.
The screening tests, each of idich has its advocates, are:-
1. Depression of the flexor reflexes in the thalamic
cat (De Maar, 1958; Bijlsma et al. 1958).
2. Depression of the activation of the E.E.G. produced
by /
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by the stimulation of the brain stem reticular
formation in experimental animals (Rinaldi and
Himeiae, 1955).
3. Inhibition of the tremor induced by Tremori-e
(l ,4-dipyro1idi-o-2-bu0yne) (Everett, Blockus
and Sheppard, 1956; Blockus and Everett, 1957)
or by nicotine (Bovet and Bongo, 1951).
The work to be reported in this chapter was therefore carried out
to find out if a1taeda0iva mechanisms could be found to explain the
effectiveness of oeyeedadeida in Parkinsonism.
Or^he-adri-e is closely related chemically to diphenhydramine
(Benadryl) and differs from it by the possession of a— o^borneth?^
substituent o— one of the benzene rings. This slight modification of
the molecule of diyha]neydepmi-e has reduced its pnOieista.minio activity
but increased its atropine-like action.
N-atey1-dor0ropida be-zeydey1 ether eydeobromida (UK. 738) is a
synthetic tropine derivative and chemically • related to atropine.
Figs. 52 , 53, and 54 show the chemical structure of o^yeedadr,i-e,
UK. 738^ and other chemical substances used in this study.
  
 
 
 
 
275.
Orphenadrine
H,C— CH — CH1 1 x x ;N-QS CH- O-CH (QH,)2. -
H2C—CH CH2 HBr
N-ethyl-nortropine benzhydryl ether ; 
hydrobromide (UK 738)
Ethopropazine
I ICH2 /CH2 
ch2
Benzhexol
Fig, 52, The structural formulae of orphenacrine,
N—■ethyl—nortropinQ henzhycLryl ether
hy&robromiae (UK. 732), Ethopropazine
anc benzhexol.
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O
H2C —CH —CH2 CH2OH
n-ch, ch-o-co-c^;*
I I |
C H — C H H
Atropine
HgC
HC 
X
HC
-CH—CH, CH,OH
I I I a—
N-CH3 CH-O-CO-C<
CH — CH2
Hyoscine
f> + X .
H v C- O-CH2-CH2-N-(ChH5)
CH:
er'
MeCCanthelinr Bromide
Fig. 53. The structural formulae of
atropine, Cyoscin^e, and
mrnhannhelin.e bromide.
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CH3
e . Cl
„X"
Edrophonium Chloride (Tznsilon) 
N-(CH3).,-SO4CH3
I I OC - n (ch3)2
Prostigmine Methyl sulphate
Tubocurarine Chloride
(chOD
Fig. 54.
+ 9 9 —.N -CHg CHg O-C- C H2-C- O- C Hg- CHr N-(C H3)3*2C I
Suxamethonium Chloride
The structural formulae of edrophonium
chloride (Tensilon), ' prostigmin methyl
sulphate, tubocurarine chloride, and
suxamethonium chloride*
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EXPERIMENTAL
1 • Hen Gastrooneaius Muscle — Sciatic Nerve Preparation
METHOD
Hens weighing between 1*5 anc 2.0 kg. were usec. The hen was
laic on its sice anc the feathers in front of the forearm of the out- 
stretchec wing were pullec out to expose the forearm vein. Anaes­
thesia was induced, with a solution of socium pentobarbitone given
slowly intravenously in a cose of 40 to 50 mg* per kg*
The anaesthetisec hen was laic on its back upon the operating
table anc the trachea was cannulatec in the manner cescribec on
page 292 anc connectec to a Starling type of artificial respirator*
The external jugular vein was then cannulatec anc connectec to a 50 ml*
burette* In some of the experiments one of the common carotic
arteries was also cannulatec anc connectec to a mercury manometer for
blooc pressure recorcing.
The left leg was preparec for incirect stimulation of the gastro­
cnemius muscle via the sciatic nerve. The leg was helc with its long
axis perpencicular to the operating table anc fixec rigicly by means
of two clamps, one at the knee joint anc the other just beyonc the
insertion of the Achilles tencon. The gastrocnemius muscle was
partially cissectec free from the surrouncing tissues anc the Achilles
tencon severec near its insertion into the calcaneus. A strong linen
threac /
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thread was tied around the free end of the tendon. The thread was led
over pulleys and attached to a myograph lever, the writing point of
which was adjusted so as to record the contractions of the muscle upon
a moving smoked surface. By means of an incision made in the midline
of the posterior aspect of the thigh, the sciatic nerve was exposed
between the hamstring muscles. The . nerve was then crushed proximaly
between the jaws of a pair of artei?’ forceps, and a pair of shielded
platinum electrodes were placed around the nerve distal to the crushed
area. The nerve was stimulated using single shocks by means of a
Dobbie Mclnnes square wave generator at a frequency of 8 per minute at
25 to 50 volts with the pulse width of 4 to 6 m.sec. The voltage and
pulse width were of such magnitudes as to give supramaximal stimulation. 
In each experiment the frequency, voltage and pulse width were kept con­
stant.
The following studies were made with this preparation:- 
(1 ) The effect of ouphrnadrine on the contracture and
neuromuscular block induced by Suxamethonium.
Control intravenous Injections of 25 ^g./kg. of Suxamethonium were
given and the effects recorded. Orphenaduinr 5.0 mg./kg. (OLthaogh in
some experiments 1 mg., 5 mg. and 6 mg. per kg. were also used) was
given. Then Suxamethonium 25 h*6* per kg. was given after about 10
minutes and the same dose repeated when the contractions had returned
to their normal level.
(2) The effect of ouphenadrine on the neuro­
muscular /
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(2) The effect of orphenadrine on the neuro­
muscular block Induced, by tubocurarine.
Control intravenous injections of from 200 to 300 jig. per kg. of
tubocurarine were given. It was usual to give about three doses
before the degree of neuromuscular block was constant. At least two
standard records were obtained before orphenadrine 3 Per leg* was
given intravenously. Tubocurarine 200 to 300 ^xg. per kg. was then
given 3 to 10 minutes after giving orphenadrine and the same dose was
repeated when the contractions had returned to normal. The dose of
tubocurarine was constant in each experiment.
(3) The effect of orphenadrine on indirect tetanisation
The muscle was tetanised for 30 seconds at a frequency of 1400 to
1500 per minute every 10 to 15 minutes. Orphenadrine 3 per kg.
was given intravenously after two or three control records had been
obtained. The frequency of the tetanising current and the period of
rest between consecutive inductions of tetanus were kept constant in
each experiment.
(4) The effect of orphenadrine on the fatigue
induced by indirect tetanisation.
The degree of fatigue was assessed by measuring the height of
contraction just before tetanisation and that just before the next
tetanisation. The degree of fatigue was expressed as a percentage of
the preceding height of contraction.
Drug solutions were injected into the rubber connection between
the /
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the vein cannula anc the burette. Each injection was followed, by an
infusion of 3 ml, of physiological saline from the burette.
2. Cat Gastrocnemius — Sciatic Nerve Preparation
METHOD
Cats weighing between 2.0 and 3*5 kg. were anaesthetised, with
sodium pentobarbitone (60 mg. per kg.) given by intraperitoneal
injection. Surgical anaesthesia was produced in 13 to 30 minutes.
The cat was then laid on its back; the legs were secured, and the
head extended. The trachea was cannulatec and this was usually con­
nected to a Starling type of artificial respirator. One external
jugular vein and one of the common carotid arteries was cannulated.
The left leg was prepared for indirect stimulation of the gastroc­
nemius muscle through the sciatic nerve in the manner described for the
hen, except that the sciatic nerve was dissected from the lateral aspect
of the tiigh instead of the posterior aspect.
Supranaazimal stimulation was employed using a voltage of between
25 and 60 volts and a pulse width of from 3 to 4 m.sec. The frequency
of stimulation was about 8 per second. The voltage, pulse width and
frequency of stimulation were kept constant for each experiment. When
the effect of the drugs on tetanus was being studied, the frequency of
the tetanising current was 1,600 per minute.
The following studies were carried out using this preparation: —
(1) /
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(1) The effect of orphenadrine on the neuromuscular block
induced hy Suxamethonium,
Suxamethonium in doses ranging from 50 Jig* to 150 Jig. per kg. was
used hut the amount was constant for each experiment. At least two
similar consecutive records were obtained as controls before orphen­
adrine was injected intravenously. The doses of orphenadrine used
were 3*0 mg. and 5*0 mg. per kg. One to 2 minutes after injecting
orphenadrine, a further dose of suxamethonium was injected and this was
repeated when the contractions had returned to control levels.
(2) The effect of orphenadrine on the neuromuscular
block induced by tubocurarine.
Tubocurarine 100 jig. to 150 Jig. per kg. was used, but the dose was
constant for each experiment. Intravenous injections of tubocurarine
were repeated until the degree of neuromuscular block became constant.
Orphenadrine was then injected intravenously. The doses of orphena­
drine used were 3*0 mg. and 5.0 mg. per kg. About two minutes after
giving orphenadrine, tubocurarine was given intravenously and the dose
was repeated when the contractions had returned to control levels. In
a few experiments, the effects of tubocurarine on indirect tetanisation
were studied before and after giving orphenadrine.
(3) The effect of orphenadrine on indirect tetanisation
The muscle was tetanised for 30 seconds at a frequency of 1,600
impulses per second every fifteen minutes. Orphenadrine 3»0 to 5*0
mg. per kg. wa3 given intravenously after at least two control records
had /
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had been obtained. The muscle was subsequently tetanised every fif­
teen minutes for an hour or longer. In some experiments up to 8 mg.
per kg. of orphenadrine was used.
3* Experiments Using the Isolated
Frog Rectus Abdominis Muscle
METHOD
The procedure used for preparing the muscle to record the effects
of drugs was essentially similar to that described by Burn (1952). An
adult frog was stunned by means of a blow on the head and was then
pithed. The pithed frog was laid on its back upon a cork-covered
dissecting board to which it was pinned. The rectus muscle was
exposed by cutting away the skin of the abdomen. The muscle was then
carefully dissected from the frog, and suspended in an organ bath of
10 ml. capacity by means of two threads tied one to either end of the
muscle. A loop was made in the thread at one end in order to fix the
muscle to the bent wire at the base of the bath. The longer thread
attached to the other end was tied to a modified frontal point writing
lever which gave a magnification of from 8 to 10 times. The bath
(Fig. 55) contained 10 ml. of oxygenated frog Ringer's Solution (NaOl,
6.5s.; KOI, 0.14 g.; CaClg, 0.12 g., NaH• CO^, 0.2 g. ; NaH gFO^ 0.01 g.,
gluoose,2 g. to 1 litre of distilled water), at room temperature.
Acetylcholine was dissolved in frog Ringer's solution to give the
required /
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Fig. 55, Diagram of the apparatus used 
for experiments upon the
' isolated frog reotus abdominis 
musole.
z
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required oonoentration and added to the bath by means of a graduated
1 ml. tuberculin syringe* The final concentration of acetylcholine
(in the bath) used to produce contractions of the muscle was from 1 to
3 Jig. per ml.
Uniform submaximal contractions to the same dose of acetylcholine
were obtained before the effects of orphenadrine were studied. The
time interval between each dose of acetylcholine was four minutes. The
resulting contractions were recorded for 43 seconds and the bath was
washed out between each dose of acetylcholine. Orphenadrine to give a
final bath concentration of from 5 pg, to 25 pg. per ml. was added 15
seconds before the acetylcholine. In some experiments the effects of
tubocurarine were compared with those of orphenadrine and in others the
effect of adding tubocurarine and orphenadrine together was studied.
Tubocurarine was added to the bath 15 seconds before acetylcholine.
4-. Experiments Using the Isolated Rat
Phrenic Nerve Diaphragm Preparation.
METHOD
N
The procedure adopted was essentially that described by Bulbring
(1946). Adult rats of either sex were killed by a blow on the head,
the throat cut and the blood allowed to drain out. The rat was then
laid on its back upon a cork—covered dissecting board to which it was
pinned. The skin over the chest was removed and the thorax opened
along the left hand side of the sternum. The frontal part of the left
thoracic /
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thoracic wall was removed and the phrenic nerve exposed. Left-sided 
pneumonectomy was performed and the left phrenic nerve carefully freed 
from fat and other tissues. The utmost care was taken not to injure 
it. The left anterior abdominal muscles were cut along the costal 
margin and, holding the • last rib with a pair of forceps, a segment of 
the diaphragm was dissected out* Two converging outs were made through 
the ribs towards the tendinous part of the diaphragm, and parallel to 
the direction of its muscle fibres. The cuts were made so that the 
point of entry of the phrenic nerve into the diaphragm lay in the 
middle of this segment. The strip of diaphragm was dissected out 
beyond its tendinous part with about 5 cm. of phrenic nerve attached 
to it. The final preparation was fan-shaped, being about 2 mm. wide 
at the tendinous end and about 2 cm. wide at the costal margin. The 
costal margin of the segment of diaphragm was fixed to a J-shaped glass 
rod by means of threads. The thread was stitched on to the tip of the 
tendinous end. In experiments where both direct end indirect stimu­
lation were to be used, fine ppattnum idres instead of thread weir used 
for the teudnuous end. The preaptattin was then set up tu a 100 ml. 
organ bath (Pig. 56) containing double glucose Tyrode • s solution (NaCl, 
8 g. ; KOI, 2 g.; Cadg, 0.2 g,. Mm£1|, 0.1 g.; NoJtCN^, O go J
NaHfcH^, 0.05 g.; glucose 2 g.j to 1 Hire of dist illtdwate r). The
J-piece held the costal margin of the segment in position at the bottom
of the organ bath while the thread or the platinum wire tied at the
tendinous end was fixed to • a light isotonic heart lever writing upon a
revolving /
  
 
 
 
 
287
Fig. 56, Diagram of the apparatus used
for recording contractions of
the rat diaphragm produced by
electrical stimulation of the " 
phrenic nerve.
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revolving smoked surface. Tyrode*s solution was supplied to the bath
from a reservoir. The temperature of the bath and the reservoir was
maintained thermostatically at 29 — 0.5°C. A sintered glass distri­
bution tube was fixed at the bottom of the bath to provide a vigorous
supply of oxygen with which the organ bath fluid was aerated in the
form of fine bubbles. The phrenic nerve was stimulated using the
electrode described by Bell (1952) so that the muscle could be stimu­
lated both directly and indirectly. Stimulation of the nerve was by
square impulses at a frequency of from 6 to 8 per minute, 10 to 15 volts
and a pulse width of . 0.5 to 1.0 m.sec. When the muscle was stimulated
directly the frequency was from 6 to 8 per minute at 30 to 50 volts and
the pulse width was 1.5 to 2.0 m.sec. In any given experiment, fre­
quency, voltage and pulse width were kept constant. Drugs in aqueous
solution were added directly to the bath by means of a 1 ml. tuberculin
syringe. The drug was allowed to act for three minutes after Wiich
the Tyrode*s solution in the bath was changed. The bath was washed
out several times with the Tyrode*s solution in between additions of
the drugs. Additions of drugs were made when the contractions had
recovered to the original size or reached a new but steady level..
This meant in some instances an interval between additions of drugs as
long as 80 minutes.
Chou (1947) using the phrenic nerve diaphragm preparation for the
assay of curare-like substances, allowed the solution of tubocurarine
to act for three minutes. In the experiments described in this
section, /
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section, this feature of Chou’s technique was therefore adopted because
it was thought that if the drug was allowed to act upon the t±ssue for 
long enough to produce its maximal ■ effect then too much time woldd be 
needed to wash the drug off the receptors.
5* Experiments on the effect of Orphenadrine
on Spinal Reflexes - Patellar Reflex and
the Crossed Extensor Reflex
METHOD
Cats weiring between 2.0 kg. and 5*3 kg. were used. Anaes­
thesia was induced as previously described (page 281 ).
The anaesthetised cat was laid on its back upon an operating
table. The trachea was cannulated and connected to a Starling type
of artificial respirator. The two common carotid arteries were
ligatured high in the neck. The cat was then turned over and an
incision made in the midline from the top of the head to the shoulders.
The muscles were freed from the vertebral column and the vertebral
arteries were ligatured by means of a strong thread passed between the
second and third cervical vertebrae. The atlanto-occipital ligament
was then incised in the midline and a probe passed through the foramen
magnum into the cranial cavity to destroy the brain. It was also
passed downwards to destroy the upper one or two segments of the spinal
cord. Bleeding was controlled by the use of very hot saline packs.
The /
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The cat was again turned on its back and its legs . secured. The
external jugular vein on the left side was canulated and connected to
a 50 ml. burette containing physiological saline. The ri^it carotid
artery was cannulated and connected to a mercury manometer and the
blood pressure recorded on a revolving smoked surface. The next stage
was dependent on the reflex to be studied.
(a) The patet pat refrox f kno e jerk o . kHio lTft limb wis twast f
at the knee. The posterior aspect of the knee was made to etl0 on a
horizontal brass bar and between two I-blocks. The position of the
leg was fixed more securely by means of two strong rlete threads
stitched through either side of the upper part of the leg and tied
securely to another horizontal brass bar above the knee. (These
horizontal bars were secured by X-blocks to fixed vertical stands on
the table.)
The skin in front of the knee was excised to expose the patellar
tendon. A veiy small incision was made on either side of the tendon
to allow a pair of platinum electrodes to be placed under the tendon
but without allowing free movement of the electrodes under it. A
strong linen thread was stitched to the front of the foot in the mid­
line. The thread was led over pulleys and attached to a myograph
lever, the writing point of which was adjusted so as to record the con­
tractions of the muscle upon a moving smoked surface.
The patellar tendon was stimulated using single shocks from a
square wave generator at a frequency of about 6 per second, at 25 to 
60 /
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60 volts and a pulse width of 1.5 to 3*5 m.second. In any one experi­
ment, the reflexes were elicited for two or three minutes with a rest
period of three minutes in between. In one experiment the frequency
of stimulation was 3 par minute and the reflexes were elicited con­
tinuously.
(b) The Crossed Extensor Reflex. The left hind limb was flexed
at the knee and the posterior aspect of the knee was made to rest on a
horizontal brass bar and held between two metallic blocks. The skin
in front of the knee was excised to expose the patellar tendon. The
tendon was severed from its insertion into the tubercle of the tibia
and dissected free from the surrounding tissues. A strong linen
thread was tied around the free end of the tendon, led over pulleys and
attached to a myograph lever, the writing point of wdich was adjusted
so as to record the contractions of the quadriceps muscle upon a moving
smoked surface. The right hind limb was then prepared for stimulation
of the sciatic nerve to produce the crossed extensor reflex (con­
traction of the left quadriceps muscle). The leg was held with its
long axis perpendicular to the operating table by tying it with
strings to a perpindicular metal bar fixed to the table. By means of
an incision made on the lateral aspect of the thigh the sciatic nerve
was exposed between the hamstring muscles. The distal portion of the
nerve was crushed between the jaws of a pair of artery forceps and a
pair of shielded platinum electrodes placed around the nerve proximal
to the crushed area. This means that nerve impulses from the sciatic
nerve /
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nerve will be oonCuoteC to the spinal oorC instead of to the calf
muscles.
The right sciatic nerve was stimulated to produce supramaximal
contractions of the left quadriceps muscle (crossed extensor reflex).
Single shocks from a square wave generator at a frequency of between
6 and 10 per minute at 10 to 40. volts • and a pulse width of 1.5 to 3*5
m.sec. were used. In each experiment the frequency, voltage and pulse
width were kept constant. In all the experiments the reflexes were
elicited for 3 to 5 minutes with a rest period of from 3 to 5 minutes.
In each experiment the periods when the reflexes were elicited and the
periods of rest were kept constant. Rest periods were introduced
because it was thought that fatigue might set in if the reflexes were
elicited continuously every 6 to 10 seconds and it might be impossible
to differentiate between depression of the reflex by the drug and
fatigue of the reflex.
Orphenadrine was given intravenously in the dose of 1 mg., 3 mg.
or 5 mg. per kg. In later experiments the initial 1 mg. per kg. dose
was omitted as it was found to have no effect on the two types of
reflexes. Each injection of orphenaCrine was followed as usual by an
infusion of 3 ml. of physiological saline. At least two control
records were obtained before the orphenadrine was injected.
6. Experiments on the BlooC Pressure
of the Anaesthetised Cat
METHOD
Cats /
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METHOD
Cats of either sex weighing between 1.5 and 3 kg. were used.
Anaesthesia was induced by means of ietrapeedtoeeal injection of sodium
pentobarbitone 50 mg. to 60 mg. per kg. This produced surgical anaes­
thesia in about 20 to 30 minutes.
The anaesthetised cat was laid on its back upon an operating table.
The legs were secured to the table and the head extended by a string
attaching the upper incisor teeth to the table. The skin covering the
neck was cut away from the sternum up to the apex of the mandible. The
trachea was exposed by blunt dissection. A strong liete thread was
passed around the trachea which was then incised transversely. The cut
edge of the partly severed trachea was held in a pair of blunt forceps
and a tracheal cannula inserted and tied into place* The insertion of
a tracheal cannula was done as a precautionary measure so that if severe
drug-induced respiratory depi*^£^j^:ion or failure occurred the cat could
be kept alive by means of artificial respiration. The amount of air
tnteeing and leaving the cannula was controlled by means of an adjust­
able valve.
One external jugular vein, usually the left, was then caeeulatei•
To do this the skin of the left anterior part of the neck was removed
and the vein exposed by blunt dissection. The fascia covering the
vein was carefully removed, two threads were tied loosely around the
vein and a bulldog clip put on to the cardiac aspect of the vein and
tied off at the cephalic end. A small transverse incision was made in
the /
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the dilated vein by means of a pair of sharp—pointeC iris scissors* A
vein cannula filled with a solution of heparin was then inserted through
the incision with the pointed end towards the heart. ' The lower thread
was now used to secure the cannula in the vein. The cannula was then
connected by means of a rubber tubing to a 50 ml. burette containing
normal physiological saline. Care was .taken to exclude all air
bubbles from the system. The bulldog clip was then removed. If,
when the clip on the rubber tubing was released, the saline in the
burette ran freely ■ into the vein, then the cannula had been correctly
inserted. ,
The next step was to cannulate the arteiy. The artery was first
tied off as near to the head as. possible. A bulldog clip was then
placed on the artery about 3 cm. below the ligature . and a second thread
was passed under the vessel approximately midway between the ligature
and the bulldog clip. A small transverse cut was made in the arteiy
by means of a pair of sharp—pointeC scissors. An artery cannula
filled with a solution of heparin was then inserted through the
incision with the pointed end towards the heart. The cannula was
connected to a mercury manometer and the space between the mercury and
the cannula filled with a twenty—five per cent (w/v) solution of sodium
thiosulphate as an anticoagulant. In some experiments physiological
saline to which heparin had been added (to give 1 : . 200 solution) was
used. All air in the tube containing the anticoagulant solution was
displaced and the pressure in the manometer was set at about. 100 to
120 mm. /
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120 mm. of mercury before connecting the cannula to the manometer. A
writing flag on one arm of the mercury manometer recorded the blood
pressure on a smoked drum.
Drug solutions were injected into the rubber connection between
the vein cannula and the burette. Each injection was followed by
infusion of 3 ml. of saline from the burette. The effect of orphen- 
adrine 3.0 mg. per kg. and 3-0 mg. per kg. on the blood pressure and
in some cats on the pressor response to adrenaline 4.0 to 8 ug. and
noradrenaline 4.0 to 8 ug. was studied. Orphanairine was dissolved
in physiological saline to give a solution containing 20 mg. per ml.
7. Experiments on the Blood
Pressure of Spinal Cats
METHOD
Cats of either sex weighing between 2 and 4 kg. were used.
Anaesthesia was induced by means of intraperitoneal injection of sodium
thiopentone (50 mg. per kg.). This produced surgical anaesthesia in
about 20 to 30 minutes.
The common carotid arteries were dissected from the accompanying
vagosympathetic trunks and tied. The trachea was next freed from the
adjoining tissues, cannulated and connected to the artificial respir­
ation pump (with the valve of the trachea cannula wide open). The cat
was then turned over and then spinalised as described on page 289. As
soon as the cord was transected, the valve of the trachea cannula was
regulated /
  
 
 
 
 
 
 
 
 
 
 
 
296.
regulated so that adequate pulmonary ventilation was obtained. The
cat was then turned on its back and the left external jugular vein
canulated and connected to a 50 ml. burette by a short rubber tube.
The right common carotid artery was then canulated and connected to
the mercury manometer as already described. The pressure of the
mercury manometer was set at about 80 mm. of mercury before the
arterial canula was connected to the manometer. The blood pressure
was recorded on a smoked surface.
Drug solutions were injected into the rubber connection between
the vein cannula and the burette. Each injection was followed by the
infusion of 3 ml. of saline from the burette.
A period of at least 43 minutes was allowed for the blood pressure
to attain a fairly constant level and no drugs were given until this
level had been maintained for 25 to 20 minutes.
8, Experiments on the Nictitating _ Membrane
of the Anaesthetised Cat
This study was made to Siei out if the fall in blood pressure
produced by injection of or^^ad^ne was due to a sympathetic ganglion
blocking effect.
METHOD
Cats of either sex weighing between 3 kg. and 5 kg* were used.
The cat was anaesthetised as already described with sodium pento­
barbitone. /
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pentobarbitone. The trachea and the external jugular vein were
cannulated and the vein cannula connected to a 50 ml. burette. The
left internal carotid artery was cannulated and connected to mercury
manometer. The head was rigidly fixed by passing a brass rod between
the jaws anC then tying the jaws firmly together with string. The
ends of the rod were then gripped firmly in clamps and these were
supported on uprights fixed to the side of the operating table. By
means of a fine needle, a silk thread was passed through the midpoint
of the margin of the nictitating membrane of the right eye and tied
firmly into place. The thread was then pulled forward anC to one
side making an angle of about 30° to the long axis of the cat. It 
was then leC around pulleys and attached to a frontal—point writing
lever. The contractions of the nictitating membrane and the blood
pressure were recorded on a smoked surface.
The right cervical sympathetic chain was CissecteC out, and a fine
cotton thread tied tightly around it as low down in the neck as possible.
The sympathetic chain was severed just below the ligature. The cut
preganglionic cervical chain was placed upon a pair of platinum elec­
trodes kept moist with normal saline. Contractions of the nictitating
membrane were elicited by stimulation of the cervical sympathetic chain
by means of square wave impulses at a frequency of 1,200 per minute,
20 volts and amplitude and a pulse width of 1.5m.sec. The nerve was
stimulated at 3 minute intervals for 5 to 10 seconds. The period of
stimulation was kept constant for each experiment. Having obtained
about /
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about six standard reproducible responses of the nictitating membrane,
a solution of orphenadrine 3*0 or 5.0 mg. per kg. was injected into the
external jugular vein about 30 seconds before the next period of
stimulation. The effects of ethopropazine 5*0 mg. per kg. and hexa- 
methonium 1.5 to 2.0 mg. per kg. were also studied.
9. Experiments on the Isolated
Perfused _ Rat Hindquarters.
This experiment was embarked upon in order to tiy to explain the
hypotensive effect of orphenairina. It was thought that this may be
due to a widespread vasodilatation. It was also performed in order to
find out if the dissipation of fatigue by orphenairina was due to a
possible vasodilator effect.
METHOD
In these experiments, the pressure at which the physiological fluid
passed through the blood vessels was kept constant. The drug-induced
alterations in the rate of outflow of the perfusion fluid were recorded
by means of a Thorpe drop recorder. The vessels were perfused with
oxygenated Locke’s solution (NaCl, 9 g*; KCl, 0.42 g.; CeClg, 0.24 g. J
NaHCO^, 0.5 g.; glucose 1 g. to 1 litre of distilled water), at room
temperature.
Rats of either sex weighing between 200 and 500 g. were killed by
a /
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a blow on the head. The throats were cut and the blood allowed to
drain out. The abdominal caviiy was opened by means of a longitudinal
incision extending from the sternum to the anus and the rectum, oeso­
phagus and the inferior and superior mesenteric arteries divided between
ligatures. The abdominal viscera were then removed and this brought
into view the abdominal aorta which was caeeulaOei. The body wall and
vertebral column were transected above the point of cannulation, the
cannula was filled with heparin and connected to the perfusion system
(Fig. 57) by means of fine rubber tubing. The hindquarters prepar­
ation was placed on a muslin rest lying in a filter funnel and the out­
flow was led via the filter funnel over the contacts of the Thorpe drop
recording assembly.
The rate of fror of fluid to the injection cannula was controlled
by a tap and could be adjusted to a suitable rate value at the beginning
of each experiment. The injection cannula (the design of which was
based upon that suggested by G-adum and Kwiatkowski, 1938) allowed the
drug solutions to be injected at a constant rate. This was achieved
by injecting the solution through the rubber cap at a rate such that
the level of fluid in the cannula was unaltered during the process.
After setting up the preparation, a uniform outflow record was
obtained for at least 10 minutes before drugs were injected. The
effects of adrenaline 0.25 yg. to 1 ug. and noradrenaline 1 jig. to
3 yg. were compared with those of orpheeadriet 25 yg. to . 250 pg.
(O.l sM. of orpfeead.riet solution was used in all instances). The
effect /
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Pig. 57. Diagram of the apparatus used
for the perfusion of'the iso­
lated rat's hindquarters.
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effect of previous administration of orphenairina on the vasoconstric­
tor response to adrenaline and noradrenaline was studied. The effect
of previous administration of Tolazine on the vasoconstrictor action of
orphenairine and noradrenaline was also studied in a few experiments.
10. Effect of Orphenadrine on the
Convulsant Activity of Leptazol
Female albino mice weighing between 18 and 26 g. were used in the
experiments. The mice were divided into groups each containing at
least 10 mice. Four control groups received leptazol alone; each
group receiving either 20 mg., 30 mg., 40 mg., or 60 mg. per kg. The
other groups were preheated with orphanairina at doe levels of 1 mg.,
3 mg, and 15 mg. per kg. Leptazol was then injected 25 to 40 minutes
after injecting orphenadrine. Aqueous solutions of leptazol and
o^phanairina were used, and the solutions were injected into one of
the tail veins. The volume of the solution of leptazol or orphen- 
airina was kept constant irrespective of the dose level and the dur­
ation of injection did not exceed three seconds. In order to camy
out the experiment the movements of the mouse were restricted by
placing it in a small metal cylinder, one end of which was perforated
to allow exposure of the tail. In order to render the tail vein more
visible, the tail was wiped with a swab of cotton wool soaked in xylene, 
The number of mice convulsing after injecting leptazol was recorded.
The mortality rate from leptazol was also recorded.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
302
11. Effect of OrphenaCrine on
Electroshock Seizures
The apparatus was similar to that employed by Ahmad and Lewis
(1960) who used the ear clip electrodes introduced by Hoyt and Rosvold
(1951)* Pour groups of 20 female albino mice weiring between 13 and
21 g. were used. Because it was thouu°t that orphenaCrine had a con- 
vulsant action of its own, supramaximal threshold current intensity of
20mA was not used in earlier experiments when the effect of 3 rag. and
12 mg. of orphenadrine per kg. was studied. The current intensity
was 17mA. In the other two groups who received 6 mg. and 13 mg. of
orphenadrine per kg. body weig°Lt respectively, the supramaximal thres­
hold current intensity of 20mA. was used. The current was allowed to
act for not more than 3 - seconds although it was interrupted earlier,
if it produced tonic extension of the hind limbs (which was regarded
as the end point). Twenty—four hours before the effects of pretreat­
ment with orphenadrine on electroshock seizures were studied, the number
of mice in each untreated group giving a positive reaction, i.e.,
showing the end point, was noted. The next day the mice were treated
with orphenadrine injected intravenously into a tail vein at dose
levels of 3 mg., 6 mg., 12 mg. and 13 mg. per Kg. 23 to 35 minutes
later, electroshock was applied using a current of the same intensity
and duration as stated above. The number showing the end point
(positive reactors) was again noted.
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RESULTS
1 . Hen G-atroonemius Muscle -
Sciatic Nerve Preparation,
(a) Effect of orpfenai■rlet on the contracture
(muscular spasm) induced by suxamethonium
In 3 out of 8 hens, orpfeeadrlne at a dose of 3*0 sg. per kg.
disieisfed the degree and duration of the contracture produced by
suxamethonium. Orpheeairlet at this dose ' itself caused neuromuscular
block in one of the 8 hens; the block lasting for 20 ' minutes (Fig.39).
In 6 of the 8 hens, pretreatment with orpftnadrlee (3 and 3 mg. per kg.)
caused an increase in the degree and duration of the neuromuscular
block induoti by a given dose of suxamethonium (12.3 to 23 pg. per kg.).
In 3 hens prolonged complete neuromuscular block occurred and in one
instance it took about 33 minutes before the hei^et of the muscle
contractions returned to the pre-injection level (Pig. 39). In 2
preparations, 60 and 90 pg. per kg, of Neostigmine (pros0igsie)
antagonised the neuromuscular block induced by suxamethonium after
pretreatment with orphtnadrdee (Pigs. 38 and 60).
(b) Effect of orphenadrdee on neuromuscular
block induced by tubocurarine.
Pretreatsent with orpfenadrlee 3 mg. per kg. caused an increase
in the degree of neuromuscular block induced by a constant dose of
tub oourariee. /
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Fig, 58. Hen gastrccnemius muscle - sciatic nerve preparation.
Pentobarbitone anaesthesia. Indirect stimulation via
the sciatic nerve. Contractions downwards. Drugs
administered intravenously.
At A, Suxamethonium 12.5 pg. per kg.
At B, Orphenairina 3.0 mg. per kg.
At C, Neostigmine 90 pg. per kg.
Pig. 59. Hen gastrocnemius muscle - sciatic nerve preparation.
Pentobarbitone anaesthesia. Indirect stimulation via
the sciatic nerve. Contractions downwards. Drugs
aiministarai intravenously.
At A, Suxamethonium 25 pg. per kg.
At B, Orphenadrine 3.0 mg. per kg.
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Fig, 60. Hen gastrocnemius muscle-sciatic nerve
preparations. Pentobarbitone anaes­
thesia, Indirect stimulation via the
sciatic nerve. Contractions downwards.
Drugs administered intravenously.
At A, stucameehonimn 2fj^ig. ppr kg.
At B, orppenadiriie 3*0 mg. ppr kg.
At C, orr>pi^n£^c^3cr^r^€J 5^0 mg. per kg.
At D, neosthggeLne 60 ug. pp^e* kg.
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Ouboourariet. The amplitude and duration of the block were increased
although in a few instances only the duration of the neuromuscular
block was significantly increased. Thus in one hen, 200 fLg» per kg.
of tubocurarine given intravenously produced a 25 to 30$ neuromuscular
block. After prttreaOmeet with crpfenairlne (3 sg. per kg.) the same
dose of tubocurarine produced about 50$ neuromuscular block (Pig. 6l).
(c) Effect of orpheeadrlee on the response
to indirect 0etaeisatlon and on fatigue
Orpheeadrlee 3.0 sg. per kg. was found to have no influence on
the response of the gastrocnemius muscle to indirect tetanisation.
The tetanic ccn0raotion was as well sustained as in the period before
treatment with crpheeadrdnt (Pig. 62). Orphenad.rine however reduced
the fatigue due to repeated indirect 0etanisa0lcn. Thus in four hens,
the average reduction in 0rl0cf he^^t after indirect 0etaeltatioe was
22$ before they received orpheeairiee. After treatment with orpfen- 
adriee this was reduced to 5$ (Table 24).
2. Cat Gastrocnemius . Muscle
Sciatic Nerve Preparation.
(a) Bf>fecO of orphenadrlet on '' neuromuscular
block induced by suxamethonium.'
Orpfeeadrlee 3.0 sg. to 6.0 sg. per kg. while not producing any
block of its own, considerably antagonised the neuromuscular block
induced /
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Fig. 61. Hen gastrooetsius suscrtesclatlc nerve
preparation. Pentobarbitone anaes­
thesia. Indirect stimulation via the
sciatic nerve. Contractions iornraris.
Drugs aisielsttrti intravenously.
At A, tubocurarine 200 yig. per kg.
At B, orpfteairdee 3»0 sg. per kg.
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Pig, 62. Hen gastrocnemius muscle-sciatic nerve
preparation. Pentobarbitone anaes­
thesia. Contractions downwards.
Drugs administered intravenously.
At T, indirect tetanisation via thesciatic nerve (1,500 impulses per 
minute).
At B, crphenairina 3«0 mg. per kg.
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Percentage Reduction in Twitch Tension
Before
Orphenadrine
After Orphenachvne
3mg/£g
I 196 19*7 76 38 1-3
n 35 29 0 0 0
m 15-1 206 6-2 +8-5 6
I7 23*3 14-7 7-5 0 7
Average 27-4 5 -6
TABLE 24. Effect of 'orphenadrine 3 mg, per kg, given
intravenously on the fatigue-induced after
hehanismhion of the sciatic nerve-gastroc-
nemius preparation of the hen.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
310.
induced by suxamethonium (Figs. 63 and 64)# This antagonism was seen
whether the block was complete or partial. In one cat, muscular
spasm induced by suxamethonium ( 50 )ig. per kg. ) in the gastrocnemius
muscle was very considerably reduced after treatment with oreeenadrinr
3.0 mg. to 6.0 mg. per kg. There was no change in the degree of
neuromuscular block after indirect tetanisation Indicating that arthrous
errhreahmrnh with orpeenadrinr had reduced the degree of neuromuscular
block induced by suxamethonium, the block was still of the depolarising
type (Pig. 65). ,
' z. -
(b) Effect of oreeenadrinr on neuro­
muscular block induced by tuboourarine
Frrhreaternt with orpheus-driBe 3*0 mg. to 3.0 mg. per kg.
increased the degree of neuromuscular block induced by a given dose of
tuboourarine. The amplitude and the duration of the neuromuscular
block were increased (Fig. 66). The effect of Indirect tetanisation
on the neuromuscular block induced by tuboourarine was unchanged by
orphrnadrinr; there was a transient decurarisation of the block
induced by 100 ^ig. to 130 jug. per kg. of tuboourarine by indirect
tetanisation of the gastrocnemius muscle both before and after treat­
ment with orphenadrine (Fig. 67)*
(0) Effect of orpernad■rinr on
indirect tetanisation.
Orphenadrine 3*0 mg. to 3*0 mg. per kg. had no effect on the
response of the gastrocnemius muscle to indirect hehanisation (Fig.68).
The /
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Fig, 6j. Cat gastrocnemius suscet-sclaOio nerve
preparation. Pentobarbitone anaes­
thesia, Indirect s0lsula0loe via the
sciatic nerve. Contractions iownvaris.
Drugs administered intravenously.
At A, suxamethonium, 150 yig. per kg.
At B, orphteairine, 5.0 sg. per kg.
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Fig. 64 Cat gastrocnemius muscle-sciatic nerve
preparation. Pentobarbitone anaes­
thesia. Indirect stimulation via the
sciatic nerve. Contractions downwards
Drugs administered intravenously.
At A, sLsc<xnethonium '5 )ig. per leg.
At B, orohenadruie, ).0 mg. ger leg.
At C, orobenadrine, 5 -0 mg. per kg.
At D, oiohenadidLne, 6 t0 mg. per kg.
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Fig. 65. Cat gastrocnemius muscle-sciatic nerve
preparation. Pentobarbitone anaes­
thesia. Contractions downwards.
Drugs administered intravenously.
At T, indirect tetanisation via the sciatic
nerve (1,500 impulses per minute).
At A, suxamethonium 100 ^ig. per kg.
At B, crphanairina, 3.0 mg. per kg.
At C, crphanairina, 6,0 mg. per kg.
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Pig. 66. Cat gastrocnemius suscle-sciatic nerve
preparation. Pentobarbitone anaes­
thesia. Indirect stimulation ve the
sciatic nerve. Contractions downwards.
Drugs aislelsterti intravenously.
At A, tutobuxuirijai e 30/ig. per kg.
At B, ororlenae)ldLne 3 •! ms* per kg.
At C, oiophenadrine 3 • ! mg. per kg.
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Fig, 67. Cat gastrocnemius muscle-sciatic nerve
preparation. Pentobarbitone anaes­
thesia. Contractions downwards.
Drugs administered intravenously.
At T, indirect h©tanisahion via the
sciatic nerve (1,500 impulses per
minute).
At A, t^oon^r-ine 100 yug. per kg.
At B, orphenadrine, 5 mg. per kg.
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Fig. 68. Cat gastrocnemius muscle-sciatic nerve
preparation. Pentobarbitone anaesthesia.
Contractions downwards. Drugs administered
intravenously.
At T, indirect tetanisation via the sciatic
nerve (1,600 impulses per minute).
At B, crphenadrine 3*0 mg. per kg.
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The tetanic contraction was as well Sustained as^im ‘‘the period before
treatment with olphteairine.
3. Isolated Frog Rectus Abdominis Muscle
Orpfteadrlee showed antagonism to acttyloholdet-ieducei contrac­
tions of the rectus muscle. Following 25 /g. per sl. of orphenairlne,
the magnitude of the acetylcholine-induced contractions was reduced
from 50 to 70$. Maximum block was often seen during the next addition
of acetylcholine following wash out of odphenadriee. Recovery of the
muscle from the orphenadriee-induced block took a considerable time in
spite of repeated washings (Pig. 69). There appears to be an additive
effect between the neuromuscular block induced by tubocurarine and that
induced by odpftnairine. Thus in one preparation (Pig. 70) orpfena- 
drine 25 pg* per sl. produced about 80j block while Oobocurarlee 2 ug.
per ml. produced about 50$ block. Both drugs given together in the
same doses produced complete neuromuscular block.
4. Isolated Rat . - Phrenic Nerve Diaphragm . Preparation
Orpfenairlee in a dose range of 1-0 pg. to 6.0 pg. per sl.
reduced the diaphragm twitch height following indirect stimulation via 
the phrenic nerve. Altogether eleven preparations were made and the
sensitivity to orphenairlet was found to vary somewat from preparation
to preparation. Tubocurarine was from 8 to 15 times more potent than
odpfenadrint. /
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Pig, 69. Isolated frog rectus abdominis muscle.
All contractions were due to 3 per
acetylcholine acting for 45 seconds.
Labelled contractions were preceded 15
seconds earlier by
At A, tubocurarine 2jug. per ml.
At B, orphenadrine, 25jig« per ml.
Fig. 70. Isolated frog rectus abdominis muscle.
All contractions were due to 3^** Per
ml. of acetylcholine acting for 45
seconds. Labelled contractions were
preceded 15 seconds eaaller by 
At A, oxo>leha^adlle e 2jug• pee ml.
At B, tuboburajOLne 2jgg. ppr ml.
At AB, oIO>r0nacbrille e 2per nl. and tubocurarine 2 jug. per ml.
LJ'l_ | |J U L! U U 1_ -
A B AB
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
319
orphenadrdnt. When complete block was induced by orphenadrint, the
response to direct stimulation showed that the sot'cre was not primarily
affected (Fig. 71 )• The neuromuscular block induced by a constant
dose of odpftnadrlnt tcmeOlmet inortastd with each subsequent addition
of the drug. Thus olphenairine 25 per sl. produced no reduction
in the twitch hei^it after acting for a period of three minutes. The
bath was washed out and crphtnadrlnt was again added to the bath to
produce a ocnoentra0loe of 25 }ig. per sl. This time an approximately
3$ reduction in twitch hei^it was produced. The bath was again
washed out and when contractions had returned to the . initial ht^^^0
oipfteadrdet was added to the bath to give the same ocncen0ra0loe as
before. A nearly complete neuromuscular block was then produced in
three slnoOts. The block became complete in spite of the fact that
the bath was washed out three times (Fig. 73)* Recovery after a block
by cipfenairint, in spite of repeated washing, usually took a long time
on the average about three times as long as after the same degree of
neuromuscular block produced by Oubocorarint. Sometimes even after
60 to 80 minutes and after repeated washing, the twitch height had
only recovered to about 60 to 70 per cent of the initial htigfO. This
finding inidcaOts that o;ipfenadrlnt is sore strongly bound to the
receptors at the neuromuscular synapse than Ooboourarint♦
HUK. 738*, 10 jig. per sl* was found not to have any significant
effect on the twitch felgfOl E0hopropaziet on the other hand in a
dose of 25 pig. per sl. behaved like orphenadrint although the neuro­
muscular /
 
 
 
 
 
 
320.
Fig. 71» Isolated rat phrenic nerve-diaphragm
preparation. Contractions induced
by indirect stimulation via the
phrenic nerve or by direct stimulation 
of the muscle - MD”.
At A, tubocurarine 4 hg« per ml*
At B, ” 6 jig. per ml.
At c, ” 8 jug. per ml.
At E, orphenairine 50 fig. per ml.
Fig. 72. Isolated rat phrenic nerve-dlaphragm
preparation. Contractions induced by
indirect stimulation via the phrenic
nerve. W = Wash out.
At A, ethopropazine 25 pg* per ml.
At B, oirphena&rine 12.5 jg. per ml.At C, neostigmine 25 jg. pear ml.
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Fig, 73. Isolated rat phrenic nerve-diaphragm 
preparation. Indirect stimulation 
via the phrenic nerve.
At A, Orphenadrine 25J^g. per nil.
At B, Edrophonium 5JJg. per ml.
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neuromuscular blocking action appears to be weaker than that of or^hm- 
adlu.ne. There appeared to be some additive effect between the block
induced by urehenadline and that induced by ethueroeazune (Pig. 72).
Neostigmine (Prosbigmun) 2.5 jig. to 25 jijg. per ml. did • not signi­
ficantly affect complete neuromuscular block induced by orehenadlUnaj
® » ■»»Edrophonium ( "Tensilon" b 5 JiS* per ml. also had no significant effect 
%
on complete neuromuscular block induced by orphendlu,iIa^i although in
this dose it antagonised a partial block induced by oiehenadruna.
There was an additive effect between the block induced by 
and that caused by u^ehenadrine (Pig. 74). It would appear from the
two preparations on which this was tested that there was no antagonism
between the blocks induced respectively by suxamethonium and olphan- 
adline on the rat’s phrenic nerve-diaphragm preparation. In fact,
o:uehenadline had a potentiating effect on the neuromuscular block
caused by suxamethonium. Thus in one preparation suxamethonium 5 jtg.
per ml. produced approximately a 40 per cent block. Olehenadlina
12.5 jig. had no neuromuscular blocking effect but this dose of olehen- 
ad.r’ina acting simultaneously with suxamethonium at the previous dose
level produced approximately 93 per cent neuromuscular block (Fig.76).
5. Effects of Olehanadli■ne on Spinal Reflexes
(a) Knee jerks. 5 cats were used for this study. Olehenadluna 
1.0 mg. per kg. had no effect on the knee jerk. On the other hand,
3.0 mg. per kg. had no effect on the reflex in 2 cats, caused depres­
sion /
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Fig, 74. Isolated rat phrenic narva-dUaehlagm
ereealabuun. Indirect stimulation
via the phrenic nerve. At D direct
stimulation of the muscle.
At A, o^^mad^^ 25 jug. per ml.
At B, tubocurarine 2 jag. per ml.
Fig. 75. Isolated rat phrenic nerve-diaphragm
preparation. Indirect sbUmolabuon
via the phrenic nerve.
At A, "UK. 738“ 5>g. per ml.
At B, UK. 738“ 10jJg. per ml.
At C, ulphrnadli.ne 1Ojig. per ml.
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Fig. 76. Isolated rat phrenio nerve-diaphragm
preparation. Indirect stimulation
via the phrenic nerve.
At A, suxamethonium 5Jig. per ml.
At B, orphenadrine 12.5 Jig* per ml.
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depression in one cat and an increase in the size of the reflex 
response in 2 cats. With regard to 5 mg. per kg. there was no effect 
in 2 cats, depression in 2 cats and in one of them there was complete 
depression of the reflex after 15 minutes (Pig. 77). In this cat the 
depression was preceded by a short-lived increase in the size of the 
reflex response.
(b) Crossed Extensor Reflex
Another 6 cats were used in this study. At a dose level of 3*0
mg. per kg., oiphenadrine produced no effect in 2 oats, increased the
size of the reflex response in another 2 cats and in the remaining 2
cats the size of the reflex response was depressed. In the dose
level of 5.0 mg. per kg., orphenadrine produced depression of the
reflex in 3 out of the 6 cats, no effect in 2 cats and increase in the
reflex response in one cat. It ■ must be mentioned that in one of the
cats which showed depression of the reflex, depression was preceded by
an increase in the size of the response. One feature of the effect of
orphenadrine in spinal cats is the production of muscle spasms which
usually starts within one minute of the injection although in one of
the 4 cats which showed this phenomenon, it was delayed for 20 minutes
after injection of orphenadrine. The spasms are usually short-lived^,
lasting only about one minute, but lasted for up to twenty minutes in
one instance. When the spasms occurred immediately after the injection
of ocphenadrcne, they were associated with an immediate increase in the
size /
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Fig. 77. Spinal Cat: Effect of orphenadrine 
on the knee jerk.
Lower record - Knee jerks elicited
for 2 minutes evezy 5 minutes.
Upper record - Blood pressure.
At A, orphenadrine 3 mg. per kg.
At B, orphenadrine,5 mg. per kg.
At C, normal saline 8 ml.
1 '-j 1 1 patellar stimulated.
Fig. 78. Spinal Cat: Effect of orphenadrine 
on the crossed extensor reflex.
At A, orphenadrine 3 mg. per kg.
At B, orphenadrine 5 mg. per kg.
327.
Fig. 79. Spinal Cat: Effect of orphenadrine 
on the crossed extensor reflex.
At A, orphenadrine 3 mg, per kg.
At B, orphenadrine 5 mg. per kg.
Fig. 80. Spinal Cat: Effect of orphenadrine on 
the crossed extensor reflex.
At A, oio^r^ejnetcad-nej 1 mg. per kg.
At B, oro>rehacad.n€3 3 mg. per kg.
At C, OIoren3dId.nr 1 mg. per kg.
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size of the reflex response (Fig. 78). Five mg. per kg. was more
potent than 3*0 mg. per kg. in producing muscular spasm. In some
cats, orphenadrine may therefore have an initial excitatory phase in
its action which is characterised by muscle spasm and an increase in
the size of the spinal reflex responses. This excitatory phase is
short-lived and may be followed by a phase of depression in which the
size of the reflex response is diminished and may in fact be completely
abolished.
6. Blood Pressure of the Anaesthetised Cat
Orphenadrine at dose levels of 3*0 mg, and 5*0 mg. per kg. pro­
duced a sharp fall in the blood pressure which usually returned to its
original level (and in some cases reached a higher level) within one
or two minutes (Figs. 81 and 82). The fall in blood pressure was
proportional to the dose given.
The pressor effects of adrenaline and noradrenaline were not
affected by pretreatment with orphenadrine but the time taken for the
blood pressure to return to its original level after it had been raised
by adrenaline or noradrenaline was veiy significantly shortened by
injecting orphenadrine 3*0 mg. per kg. at the height of the pressor
effect (Fig. 81).
7. Blood Pressure of the Spinal Cat
Orphenadrine at dose levels of 3*0 mg. or 5*0 mg. per kg. produced
a /
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Fig. 81. Cat: Pentobarbitone anaesthesia.
Effect of orphenadrine on the blood
pressure. Blood pressure record
from the common carotid arteiy.
Drugs administered intravenously.
At A, orphenadrine 3 mg. per kg.
At B, adrenaline 8 jug.
At C, noradrenaline 8jig.
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Fig. 82. Cat; Pentobarbitone anaesthesia.
Effect of orphenadrine on the blood
pressure. Blood pressure record
from the common carotid arteiy.
Drugs administered intravenously.
At C, oipjhenacbihie 3 per kg. 
At A, adrenaLine 4 Jig-
At B, noradrenaline 
At D, oipriiemuLrinie 5 mg. per kg.
Fig. 83. Spinal Cat.
Effect of orphenadrine on the blood
pressure. Blood pressure recordfrom the common carotid artery.
Drugs administered intravenously.
At A, orphienadrine , 1 mg. per kg. 
At B, normal saline 3 ml.
At C, OJp^henab^ine, 3 mg» per kg. 
At D, orphenadrine, 5 nm. per kg.
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a sharp fall in the blood pressure level, which returned to its ■ 
original value (and in some cases reached a higher level) within one
or two minutes# The fall in blood pressure was proportional to the
dose given (Fig# 83).
8. Nictitating Membrane of the Anaesthetised Cat
Orehenadrine in doses of 3*0 mg. said 5*0 mg# per kg. showed no 
direct effects upon the nictitating membrane of the anaesthetised cat.
It also caused no significant depression in the magnitude of contrac­
tions follovdng tetanrsatron of the cervical sympathetic. Ethopropa- 
zine 5.0 mg. per kg. ((n 2 out.of 3 cats) had a somewhat greater 
depressant effect on the contractions due to tetanrsatron of the cer­
vical sympathetic. This depressant effect on the cervical sympa­
thetic was very much less than that due to n3xametnunium 1.5 to 
2.0 mg. per kg. (Fig. 824), a^ittmuub the fall in blood pressure was
much more marked with 5.0 mg. per kg. of ethoprueazine#
9. Isolated Perfused Rat Hindquarters
Orphenadrine from 50 to 250 usually caused vasoconstriction,
but in several experiments 50 jig. had no effect on the vasomotor tone.
The degree of vasoconstriction was proportional to the dose of orphen- 
adrine given (Fig. 85). There was an additive effect between the
vasoconstrictor action of adrenaline and noradrenaline and that of
oipn3nadrrne (Figs. 85, 86 and 87). Pretreatment with tolazoline did
not /
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Fig. 84. Cat. Pentobarbitone anaesthesia.
Contractions of nictitating membrane
elicited at intervals of three
minutes by preganglionic stimulation
at a frequency of 1,200 impulses per
minute, 20 volts amplitude and pulse
width of 1.5m.sec. for 5 seconds.
The uppermost tracing is a record of
the blood pressure from a common
carotid artery.
At A, orppenaadine, 3 mg. per kg.
At B, orphenadrine, 5 mg. per kg.
At C, enherrirpzina 3 mg. per kg.
At D, enherrprpzine 5 mg. per kg.
At E, henamethenanul 2 mg. per kg.
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Fig. 85. Perfusion of isolated rat 
hindquarters; depressions 
indicate vasoconstriction.
At A, noradrenaline 2 pxg.
At B, noradrenaline 3 jig. 
At C, orpnenacbeLne jO .g. 
At D, ororenadrine, 125 jg. 
At E, ororenadrine, 250 jig.
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A A B C C ♦ t ♦ ♦- C A CA D C
Fig. 86. Perfusion of isolated rat
hindquarters. Depressions
indicate vasoconstriction.
At A, noradrenaline 2 gig. 
At B, oiphienadrirne 50 pg. 
At C, oip>henadrine *12 j gig. 
At D, toiazolirne 5 mg.
Fig. 87. Perfusion of isolated rat
hindquarters. Depressions
indicate vasoconstriction.
At A, adrenaline 5 pg.
At B, orphenadrine 125 jg,
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not prevent the vasoconstrictor action of opphnnadpnnn (Fig# 86).
10. The Effect of Oppheaadpnnn on the
Convulsant Activity of Leptazol
Oppeeaadpnnn at dose levels of 1 mg., 3 mg., and ’ 15 mg. per kg. had
no effect on the coavulsaat activity of leptazol (Table 25). However,
at a dose level of 15 mg. per kg. there was a significant reduction in
mortality due to leptazol. Thus the mortality due to 40 mg. per kg.
of leptazol was reduced from 50 per cent to 0 per cent and the mor­
tality due to 60 mg. per kg. of leptazol was reduced from 60 per cent
to 20 per cent (Table 26). In contrast, 1 mg. and 3 mg. per kg. of
oipennadpnan had no effect on the mortality due to leptazol.
11. The effect of Opphenadpnae
on Electroshook Seizures
Opphnnadpiae at a dose level of 3 mg. and 6 mg. per kg. had no
effect on the incidence of electroshock seizures. At a dose level of
12 mg. per kg. there was some reduction in the incidence of electro­
shock seizures. A hi$ily significant reduction was noted with 15 mg.
per kg. (Table 2?). Thus 6 out of 20 mice showed positive reactions
to electroshock before treatment with rpphenadpnae 1.5 mg. per kg.
while no mice showed a positive reaction after this treatment.
 
    
 
 
    
 
Dose of
Oiphenadrine
Percentage of Animals Convulsing
Leptazol
20 mg/Kg.
Leptazol
30 mg/Kg.
Leptazol
40 mg/Kg.
Leptazol
60 mg/Kg.
- 20% 70% 90% 100%
1 mg./Kg. - 70% 100% 100%
3 mg./Kg. 20% 80% 90% 100%
15 mg./Kg. - 70% 80% 100%
TABLE 25* Effeot of pretreatment with
orphenadrine on the convul­
sant aotivity of Leptazol,
Dose of
Orphenadrine
Percentage of Mortality
Leptazol
20 mg/Kg.
Leptazol
30 mg/Kg.
Leptazol
40 mg/Kg.
Leptazol
60 mg/Kg.
- 0% 0% 50% 60%
1 mg./Kg. 0% 0% 50% .1 70%
3 mg./Kg. 0% 0% 40% 60%
15 mg./Kg. 0% 0% 0% 20%
TABLE 26. Effeot of pretreatment with
orphenadrine on the mortality
due to Leptazol,
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Dose of
Opphnaadpnne
No. of positive
(out of 20 mice)
Before
Opphnaadpnne
After
Opphnaadpnan
3 mg./Kg. 5 3
6 mg./Kg. 7 7
12 mg./Kg. 3 3
13 mg./Kg. 6 0
TABLE 27. Effect of p^tma^e^ with
rpphenadpnne on electro­
convulsive seizures.
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DISCUSSION
The experiments on the isolated frog rectus muscle and on the rat 
phrenic nerve-diaphragm preparation demonstrated the neuromuscular 
blocking activity of orphenadrine. There is an additive effect 
between the neuromuscular blocking activity of orphenadrine and that 
of tubocurarine and it may reasonably be concluded that in these two 
preparations the block produced by orphenadrine is allied to the com­
petitive type. In these two preparations tubocurarine is about 8 to 
15 times moie potent than orphenadrine.
It would appear that in the cat the neuromuscular blocking potency 
of orphenadrine is not as great as in the frog or the rat. Thus 
150 jig* per kg. of tubocurarine will produce 20 to 50 per cent block in 
the oat and yet orphenadrine in a dose of 6 mg. per kg. did not pro­
duce any visible neuromuscular block. , However, the profound anta­
gonism to suxamethonium-induced neuromuscular block and the potentiation 
of tubocurarine -induced block on the cat's gastrocnemius muscle- 
sciatic nerve preparation demonstrate the fact that although no reduc­
tion in twitch tension accompanies an intravenous dose of 5 mg. to 6 mg. 
of orphenadrine, profound changes take place at the neuromuscluar syn­
apse which affect the pharmacological activity of the drugs at this site 
It is likely that orphenadrine, like tubocurarine, produces its neuro­
muscular blocking activity by competing with acetylcholine and other 
depolarising agents for the end plate receptors to which these compounds 
become / .
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
339.
become attached or with which they react.
In the hen the action of onpeeaadpnnn at the neuromuscular
junction is difficult to assess. Oppeenadpine can produce a mild
degree of neuromuscular block at a dose level of 3*0 mg. per kg. and it
potentiate the block induced by tubocurarine. Its action on the effects
of suxamethonium is complicated. Thus opphenadpian is capable of
reducing the degree of contracture induced by suxamethonium but in a
majority of oases it prolongs the neuromuscular blocking activity of
this drug.
Suxamethonium and decamethonium (C.jo) 8^ generally accepted as
typical depolarising drugs, but it is now known that this is only true
for certain animal species. Zaimis (1952 and 1953) showed that in
monkeys, dogs, rabbits and the hare, decamethonium behaves like a com­
petitive neuromuscular blocking agent. Hall and Parkes (1953) showed
that the neuromuscular block induced by decame^oni^ and suxamethonium
in guinea pigs was of the competitive variety. Churchill--avicdon and
Richardson (1952 and 1953) demonstrated that in patients suffering from
myasthenia gravis, decamethonium behaved as a competitive neuromuscular
blocking agent. In birds, suxamethonium when injected intravenously
produced contracture and a decrease in the amplitude of the height of
the muscle contractions. Crema, Scrgnamiglnr and Bovet (1959) showed
that these two phenomena of contracture and neuromuscular block were
relatively independent of each other*. They found that tubocurarine
antagonised decamethonium with regard to the contracture, whilst their
blocking /
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blocking activities were additive. They suggested that in birds the 
contracture was due to depolarisation but the neuromuscular block was 
of the competitive variety.
As already stated., the results of the experiments reported in this 
chapter show that orphenadrine can prolong the neuromuscular block 
induced by suxamethonium, an action not unlike that reported for tubo­
curarine by Crema and his colleagues. Further, after pretreatment 
with orphenadrine, the block induced by suxamethonium is antagonised by 
neostigmine ■ - indicating that the block is now of the competitive type. 
It is reasonable, therefore, to conclude that in the hen orphenadrine 
also behaves like a competitive neuromuscular blocking agent. Orphen­
adrine probably changes the nature of the membrane at the neuromuscular 
synapse and thus changes the nature of the block caused by a typical 
depolarising drug to a competitive type. This is analagous to the 
state in man where, as Zaimis (1953) suggested, a change occurs at the 
muscle membrane of the neuromuscular junction in patients suffering 
from myasthenia gravis causing a transformation of the pure depolar­
isation caused by decamethonium into a true competitive block.
In rats, complete agreement has not been reached on the mode of 
action of suxamethonium and decamethonium on the neuromuscular synapse 
but Jarcho and his colleagues (1930 and 1951 ) have shown that in the 
innervated muscle of the rat, a partial neuromuscular block induced by 
tubocurarine could be completed by decamethonium. They also found 
that both tubocurarine and decamethonium caused a reduction in end­
. plate /
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plate potential in the innervated muscle of the rat. The results in 
the rat are in contrast to those obtained in the cat. In this species 
decamethonium produces a depolarising block and tubocurarine, a com­
petitive block; each drug antagonising the neuromuscular blocking
activity of the other (Paton, 1951). It would appear therefore that
in rats decamethonium and suxamethonium behave at least in part, as
competitive neuromuscular blocking agents. This explains the findings
in the present study that in the rat phrenic nerve diaphragm preparation
orphenadrine - and tubocurarine potentiated the neuromuscular blocking
activity of suxamethonium.
In the rat phrenic nerve diaphragm preparation, it was found that
the neuromuscular blocking activity of orphenadrine lasted longer than
that caused by tubocurarine in equipotent doses. A similar effect was
also seen in the isolated frog rectus preparation. In the rat phrenic
nerve diaphragm preparation, it was also found that subsequent add­
itions of orphenadrine, after tie muscle had apparently recovered from
the effect of the previous dose, tended to increase the degree of
neuromuscular block. Thus in one preparation orphenadrine 25 jig. per
ml. produced no neuromuscular block on the first addition, but on the
third addition produced complete neuromuscular block (Fig. 73, p. 321 ).
It is reasonable to conclude that although the neuromuscular
blocking activity of tubocurarine may be more than ten times that of
orphenadrine, the effect of the latter on the neuromuscular synapse
lasts much longer. In the cat gastrocnemius sciatic nerve prepar­
ation /
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preparation the effect of orphenadrine on the neuromuscular synapse (as
judged by its antagonism to the neuromuscular block induced by suxa­
methonium lasts for about one hour.
The effects of orphenadrine on the convulsant activity and mor­
tality due to leptazol, and on electroshock seizures are of great
interest. As already stated, orphenadrine even in rather hig£i - doses
(15 mg. per kg.) had no effect on the convulsant activity of leptazol.
This is in contrast to the results of Cronheim (1938) who found that
orphenadrine lowered the threshold of leptazol-induced convulsions.
It must be mentioned, however, that it was observed that the mouse
became more agitated in the first minute or two after injecting 15 mg.
per kg. of orphenadrine intravenously. Two out of 52 mice given this
dose of orphenadrine died from convulsions within the first two minutes
of the injection. It appears therefore, that orphenadrine at this
dose level may have an initial excitatory phase soon followed by a
depressant action. Thus it is conceivable that if leptazol was
injected within two minutes of injecting orphenadrine, there mi^it have
been an increase in the convulsant activity of leptazol, in other 'words
a lowering of the threshold of the convulsant action of leptazol.
Cronheim, however, did not state the time relationship between the
administration of both drugs.
Of greater interest is the fact that orphenadrine at a dose level
of 15 mg. per kg. significantly reduced the susceptibility of mice to
electroshock seizures and also significantly decreased the mortality
from /
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from leptazol. It was noted that the mice which died from leptazol 
were from among those that showed full extension of the hind limbs 
during the later phase of the leptazol-induced convulsions. It was 
noted also that although orphenadrine at a dose of 15 mg. per kg. did 
not affect the clonic phase of leptazole-induced convulsions, it 
reduced the tonic phase, i.e., the full extension of the hind limbs.
It is difficult to explain this action of rpphenadpnae at this dose
level but Goodman, Grewal, Brown and Swinyard (1953) in a study of the
modification of maximal seizures induced by leptazol and electroshock
in mice by anticonvulsants, made the point that the initial clonus of
leptazol-induced seizures is probably due to the early selective
stimulation of the motor cortex, before the intravenously-injected
leptazol had reached a concentration capable of causing the localised
areas of hi^ frequency repetitive discharges and the appropriate
seizure spread there-from^^^ is responsible for the production of
the tonic seizure (extension of the hind lnmeo). It is therefore
probable that opphenadpnne at this dose level (15 mg. per kg.) inhibits
seizure spread in the cerebrospinal axis. The site of this naeibntnon
has not been determined in this study but it must not be forgotten that
a peripheral skeletal muscle relaxant effect which oiphenadpiae has been
shown to possess may contribute to this anticonvulsant property. The
fact that opphenadpnnn did not reduce the incidence of clonic con­
vulsions can, however, be interpreted according to the hypothesis of
Goodman and his colleagues (1933) to mean that the inenbitopy effect
is /
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is not at the level of cerebral cortex; in other words the inhibi tion
of seizure spread must be at a level below the cerebral cortex.
The relationship between chemical structure and pharmacological
activity is very complex and only generalisations (which will neces­
sarily have a number of exceptions) can be made. The neuromuscular
blocking activity of tubocurarine, decamethonium and suxamethonium
is almost certainly due to the possession of quartenary nitrogen
atoms which have certain physio-chemical characteristics in relation
to the size of the groups they cany (Barlow and Ing, 1948). Taylor
(1951), in a review, made the point that most curariform agents con­
tain nitrogen atoms and these occur as full quartenaries. Compounds
containing tertiary nitrogen atoms, however, can be active as neuro­
muscular blocking agents. If one studies the chemical formulae of
orphenadrine or ethopropazine, it will be seen that a tertiary nitro­
gen atom is present in the side chain. It is possible, therefore,
that the neuromuscular blocking activity is due to this tertiary
nitrogen atom. It may be that the neuromuscular blocking activity of
orphenadrine or ethopropazine can be increased by converting the
nitrogen atom into a fully ionised quartenaiy. It must be mentioned,
however, that in view of the fact that orphenadrine and ethopropazine
are not straight chain compounds, but contain benzene rings, the effect
of quarterni-sing the nitrogen in ' the side chain cannot be easily fore­
cast (Muir, 1961 ; personal communication). UK. 738 and benzhexol do
not contain this tertiary nitrogen atom amd do not have any significant
neuromuscular /
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neuromuscular blocking activity. The activity of atropine and 
hyoscine resides in the tropic acid moiety wdioJh does not contain any 
nitrogen atom. The bases - tropine and scopine - although containing 
nitrogen atoms, are relatively inactive pharmacologically (Goodman and 
Gilman, 195.8). Atropine and hyoscine do not therefore have any neuro­
muscular blocking activity unless given in very hi^ doses. On the 
other hand oxyphenonium and methantheline which have a quarteimazy 
nitrogen possess neuromuscular blocking activity vhen given in moderate 
doses (Goodman and Gilman, 1958).
One interesting point emerges from this study - the possible
clinical use of orphenadrine to counteract the side-effects of suxa­
methonium. Suxamethonium is now frequently used as a muscle relaxant
in surgical practice and to prevent fractures during electroconvulsive
treatment (Thesleff, 1952; Holt, McCandless, Yacoubain and Mebed,
1953; Murray, 1953). One of the chief disadvantages of suxamethonium
is the incidence of severe muscular pain occurring from about 8 to 24
hours ' after its administration and lasting for up to six days
(Churohill-Davidson, 1954; leatherdale, Mayhew and Williams, 1959;
Pearcy and Pick, 1960; Poster, 1960). The- incidence varies from 6 •
to 66 per cent in different published series. Up till the present,
no adequate treatment has been found for this vezy incapacitating side-
effect. It has been suggested by Morris and Dunn (1957) that 5 mg. - of
tubocurarine or 40 mg. of gallamine should be given prior to the
administration of succinyloholine in order to reduce the incidence of
pain, /
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pain. This has not been received with much enthusiasm as both drugs
have significant neuromuscular blocking actions of their own* In
view of the marked antagonistic effect of orphenadrine on suxamethonium
-induced block clinical trial of orphenadrine in these patients might
be worth while. It is suggested that 100 to 150 mg. by mouth three
or four times daily would be a suitable dose and clearly should be
started as soon as possible after the operation or electroconvulsive
therapy. Presumably premedication with orphenadrine would be inadvis­
able as this is likely to increase the requirement of suxamethonium.
Purthermore, it has been shown that the intensity of muscular twitching
and fasciculation occurring with suxamethonium before the onset of
paralysis has no significant effect on the incidence of post-
suxamethonium muscular pain (Leatherdale, Mayhew and Williams, 1959).
Hitherto no satisfactory antidote to the neuromuscular block
caused by suxamethonium has been found. In some cases the prolonged
or complete neuromuscular block has been found to be due to the "dual"
blockade of suxamethonium in which case the block is of the competitive
type. Such neuromuscular block therefore responds to treatment with
neostigmine with or without atropine (Bullough, 1957).
In other oases, the complete prolonged neuromuscular block
associated . with prolonged apnoea is due either to inadvertent over­
dosage or to a low serum or tissue cholinesterase (Browne, Collier and
Somers, 1952; Evans,.Gray, Lehman, and Silk, 1952; Stoddart, I960).
In these cases neostigmine is of no value and may even prolong the
neuromuscular /
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neuromuscular block* The results of the experiments in this study
indicate that rpphnnadpinn may be an effective antidote in such cases
and a clinical trial is considered to be worthwhile. At present
opphnnadiiae is not available in a preparation suitable for parenteral*
administration to human subjects. In experimental animals no dele­
terious effects on the veins were noted when aqueous solutions con­
taining 10 mg. to 20 mg. of oiphenadpnae per ml. were given intra­
venously. It is estimated that about 50 to 200 mg. of oppheaadpnae
given intravenously will be adequate in reversing complete neuromuscular
block in a normal adult male. Although rpphenadpine causes a fall in ' 
blood pressure when admnanstepnd intravenously, this is short-lived
and can be substantially prevented by giving adrenaline or adrenaline­
like drugs immediately prior to opphenadpnne.
Most of the above discussion has been on the incidental findings
which may be of use therapeutically. Attention will now be directed
to the question of the mode of action of drugs which have been found
to be effective in the relief of the rigidity and tremor of Papknaooa- 
ism. Most of this discussion will be on the mode of action of
oppeeaadpnnn and on how rigidity is relieved, as much more is known
about the control of muscle tone than about the physiology of tremor.
Furthermore, the experimental work described in this section was
undertaken with the aim of explaining how opphnnadpiae relieves
rigidity, muscle weakness and easy fatiguability in patients suffering
from poot-enrephalitio Parkinsonism.
In /
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In Chapter I (General Introduction) an account was given of how
skeletal muscle tone is controlled. The most important conclusions
to be drawn from that discussion are:
(1) That the cells of the reticular formation of the brain stem
act as supraspinal intenurncial neurones to vhioh the basal ganglia,
diencephalon, cerebellum and cerebral cortex are connected. In
Parkinsonism the facilitatoiy system of the reticular formation is
overactive and this is associated with a great increase in the gamma
efferent discharge to the mussle spinddes. A drug which depresses
the acacviti of the s slls of She reeiiular formation will therefore 
abolish the excess gamma efferent discharge and hence eyiertfnnonty
of the skeletal muscles.
(2) The reticular formation influences the spinal cord through
spinal intenumial cells. Spinal reflex activity is mediated
throouh the nnteJunmcial neurones. A drag which depresses the
spinal nnteauieurones will also reduce rigidity.
(3) That hypertonia cua f b fbolinhed by a break in the reflex 
arc ff hhs sevff mcehanPuf rpifopnbblh oof the hypertonia. Thus 
rigidity can be relieved or abolished by depression of the afferent
discharge from the muscle spindles or by depressing the gamma efferent
discharge by blockade at the motor end plates of the intrafusal fibres
of the muscle spindle. Rigidity can also be abolished by neuro­
muscular block at the motor end plate in the ex^a^sel fibres. Prom
this brief resume it can be readily appreciated that a drug does not
necessarily need to have an action on the ohinculao formation or the
basal /
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basal ganglia and diencephalon in order to be effective in the treat­
ment of Parkinsonism. Figure 88 indicates the possible sites of 
action of drugs used for the relief of rigidity in Parkinsonism.
An attempt will now be made to explain the mode of action of 
orphenadrine in Parkinsonism. Orphenadrine has been shown in this • 
study to have a curare-like action on the motor end plate (of extra- 
fUsal fibres) although in cats and therefore probably also in man 
(Paton, 1951) the neuromuscular block is so weak that in conventional 
doses there will be no reduction in the power of the muscles; in fact 
some increase in muscle power may result from such weak neuromuscular 
blocking activity. This is not infrequently observed in cats with 
the first dose of tubocurarine of about 50 to 100 jig. per kg. which, 
instead of producing a reduction in the twitch tension, increases it. 
This increase in the twitch tension is said to be due to muscular
relaxation from weak neuromuscular block. It is therefore reasonable
to postulate that one of the ways whereby rigidity is relieved by 
orphenadrine is by a peripheral tubocurarine-like action at the neuro­
muscular synapse.
In Parkinsonism and decerebrate rigidity, there is an increase in
the gamma efferent discharge to the muscle spindles (Hunt, 1951). It
has now been shown that suxamethonium in subparalytio doses increases
the afferent discharge from the muscle spindles in the cat (Granit,
Skoglund. and Thesleff, 1953 a and b). They suggested that this
acceleration of spindle afferent discharge is due to a direct action
on /
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. 88. Diagram showing some of the fibre 
connections between various struc­
tures involved in the pathogenesis 
of hypertonus in Parkinsonism.
The diagram also indicates the 
possible sites of action of drugs 
used, for the relief of rigidity in 
Parkinsonism. The more important 
sites of action are probably - ■ 
k9 B, E, P and. G.
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on the sensoiy endings of the muscle spindle. Smith and Eldred (1961) 
have, however, shown that this acceleration in the spindle afferent 
discharge is due to active contraction of the intrafusal fibres of the 
spindle probably as a result of depolarisation at the end-plate region 
of the intrafusal fibres. In view of the fact that orphenadrine 
antagonises the effect of suxamethonium on the motor end plate of the 
gastrocnemius muscle of the cat, it may well have a depressant effect 
on the spindle discharge produced by suxamethonium. Further work on
this aspect is indicated.
From the above discussion, one can justifiably postulate that 
orphenadrine can produce skeletal muscular relaxation from purely 
peripheral mechanisms namely by -
(1) A curare-like action on the synaptic membrane at the neuro­
muscular junction.
(2) A possible depressant effect on afferent spindle discharge 
probably from a depressant action on the motor end plate of the 
intrafusal fibres of the muscle spindle.
(3) A local anaesthetic effect which has been demonstrated by
Bijlsma et al. (1936) may also contribute, although only in a 
minor way. The effect of a local anaesthetic action of a 
drug on rigidity has been discussed - Chapter I (page 21).
The effect of orphenadrine on monosynaptic and polysynaptic 
spinal reflexes is of some interest. Orphenadrine does not have a 
specific and constant effect on the spinal reflexes. This means 
that /
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that orphenadrine does not rely on a depressant effect on the spinal 
cord for its skeletal muscle relaxant properties. However the 
skeletal muscle relaxant action from the peripheral mechanism already 
described will be enhanced by a depressant action on the spinal oord. 
On the other hand a stimulant effect on the spinal reflexes may 
antagonise the peripheral muscle relaxant property. In this con­
text reference should be made to the muscle spasms seen in some of 
the spinal cats after the administration of orphenadrine. It may 
be that the myoclonic jerks idich were noted as a side-effect of 
oiphenadrine in human subjects are of spinal origin.
The effect of orphenadrine on the reticular formation or the 
diencephalon has not been investigated in this study. Bijlsma et 
al. (1956) and De Maar (1936) found that 0.3 to 2.0 mg. per kg. of 
orphenadrine given intravenously in spinal cats caused no constant 
changes in the ipsilateral flexor reflex of the cat while in a 
thalamic cat 0.3 mg. per kg. of orphenadrine injected into the verte­
bral artery caused a depression of the flexor reflexes. An increase 
in the reflex was, however, obtained by injecting orphenadrine (l mg. 
per kg.) into thalamic cats! They concluded, rather erroneously, 
that the site of action of orphenadrine in relieving muscular 
rigidity was on the thalamus. That orphenadrine may have some 
action on the diencephalon or the reticular formation has not been 
excluded but as already emphasised, its muscle relaxant property can 
be /
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be explained almost entirely by its action at the neuromuscular
junction and probably also at the motor end plate region of the
intrafusal fibres of the muscle spindles. The relief of chronic
muscle spasm from various causes such as myositis, fibrositis,
sciatica) by orphenadrine given orally (Finch, 1939) is almost 
certainly due to this peripheral muscle relaxant property. It seems
unlikely that depression of spinal reflexes with consequent relief of
skeletal muscular rigidity can be achieved by conventional oral dosage
in man and in any case the action of orppenadrine on spinal reflexes
is not constant;.
Orphenadrine causes a mild to moderate degree of euphoria when 
given to patients. It is not clear how orphenadrine produces this 
action. It is possible that the euphoria is due to the effect of 
orphenadrine on the brain monoamine oxidases or on the metabolism of 
3 hydroxytiyptamine (3HT) in the brain. It may be of some signifi­
cance that drugs which alter the levels of the free and bound 5HT in 
the brain, e.g. reserpine can produce both mental depression and 
Parkinsonism (Muller and his collaborator’s, 193^; Shuman, 1933;
Munch-Peterson, 1936). Further study is required on the effects of 
orphenadrine and other anti-Parkinsonian drugs on brain 3HT and
other amines.
The effect of orphenadrine on the fatigue induced by repeated 
indirect tetanisation of the hen's gastrocnemius muscle is of 
interest. /
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interest. In an earlier section of this thesis attention has been 
drawn to the phenomenon of easy fatiguability of skeletal muscles in 
Parkinsonism. It has been shown that although hyoscine administored 
suboutaneously is probably the most effective drug for the relief of 
tremor and rigidity, the muscles tend to be more easily fatigued.
This indicates that easy fatiguability is not altogether due to 
rigidity. Patients treated by the author with orphenadrine have 
often stated that they are less easily fatigued. This fact has 
recently been stressed by Dutch investigators (Bailly-Salin et al., 
1961), One of their patients interpreted the meaning of Disipal (the 
trade name for orphenadrine) as "dissipation of fatigue". It is not 
known how orphenadrine produces this effect on fatigue either in human 
subjects or in experimental animals. Bijlsma et al (1956) showed 
that in frogs, orphenadrine caused vasodilatation. This would have 
offered an easy explanation but for the findings of the present writer 
that in the perfused rat's hindquarters, orphenadrine caused vaso­
constriction. However, the action of orphenadrine on the blood 
vessels of skeletal muscles in intact animals has not been determined. 
Further studies are required to assess the role of increased muscle 
blood flow in the relief of fatigue.
It is possible that orphenadrine may have an effect on carbo­
hydrate metabolism especially that of lactic acid metabolism. It 
is well known that its accumulation in the muscle leads to fatigue.
It may be that orphenadrine relieves fatigue by enhancing the activity 
of /
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of lactic acid dehydrogenases with the result that more lactic acid 
is oxidased and the fatigue relieved. It may however increase the
synthesis of adinosine triphosphate (A.T.P, ). Further studies on
these aspects are indicated. The skeletal muscle relaxant property 
of orphenadrine may also play a part in the relief of fatigue. In 
the human subject there is little doubt that the euphoria produced by 
orphenadrine may favourably influence muscle fatigue. Under the 
influence of orphenadrine some Parkinsonian patients become less 
aware of their disabilities and may attempt physical effort of which 
they are quite incapable. Schwab and Prichard (1931), writing on 
the neurological aspects of fatigue, made the important point that 
fatigue does not necessarily mean that the muscle is incapable of 
further immediate response; more often it signifies an increasing 
conscious desire to stop the action. On the other hand a strong 
desire to complete the action will result in a prolongation of the 
period before voluntary fatigue sets in. Thus the euphoria produced 
by orphenadrine may increase the patient's "will power", and so delay 
the onset of fatigue. Perhaps the drowsy and dazed state produced 
by hyoscine decreases "will power*" and thus tends to produce a state 
of easy fatiguability.
It has been shown that drugs which relieve Parkinsonian rigidity 
do not necessarily have the same mechanism of action, Orphenadrine 
has been shown to have neuromuscular blocking activity while benz­
hexol and UK. 738 (in the limited number of experiments performed) 
have /
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have little or no effect on the neuromuscular junction. Benzhexol 
probably produces its effects primarily by a central action. The 
recent case report by Siigh (1961) is of interest. A 47 year old 
woman suffering from post-encephalitic Parkinsonism had had no 
relief from benzhexol hydrochloride (10 mg. daily) and in a fit of 
depression swallowed 75 mg. of the drug. On admission to hospital 
she was confused and agitated but the Parkinsonian rigidity and tremor 
had completely disappeared. She was found however to have signs of 
cerebellar dysfunction, namely slurred speech, coarse horizontal 
nystagmus, and intention tremor. About 24 hours later these signs
had disappeared but the Parkinsonian rigidity and tremor had returned. 
In Chapter I (General Introduction) it was noted that the cerebellum 
was concerned with the maintenance of muscle tone probably by con­
trolling the gamma efferaet discharge to the skeletal muscles (Granit, 
Holmgren and Merton, 1955). Although Singh did not comment on the 
significance of the cerebellar dysfunction in his patient, these 
findings suggest that the relief of Parkinsonian rigidity by benz­
hexol may be due (at least in part) to ' a depressant action on the 
cerebellum thereby reducing the gamma efferent discharge. De Maar 
(quoted by Bijlsma, 1956) found that benzhexol depressed spinal 
reflexes in cats althouuh in a few experiments using benzhexol 
(0.23 mg. to 1.0 mg. per kg.), an effect on spinal reflexes could not 
be demonstrated by the present writer. If benzhexol depressed spinal 
reflexes this could also account for its effect on muscular rigidity.
"UK. 758" probably produces its effect by a central depressant 
action /
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action on the diencephalon and on the brain stem. It has little or 
no neuromuscular blocking activity. Thus 10 pg. per ml. of orphen­
adrine produced about JO per cent block in a rat phrenic nerve 
diaphragm preparation while the same dose of UK. 738 produced no 
neuromuscular blockade. The clinical dosage of orphenadrine and 
UK. 738 ure 100 mg. and 4 mg. respectively. Thus even in such 
relatively high concentration UK. 738 showed no neuromuscular blocking 
activity.
SCREENIUG- TESTS FOR DETECTING DRUGS ~HICH MYT
BE OF THERAPEUTIC VALUE IN PARKINSONISM.
(a) The use of inhibition of the flexor reflex 
in thalamic animals as a screening test.
Hyoscine has been shown to depress spinal polysynaptic reflexes 
in thalamic animals but not decerebrated or decapitated (spinal) 
animals (Teuchmann, 1949). This was rightly interpreted to mean that 
the site of action of hyoscine is at the level of the diencephalon.
It was thought that all drugs used in the treatment of Parkinsonism 
owe their therapeutic efficacy to a hyoscine-like action on the 
diencephalon. De Maar (1956) and Bijlsma (1956) concluded , that the 
depression of the flexor reflex in thalamic animals might be a useful 
screening test for anti-Parkinson drugs. “hen a drug has a signifi­
cant depressant action on spinal reflexes in spinal animals or when 
it has a significant neuromuscular blocking action in the dose range 
that /
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that blocks the spinal reflexes, this test, however, is of no value in 
deciding whether a drug has its action at the diencephalic level or 
lower down the cerebrospinal axis. Furthermore, as already stressed, 
the lack of a depressant effect on the diencephalon does not mean that 
the drug cannot be of use in the treatment of Parkinsonism as the 
rigidity can be relieved by other means.
(b) Depression of activation of the E.E.G. produced
by stimulation of the brain stem reticular
formation as a screening test.
Rinaldi and Himwich (1955) found that atropine prevented the 
appearance of E.E.G. activation (low voltage fast waves) when the brain 
stem was stimulated.. They regarded atropine as the best anti­
Parkinsonism drug and found that it had the maximal effect (4+) iu 
preventing this E.E.G. activation, followed by diphenydramine, benz- 
hexol and caramiphen (5+), then diethazine (2+) and mephenesin (1+), 
while rasarpiia and amphetamine did not cause any depression but 
rather increased the activating influence of brain stem stimulation. 
They suggested that the prevention of the alerting reaction in the 
E.E.G. may be used as a pharmacological screening test for drugs 
likely to be of use in Parkinsonism.
It is clear that while this may be a useful test, all drugs 
likely to be of use in the treatment of Parkinsonism cannot be selected 
by means of this test. Curare and Hephe^s^ do not cause any changes 
in the E.E.G. (Goodman and Gilman, 1958; Berger, 1949; Stephen and 
Chandy /
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Chandy, 1947) and yet these drugs reduce Parkinsonian rigidity. 
Furthermore, it is now established that there may be a lack of 
correlation between the effects of a drug on electrical activity and 
on behaviour (Bradley and Elkes, 1957; Elkes, 1958). Thus atropine 
causes a high voltage slow activity which in general terms is not 
unlike that seen in sleep; the animals however, are alert and awake 
and may show signs of excitement and over-activity. Physostigmine
causes the appearance of low voltage fast activity but the animals are 
quiet and may apparently be asleep. Amphetamine however gives rise 
to a low voltage fast activity and correspondingly the animals are 
alert, restless and excited. The influence of a drug on the cephalic
and caudal effects of . electrical stimulation of the brain stem are
therefore not always identical. With regard to Parkinsonism the more 
important aspect of brain stem stimulation to study is the caudal 
effect, i.e., the effect on the spinal cord and the skeletal muscles 
especially with regard to muscle tone and tremor. Study of the 
cephalic effects of brain stem stimulation is less important and in 
any case does not yeild information upon the events taking place in 
the skeletal muscles. . It can therefore be appreciated that the test 
proposed by Rinaldi and Himwich is not altogether satisfactory and 
cannot serve as a universal screening test. Depression of the 
effects of brain stem stimulation on skeletal muscle activity using 
an electronyogram will be of greater value as a screening test 
although it must be emphasised that some of the drugs showing a 
depressant /
  
560
depressant activity may prove to be of no clinical value. This test 
does not indicate where the precise site or sites of action of the 
drug are, as this may be anywhere between the reticular formation and 
the skeletal muscle.
(c) Inhibition of tremor induced by Tremorine
(1. 4-dipy^?oliciico-2-butyie) (Everett, Blockus
and Sheppard, 1956; Blockus and Everett, 1957)
as a screening test.
There are various objections to the use of this test as a 
screening test. In the first place the mode of action of Tremor'ine
is unknown although it has been shown by Ahmed and Taylor (1959) that 
the drug induces tremor which is veiy similar in its physical charac­
teristics to that of Parkinsonism; both are of the sinusoidal type. 
Secondly, Desci, Varszegi and Mehes ( 1961 ) have shown that tolerance 
to Tremor'ine is virtually complete after 5 to 6 administrations of 6 
to 18 mg. per kg. of the drug at two-day intervals! Sensitivity, 
however, returns on discontinuing its administration for two to three 
weeks. This development of tolerance is a serious obstacle as it may 
lead to wrong conclusions as to the potential usefulness of a drug in
Parkinsonism.
(d) Inhibition of tremor induced by Nicotine 
(Bovet and Bongo, 1951) as a screening test.
Here again we do not know how nicotine produces tremor in
experimental animals. More important still, not all drugs which have
been /
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been found to be of therapeutic value in Parkinsonism inhibit
nicotine-induced tremor. Thus atropine and even hyoscine which is
probably the most effective drug for the relief of tremor and rigidity
of Parkinsonism do not inhibit the tremor induced by nicotine.
CONCLUSION
From the above discussion, it is clear that none of the screening
tests so far devised is universally applicable, since drugs giving
negative results with one of the tests can still be effective in the
treatment of Parkinsonism. The most rational way to investigate the
mode of action of drugs of therapeutic value in Parkinsonism and of
new chemical substances is to study their effects at the key points
(indicated in Fig. 88) in the chain of events leading to the pro­
duction of rigidity or increased tonus. A definite depressant action
at any one of these points will indicate that the substance is of
potential value in the treatment of Parkinsonism. There is no doubt
that this method, using a physiological approach, is best and it is
by this means that the mode of action of drugs of therapeutic value
in Parkinsonism can be elucidated more precisely. The afferent
spindle discharge is the final regulator of skeletal muscle tone and
a plea is made that the effect of drugs on afferent spindle discharge
should be studied. Substances which depress afferent spindle dis­
charge either by preventing depolarisation at the end plate region of
the intrafusal fibres or by a direct depressant action on afferent
nerves /
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nerves from muscle spindles are likely to be of potential value.
Suxamethonium is a good research tool in this respect.
Because excessive salivation is frequently present in Parkinsonism
it is desirable that anti-Parkinsonism drugs should possess atropine­
like anti-muscarinic activity. • This anti-muscarinic activity should,
however, be much less than that of atropine otherwise patients will
complain of excessive diyness of the mouth, blurred vision from
mydriasis, and constipation. It is therefore essential to compare
the anti-sialogogue activity, the spasmolytic activity on guinea pig
ileum and the mydriatic action of the drug with those of atropine.
It must however not be assumed (as appears often to be the case) that
atropine-like activity on the guinea pig ileum (spasmolytic activity)
means that the drug will have a skeletal muscle relaxant property.
It is now well recognised that two or more drugs sometimes
produce a better therapeutic effect in Parkinsonism than a single
remedy (Schwab and Tillman, 1949; G-illiespy, i960). Controlled
studies on this aspect have not been carried out but clinical
experience in some of the patients investigated suggests that true
synergism exists between orphenadrine and benzhexol. Although the
anti-Parkinsonian drugs do not have a common chemical basis for
their action and the pharmacological actions may differ from one
another, the fact that there is a multiplicity of effective sites of
action explains the synergism of effect between many drugs used in
the treatment of Parkinsonism. It can readily be understood that
because /
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because of disturbing side-effects, or because of toxicity it is not 
often possible to exceed a particular dose level for any one drug. At 
this dose level the drug may only partially relieve the rigidity and 
tremor. In order to produce greater degree of relief, ad ministration 
of another drug or drugs will be required. If the toxicity is due to 
excessive action at a particular site then clearly drugs having the 
same mode of action at this site should not be used while drugs 
relieving the rigidity by their action at a different site will be 
indicated. It is therefore possible to increase the relief given to 
the patient without increase in toxicity by giving two drugs such as 
orphenadrine and benzhexol or UK. 738.
Atropine, hyoscine and the galenical preparations belladonna and
stramonium have a veiy much higher ■antr-muscarrnrc activity than the
newer synthetic drugs used in the treatment of Parkinsonism. These
synthetic drugs, benzhexol, orphenadrine, etc., while relieving
rigidity and tremor, may not materially affect the hyperca^^'a^on if
this is excessive. In such cases, instead of increasing the dose of
these synthetic drugs, with the risk of producing disturbing side-
effects, clinical experience has shown that administration of a small
dose of atropine or a galenical preparation can relieve the hyper­
salivation without producing toxic effects. The only difficulty is
the possibility of rather rapid emergence of tolerance with the result
that larger and larger doses have to be administered. Synergism may
exist between drugs which have primarily a thymoleptic action (even
though /
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though they have no skeletal muscle relaxant property) and the 
standard preparations of therapeutic value in the treatment of 
Parkinsonian tremor and rigidity. The feeling of well-being so 
produced is good for morale, especially in depressed patients and 
it tends to lessen fatigue which is a common complaint in Parkinsonism.
565.
SJMhAAY
Pharmacologieal studies with orphenadrine show that it has a 
definite neuromuscular blocking action in the frog and in the rat.
In the cat, however, the neuromuscular blocking action is veiy much 
less. It is suggested that one of the ways by which orphenadrine 
reduces Parkinsonian rigidity is through its peripheral skeletal 
muscular relaxant property. The euphoric action noted in human 
subjects and the peripheral skeletal muscular relaxant property 
contribute to the favourable effect of this drug on the muscle weak­
ness and easy fatiguability in patients suffering from Parkinsonism.
* H
Benzhexol and UK. 758 do not possess a neuromuscular blocking 
action. Ethopropazine, on the other hand, shows a neuromuscular 
blocking action in the rat. It is possible that one of the ways 
whereby ethopropazine relieves rigidity is through its peripheral 
skeletal muscular relaxant action.
It is the opinion of the writer that a depressant action on the 
cerebellum is probably one of the ways by which benzhexol relieves 
the rigidity of Parkinsonism.
In the cat, orphenadrine antagonises the neuromuscular block 
induced by suxamethonium. This suggests the possible use of
orphenadrine as an antidote to suxamethonium when the latter has 
caused complete and prolonged neuromuscular block in human subjects.
It is also suggested that orphenadrine may be of therapeutic value in 
the prevention of muscle pain after the administration of suxamethonrnmn.
 566.
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SUMMARY
CLINICAL ^t:d pharmacological studies
IN POST ENCSPHALITIC PARKINSONISM
Chapter I. General Introduction
This chapter deals mainly with the control of skeletal muscle
tone and the physiology of tremor* The clinical features and treat­
ment of Parkinsonism are also discussed.
Chapter II. Crises in Post-Sncephalitic Parkinsonism .
A study of 67 patients with post-encephalitic Parkinsonism
revealed three types of crises; they can be described as oculogyric,
sweating and breath-holding.
The clinical accompaniments of oculogyric and sweating crises are
described. Attention is drawn to the vasomotor changes which occur
during severe oculogyric and sweating crises and to changes in mood
during oculogyric crises.
The pathogenesis of the oculogyric crisis is . discussed. It is
suggested that ocular deviation is the consequence of a vestibulo-
ocular reflex in patients with brain stem lesions involving the
vestibular pathway. The emotional changes which accompany oculogyric
crises are probably the result of stimulation of the diencephalon.
The role of emotion in precipitating oculogyric crises is con­
firmed. When emotion is known to play a part, it is suggested that
the . mechanism includes a conditioned reflex. Alternatively it may be
that /
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that the onset of emotional disturbance sometimes permits activity in
the vestibulo-ocular reflex; activity which in the non-emotional state
is materially inhibited.
Chapter HI. Drug Therapy in the Crises of
Post-Sncephalitic Parkinsonism
The treatment of severe oculogyric and sweating crises in 11
patients with post-encephalitic Parkinsonism has been studied.
The value of 200 mg. sodium phenobarbitone given intramuscularly
or sodium amylobarbitone 200 to 300 mg. given orally was assessed.
Neither of thesefbrms of treatment affected the natural course of
crises when these were in the category classified as "severe".
A therapeutic trial was carried out to evaluate sodium pheno­
barbitone 150 mg. given intravenously and 30 mg. given intramuscularly
in severe crises, using injections of normal saline as the qontrol.
Relief was obtained in 20 to 40 minutes after these injections of the
barbiturate. Injections of normal saline were ineffective. It is
suggested that in severe crises sodium phenobarbitone injected intra­
venously is the treatment of choice. Although parenteral injections
of hyoscine hydrobromide is effective in controlling severe oculogyric
crises, the use of intravenous sodium phenobarbitone is to be preferred, 
The use of parenteral injections of atropine sulphate is not recom­
mended.
The prophylactic value of sodium phenytoin was determined in 3
patients suffering from severe oculogyric crises. This drug altered
the /
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the character of the oculogyric crisis but did not reduce its
frequency or severity.
The writer has no experience of oculogyric crises induced by
drugs of the phenothiazine series such as Perphenazine, but there
appears to be a prima facie case for the intravenous injection of
sodium phenobarbitone in this type of medical emergency.
Chapter IV» The Electroencephalogram in
Post-Encephalitic Parkinsonism
Eleotroenoephalographic study of $0 patients suffering from
post-encephalitic Parkinsonism showed that over half of them have low
voltage alpha rhythm (below 40 pv.)# It would appear that in post­
encephalitic Parkinsonism the phenomenon of low voltage E.E.C.’s is
most frequently seen in patients who are known to be liable to oculo­
gyric crises and in those who suffer from severe rigidity and who are
incidentally often bedfast.
There was a very high incidence of theta activity most prominent
frontally. The records of 9 patients were regarded as definitely
abnormal because of the presence of high voltage theta and delta
activity. Abnormal records were more common in patients who suffer
from severe rigidity. •
The E.E.Cr. during an oculogyric crisis has -the following charac­
teristics: anteriorly there are high voltage spike potentials, in the
other areas there is a general lowering of voltage, beta activity may
become /
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become more obvious.
Administration of 1*3 mg. of prostigmin intramuscularly had little
or no effect on the E.E.G.
Chapter V. Deformities in Post-encephalitic Parkinsonism
The deformities of the hand in post-encephalitic Parkinsonism have
been classified as Types I, II and III. Type I (main d^ccouchfip^
deformity) is the most common form.
Talipes equino varus deformity is the common deformity of the
foot in Parkinsonism.
Scoliotic deformity of the spine, especially of the cervical spine,
is common. The scoliosis is usually concave to the less rigid side.
The factors of importance in the pathogenesis of deformities
include; skeletal muscular weakness, rigidity and involuntaiy muscle
spasms. Muscle weakness is the most important factor. It is
emphasised that deformity is not due to the action of the rigid muscles
(as is commonly thought), but results from an uncounterbalanced action
of the stronger and less rigid muscles. The opposing weaker and more
rigid muscles are lengthened.as a result.
It is suggested that the effect of posture is probably the most
important factor responsible for dribbling of saliva.
The use of splints and lamb ’ s-wool in the management of some
types of deformities is discussed.
Chapter VI /
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Chapter VI. Assessment of Drug Therapy
in Parkinsonism
The relative therapeutic value of orphenadrine and "UK. 738"
(Sandoz) were studied by means of a double blind trial. Orphenadrine 
100 mg. thrice daily was found to be about three times as effective as
"UK. 738" 4 mg. t.d.s.
The methods of assessment of the efficacy of drug therapy in
Parkinsonism are reviewed and the value of objective measurements is
demonstrated. It can be said that the results of objective measure­
ments usually run roughly in parallel with an assessment of the
patient's condition as determined by the clinician - and especially
when the initial degree of disability is moderate.
By means of "acute" experiments it was shown that after oral
administration of orphenadrine, peak activity occurred in about two
hours whereas peak activity due to benzhexol occurred in two to three
hour's. It was not possible to demonstrate clearly defined peak activity
for the drug "UK. 738". Failure to carry out the objective tests at the
time of maximal activity of drugs is an important source of fallacy in
clinical trials designed to assess the relative merits of preparations
used to combat the disabilities associated with Parkinsonism.
Chapter VII. The sites and mode of action of
orphenadrine and other drugs used
for the relief of rigidity and muscle
weakness in Parkinsonism
Pharmacological /
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Pharmacological studies with orphenadrine show that it has a
definite neuromuscular blocking action in the frog and in the rat.
In the cat, however, the neuromuscular blocking action is very much less.
It is suggested that one of the ways by which orphenadrine reduces
Parkinsonian rigidity is through its peripheral skeletal muscular
relaxant property. The euphoric action noted in human subjects and
the peripheral skeletal muscular relaxant property contribute to the
favourable effect of this drug on the muscle weakness and easy fatigu­
ability in patients suffering from Parkinsonism.
Benzhexol and UK. 738 do not possess a neuromuscular blocking
action. Ethopropazine, on the other hand, shews a neuromuscular
blocking action in the rat. It is possible that one of the ways
whereby ethopropazine relieves rigidity is through its peripheral
skeletal muscular relaxant action.
It is the opinion of the writer that a depressant action on the
cerebellum is probably one of the ways by which benzhexol relieves
the rigidity of Parkinsonism.
In the cat, orphenadrine antagonises the neuromuscular block
induced by suxamethonium. This suggests the possible use of orphen­
adrine as an antidote to suxamethonium when the latter has caused
complete and prolonged neuromuscular block in human subjects. It is
also suggested that orphenadrine may be of therapeutic value in the
prevention of muscle pain after the administration of suxamethonium.
